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Letters 
Sally Provence’s autism 
work deserves mention 
The article on autism in the 
Summer 2004 issue brought 
back interesting memories. 
In 1953 I was on the pediatric 
house staff, and my first experi¬ 
ence with autism was in the 
family: a nephew who did not 
walk or talk at age 2, did not 
seem to relate to others, had 
odd and limited food prefer¬ 
ences and could spend much 
of his day sitting in the corner 
spinning toy tops. 
We asked Sally Provence of 
the Child Study Center to see 
him. She made the diagnosis of 
autism. Since his parents were 
busy with three other children 
and their work, etc., Sally sug¬ 
gested he live with his grandpar¬ 
ents for a year. They were retired 
and could give him theirfull 
attention. Within the year the 
boy was relating to others and 
talking. Today he lives alone and 
holds a responsible technical 
job that requires some contact 
with others. 
Naturally the family gives 
full credit to Dr. Provence for 
this success. She deserves 
recognition for her insight into 
the psychological problems 
of children. 
Ira Gabrielson, m.d., hs '53 
Drexel University 
College of Medicine 
Philadelphia, Pa. 
Rolling tells a story 
that needs to be heard 
Thank you so much for including 
an article about Cretchen 
Berland’s documentary Rolling 
[“Life on Wheels,” Summer 
2004]. I had heard a great deal 
about this film and became 
convinced even more that this 
was a "must-see.” I, too, use a 
wheelchair; many of the experi¬ 
ences portrayed seemed to have 
mirrored my own quite closely. 
I was especially intrigued 
that Dr. Berland chose subjects 
who were not "down and out,” 
but rather were people who 
had had and continue to have 
enriching lives. I hope that I 
have been successful in convinc¬ 
ing the chair of my department 
that Dr. Berland’s work is some¬ 
thing that should be seen by 
the rest of the faculty. I am sure 
that by seeing Rolling, aware¬ 
ness of and sensitivity to the 
multitude of experiences of 
others in wheelchairs will be 
greatly enhanced. 
Cindy R. Miller, m.d. 
Section Chief, Pediatric Radiology 
Yale-New Haven Hospital 
First among surgeons, 
last in the spotlight 
I noted the letter in the Summer 
2004 issue of Yale Medicine 
about MaxTaffel. I was a resident 
in surgery at Yale from 1960 
through 1966, and during that 
period had an occasion to visit 
MaxTaffel at his home one 
evening along with several of my 
resident colleagues. Although he 
rarely discussed his past, we did 
hear a bit of his World War II 
experiences while at One Tree Hill 
in New Zealand performing sur¬ 
gery for injured soldiers from the 
South Pacific campaigns. Most 
of the evening’s discussion was 
about various surgical subjects. 
At one point I walked past a 
small room that contained a 
desk, books, lots of papers strewn 
here and there and a few framed 
things on its walls. One of the 
framed objects was a certificate 
from the American Board of 
Surgery. Looking closer, I saw that 
it was certificate No. 1! I asked 
Dr. Taffel about this and he told 
us that four young surgeons 
journeyed to Philadelphia in 1937 
to take the very first American 
Board of Surgery examination. 
Dr.Taffel was awarded the first 
certificate. After completing the 
two-year chief residency in 1966, 
I was certified by the American 
Board of Surgery in 1967 and was 
awarded certificate No. 14899 (a 
less auspicious number than Dr. 
Taffel’s, but I was pleased!). I feel 
certain that none of us would 
have heard about this from Dr. 
Taffel had I not stumbled on the 
certificate. I knew him to be a 
humble man, a dedicated teacher 
and a meticulous surgeon, and it 
seems fitting that he was the first 
to pass the American Board of 
Surgery examination. 
A. Griswold Bevin, M.D. ’60, HS '66 
Chapel Hill, N.C. 
Suspicions about hair dye 
are confirmed 
I read with great personal inter¬ 
est the article about Dr. Zheng, 
"Increased Risk of Non-Hodgkin's 
Lymphoma Linked to Hair Dye” 
[Summer 2004]. 
My late sister did use dark 
hair dye for years, and I found 
this article about Dr. Zheng’s 
research interesting, in that 
work is still being done on this 
possible relationship. I think 
that this research is important, 
taking into account the large 
number of women who do use 
hair dyes. 
William J. Waskowitz, m.d. '57 
New Britain, Conn. 
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From the Editor 
Waiting it out in Haiti 
At this writing at the end of September, Haiti has just endured 
another storm and io days of devastation following Hurricane 
Jeanne. Fifteen hundred people have died in the flooding 
and mudslides that swept the coastal region near Gona'ives, 
the country’s second-largest city. Today’s Miami Herald tells 
the deeply unsettling story of a mother who was forced to 
choose between rescuing her 6-year-old son and holding on 
to her 4-year-old daughter as she struggled to escape the 
rising flood waters. Now she is worrying about the child who 
survived. Will enough food arrive to keep the girl nourished? 
Will cholera and other diseases spare her? 
Public health in Haiti and the impoverished country’s 
long history of suffering are at the heart of this issue’s 
cover story (“A Film to Finish,” page 18) by alumna Amelia 
SECOND OPINION BY SIDNEY HARRIS 
Shaw, m.p.h. ’03. Shaw had to leave Haiti during an earlier 
moment of tumult this year—the riots preceding the ouster 
of President Jean-Bertrand Aristide in February—but she 
returned in July to continue work on the documentary film 
she is making about the impact of aids in Haiti. Two 
months later, she was waiting out a different kind of storm 
and glad to be back, despite the element of danger. As her 
Haitian colleague Liony Accelus says, “Our film is really 
going to change the way Haitians think about treating aids.” 
As you will read, they risked their lives to make it. 
Managing Editor John Curtis happened upon Shaw’s 
story last winter during a conversation with faculty member 
Kaveh Khoshnood, m.p.h. ’89, ph.d. ’95, and has been in 
contact with her ever since. With the article written and laid 
out, we listened to the hurricane reports from Port-au-Prince 
in September and noted one voice with special interest. 
Shaw, who had worked as a summer intern at National Public 
Radio, was now covering the hurricane’s aftermath for npr. 
In an e-mail in late September, she reported that the people 
in her story—Accelus, Moliere Jean and Uncle Big—all sur¬ 
vived the storms. 
Shaw’s article shows one way in which Yale has an 
impact on the world of health and medicine. We’re impressed 
by her reporting and writing and proud to have her byline 
in Yale Medicine. The best epilogue to her story would be a 
healthier Haiti. 
September’s news also brought a happy footnote to 
another celluloid story. Gretchen K. Berland, m.d., an assist¬ 
ant professor of medicine who is also a documentary film¬ 
maker, was awarded a $500,000 “genius grant” from the 
John D. and Catherine T. Mac Arthur Foundation. The five- 
year, no-strings-attached fellowship will support her work on 
projects similar to Rolling, in which she provided cameras to 
three people who use wheelchairs and created a compelling 
portrait of their everyday lives. Rolling was the subject of a 
feature article (“Life on Wheels”) in the Summer 2004 issue 
of Yale Medicine. 
Michael Fitzsousa 
michael.fitzsousa@yale.edu 
chronicle news from cedar street 
New travel restrictions 
bar Cuba rotations 
A program that allowed Yale residents 
to observe the island nation’s health 
care system ends. 
For each of the past four years, up to 
four residents at Yale-New Haven 
Hospital have spent six weeks studying 
health care in Cuba. Those rotations 
are unlike other foreign rotations that 
take residents to more than a dozen 
countries, said Michele Barry, m.d., hs 
’77, co-director of the Yale/Johnson & 
Johnson Physician Scholars in Inter¬ 
national Health program, which sends 
40 Yale residents abroad each year. 
“It’s a little bit different than our 
other rotations in underserved areas, 
where they desperately need doctors,” 
Barry said. Cuba has no shortage of 
physicians and Barry sends residents 
to Cuba, she said, to observe the Cuban 
approach to primary care. “They have 
a physician assigned to an entire 
neighborhood. The physician takes 
ownership of the neighborhood’s 
health and does outreach in a way 
that we have never been very effective 
at,” Barry said. 
That exposure to Cuban health care 
practices is no longer possible because 
of new restrictions on travel to Cuba 
that tire U.S. Department of the Treasury 
put into effect on June 30. Among other 
limits on travel by American citizens, 
students must stay in Cuba for at least 
10 weeks, too long for hospital resi¬ 
dents, Barry said. 
The rotations in Cuba were organ¬ 
ized through Medical Education Cooper¬ 
ation with Cuba (medicc), a nonprofit 
organization that has sent almost 900 
students from more than 100 medical, 
nursing and public health schools to 
Cuba since 1997. “These regulations 
will make it very difficult for health sci¬ 
ences students to study in Cuba, since 
most academic institutions do not have 
the resources to organize a course of 10 
weeks,” said medicc’s director, Diane 
Appelbaum, R.N., m.s. 
The new guidelines, she said, restrict 
medicc in several ways. For one, it’s 
not an academic institution, the only 
entity now allowed to send faculty, 
staff or students to Cuba. The new 
guidelines also require that students 
wishing to study in Cuba must do so 
as part of accredited courses in the 
institution in which they are enrolled, 
rather than under the auspices of 
other organizations or programs. And 
the courses medicc offers in Cuba 
only last between two and six weeks. 
For most of Fidel Castro’s reign, 
which began in 1959, the United States 
has restricted travel by U.S. citizens 
to Cuba. Typically only scholars, jour¬ 
nalists and Cuban-Americans with rela¬ 
tives on the island have been allowed 
to travel there. The latest restrictions 
are based on recommendations by tire 
Commission for Assistance to a Free 
Cuba, which President Bush created 
last fall to find ways to move Cuba 
toward democracy. The new rules do 
not affect graduate students pursuing 
independent research. 
Barry sees a political motive for 
the new rules—a desire to garner sup¬ 
port from conservative Cuban exiles 
in Florida in the presidential election. 
And she believes the restrictions are 
counterproductive. “I only see good 
things coming out of the exchange,” 
Barry said. I do not think a country 
like the United States should foster 
censorship and thus prevent an 
exchange of ideas and cultures which 
could effectively promulgate democ¬ 
racy in Cuba.” 
—John Curtis 
Neurobiologist Hockfield 
leaves provost post 
for presidency of mit 
When she embarked on her career 
as a neurobiologist in the early 1980s, 
Yale Provost Susan Hockfield, ph.d., 
never imagined that her academic path 
woidd take her from running a labora¬ 
tory to running a university. She devoted 
herself to research, devising novel uses 
of monoclonal antibody technology 
and discovering a gene that may play 
a role in brain cancer. “Being a scien¬ 
tist is a wonderful, wonderful career,” 
she said in September in her office 
on Hillhouse Avenue. “I had no aspira¬ 
tions to move into positions of aca¬ 
demic leadership.” 
But early on her administrative skills 
emerged. After she came to Yale in 
1985, she ran a summer program in 
neurobiology at the Cold Spring Harbor 
Laboratory on Long Island, where she 
had previously worked. At Yale, Hock¬ 
field, the William Edward Gilbert 
Professor of Neurobiology, served as 
director of graduate studies in the 
medical school’s Section of Neurobiology 
and on the graduate school’s executive 
committee. In 1998 she was named 
dean of the Graduate School of Arts 
and Sciences (the first member of the 
medical school faculty appointed to 
that post), and in January 2003, she 
became provost when her predecessor, 
Alison Richard, ph.d., was chosen to 
lead Cambridge University. 
As provost she has worked to advance 
science, medicine and engineering 
at Yale—initiatives that include a $500 
million investment in facilities. She 
has also fomented interdisciplinary col¬ 
laborations throughout the university. 
Neurobiologist Susan Hockfield is leaving 
Yale after almost two decades to become the 
president of the Massachusetts Institute 
of Technology. 
In August the Massachusetts Insti¬ 
tute of Technology (mit) announced 
that Hockfield would become its 16th 
president, the first woman and the first 
life scientist so named. She will move 
to Cambridge, Mass., with her husband, t 
Thomas N. Byrne Jr., m.d., hs ’81, 
z 
clinical professor of neurology, neuro¬ 
surgery and medicine at the medical 
school, and their daughter, Elizabeth, 
13, in December. 
At mit she replaces Charles M. 
Vest, ph.d., who announced his 
retirement last year after 14 years lead¬ 
ing the school. (In October, President 
Richard C. Levin appointed Deputy 
Provost Andrew D. Hamilton, ph.d., 
to succeed Hockfield.) 
"mit is an inspiring place, populated 
by inspiring people,” Hockfield said. 
“From my first conversations in the 
search process, the Institute’s central 
themes—the pursuit of truth, integrity 
and the great meritocracy—have reso¬ 
nated with my own core values.” 
Although mit, with its strong 
reputation in engineering, has never 
before named a biological scientist 
as its leader, Hockfield said that the 
school’s grants and contracts sup¬ 
porting research in the life sciences, 
largely from the National Institutes 
of Health, have grown at a remark¬ 
able rate over the last decade. And 
the school is constructing a three- 
building complex devoted to neuro¬ 
science. With its strengths in 
engineering, the physical sciences 
and the biological sciences, she 
believes mit is well-positioned for 
collaborative, interdisciplinary 
science. “I am hoping to do what I 
can to encourage bridge-building 
among these disciplines,” she said. 
She also plans to continue the prac¬ 
tice of past mit presidents who have 
served as advocates for sound national 
policies on science, technology and 
higher education. (The school main¬ 
tains an office in Washington, which 
she will visit once a month.) One of 
her main concerns is that American 
students are falling behind their peers 
around the world in math and science. 
She’d like to see improvement in math 
and science education from kinder¬ 
garten through high school, to engage 
and inspire students. “Almost every 
child gets a thrill from building and 
inventing things that work,” she said. 
“Math and science in our schools 
can do a better job in tapping and 
encouraging that creative energy.” 
For now, though, her attention is 
on mit. “My overarching goal is to 
help mit to be an even greater mit,” 
she said. “I hope that mit is increas¬ 
ingly seen as among the very best 
places in the world for people—faculty, 
staff and students—who are enor¬ 
mously inspired by innovation in both 
teaching and research.” 
-J.C. 
chronicle 
Yale cme gets a new lease 
on lifelong learning as it 
adapts to the Internet age 
Nearly 25 years ago, when Continuing 
Medical Education (cme) at Yale was 
created to develop programs that pres¬ 
ent the most current information and 
research to a broad range of medical 
professionals, the practice of medicine 
was very different. Advances in medi¬ 
cine did not occur at such a rapid pace, 
managed care had not permeated the 
medical landscape and 15-minute office 
visits were not yet the norm. 
Today, as physicians try to keep 
up with their profession in a changed 
medical environment, Yale cme is 
overhauling its continuing education 
activities, which include courses and 
conferences, regularly scheduled grand 
rounds and two newsletters (The 
Medical Letter and Diabetes Newsletter) 
that include tests on their content for 
cme credit. Its goal is to build cme at 
Yale into an educational clearinghouse 
that acts not only as a resource, but as 
the facilitator of new information. 
“One of the challenges in the envi¬ 
ronment is that physicians, because 
of managed care, find it increasingly 
difficult to leave the practice and go to 
a meeting,” said Lawrence S. Cohen, 
m.d., hs ’65, the Ebenezer K. Hunt 
Professor of Medicine, special advisor 
to the dean and chair of the cme 
Faculty Advisory Committee. In 
response, Yale cme is taking advantage 
of the Internet to streamline many of 
its activities. A revamped website allows 
participants to register for conferences 
online and access The Medical Letter 
and its corresponding exams at their 
convenience. (The Diabetes Newsletter 
will be available online sometime next 
year). In addition, physicians will be 
able to take online courses and exami¬ 
nations for cme credit within the next 
few months. 
“On a practical basis, we are formal¬ 
izing activities that have been ongoing 
at the School of Medicine, such as 
grand rounds and tumor boards (which 
meet to discuss cancer cases), and 
making them easily accessible to cme 
for credit,” said Cohen. "Most impor¬ 
tantly, we are uncovering, not surpris¬ 
ingly, a wealth of investigators/educators 
who are in the process of putting 
together programs appropriate for cme 
at Yale.” 
A major issue is compliance with 
guidelines set by the Accreditation 
Council for Continuing Medical Educa¬ 
tion (accme), including standards for 
commercial support that outline the 
steps that must be taken when accept¬ 
ing financial support from sources 
such as drug companies and device 
manufacturers. Two years ago the pro¬ 
gram’s accreditation was at risk over 
shortcomings in its record keeping and 
compliance with accme rules. Then 
Mary D. Marcarelli became director of 
cme, which is now up-to-date on 
accme standards and has trained 
almost 50 departmental coordinators 
to ensure compliance. In July the Yale 
cme program learned it received full 
accreditation from the accme through 
June 2008. 
Plans under consideration for the 
future include video coverage of 
grand rounds on the Web; a lecture 
series focusing on research that can 
be directly translated to patient care; 
and the production of a cme program 
through the cable channel Discovery 
Health to offer cme credit to those 
unable to travel to conferences. The 
next few years may also usher in 
the use of handheld personal digital 
assistants to deliver cme course 
materials and the revival of the Mini- 
Med School Program, begun in 1995, 
which presented a series of lectures 
to the general public. 
cme at Yale has become a high- 
profile project, and will continue to 
evolve as new technologies, research 
and treatments become available. 
“Medicine moves forward,” said 
Marcarelli. “We’re moving with it.” 
—Jill Max 
Yale CME can be found online at cme.yale.edu/. 
A conservative “hit list” 
targets aids researchers, 
including some at Yale 
In the fall of 2003 Margaret R. Weeks, 
ph.d., got a call from her project offi¬ 
cer at the National Institute on Drug 
Abuse (nida). Weeks, an anthropolo¬ 
gist and the associate director of the 
Institute for Community Research in 
Hartford could hear the stress in her 
project officer’s voice. The National 
Institutes of Health (nih) needed an 
immediate report on her study that 
recruits drug users to spread a mes¬ 
sage about how to prevent hiv/aids. 
“We were two and a half years into 
a four-year study. We didn't have find¬ 
ings,” Weeks told the audience at aids 
Science Day in April, describing her 
response. She said, ‘Give me anything 
you can.’ ” 
Weeks and her project, which is 
affiliated with the Center for Interdis¬ 
ciplinary Research on aids based at 
; the School of Public Health, were on 
what came to be known as the “hit list” 
of about 200 federally funded studies 
deemed by the conservative Traditional 
Values Coalition to be “prurient,” 
“smarmy” and having “little or no bear¬ 
ing on public health.” The list found 
its way to Congress, which demanded 
explanations. Elias A. Zerhouni, m.d., 
director of the nih, looked into the 
studies and went back to Congress with 
a vigorous defense. 
The project Weeks is leading recruits 
active drug users and trains them to 
become peer health advocates who can 
introduce harm reduction measures 
into drug use sites. Weeks was one of 
four panelists at aids Science Day to 
discuss the implications of this list. 
Michael H. Merson, m.d., dean 
of public health and moderator of the 
panel, said the list made him think 
back to the 1950s and another politi¬ 
cian with a list. “As someone who has 
his name on this list, I immediately 
recalled the words of Senator Joseph 
McCarthy,” he said. Merson appeared 
on the list as principal investigator 
of studies on drug use in high-risk set¬ 
tings and aids in China. 
Panelist Judith Auerbach, vice presi¬ 
dent for public policy at the American 
Foundation for aids Research (amfAR), 
placed the “hit list” in the context of 
other assaults on science. She noted 
that the Union of Concerned Scientists 
issued a report in February that cited 
examples of what it called the adminis¬ 
tration’s distortion of science, and scores 
of scientists, including 20 Nobel lau¬ 
reates, issued a statement accusing the 
administration of misrepresenting 
scientific findings. 
Studies on air pollution, mercury 
emissions, lead in water and global 
warming—which affect key industrial 
constituents of the Bush administra¬ 
tion—have been questioned, Auerbach 
said. Religious views have dominated 
discussion of condom use, sex and the 
sale of contraceptives over the counter. 
“All of this misuse or misinterpreta¬ 
tion of science is happening in a very 
political context,” Auerbach said. “The 
goal of the attacks is to disallow certain 
kinds of research.” 
“Some of what is going on is not 
entirely new,” said Kevin Cranston, 
m.div., acting director of the hiv/aids 
bureau at the Massachusetts Department 
of Public Health, “even if in a matter 
of degree it is entirely unprecedented.” 
Ana Oliveira, executive director of 
Gay Men’s Health Crisis in New York, 
said organizations in Washington and 
San Francisco have undergone audits 
of their grant funding. “The kind of 
threat and intimidation an audit repre¬ 
sents is unbelievable. It diverts pre¬ 
cious time and resources.” 
Indeed, Weeks said her entire office 
mobilized to gather information for the 
nih. “Everyone stopped what they were 
doing and helped,” she said. Apart from 
the waste of time and energy, Weeks 
said, targeting individual projects and 
scientists has the effect of chilling stud¬ 
ies of controversial topics. “We absolutely 
cannot use this as a reason to shy away 
from this research,” she said. 
—John Curtis 
YALE JOINS DIABETES TRIAL 
The School of Medicine has joined 11 other 
medical centers in a national study that will 
compare three treatments for type 2 dia¬ 
betes in children and teenagers. The study is 
the first clinical trial to look at the impact of 
intensive lifestyle change designed to lower 
weight by cutting calories and increasing 
exercise. It is also the first trial sponsored 
by the National Institute of Diabetes and 
Digestive and Kidney Diseases to focus on 
type 2 diabetes in youth. 
The five-year trial will look at how each 
treatment option, including drugs currently 
used in adults, controls blood glucose levels 
in younger patients. It will also evaluate 
safety and the effects of treatments on 
insulin production, insulin resistance, body 
composition, nutrition, physical fitness and 
risk factors for disease. 
The principal investigator at Yale is Sonia 
Caprio, m.d., associate professor of pediatrics 
(endocrinology). 
—J.C. 
EYEWITNESS ACCOUNTS FLAWED 
Soldiers engaged in survival training had 
trouble identifying people they encountered 
during threatening and stressful events, 
according to a Yale study published this 
Spring in the International Journal of Law 
and Psychiatry. 
“Contrary to the popular concept that 
most people would never forget the face 
of a clearly seen individual who had physi¬ 
cally confronted them and threatened them 
for more than 30 minutes, a large number 
of subjects in this study were unable to 
correctly identify their perpetrator,” said 
Charles A. Morgan ill, m.d., associate clinical 
professor of psychiatry. 
Morgan studied more than 500 soldiers 
who were subjected to stress modeled 
after the experiences of prisoners of war. For 
48 hours prior to questioning, they were 
deprived of food and sleep. Asked to identify 
their guard and interrogator a day later, 
those who experienced less stressful interro¬ 
gations had better recognition. 
“The present data have a number of 
implications for law enforcement personnel, 
mental health professionals, physicians, 
attorneys and judges,” Morgan said. 
—J.C. 
8 Rounds MEDICINE AND HEALTH AT YALE 
Quickening the pace 
from bench to bedside 
A new program speeds laboratory 
findings into the clinic, cutting 
years from the process. 
Just eight months after scientists in a 
lab on Cedar Street devised a new 
approach for treating ovarian cancer, 
clinical trials began in June at Yale’s 
gynecologic oncology clinic a block 
away on Howard Avenue. The experi¬ 
mental protocol is among four clinical 
trials under way in the Discovery to 
Cure program—an informal collabo¬ 
ration that began in the late 1990s and 
took on its new name in June. The pro¬ 
gram is designed to speed progress in 
detecting and treating women’s repro¬ 
ductive cancers through an unusual 
alliance of basic researchers, clinical 
investigators and nurses. The clini¬ 
cians report directly back to the labora¬ 
tory scientists, who incorporate findings 
into planning for new research. 
The latest study uses the anticancer 
drug phenoxodiol to sensitize ovarian 
cancer cells before chemotherapy. 
Phenoxodiol, developed in Australia for 
possible use as a treatment for cancer 
and cardiovascular disease and as an 
anti-inflammatory, was among about 
200 compounds screened for their anti¬ 
cancer properties by Gil Mor, m.d., 
ph.d., an associate professor of obstet¬ 
rics, gynecology and reproductive 
sciences, and his team. Phenoxodiol 
attacks a problem common in cancer 
cells: normal cell death is blocked, 
allowing cells to proliferate and form 
tumors. The drug, which affects 
intracellular signaling, helps activate 
caspases, the enzymes that regulate 
cell death. Mor said the intravenous 
treatment renders the cancer cells up 
to 100 times more vulnerable to the 
chemotherapy drugs cisplatin and 
paclitaxel. This sensitization allows 
doctors to prescribe lower doses of 
chemotherapy, reducing the damage 
to healthy cells that can cause debili¬ 
tating side effects. 
“Our new approach was not to 
develop new cytotoxic drugs but to 
find something specific that will 
remove those blockers [to cell death] 
in the cancer cell without affecting 
normal cells,” said Mor. 
Mor is encouraged by how quickly 
discoveries about molecular pathways 
are being tested in patient trials. “All 
these findings are immediately brought 
to the clinic,” he said. “This is quite 
unusual. Findings in the lab can take 
years to get to the clinic.” 
Once his group developed its 
therapy, Mor said, it took about eight 
months to gain approval from the 
medical school’s institutional review 
board, the Human Investigation 
Committee, and then recruit 40 
patient volunteers to take part in a 
combined Phase I/Phase 11 trial 
that tests both safety and effective¬ 
ness. Mor said the researchers save 
time because lab investigators have 
immediate access to tissue samples 
from cancer patients and a clinical 
population that allows them to launch 
a trial quickly. In one instance in 
I999- he noted, a basic science lab 
without close ties to a clinic couldn’t 
get an ovarian cancer drug into 
clinical trials until 2003. 
“The time cut is years,” said Mor’s 
clinical colleague, Thomas J. Rutherford, 
ph.d., m.d., fw ’94, associate profes¬ 
sor of obstetrics and gynecology. 
Rutherford said the researchers learn 
not only from each other but also 
from others on the team, including 
nurses, who have insights into man¬ 
aging clinical problems. “If you’re 
willing to talk and listen—and I’d say 
listening is most important—there’s 
a tremendous amount of information 
people will give you.” 
The Discovery to Cure program 
sponsors research on four gynecologi¬ 
cal cancers: ovarian, cervical, uterine 
and breast. 
Of these cancers, ovarian cancer 
poses a particularly daunting problem, 
because it is rarely discovered in its 
early stages. When diagnosed in the 
advanced stages, the five-year survival 
rate ranges from 20 to 40 percent. Mor 
and Rutherford are working to develop 
a blood test to detect the cancer early, 
collaborating with Peter E. Schwartz, 
m.d., hs ’70, the John Slade Ely Profes¬ 
sor of Obstetrics and Gynecology. 
Rutherford is optimistic. “We have 
identified what we think to be protein 
markers for early ovarian cancer,” he 
said. “If it proves to be true, it will be 
a good thing.” 
—Cathy Shufro 
Study suggests marijuana 
induces temporary 
schizophrenia-like effects 
Anyone who inhaled in the 1960s 
can recall the effects of cannabis— 
euphoria, paranoia, changes in per¬ 
ception, an inability to concentrate 
and short-term memory failures. 
A laboratory-controlled study by Yale 
scientists published in the journal 
Neuropsychopharmacology last summer 
has found that delta-9-tetrahydro- 
cannabinol (thc), the active ingredient 
of cannabis, transiently induced a 
range of schizophrenia-like effects in 
healthy people. And in the past year, 
three large epidemiological studies 
have supported the long-suggested 
link between cannabis use and a risk 
of schizophrenia. 
“No one really knew how cannabis 
worked until about 10 years ago,” said 
D. Cyril D’Souza, m.d., associate pro¬ 
fessor of psychiatry and lead author of 
the study. “The discovery of cannabi- 
noid receptors and several other 
advances in the basic pharmacology 
of the cannabinoid receptor system 
have renewed interest in that associa¬ 
tion between cannabis and psychosis.” 
Because animal models of psychosis 
have significant limitations, scientists 
have used drugs to induce transient 
psychosis in humans. “Perhaps by 
studying drug-induced psychosis, that 
might lead us to a better understand¬ 
ing of psychoses in general and schizo¬ 
phrenia in particular,” D’Souza said, 
adding that this is the first study, to his 
knowledge, that has applied measures 
for schizophrenia to study the effects 
of thc in healthy people screened for 
any vulnerability to schizophrenia. 
In the study, thc induced tempo¬ 
rary responses similar to the three 
domains of schizophrenia: positive 
symptoms such as paranoia and disor¬ 
ganization of thinking, negative 
symptoms such as blunted affect and 
reduced spontaneity, and cognitive 
deficits such as memory lapses. On 
three test days at least a week apart, the 
researchers administered thc to 22 
test subjects—including Yale medical 
students and undergraduates and other 
volunteers. All had used cannabis pre¬ 
viously but none had ever been diag¬ 
nosed with cannabis abuse disorder or 
a major psychiatric disorder. On each 
test day the subjects received one of 
three injections, a placebo or a low or 
medium dose of thc, before taking a 
series of behavioral and cognitive tests. 
The subjects reported how they 
felt, using a scale of feeling states 
associated with cannabis effects—high, 
calm, relaxed, tired, anxious and 
panicked. Some subjects experienced 
schizophrenia-like symptoms lasting 
between half an hour and an hour. In 
addition, thc induced euphoria and 
raised levels of cortisol and prolactin, 
biological markers for activity of 
cannabinoid receptors. 
The tests relied on self-reporting 
and the observations of trained 
researchers, which at times differed 
from those of the subjects. “We had a 
subject who refused to complete some 
of the cognitive testing because she 
was convinced we were trying to trick 
her,” said D’Souza. “But when we asked 
if she felt paranoid, she said ‘no.’ ” 
Follow-up months after the study 
revealed no side effects among 
participants. 
Ultimately, D’Souza said, the 
research may provide clues about the 
pathophysiology of psychotic disor¬ 
ders. “By understanding how cannabis 
produces psychosis, that may help us 
understand what goes wrong in schizo¬ 
phrenia,” he said. 
—John Curtis 
HICH-FAT DIET RAISES CANCER RISK 
It’s long been a tenet of good nutrition that 
too much fat and animal protein can clog 
the arteries and raise cholesterol. A new 
study by Yale researchers found that such a 
diet also increases the risk of non-Hodgkin’s 
lymphoma (nhl), a cancer that attacks the 
lymphatic system. 
The study reaffirmed another mantra of 
dieticians and nutritionists—consumption 
of high-fiber fruits and vegetables such as 
broccoli, lettuce, tomatoes and cauliflower is 
associated with a lower risk of nhl. 
“An association between dietary intake 
and nhl is biologically plausible because 
diets high in protein and fat may lead to 
altered immunity, resulting in increased 
risk of nhl,”said Tongzhang Zheng, sc.D., 
associate professor of epidemiology (envi¬ 
ronmental health). Zheng was the principal 
investigator of the study of Connecticut 
women, which was published in the Ameri¬ 
can Journal of Epidemiology earlier this year. 
“The antioxidants found in vegetables and 
fruits may result in a reduced risk of about 
40 percent.” 
—J.C. 
HIGH VOLUME NOT ALWAYS BEST 
The conventional wisdom suggests that only 
hospitals that perform at least 400 angio¬ 
plasties a year should be allowed to offer the 
procedure. A higher volume, the reasoning 
goes, leads to better outcomes. 
But researchers at Yale and the University 
of Pennsylvania challenge that view in a 
study published in the Journal of the 
American College of Cardiology. The study of 
362,748 angioplasties performed between 
1998 and 2000 found comparable outcomes 
in medium- to very-high-volume hospitals. 
Yet some low-volume hospitals provided 
excellent care while some high-volume hos¬ 
pitals did not, said Saif S. Rathore, m.p.h., a 
lecturer in cardiovascular medicine, and one 
of the study’s authors. 
“If you accept volume [as the only stan¬ 
dard],” Rathore said, “you essentially consign 
all low-volume hospitals to being of poor 
quality and you give all high-volume hospi¬ 
tals a pass on quality. What we ought to be 
doing is identifying those hospitals or doc¬ 
tors that provide better quality of care.” 
—J.C. 
Findings from the bench 
In the kitchen, a way 
to treat cystic fibrosis? 
A spice may protect a mutant, but 
functional, protein from the cell’s 
quality control system. 
A possible compound for the treatment 
of cystic fibrosis may be as close as the 
kitchen spice rack. Researchers at Yale 
and the University of Toronto reported 
recently in Science that curcumin, an 
element of the spice turmeric, helps 
correct a protein defect associated with 
this genetic disease. 
Through a mechanism that is not 
completely understood, curcumin 
protects a mutant, yet functional, pro¬ 
tein from the cell’s quality control 
machinery. Cystic fibrosis stems from 
a defect in this protein, the cystic 
fibrosis transmembrane conductance 
regulator (cftr), which moves chloride 
across cellular membranes to maintain 
a balance of ions and water. When that 
balance is disrupted, mucous becomes 
a sludge that clogs respiratory and 
digestive pathways, ultimately causing 
infections. Most people with cystic 
fibrosis do not live past the age of 30. 
The most common form of cystic 
fibrosis is called delta F508, and is due 
to the deletion of a single amino acid 
from the sequence of cftr. Although 
the protein is still able to mitigate most 
cystic fibrosis symptoms, cellular qual¬ 
ity control machinery tags it for degra¬ 
dation, because without the amino acid 
it cannot fold properly. “Even though 
[it] works, it gets thrown out,” said 
Michael J. Caplan, m.d. ’87, ph.d. ’87, 
professor of cellular and molecular 
physiology and cell biology and the 
principal investigator of the study. 
Working with Marie E. Egan, m.d., 
associate professor of pediatrics and 
cellular and molecular physiology, 
and others, he may have found a way 
to subvert quality control. 
As part of the quality control process, 
some chaperone proteins bind to cal¬ 
cium, commonly found in the endo¬ 
plasmic reticulum (ER). To help cftr 
evade quality control, Caplan and Egan 
sought compounds that would disable 
the chaperones by depleting calcium 
stores in the ER. Previously identified 
compounds blocked calcium pump 
action in the ER, but proved to be toxic. 
A search through the literature turned 
up curcumin, a weak inhibitor of ER 
calcium pumps. 
Remarkably, it worked—and well, 
at least in tissue culture and mouse 
models. The researchers noted a 
restoration of ion transport in mice 
that received curcumin, and in cell 
lines bathed in curcumin, a fraction 
of the mutated protein migrated to 
the cell membrane and restored a sig¬ 
nificant level of ion transport function. 
Given these findings, Egan and 
Caplan plan to collaborate with the 
Cystic Fibrosis Foundation and Seer 
Pharmaceuticals in a clinical trial to 
assess curcumin’s potency in patients 
with cystic fibrosis. However, Egan 
stresses that more research is needed: 
“What it does to people versus what it 
does in mice may be very different. We 
first need to get a better handle on the 
mechanism,” Egan said. To that end, 
Egan and Caplan are trying to determine 
whether curcumin blocks calcium pump 
action or whether it binds to cftr to 
help stabilize it. They are also investigat¬ 
ing whether the active compound is cur¬ 
cumin or a metabolite of curcumin. If 
the data from both the clinical and basic 
research investigations prove its efficacy, 
curcumin may be the first cystic fibrosis 
drug that treats the cause of the disease 
rather than just the symptoms. 
—Kara Nyberg 
PICTURING AN ENZYMATIC RNA 
Molecular players 
shown to affect nerve fibers 
in multiple sclerosis 
Until recently, researchers knew very 
little about the neural molecules associ¬ 
ated with secondary progressive multi¬ 
ple sclerosis (MS), a nerve-degenerating 
autoimmune disease that afflicts almost 
3 million people worldwide. Scientists 
had typically studied the disease in 
mouse models, but Stephen G. Waxman, 
ph.d., m.d., professor of neurology, 
pharmacology and neurobiology, and his 
colleagues looked for clues at the 
source—postmortem spinal cord tissue 
from MS patients. In a study published 
in May in the Proceedings of the National 
Academy of Sciences, Waxmarfs team and 
researchers from the VA Connecticut 
Healthcare System in West Haven and 
University College London described 
the first observations in humans of key 
molecules that contribute to nerve fiber 
degeneration. These molecules, though 
produced to compensate for a short in 
the neural signaling circuit, ultimately— 
and ironically—initiate a series of events 
that cause nerve damage. 
To relay signals to other neurons, 
healthy nerve cells are studded with 
sodium channels that open in succes¬ 
sion along the nerve fiber to allow in 
surges of sodium when neurons become 
activated. To help propagate this signal, 
an outer coating of myelin insulates the 
nerve cells. But in those with MS, the 
myelin breaks down, causing a short in 
the signal circuit. Waxman and col¬ 
leagues found that MS neurons compen¬ 
sate for this defect by overexpressing the 
sodium channel Navi .6—normally pres¬ 
ent only at small regions called nodes 
of Ranvier—all along the nerve fiber to 
improve the signal relay. However, 
the atypical Navi.6 expression appears 
to cause more harm than good, as it 
coincides with regions of axon injury. 
There are at least io types of sodium 
channels in human nerve cells, each 
with a different task, Waxman explained. 
“It’s as if you have io different types of 
batteries. Only the right batteries will 
make a device work properly.” In this 
case, the cells are using the wrong bat¬ 
teries in the wrong place. The 
researchers observed that another pro¬ 
tein called ncx, a sodium-calcium 
exchanger, is expressed near Navi.6 
sites. The aberrant placement and over¬ 
abundance of Navi .6 causes too much 
sodium to enter the cells. Overexpres¬ 
sion of ncx adjacent to Navi.6 chan¬ 
nels presumably flushes out the excess 
sodium and replaces it with calcium. 
But too much calcium provokes molecu¬ 
lar chain reactions, sending cells into 
activity overdrive that results in cellular 
damage and disease symptoms. 
In a field long dominated by 
immunobiologists, Waxman is enthusi¬ 
astic about the contributions to the 
understanding of MS that he and his 
neurobiologist colleagues are making. 
“We are chipping away at the disease 
molecule by molecule, and we are 
understanding more about the disease 
process," he said. Based on his research, 
Waxman is eager to try targeting the 
neurons for treatment; all approved M S 
therapies currently target the immune 
system. Consistent with his research 
findings, he said, “Drugs that block 
sodium channels prevent axonal death.” 
Consequently, he is involved in an 
upcoming clinical trial that will test 
sodium channel blockers in MS patients. 
—K.N. 
More than 20 years ago scientists discovered 
that rna, and not just proteins, could act 
like an enzyme. Now Yale researchers have 
obtained the first X-ray crystal structure of 
this type of enzymatic rna. The image caught 
an rna molecule as it spliced together two 
exons, the parts of a gene that code for pro¬ 
teins. Also visible in the image were a full- 
length noncoding intron and metal ions 
bound in the molecule’s active site. 
The rna acts like an enzyme so it can 
overcome an inherent hindrance to protein 
synthesis—the intron that separates the 
exons. With the help of the metal ions, 
the rna connects the exons and removes 
the intron sequence. 
“This is the first rna splicing complex 
to be visualized in molecular detail,” said 
Scott A. Strobel, ph.d., professor of molecu¬ 
lar biophysics and biochemistry and chemis¬ 
try, and principal investigator of the study 
published in the journal Nature in June. 
—K.N. 
HOW SALMONELLA SURVIVES 
Yale scientists have discovered how Salmo¬ 
nella, a bacterium that causes food poisoning 
and typhoid, escapes the innate immune 
system’s efforts to destroy it. Typically, bacte¬ 
ria are gobbled up by macrophages, which 
send bacteria to an execution chamber called 
a lysozome for degradation. 
While they await degradation, Salmo¬ 
nella sit in a holding cell called a vacuole and 
begin to plan their escape. They secrete a 
protein, SopB, that changes the composition 
of the vacuole. This allows the bacterium 
to escape and find a friendlier compartment 
where they can replicate and avoid innate 
immune defenses. 
“Salmonella have an elegant strategy 
for surviving and replicating and avoiding 
this cellular disposal system,” said Jorge 
E. Galan, d.v.m., ph.d., chair of the Section 
of Microbial Pathogenesis, the Lucille 
P. Markey Professor of Microbiology and 
principal investigator of the study pub¬ 
lished in Science in June. “Our work is 
revealing a fundamental mechanism by 
which these bacteria cause disease— 
and may lead to new targets or strategies 
for controlling them.” 
—John Curtis 
Books & ideas bookshelf 
Who’s minding 
the bookstore? 
Don Levy’s career has taken him from reporting to 
academia and, now, to selling medical textbooks. 
By Cathy Shufro 
Yale Medical Bookstore manager Donald M. Levy was ring¬ 
ing up three hefty surgery texts when he suggested to the 
customer, a surgical resident, that he take a look at Zollinger’s 
Atlas of Surgical Operations. 
Levy wasn’t expecting to make a sale: the Atlas costs 
$199, about what the resident had just spent. Nevertheless, 
the surgeon opened the book, checked the index and began 
reading. “This is the operation I had to do yesterday,” he 
said. “If I’d had this book, I would have been better off.” 
He bought the book. 
Making that sale wasn’t Levy’s primary motive. “I don’t 
like being sold stuff, myself,” says Levy, a warm, talkative 
man who remembers customers by name. “There’s a subtle 
difference between offering and selling.” 
Levy has managed the store at 320 Congress Avenue, 
which is owned by Barnes & Noble, since it opened in 
October 2001. He came to the medical school campus from 
the main Barnes & Noble store on Broadway. But before he 
got into the book business he spent 10 years as a television 
reporter in upstate New York, Vermont, Ohio and Kentucky. 
A complex career path next led him into journalism 
education at Syracuse University; graduate studies in reli¬ 
gion at Yale, where he received a master’s degree in 1992; 
and a brief tenure running his own company selling out-of- 
print volumes in philosophy, psychology and religion. When 
the advent of Internet shopping undermined his sales, he 
joined Barnes & Noble. 
Running the store gives him a chance to draw on his 
interest in religion and healing. For example, to customers 
fresh from the doctor’s office he can recommend a mass 
market book on diabetes or heart disease “You’re kind of 
being pastoral.” he says. “You show them the section and 
maybe you ask a few questions.” 
The bookstore offers shelf after shelf of review books 
and primers like Clinical Microbiology Made Ridiculously 
Simple and Laughing Your Way to Passing the Pediatrics Boards. 
Also for sale are medical accessories and necessities, includ¬ 
ing one big seller, a $16 dissection kit. It contains tweezers, 
pick, scalpel, scissors and replacement scalpel blades in a 
box—-“all Larry Rizzolo-approved”—a reference to Lawrence 
J. Rizzolo, ph.d., one of the directors of the first-year anatomy 
course. The store also carries tuning forks, Babinski ham¬ 
mers and stethoscopes. 
“I really like selling ’scopes,” says Levy after watching a 
student equivocate between navy and burgundy models. “It’s 
an important purchase, and it’s a personal fashion statement.” 
Levy welcomes ideas from customers. “My customers 
help me manage my bookstore if I’m careful to listen to 
them,” he says. He started carrying cotton lab coats when 
customers requested them and he listens to the medical 
students who compare notes on various texts. “I like it when 
students come in really informally and pick each other’s 
After a varied career that included forays into television journalism 
and academia, Don Levy now manages the Barnes & Noble Medical 
Bookstore on Congress Avenue. 
brains,” says Levy. He began the year with four student texts 
for hematology. Very quickly, students had reached a consen¬ 
sus that Hematology at a Glance was the best. 
Even when students are looking for a particular title, 
Levy likes to suggest alternatives. “They will come in and 
say ‘Do you have that blue book for icu?’ I tell them, ‘This 
is the book they told you to get. It’s a great old book, but it’s 
1998. This is the standard, but I want you to look at this.’ ” 
Then he’ll show them another guide, published in 2001. 
“That way,” he says, “they feel like they made a much more 
informed purchase than if they came in like lemmings and 
bought the one they were told to buy.” 
—Cathy Shufro 
Bookshelf is a column in Yale Medicine focusing on matters 
related to books and authors at the School of Medicine. 
Send ideas to Cathy Shufro at cathy.shufro@yale.edu. 
BOOK NOTES 13 
James P.Comer.m.d. 
Leave No Child Behind: 
Preparing Today’s Youth for 
Tomorrow’s World 
by James P. Comer, m.d., m.p.h., 
hs ’66, associate dean of the 
School of Medicine and the 
Maurice Falk Professor of Child 
Psychiatry in the Child Study 
Center (Yale University Press) 
j Comer offers proof that stu¬ 
dents from all backgrounds can 
learn at a high level, adopt 
positive attitudes and prepare 
for fulfilling adult lives if they 
learn in schools that provide 
adequate support for their com¬ 
plete development. Comer 
draws on his own experiences 
as the creator of the School 
Development Program. 
Metamorphoses: Memoirs of 
a Life in Medicine 
by William G. Anlyan, m.d. '49 
(Duke University Press) Born 
in Alexandria, Egypt, in 1925, 
Anlyan attended Yale as both an 
undergraduate and a medical 
student before leaving for Duke 
University in 1949 for an intern¬ 
ship in surgery. Among other 
things, he describes changes in 
the world of medicine, recalling 
an era when medicine focused 
on controlling infectious dis¬ 
eases like tuberculosis and polio. 
What Every Senior Needs to 
Know About Health Care 
i by James J. Nora, m.d. ’54 
(University Press of Colorado) 
This guide to the medical, finan¬ 
cial and social issues of today’s 
American health care system is 
written for people 50 and older. 
The author discusses mental and 
social health, elder abuse, retire¬ 
ment, end-of-life issues and 
health maintenance strategies 
involving nutrition, fitness and 
the avoidance of risk factors. 
The Packard Weight Health Plan: 
A Medically Based 5-Step Program 
for Permanent Weight Loss 
by Andrew R. Packard, m.d. ’77 
(Ballantine Books) Packard, who 
in his medical practice sees the 
chronic pain and illness that are 
directly related to excess weight, 
details his plan for "weight 
health” for life—one that is not 
a diet plan. The key to regulat¬ 
ing weight, he feels, lies in 
understanding the triggers for 
releasing the neurohormones 
dopamine, serotonin, gaba and 
endorphins and other hormones 
like leptin, insulin and ghrelin. 
Hyperbaric Medicine Practice, 
2nd ed. 
edited by Eric P. Kindwall, m.d. ’6o, 
and Harry T. Whelan, m.d. (Best 
Publishing) An international 
group of more than 40 hyper- 
baricists provides practical infor¬ 
mation on the application of 
hyperbaric oxygen therapy in 
the treatment of patients. 
The Doctors’ Plague: Germs, 
Childbed Fever, and the Strange 
Story of Ignac Semmelweis 
by Sherwin B. Nuland, m.d. ’55, 
hs '61, clinical professor of sur¬ 
gery (W.W. Norton & Co.) Before 
the discovery of bacteria and 
bacterial diseases and before 
Pasteur, Lister and Koch, the mid- 
19th century Viennese physician 
Ignac Semmelweis insisted that 
doctors should wash their hands 
before examining patients. 
Although his observations were 
largely ignored in his lifetime, 
Semmelweis is remembered for 
this now commonplace practice. 
Clinical Management of 
Hypertension, 7th ed. 
by Marvin Moser, m.d., clinical 
professor of medicine (Profes¬ 
sional Communications) This 
book reviews the results of 
major clinical trials completed 
over the past 20 years, with spe¬ 
cial emphasis on newer trials 
completed within the last sev¬ 
eral years.The author discusses 
treatment of hypertension and 
reviews drug therapies. 
Understanding Cosmetic Laser 
Surgery: A Description of 
the Processes and Procedures 
Available in Cosmetic Laser 
Surgery 
by Robert C. Langdon, m.d., hs 
’84, assistant clinical professor 
of dermatology (University Press 
of Mississippi) Laser treatment 
is an alternative to more invasive 
cosmetic procedures and can 
be used to reduce facial and 
body scars and remove lesions, 
tattoos and hair. In this book for 
the general reader Langdon 
describes the technology of the 
laser as well as the basics of 
laser surgery, its risks and post¬ 
operative recovery. 
Discrete Distributions: 
Applications in the Health 
Sciences 
by Daniel Zelterman, ph.d. ’83, 
professor of public health (biosta¬ 
tistics) (Wiley) This book pro¬ 
vides an overview of discrete 
distributions and their applica¬ 
tions in the health sciences. 
Zelterman focuses on real exam¬ 
ples, giving insight into the util¬ 
ity of the models, the properties 
of each distribution and the 
methods that led to their devel¬ 
opment. Examples come from 
the health sciences, including 
cancer and epidemiology, and 
from demography. 
On the Take: How Medicine’s 
Complicity With Big Business 
Can Endanger Your Health 
by Jerome P. Kassirer, m.d., 
adjunct professor of medicine 
(Oxford University Press) 
Compiled from interviews with 
hundreds of physicians, Kassirer’s 
book delves into the kind, extent 
and consequences of physicians’ 
collaborations with industry. 
Pediatric Toxicology: 
Diagnosis & Management of 
the Poisoned Child 
by Timothy B. Erickson, m.d., 
William R. Ahrens, m.d., Steven 
E. Aks, o.d., Louis Ling, m.d., 
and Carl R. Baum, M.D., assistant 
professor of pediatrics (McGraw- 
Hill Professional) Evidence- 
based and age-specific, this 
book guides the clinician 
through the diagnosis and 
management of the poisoned 
pediatric patient. Features 
include case presentations 
throughout; a self-assessment 
section with more than 200 
questions; antidote dosage 
tables; color plates; and cover¬ 
age of herbal products, vita¬ 
mins, cosmetics, spider bites 
and snake bites. 
Atlas of Foot and Ankle 
Sonography 
by Ronald S. Adler, ph.d., m.d.. 
Carolyn M. Sofka, m.d., and 
Rock G. Positano. d.p.m., m.sc., 
m.p.h. '89 (Lippincott Williams 
& Wilkins) This atlas is a com¬ 
plete guide to using ultrasound 
to diagnose foot and ankle 
disorders. More than 160 illus¬ 
trations display both normal 
ultrasound anatomy and a vari¬ 























Clone Being: Exploring the 
Psychological and Social 
Dimensions 
by Stephen E. Levick, m.d., hs 
'78 (Rowman & Littlefield) Levick 
uses narratives of patients from 
his own practice along with stud¬ 
ies of twins, namesakes, adoptees 
and offspring of famous parents 
to anticipate the challenges that 
human clones and their "families” 
will face and how to meet their 
psychological and social needs. 
Against the Spirit of System: 
The French Impulse in 
Nineteenth-Century American 
Medicine (paperback) 
by John Harley Warner, ph.d., 
professor and chair of the history 
of medicine, American studies 
and history (Johns Hopkins 
University Press) Warner 
describes how, between the 
1810s and the 1860s, when 
Paris emerged as the center of 
Western medicine, hundreds 
of Americans studied in Parisian 
hospitals and dissection rooms 
and then applied their new 
knowledge to advance their 
careers at home and to reform 
American medicine. 
A Woman’s Guide to Sexual 
Health 
by Mary Jane Minkin, m.d. ’75, 
hs ’79, clinical professor of 
obstetrics, gynecology and repro¬ 
ductive sciences, and Carol V. 
Wright, ph.d. (Yale University 
Press) This guide includes 
explanations of how the female 
body works, problems that may 
arise and comprehensive solu¬ 
tions for women of all ages who 
are concerned with their repro¬ 
ductive health. 
The Early History of Hospice 
Buffalo 
edited by Abel K. Fink, ed.d., 
and Donald P. Shedd, m.d. ’46, 
hs ’53 (The Center for Hospice 
& Palliative Care) This book 
traces the course of Hospice 
Buffalo from its inception in 
1974, including the educational 
effort that was required to 
convey to the public and the 
professions the full meaning 
of the hospice concept. 
The Whistlers’ Room: Stories 
and Essays 
by Richard A. Selzer, m.d., hs ’61 
(Shoemaker & Hoard) Selzer’s 
latest book contains 24 pieces 
from diaries, memoirs and 
essays. The title piece is the story 
of three World War I soldiers 
who were shot in the larynx and 
could only communicate by 
forcing air through tubes in 
their throats. 
The descriptions above are based on 
information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to cheryl.violante@yale.edu 
IN CIRCULATION 
Gift endows library post and pays 
tribute to “a nurturing treasure” 
John Robinson Bumstead surely knew the story of how his father 
became the first physician to administer penicillin in the United 
States. He was 17 years old in March 1942 when his father, John Henry 
Bumstead, m.d., was caring for 33-year-old Anne Miller. Neither 
transfusions nor surgery nor sulfa drugs had cured Miller of a strepto¬ 
coccal infection. She was dying and Bumstead was desperate. His 
colleague, physiologist John F. Fulton, ph.d., m.d., had befriended the 
Australian researcher Howard W. Florey, ph.d., and helped him come 
to the United States to begin production of penicillin; Bumstead 
asked Fulton to obtain a sample of the still-experimental antibiotic. 
It worked, and Miller lived to be 90. 
When he died in July 2003, the younger Bumstead remem¬ 
bered in his will the medical library, as well as Connecticut’s 
historic Mystic Seaport, where he was a librarian, and New Haven’s 
St. Thomas’ Episcopal Church, where he was a parishioner. Bumstead 
left $1.2 million to the Harvey Cushing/John Hay Whitney Medical 
Library. Director R. Kenny Marone, m.l.s., used the gift to endow a 
librarianship at what she calls “one of the premier medical historical 
libraries in the world.” 
Built in 1940, the library was established by three men who 
donated their collections of tens of thousands of volumes of medical 
literature: neurosurgeon Harvey W. Cushing, M.D.; Swiss tuberculosis 
specialist Arnold C. Kiebs, m.d.; and Fulton. Cushing, says librarian 
Toby Appel, ph.d., m.l.s., saw the library as “the heart of the medical 
school,” a uniting force in an age of increasing specialization. Thanks 
to Bumstead’s gift, Appel is now the John Robinson Bumstead 
Librarian for Medical History. 
The two-story room that holds much of the 125,000-volume 
historical collection has a vintage air, with a vaulted wooden ceiling, 
twin balconies and a fireplace. “There’s something special when you 
can walk in and see Volume One of The Lancet," says Marone. “We just 
have marvelous resources.” Among those using the historical library 
now is medical historian Michael Bliss, ph.d., at work on a biography 
of Cushing. 
Surgeon, historian and writer Sherwin B. Nuland, m.d. ’55, 
HS ’6i, is among those who have written about the room and its 
“treasured stacks.” In Doctors: The Biography of Medicine, he writes: 
“Of all the libraries in all the educational institutions of our world, 
there is none quite like this one.... a sanctum containing the lore 
and the collected reminiscences of the art of healing ... a nurturing 
spring for renewal and strengthening of purpose.” 
—Cathy Shufro 
ON CAMPUS 
A human rights view 
of health care 
"What is the cost of not doing 
the right thing?” Paul Farmer, 
m.d., ph.d., asked in March dur¬ 
ing a talk sponsored by the 
Diversity Action Committee at 
the School of Nursing. With that 
question he challenged the cost- 
benefit analysis that underpins 
most global health projects. 
In Haiti, where he has spent 
most of his career, no patient, 
he said, has ever told him, 
"Thank you very much for offer¬ 
ing me this therapy, but it’s 
really not cost-effective here.” 
In 1987 Farmer co-founded 
Partners In Health (pih), which is 
dedicated to improving health 
care in poor countries, pih’s low- 
cost projects have achieved 
impressive outcomes in settings 
where resources were thought 
to be too scarce to make mod¬ 
ern interventions practical. Their 
cure rate for multidrug-resistant 
TB—using innovative drug pro¬ 
curement strategies and locally 
trained community health 
workers—was 83.3 percent in 
the slums of Lima, Peru. The 
same model delivers antiretrovi¬ 
rals for aids patients in rural 
Haiti and in inner-city Boston. 
He urged his listeners to 
have a "technically correct 
human rights perspective,” in 
which feasibility is a problem 
to be solved, rather than an 
excuse for inaction. 
—Colleen Shaddox 
Cautious excitement about 
a “living cancer reagent” 
The patient was a 57-year-old 
radiologist with advanced 
melanoma.The treatment was 
experimental—it combined 
immune-sensitized T cells with 
chemotherapy, and it had 
worked for a 16-year-old boy at 
death's door. After years of 
unsuccessful trials, the therapy 
had evolved to the point where 
it made a volleyball-sized tumor 
disappear from the boy’s pelvis 
and left him free of disease. 
Did the new patient want to 
try it? “He said,‘Absolutely, doc. 
I want to receive this new treat¬ 
ment while it’s still working!’ ” 
recalled Steven A. Rosenberg, 
m.d., ph.d., head of the surgery 
branch at the National Cancer 
Institute. 
The patient was joking, but 
years of effort with vaccine and 
cell transfer therapies for cancer 
are starting to pay off, Rosenberg 
said at Cancer Center grand 
rounds in May. Combining CD4 
cells with sensitized CDS cells 
in the right proportion made the 
difference. "We gave the [16- 
year-old] patient a cell packet of 
23 grams, and it made over half 
a kilogram of tumor disappear,” 
he said. "The reason is that it’s 
a living cancer reagent.These 
cells continue to live and pro¬ 
duce anticancer activity inside 
the patient.” 
—Michael Fitzsousa 
Art and plague 
in the Middle Ages 
When the plague reached 
Europe in 1348 it was seen as a 
divine punishment. How else 
to explain a disease that killed 
entire families with no regard 
for their station in life and 
wiped out as many as two- 
thirds of a city’s inhabitants? 
Along with the civic disrup¬ 
tion came a spiritual catastro¬ 
phe. The plague struck so swiftly 
that it denied its victims the 
chance to indulge the rituals 
that eased the passage to death, 
said John T. Paoletti, ph.d. ’67, 
professor of art history at 
Wesleyan University. 
As the plague spread, artists 
turned to images of Madonna of 
the Misericordia and St. Sebastian, 
protectors against the plague, 
Paoletti said. Cherubic angels 
flinging arrows at their victims 
symbolized the still-unexplained 
plague as victims sought protec¬ 
tion from saints and the Virgin 
Mary, who offered her cloak as 
a shelter. Medicine of the time 
offered little hope against 
the plague. 
“Your salvation is dependent 
upon a confession, on other 
sacraments, sometimes the 
Eucharist," he told an audience 
at the Program for Humanities 
in Medicine in April."The doctor 
is dead. The confessor is dead. 
And if they’re not, they’re not 
going to come to your house.” 
—John Curtis 
Striving not to narrow, but to 
eliminate, racial disparities 
For years health statistics have 
revealed a grim dichotomy- 
members of racial and ethnic 
minority groups bear a greater 
burden of chronic and infectious 
disease. "The problem is here 
because we ignored the warning 
signs,” said John Ruffin, ph.d., 
director of the National Center 
on Minority Health and Health 
Disparities. 
Addressing an audience of 
health care providers at the 
annual meeting of the Division 
of Prevention and Community 
Research at the Department 
of Psychiatry in April, Ruffin 
said, "If health disparity is to 
be eliminated it is going to be 
eliminated by you, not by us 
in Washington.” 
To that end Ruffin has 
worked to provide the tools to 
health care professionals. New 
programs to investigate health 
disparities, he said, will repay 
student loans of physicians, 
establish centers of excellence 
and endow underfunded insti¬ 
tutions.The nih has also 
adopted a strategic plan to 
address health disparities. 
"I do believe we are not talk¬ 
ing about narrowing health 
disparities,” Ruffin said. “I really 
believe we are talking about 
eliminating health disparities.” 
—J.C. 
A life among the 
viruses 
Jordi Casals-Ariet spent his life studying and categorizing viruses, 
and in 1969 his search for the agent behind the mysterious 
Lassa fever almost killed him. But his near-lethal infection paved 
the way for improvements in lab safety. 
By Kendall Powell 
When virologist Jordi Casals-Ariet, m.d., 
died last February at age 92, his obitu¬ 
aries highlighted two salient facets of 
his life; the system he designed for clas¬ 
sifying the viruses that he spent his life 
studying, and how one of those viruses 
almost killed him in 1969. 
The virus first appeared that same 
year in three missionary nurses in 
Nigeria—a mysterious fever killed 
two of them in days. Casals-Ariet’s 
laboratory at the School of Public 
Health seemed the logical place to 
study samples of the nurses’ blood 
containing the virus. The Yale Arbo¬ 
virus Research Unit (yaru) held the 
world’s most extensive collection 
of arboviruses, which are spread by 
blood-sucking insects, and the pres¬ 
ence of leading virologists on the 
faculty offered the best chance of iso¬ 
lating the agent behind the fever. 
Casals-Ariet and Sonja M. Buckley, 
m.d., an expert in tissue cultures, took 
on the task of isolating and identifying 
the lethal virus, named Lassa for the 
Nigerian town where it appeared, and 
altered their laboratory methods accord¬ 
ingly. They limited access to the virus 
and sealed off several lab rooms at the 
Laboratory of Epidemiology and Public 
Health. “I slowed down and became 
meticulous in my techniques,” Buckley 
recalled in her autobiography, “since we 
could not know how highly virulent this 
infectious agent might be.” 
Early in June 1969, three months 
after the virus arrived at Yale, Casals- 
Ariet fell ill with fever, chills and severe 
muscle aches, which he brushed off as 
a cold. By June 15 he was in an isolation 
unit. His only hope was the surviving 
nurse, Lily Pinneo, who was recovering 
at home in Rochester, N.Y. Researchers 
and doctors debated whether to give 
Casals-Ariet her antibody-containing 
plasma. Although they were convinced 
he had Lassa fever, a confirmation would 
take 96 hours, time he didn’t have. If 
they were wrong, an infusion of anti¬ 
bodies might cause a cross-reaction. 
Robert W. McCollum, then chair of the 
Department of Epidemiology and Public 
Health, said yaru researchers ultimately 
recommended using the antibodies. 
“Nobody knew what else to do,” he 
said in an interview from his home in 
New Hampshire. 
Casals-Ariet recovered and con¬ 
tinued his research. That Thanksgiving, 
however, lab technician Juan Roman 
became ill and died. Lassa fever was 
confirmed, sending chills through the 
research group—Roman had never 
worked with the virus. Work on the live 
virus was halted and all samples were 
opposite top His efforts to identify the 
virus underlying Lassa fever almost cost Jordi 
Casals-Ariet his life. It’s still unclear how, 
despite extraordinary laboratory precautions, 
he became infected. 
BACKGROUND In June 1969,days before he 
became infected with Lassa fever, Casals-Ariet 
(second row, fifth from left) posed for an annual 
photo with the infectious disease faculty at 
the School of Public Health. 
RIGHT Sonja Buckley, an expert in tissue 
culture, collaborated with Casals-Ariet in the 
investigation of Lassa fever. 
sent to a maximum-security lab at the 
Centers for Disease Control (cdc). 
How Casals-Ariet and Roman con¬ 
tracted Lassa fever remains a mystery. 
McCollum and others suspect that the 
two inhaled virus particles from dust 
kicked up by infected mice. Casals-Ariet 
worked in the same room with the cages 
and Roman may have passed by the 
room or talked to him from the doorway. 
“The incident forced changes to 
biosafety nationally, and was one of the 
seminal events in [bringing about mod¬ 
ern] biosafety,” said Ben Fontes, m.p.h., 
the biological safety officer for Yale and 
a Certified Biological Safety Professional 
accredited by the American Biological 
Safety Association. He credits the yaru 
group’s extremely careful precautions 
with preventing other infections at Yale. 
Yet, as a result of these and other labo¬ 
ratory infections, a classification system 
for viruses, bacteria and other pathogens 
was created to ensure safe working con¬ 
ditions. After Roman’s death, unidenti¬ 
fied infectious agents like Lassa were 
sent to the safest possible lab facilities. 
Casals-Ariet went on to investigate 
Lassa outbreaks in West Africa. In 1973 
biologists in Sierra Leone, aided by 
the Yale and cdc teams, determined 
that Lassa virus spread from wild rats 
to humans. Casals-Ariet also worked 
with the cdc to set up what eventually 
became the World Health Organiza¬ 
tion’s reference collection of arboviruses. 
His longest-lasting research legacy, 
however, may be the virus classifica¬ 
tion system he developed that shows 
the relationships of different animal 
and human viruses—critical infor¬ 
mation for developing vaccines and 
tracking and treating epidemics. 
Kendall Powell is a freelance writer in Denver. 
Liony Aceelus, an aids counselor, 
worked with Amelia Shaw to 
produce a film that gathered the 
stories of Hiv-positive people, 
in an effort to break the silence 
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Most descriptions of Haiti include the phrases “poorest nation,” “ravaged by dictators” or “highest 
aids rate.” These are all true. But to public health alumna and documentary filmmaker Amelia Shaw, 
there is really only one way to describe Haiti: the land where magic and danger collide. 
A LETTER FROM HAITI 
Text and video stills by Amelia Shaw, m.p.h. '03 
Armed troops and gangs were 
a frequent sight on the streets of 
Port-au-Prince as the country 
erupted in opposition to President 
On a trip to Jscmei, two hours 
from Port*au-Prince,5Haw 























20 A film to finish 
he sun rises on Airport 
Road, a bustling thorough¬ 
fare in Port-au-Prince. My 
assistant, Moliere Jean, is 
driving and Liony Accelus, 
an hiv/aids counselor, is in 
the back seat. We are going 
to meet Liony’s Uncle Big, a 
famous voodoo doctor four 
hours away in Haiti’s bread¬ 
basket, the Artibonite Valley. 
The radio blares 
about today’s demonstra¬ 
tion against the govern¬ 
ment. It’s early February 
and for three months 
students have demanded the resignation of President Jean- 
Bertrand Aristide. Their cry has been taken up by business 
leaders and civil society, who say Aristide is responsible for 
the disappearance of journalists, the death of the economy 
and violent attacks on peaceful protesters. But most people 
are just angry at being poor. When Aristide became presi¬ 
dent in 1994 most Haitians believed that this priest from 
the slums would lift them out of poverty. Yet most Haitians 
have only gotten poorer; today more than 80 percent of 
Haitians live in poverty and many of them blame Aristide. 
Moliere winces and shakes his head. Forty people 
have been killed and hundreds wounded in antigovernment 
demonstrations. It has become increasingly difficult to work 
in Port-au-Prince. More than once Moliere and I have hid¬ 
den in an alley or screeched up the road in reverse because 
demonstrations disintegrated into a storm of tear gas, stones 
and bullets as protesters dashed with riot police or Aristide’s 
armed supporters, known locally as chimeres. I look out the 
window and wonder what today’s demonstrations will bring. 
I first went to Haiti as a Yale student on a Downs 
Fellowship in the summer of 2002, to coordinate a film proj¬ 
ect about aids and social stigma. Due to funding problems, 
the project was never completed. I returned to Yale to finish 
master’s degrees in public health and African studies, yet 
I could not let go of my memories of Haiti and her coura¬ 
geous hiv community. 
Right before I graduated in May 2003 I won a 
Fulbright Scholarship, and that fall I touched down in Port- 
au-Prince. “I made it,” I kept thinking, and was both exhila¬ 
rated and overwhelmed. I had worked as a summer intern 
at National Public Radio (npr), but I had never made a film 
before. Making films, I felt, couldn’t be that different from 
making radio. The trick is to tell a good story. 
I wanted to record the stories of people living with 
hiv/aids, and distribute them in Haiti as a way to reduce 
stigma and discrimination. Haiti’s national television net¬ 
work was behind me, as were international organizations 
willing to use the videos in outreach campaigns. In a country 
where almost half of the people cannot read or write, videos 
and group discussions can break the silence about aids. 
Over six months, I filmed dozens of men and women— 
some of whom hid their faces—as they shared a bit of their 
lives. Some spoke of their fear of orphaning their children, 
others of their shame at public humiliation, but most spoke 
of their desire to live and do a little bit of good in the world. 
I met Liony through the small, vocal, Hiv-positive net¬ 
work in Port-au-Prince. Liony is unforgettable. Tall, dapper, 
with a wife and a handful of children, he has a talent for 
making people listen. He spends most of his time working 
in a grass-roots organization as one of Port-au-Prince’s only 
aids counselors. 
“People think I am a curiosity," he says, chuckling. 
“Sometimes I sit for hours on my doorstep and answer peo¬ 
ple’s questions. ... Yes, I still live with my wife, yes we eat 
the same food, yes my kids play with other kids. Do I sleep 
with her?” He winks and laughs. “Yes I do, with condoms 
of course. ... though not so much anymore. I need to keep 
my strength, mon cher!” 
Liony gets free antiretrovirals (arvs) at the Haitian 
Study Group on Kaposi’s Sarcoma and Opportunistic 
Infection (ghesicio), one of two research centers in Haiti 
that distribute medicine to people with full-blown aids. 
Haiti has about 400,000 aids cases in a population of 8.2 
million, yet only 1 percent receive aids drugs, either 
through ghesicio in Port-au-Prince or the Zanmi Lasante 
clinic in central Haiti run by Paul Farmer, m.d., ph.d. 
This may soon change. With millions of dollars pouring 
in from the Global Fund To Fight aids, Tuberculosis 
and Malaria as well as President Bush’s Emergency Plan 
for aids Relief, more than 30 percent of Haiti’s aids 
patients—120,000 people—are expected to receive arv 
treatment in the next five years. 
jassse 
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Unlike other voodoo doctors Liony’s 
Uncle Big does not claim he can 
cure aids.“The problem isn’t mysti¬ 
cal,” he says. "It’s medical.” 
“You know, if I hadn’t gone to the houngan two years 
ago, I probably never would have gotten so sick,” Liony says, 
shaking his head, “But then again I wouldn’t be on treat¬ 
ment now either.” 
A houngan is a voodoo doctor. And when people are 
sick in rural Haiti, the houngan is usually the first person 
they’ll see. Most rural Haitians believe that illness is the 
result of evil, caused by a vengeful or jealous neighbor. And 
with only 2.5 physicians per 10,000 people, health care in 
rural areas is not always an option. So the houngan becomes 
a logical place to seek help. Unfortunately for people with 
aids, the treatment they get from a houngan usually makes 
their situation worse. 
“I had to drink this brown liquid and sleep outside 
for days at a time. I spent my savings on it. And in the end, 
man, I just got sicker and poorer,” Liony says. After a few 
weeks, Liony’s father found him weak and shivering, and 
carried him to a health clinic. 
“I had pneumonia,” Liony says. “But the good thing 
is, I went on medications.” When Liony’s doctor saw that his 
T-cell count was below 200, he referred Liony to gheskio 
for treatment. 
“aids is aids. A curse is a curse.” 
We enter the sprawl of Cite Soleil, the slum on the edge of 
Port-au-Prince famed for its mind-bending poverty and 
patrolling chimeres. We weave through crowds of people step¬ 
ping crisply over open sewage. A lucky few are on their way 
to jobs in the industrial complex, assembling baseballs or 
T-shirts for a buck fifty a day. In a country where unemploy¬ 
ment soars to 70 percent, $1.50 seems like a godsend. We 
come to a roadblock guarded by kids with dreds, and Moliere 
instinctively turns down the radio and flashes an open palm. 
“Cinq ansi” the hand says, “Five years! Five more years for 
Aristide!” Moliere doesn’t support Aristide, but here an open 
palm is a ticket to safety. 
We leave Cite Soleil and drive over broken roads, 
past fishing villages, rice paddies and women hawking 
peanuts and melons. Then the land dries up and the 
dust rises. 
“See those up there?” Liony says, pointing to little 
shacks on the hillsides. “Those are all peristyles, the temples 
where houngans receive their clients.” Peristyles dot the 
naked hillsides as far as the eye can see. 
We walk a maze of dusty footpaths to Big’s peristyle. It 
is a work of art. The temple walls are covered with murals of 
saints, serpents and mermaids, and the air flutters under a 
canopy of colored streamers. Big is sitting outside on a stool 
in front of a large painting of the Virgin Mary and a rainbow. 
“Uncle Big!” Liony calls out, and Big chuckles and 
spits. He has a fat belly and old red eyes. He waves children 
away and gestures for me to sit. I ask him what he knows 
about aids. His response leaves me floored. 
“aids is aids. A curse is a curse. Now diarrhea can be 
supernatural. But aids ...” Big pauses to spit in the dirt, 
“nope, aids can’t.” 
Most houngans claim they can cure the “aids curse,” 
called mb sida in Creole. They say you get mb sida when 
your enemy makes a powder out of someone who died from 
aids and blows it on you. If Big thinks someone might 
have aids, I ask, what does he tell them? 
“What can I tell them? I say, did you go to the doctor 
... no? Well then go and get an hiv test. Then you can 
come back.” 
In Haiti, this is unheard of. Most people prefer not to 
know their serostatus—a positive result hangs like a death 
sentence. But being told to get an hiv test by a houngan 
could be just the encouragement people need to seek testing 
and counseling. 
“If the test is positive, I say there is nothing more 
I can do.” Big raises his hands in the air. “Because the prob¬ 
lem isn’t mystical, it’s medical. And they need to go see a 
medical doctor to resolve it. I can’t cure aids!” 
But what about all the houngans who say they can? 
“Ah! It’s all bluff! Bluff!” Big is clearly upset by the 
question. “Houngans can’t treat aids! I mean, look around, 
now honestly, what would I use to treat aids?” 
I do look around. I see a skull lying on a miniature 
coffin, a brown baby doll head, an American flag and three 
plastic coke bottles. Less than 20 years ago scientists were 
asking themselves the same question—what can we use 
to treat aids? Well, we’ve got our answer. Treatment exists. 
Now the big question is, how do we get treatment to the 
people who most need it—poor people living on the margins 
of global society? 
Sitting in Big’s peristyle in the dusty plains of the 
Artibonite, it dawns on me that for Haiti the answer may sit 
at the crossroads of public health and voodoo. Public health 
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Amelia Shaw in a self-portrait 
taken at Big’s peristyle. 
professionals around the world need to keep advocating for 
affordable drugs in poor countries. And then they need to 
collaborate with the people on the ground who really make 
a difference. 
No matter how unorthodox his methods, a guy like 
Big is saving lives. By affirming the role of medicine in a 
world dominated by the supernatural, he is directing rural 
people to the tests and treatment they need. If more houn- 
gans follow Big’s lead, Haiti could see a turning point in the 
fight against aids. 
A hospital becomes a war zone 
On our return the capital disintegrates into chaos. 
The radio reports that a student was shot with a tear- 
gas canister and taken to Canape Vert hospital for emergency 
surgery. While doctors are trying to remove the canister 
from his abdomen, it explodes. I am picturing white smoke 
pouring out of a wound in a young man’s body. The hospital 
is evacuated. The student dies. His classmates surround the 
hospital, enraged. 
As the violence escalates I am drawn to epicenters of 
conflict to film, to record, to try and understand the country. 
I sometimes want to play reporter, but it isn’t journalism that 
inspires me—it’s public health. Because journalists are cyni¬ 
cal, and I still believe in the power to change. 
Moliere and I leave Liony at his house and then go to 
the hospital. The chain of events is fast and brutal. Students 
drag abandoned cars into the road and light them on fire. 
The riot police finger their Mi6s. Pistols crack on the hill¬ 
side, and a woman screams, “The chimeres are coming down 
the hill!” The road explodes in a flurry of shouts and lost 
shoes. The police storm the flaming barricades—sparks fly, 
bullets fly, students fly or hit the ground and pray. 
Rat tat tat tat tat tat tat. 
If you have ever stood near machine gun fire, you know 
the sound: loud, and very, very mean. The hospital becomes 
a battleground. Patients in white robes running in panic tot¬ 
ter and fall in the courtyard. Doctors scream. Students hide 
and riot police chase them from room to room. In the confu¬ 
sion, a woman is raped on the operating table. She had been 
recovering from minor surgery; her story was broadcast on 
that night’s news. 
I run through the thick smoke with my camera, and 
2 come face to face with a riot police officer in sniper position, 
his M16 trained on my left shoulder. I feel a hot red point 
where the bullet would enter. He is screaming at me, and 
I am paralyzed. When I hear Moliere’s frantic footsteps 
behind me, I shout the only thing that comes into my head: 
“i AM A JOURNALIST! I AM A JOURNALIST!—PLEASE! 
don’t shoot!” My only proof is my expired intern badge 
from npr, but in retrospect, I believe this saves us both. Lucky 
for me, dead white journalists are bad press for Aristide. 
In darkness, a candle brings light 
Haitians have a saying: “When you run from the rain you 
only end up falling in a big river.” 
In the weeks that followed, the country crumbled 
around our ears, and in mid-February the city imploded. 
People stayed indoors while businesses were looted, neigh¬ 
borhoods were barraged with tear gas and roads blocked by 
flames. The nights were filled with gunfire and shouts and 
the days saw hospitals overflowing. Yet the storerooms were 
bare and many doctors stayed home because, as in the case 
of Canape Vert, even the hospital becomes a war zone. 
I watched my work become insignificant as people’s 
conception of risk changed entirely. It is hard to think 
about aids when staring down the barrel of a gun. So while 
I wasn’t surprised when, a few days before Aristide left the 
country on February 28, I was told by the U.S. Embassy to 
evacuate, I was overcome with a feeling of great loss. 
But in moments of darkness, one candle brings light. 
While I am packing my bags, my cell phone rings. It 
is Liony. 
“Amelia! When are we going back to the Artibonite? 
We need to film another interview with Big!" 
Liony is unstoppable. A group of armed rebels— 
disgruntled chimeres, drug traffickers and convicted crimi¬ 
nals—had taken over the Artibonite the week before and 
were moving south. They have sealed off the country’s 
northern corridor, setting the stage for a scene Haitians have 
seen too many times: state decapitation. Whereas over a 
decade ago, Aristide rose to the presidency on an unprece¬ 
dented wave of popular support, this week he is about to 
become just another overthrown dictator in Haiti. 
When I tell Liony I’ve been ordered to evacuate, he 
doesn’t miss a beat. 
“Don’t worry, you’ll be back. We have a film to finish.” 
His voice is both confident and nonchalant. “You know, our 
film is really going to change the way Haitians think about 
treating aids.” 
For the rest of the afternoon, my cell phone does not 
stop ringing. Liony has mobilized the entire aids commu¬ 
nity to give me a message: "Hey Amelia! Don’t lose hope! 
You’ll be back—we have a film to finish!” I am touched that 
they are calling to comfort me—after all, I am the healthy 
one getting out. 
Yet I learned that day that the optimism of hiv- 
positive Haitians is unbreakable. By force of will, they beat 
the odds and survive in a world where magic and danger 
collide—often with deadly consequences. These people are 
heroes. They are also Haiti’s hidden treasure. Because when 
the rumbling stops and the smoke clears, Liony and his 
comrades will be the first to climb from the wreckage. They 
will smile and rub their hands, ready to rebuild stone by 
stone. And God willing, I will be there with them too. After 
all, we do have a film to finish.YM 
In late July Yale Medicine received this e-mail from Amelia Shaw: 
I arrived in Haiti two days ago.... It has been an emotional journey. 
The poverty here is stultifying—it shocks you even when you 
expect it. Things are much calmer than when I left, but a lot of 
unreported violent crime occurs in the slums, where most of my 
friends live. And floods have knocked out parts of their houses, 
leaving them open to intruders. People seem tired, very weary of 
“the everyday” in Haiti, which includes the most hair-raising bits 
and pieces of reality. The money has deflated in value, but prices 
have not, and a lot of people can’t buy food. 
But the good things are there too—the electricity is on 
most of the time. And the musicians have returned, which is a 
sign of relative stability. United Nations vehicles are everywhere, 
and hopefully the police are strengthening in numbers. 
I saw Liony today. It was such a happy moment! That has 
been the best for me, to see the people I have worked with so 
closely! I am so happy to be back here! It is wonderful, though it 
also makes my heart bleed. 
Amelia Shaw, m.p.h. ’03, graduated from Yale in 2003 with joint 
master’s degrees in public health and African studies. She returned 
to Haiti in July 2004. 
Staying safe abroad 
Facing instability like the recent 
upheaval in Haiti may be the 
norm rather than the exception for 
people working in international 
health, says Frank J. Bia, m.d., 
m.p.h., fw ’79, co-director of the 
Yale/Johnson & Johnson Physician 
Scholars in International Health 
program, which sends residents to 
more than 14 countries. “The inher¬ 
ent nature of international health 
is working in an unstable world,” 
says Bia, professor of medicine 
(infectious disease) and laboratory 
medicine. “It’s unstable because 
it’s unfair, and I think it’s getting 
worse.” Increasingly, he said, the 
world's poor are becoming aware 
of "how bad off things really are in 
terms of the increasingly skewed 
distribution of both wealth and 
technological resources.” 
Since the international pro¬ 
gram began in 1981, more than 
100 Yale residents have volun¬ 
teered for a month or two at 
Haiti’s Hopital Albert Schweitzer. 
The program has rarely suspended 
activities due to turmoil abroad, 
but temporarily stopped sending 
physician volunteers to Haiti this 
year, said program co-director 
and professor of medicine and 
public health Michele Barry, M.D., 
hs ’77. She expected that rota¬ 
tions in Haiti would resume later 
this year. (Four years ago Yale sus¬ 
pended its program in Zimbabwe 
in the wake of widespread vio¬ 
lence there.) 
Second-year resident Emmanu- 
elle Clerisme-Beaty, m.d. ’02, 
found herself in a strange situa¬ 
tion while volunteering in Haiti 
last January in the weeks preced¬ 
ing the ouster of President Jean- 
Bertrand Aristide. Although most 
foreigners felt safe at the hospi¬ 
tal, she was harassed by hospital 
workers who wanted her to join 
protests against the hospital 
administration. Clerisme-Beaty, 
who grew up in Haiti and speaks 
Creole, was taken for a “local.” 
“It got pretty scary,” she recalls. 
She chose to leave a few days early, 
catching a ride to the airport before 
dawn to reduce the danger of 
being robbed on the road. Clerisme- 
Beaty feels ambivalent about the 
experience. “Being there, you knew 
you were needed, and you were 
appreciated,” she says, adding, “I 
didn’t really feel safe.” 
For those in charge of send¬ 
ing students and residents abroad, 
security is always a concern. 
Summers are nerve-wracking for 
Curtis L. Patton, ph.d., head of 
the Division of Global Health at 
the School of Public Health. Patton 
directs the Downs International 
Health Student Travel Fellowship 
program, which funds research 
for about 16 students of public 
health, nursing and medicine who 
spend a summer abroad. 
He relies on four sources to 
judge the safety of research 
sites: advisories from the State 
Department and the Centers for 
Disease Control and Prevention, 
Yale College’s list of countries 
declared off-limits to undergradu¬ 
ates and information gleaned 
directly from people at the sites. 
This spring he advised one student 
to avoid Haiti. She went anyway, 
and “she seems to be fine,” 
Patton reported in mid-summer. 
He barred another student from 
studying diarrheal diseases in Iraq; 
she went to Tanzania instead. 
“I have my heart in my throat 
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For almost two decades Arthur Norwich has 1 
been unraveling a basic biological mystery: 
how proteins achieve their native shapes. 
By Cathy Shufro 
Photograph by Terry Dagradi 
hristian B. Anfinsen, ph.d., 
a biochemist at the National 
Institutes of Health (nih), 
in the early 1960s answered 
one of biology’s fundamental 
questions. He explained 
where proteins get the march¬ 
ing orders that direct their 
metamorphosis from amino 
acid chains into active, func¬ 
tional three-dimensional sheets and helices. Function follows 
form, and those distinctive shapes dictate how the proteins 
work. Shape allows the lock-like structure of an antibody to 
trap the key-shaped antigen to fight infection; it allows an 
enzyme to work on a specific substrate to speed up a chemi¬ 
cal reaction, such as digesting food; and it permits a hemo¬ 
globin protein to bind to oxygen and carry it in the blood. 
But when a protein is improperly folded, its function is lost, 
and that can lead to disease. 
Scientists already understood that dna embodies a 
code that is transcribed onto rna, which in turn directs the 
cell to produce the 30,000 vital proteins that are the body’s 
building blocks. Scientists recognized that these polypeptide 
chains—composed of the 20 amino acids—don’t function 
as proteins until they have folded, but they did not know, 
before Anfinsen, where proteins got the instructions to fold. 
Anfinsen shared a Nobel Prize in chemistry in 1972 
for a simple experiment that yielded remarkable results. He 
unfolded an enzyme to see if it could find its way back to 
its active, folded form. It did, showing that the sequence of 
amino acids itself contains the information that tells a pro¬ 
tein how to fold, and that the protein folds spontaneously. 
That seemed to be the final answer when Arthur L. 
Horwich, m.d., hs ’78, was studying biochemistry as a fresh¬ 
man at Brown University in 1969. But 18 years later, Horwich, 
by then an assistant professor of genetics at Yale, began to 
think there might be more to protein folding. While studying 
the passage of unfolded proteins through membranes into 
mitochondria, the cell’s power source, he asked whether a 
specialized protein might be assisting the folding process. 
Anfinsen had correctly discerned that amino acid 
do provide the information needed for folding, but 
evidence that many amino acid chains need 
machines” that provide that help. 
The chaperonin GroEL, shown 
here with the co-chaperonin GroES, 
helps proteins fold properly. 
Now the Eugene Higgins Professor of Genetics and 
Pediatrics and a Howard Hughes Medical Institute 
(hhmi) investigator, Horwich has spent 17 years studying 
those machines. 
“This work is as basic to biology as understanding the 
nature of genes and how genes are expressed and translated 
into proteins,” says colleague Richard P. Lifton, m.d., ph.d., 
the chair and Sterling Professor of Genetics at Yale and an 
hhmi investigator. “The part that is really breathtaking about 
Art’s work is that he went all the way from basic discovery of 
the protein-folding machine to understanding how it works 
on an atomic level. ... It’s just one of the nicest pieces of work 
one will ever see in biology.” 
Seeking what's never been seen 
Horwich rarely sets foot in his office at the Boyer Center for 
Molecular Medicine. He’d rather be in the lab. 
“I just have never matured beyond postdoc,” jokes 
Horwich, a slim man with unruly brown hair, glasses and a 
droopy, graying moustache. “I still work at the bench every 
day. I still like to do my own experiments. I like to be able to 
live with and suffer through the problems of understanding 
how things work side by side with my own people, and I 
always have one or two things for myself that I consider my 
own laboratory struggle.” 
When Horwich must be away, he calls daily to check on 
the progress made by his 10-member team. “I drive them nuts.” 
“He’s a very, very intense person,” says Krystyna }. 
Furtak, m.s., an hhmi research technician who has worked 
with Horwich for 20 years. 
Dressed in faded corduroys, winter and summer, 
Horwich sets up his experiments beside the makeshift office 
he has created at the end of his bench, where piles of journals 
and papers rise from the floor and windowsill. The lab draws 
Horwich like a magnet, because there each day holds out 
the chance, however small, “to see something that’s not been 
seen before.” 
Horwich grew up in River Forest, a Chicago suburb 
where he enjoyed snowball fights that endangered priceless 
stained-glass windows in the neighborhood’s Frank Lloyd 
Wright homes. His father, Walter, a Chicago businessman, 
shares Horwich’s interest in science. 
“He was a sort of frustrated scientist,” Horwich says. 
“He let me be a ham [radio] operator and he was just as inter- 
ested as me. He was up on the roof with me putting up 
antenna systems. He had to draw the line when I wanted to 
bounce the signal off the moon. He wouldn’t let me put a 
dish up on the roof.” 
Horwich graduated in 1975 from Brown Medical 
School, where he was class valedictorian, a fact he mentions 
only to tell a story on himself. “I gave this speech saying 
Brown should train great primary care physicians. So I 
promptly went off and did research.” He jokes that his par¬ 
ents took the speech to heart. “I think the folks are still 
waiting for me to practice medicine.” 
During his pediatrics residency at Yale he felt the 
lure of genetics. After his residency, he spent three years at 
the Salk Institute in California with tumor biologists Walter 
Eckhart, ph.d., and Tony Hunter, ph.d. 
“I watched Tony make what is probably one of the 
most important discoveries of the latter part of the 20th cen¬ 
tury,” Horwich recalls. In 1979 Hunter discovered tyrosine 
phosphorylation, a process that plays a role in normal cell 
signaling and growth and that also contributes to the forma¬ 
tion of cancerous tumors if it goes awry: of 300 genes impli¬ 
cated in cancer, 90 encode tyrosine kinases. 
“Art still works in the lab, which amazes me,” says 
Hunter, still at the Salk Institute. “He seems to have retained 
the enthusiasm for science and the day-to-day excitement 
that most well-established scientists running big labs seem 
to lose.” 
Horwich returned to Yale in 1981 to work with 
human geneticist Leon E. Rosenberg, m.d., hs 63, who 
later became dean of the School of Medicine. I worked 
with a large number of postdoctoral fellows, but none had 
Art’s combination of brilliance, a love of experimentation 
and a fearlessness to learn what he needed to learn to 
go further,” says Rosenberg, now a professor at Princeton. 
A late-night discussion and a mutant yeast 
Horwich’s first significant discovery grew out of a late-night 
conversation in 1987 with then-graduate student Ming 
Cheng, m.d., ph.d., about whether unfolded proteins cross¬ 
ing membranes into mitochondria might get help folding 
into active forms. “Maybe there’s such a thing as a folding 
machine,” Horwich proposed. Using a library of mutant 
yeast strains, they looked for one in which a protein that had 
clearly entered the mitochondria had reached its mature 
size, yet showed no sign of enzyme activity. That would sug¬ 
gest that it had not folded. They found such a mutant within 
days. They could hardly believe what they were seeing. 
They traced the mutation that disabled folding to a 
defective gene for mitochondrial heat shock protein (called 
Hsp6o). Heat shock proteins, scientists believed, played 
a role in protecting already folded proteins. When Horwich 
and Cheng inserted a normal gene for Hsp6o into the 
mutant yeast, protein folding resumed. 
“It didn’t just hold the proteins,” says Horwich, who 
still sounds excited 17 years later. “It folded them. It was a 
folding machine.” 
But Hoiwich’s team was not ready to announce the dis¬ 
covery. “We thought there must be something else to explain 
it. ... We were terrified of being wrong.” They worked with 
another group in Germany to confirm their findings. That 
group was led by Franz-Ulrich Hartl, m.d., ph.d., a director 
of the Max Planck Institute of Biochemistry, who along 
with Horwich and R. John Ellis, ph.d., of the University of 
Warwick in the U.K., won the 2004 International Award 
from the nonprofit Gairdner Foundation, which recognizes 
outstanding achievements in biomedical research. The three 
were honored for having “revolutionized our understanding 
about basic cellular functions.” 
In 1989, after a year of testing and retesting of a 
variety of proteins in mutant yeasts, Horwich and Hartl pub¬ 
lished their findings in Nature. Working together, the 
scientists and their teams went on to show that specialized 
proteins mediate protein folding in archaebacteria, pro¬ 
karyotes and eukaryotes. 
In the years that followed their discovery of the role of 
Hsp6o, Horwich and his colleagues turned to understand¬ 
ing the inner workings of a closely related folding machine 
in bacteria called GroEL, using genetic, biochemical and 
structural methods. Like Hsp6o, GroEL is a chaperonin, a 
double-ringed molecular “machine” that resembles two 
stacked doughnuts. 
Chaperonins begin their work by binding an unfolded 
or misfolded polypeptide molecule inside one of the rings 
(see diagram on page 29). The working principle, Horwich 
says, is that unfolded or misfolded polypeptide chains 
expose hydrophobic (“greasy”) surfaces that become buried 
to the interior in the fully folded, functional (‘ native ) form. 
In the nonnative state, the exposed surface of one protein 
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can stick to that of another, setting off a process of multi- 
molecular aggregation. This results in an inactive protein 
that cannot perform its intended function; in addition, 
aggregates can harm the cell. Binding in a chaperonin ring 
serves to mask such surfaces of the nonnative protein, 
because the chaperonin itself has a cavity lining that is a 
hydrophobic surface, which interacts with that of the 
nonnative protein. It is thus prevented from aggregating. 
The machine then switches to a folding-active state by 
binding atp, a unit of energy currency, and a lid structure, a 
co-chaperonin called GroES. The chaperonin ring that binds 
GroES undergoes large, structural changes that cause its 
hydrophobic lining to turn away from the bound polypeptide 
and interact directly with GroES. In the process, the poly¬ 
peptide is released into the now-encapsulated chamber, 
where it folds to its native form. Proper folding is favored in 
this chamber, because the polypeptide is in solitary confine¬ 
ment with nothing else to aggregate with, and because it is 
now next to watery walls that encourage the burial of its 
hydrophobic surfaces and exposure of its watery ones, prop¬ 
erties of the final native state. Finally, after io seconds, a step 
of conversion of atp to adp causes the machine to release 
the lid structure, and the polypeptide leaves the cavity. As the 
cavity of the ring that had been occupied becomes emptied, 
the other ring swings into action to perform the same func¬ 
tion with another polypeptide chain. 
But each protein does not always fold properly on 
the first try, and Horwich says the protein-folding mechanism 
reveals something fundamental about where a living cell 
directs its energy. The machine will try again and again to fold 
the protein correctly. Each cycle consumes seven atps (energy¬ 
storing molecules), and for some proteins, up to 20 trials may 
be required. “Think of the cost,” says Horwich. “It’s a very 
expensive process. Tire cell has decided it will spend a lot of 
atp to try and correctly edit the protein-folding process.” 
The consequences of misfolded proteins can be dire. 
Misfolded proteins are linked to hundreds of devastating 
diseases—including amyloid diseases such as Alzheimer’s, 
Parkinson’s, Huntington’s, als (also known as Lou Gehrig’s 
disease) and spongiform encephalopathies like mad cow 
disease. In the amyloid disorders, misfolded proteins stick 
together to form fibrils, or plaques, in the brain. Scientists 
are not yet sure how these diseases occur. For example, they 
don’t know whether the fibrils themselves injure the brain or 
This view of the chaperonin 
molecule shows GroEL and GroES 
in images taken from crystal 
structure determinations carried 
out in collaboration among 
Arthur Horwich, Paul Sigler and 
colleagues. 
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whether the misfolded proteins cause damage on their way 
to forming fibrils. 
Looking outside the cell 
After two decades of studying the genesis of proteins within 
the cell, Horwich is interested in what happens to proteins 
in the extracellular spaces of the brain. During a break from 
the lab on a hot afternoon last summer, he mentions being 
both troubled and intrigued by a recent article in Nature 
examining the aging of the human brain. The article, “Gene 
Regulation and dna Damage in the Ageing Human Brain,” 
reports that brain function begins to deteriorate when we get 
“old"—age 40. “That’s the shocker,” says Horwich. “All the 
good things are going down—vesicular trafficking, synaptic 
plasticity. The dna is damaged increasingly. ... Yet all these 
machines that help us to repair damage, including the heat 
shock proteins, are getting induced.” 
He sees some good news in this observation: ramped- 
up defenses suggest avenues for treating disease. Horwich 
envisions two approaches. “If you want to think about what 
to do about neurological diseases that involve misfolded pro¬ 
teins, you could shut down production of the proteins that 
get misfolded. Or you could upregulate this line of defense 
[provided by molecules like chaperonins].” 
He wonders whether the body has other machines 
similar to chaperonins that might prevent the misfolding 
of proteins that causes disease. “What other machine is out 
there that we’ve really missed, that’s outside the cell? Every¬ 
one’s been focused inside the cell.” 
One step is to learn about the structure of the fibrils 
formed by misfolded proteins in the brain. Horwich and 
his team, in collaboration with Wayne Hubbell, ph.d., at 
ucla, have been using a spectroscopy approach to study how 
the normal structure of a serum protein, transthyretin (pre¬ 
albumin) gets converted into an amyloid in a disease known 
as familial amyloid polyneuropathy. 
“I really want to focus on these things. I don’t have an 
unlimited amount of time. After reading the Nature paper 
about the brain, I’m not too optimistic,” says Horwich with 
a wry smile. He’s 53. 
Horwich is not wedded to the idea of curing disease, 
however. “Of course it would be wonderful,” he says per¬ 
functorily. And he does not seem interested in fame. Although 
he was recently elected to the National Academy of Sciences, 
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In the diagram below, a polypep¬ 
tide passes through the folding 
machine GroEL to achieve its proper 
three-dimensional shape. Each 
cycle consumes seven energy¬ 
storing ATP molecules, and for 
some proteins up to 20 trials may 
be required for successful folding. 
and although as a Gairdner winner he has, statistically, 
nearly a one-in-four chance of going on to win a Nobel, 
Horwich shrugs when he is described as a distinguished sci¬ 
entist. It’s the science itself that drives him. “I’m particularly 
interested in seeing the beauty of how Mother Nature has 
handled the problems of protein folding and this last step 
of information transfer. ... Mother Nature decided it’s not 
going to leave even the step of protein folding to chance.” 
Outside the lab, fishing and tennis 
Although Horwich spends long hours in the lab, that’s not 
to say he works nonstop. On weekends, he plays tennis, 
sometimes with his 24-year-old daughter Annie, a photogra¬ 
pher. A few years ago, 26-year-old Michael, an m.d./ph.d. 
student at the University of Massachusetts, introduced his 
father to fly-fishing. When it comes to fishing nowadays, his 
youngest child, sixth-grader Dave, is “a complete fanatic.” 
Horwich is happy to get away occasionally, taking a 
few days off to relax on Block Island or backpack in the 
Adirondacks, “because you think about things on a different 
plane when you’re not right up against it. I’m OK with 
being away from it for a while, but there’s a feeling that it’s 
time to get back and touch it again.” 
His wife, Martina Brueckner, m.d., fw ’90, under¬ 
stands the pull of the laboratory. An associate professor 
of pediatrics (cardiology), she studies the development of 
left-right asymmetry in the embryo, which affects the 
placement of the heart and viscera. They both spend long 
hours in the lab. 
What keeps him in the lab is not the anxiety of fall¬ 
ing behind, says Horwich. “It’s just: can we find the next 
really big thrill? There’s no substitute for the thrills we’ve 
had. Most people are lucky if they have one. I’ve had two.” 
The first came after he and Cheng found the yeast 
mutant that failed to fold proteins. The second came when 
Horwich saw for the first time the structure of the bacterial 
chaperonin. For four challenging years in the 1990s, 
Horwich and his team had collaborated with the group led 
by the late Yale structural biologist Paul B. Sigler, m.d., 
ph.d., trying to get an image of the protein molecule. They 
grew hundreds of crystal forms of GroEL, altering each 
slightly in hopes of finding one that would create a clear 
image by means of X-ray crystallography. Then, at last, one 
of Horwich’s graduate students, Kerstin Braig, hit upon a 
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crystal that worked. It was a molecule that had an accidental 
mutation that made it diffract well. Horwich calls the dis¬ 
covery pure luck. 
Just a few days later, Horwich’s and Sigler’s groups 
drove to the synchrotron at Cornell in Ithaca, N.Y., where 
they could use its high-intensity X-ray source to collect more 
data about the molecule. Assembling the data, or “phasing 
the crystal,” required several trips over several months, and 
Zbyszek Otwinowski, ph.d., a member of Sigler’s lab at the 
time, performed what Horwich describes as “an amazing 
feat.” In just two days, Otwinowski “solved the structure” of 
GroEL and created a three-dimensional model of the protein. 
“We worked for four years trying to get the crystalline 
structure of this, and there it was, at atomic-level resolution. 
That was a religious moment.” 
Having experienced these highs creates a certain 
tension. “It’s a wonderful experience, but you always won¬ 
der, are you ever going to have another really fabulous 
revelation? You try to set things up so you will. You tiy to see 
beyond where things are, to see a way to open up a system 
so you can see how things work in one fell swoop. Science is 
usually more incremental, and that’s OK. It’s where you 
get to see a whole vista at once—that is really special stuff. 
“It’s like pulling Venus from the waves. You have 
no idea what you’re going to see until you see it. It’s just 
unbelievable.” ym 
Cathy Shufro is a contributing editor of Yale Medicine. 
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Recreating 
the residency 
Under new rules, residents may not work more than 80 hours a week 
This change has forced physicians to rethink the underpinnings not only of training, 
but also of patient care. 
By Peter Farley 
Photographs by John Curtis 
n the night of March 4, 1984, 
an 18-year-old patient named 
Libby Zion was admitted to 
the emergency room of Cornell 
Medical Center’s New York 
Hospital complaining of fever 
and an earache. Just hours 
later, while in the care of the 
hospital’s residents, she lay 
dead. Zion’s father, Sidney 
Zion, was a prominent, well-connected journalist and a for¬ 
mer federal prosecutor, and in what would soon become 
notorious as “the Zion case,” he and his wife filed suit, 
claiming that the negligence of the hospital’s overly fatigued 
and poorly supervised house staff was the direct cause of 
their daughter’s death. 
In the end, a New York grand jury did not find suffi¬ 
cient evidence that overtired residents were responsible 
for Zion’s death, and postmortem lab results suggested that 
she had died from an overdose of cocaine. But the enormous 
publicity surrounding the Zion case cast a bright light on 
aspects of graduate medical education that the American 
public had long ignored. Medical residents’ duty hours, once 
an esoteric and jealously guarded prerogative of medical 
school faculty and hospital administrators, had become the 
focus of intense interest on the part of legislators and regula¬ 
tory boards nationwide. 
In the wake of the Zion case, New York state and 
Puerto Rico enacted statutes that set limits on duty hours for 
hospital house staff. But the most significant shock wave 
from the case wasn’t felt until July 2003, when the Accredita¬ 
tion Council for Graduate Medical Education (acgme), citing 
concerns for patient safety, imposed strict limits on residents’ 
duty hours at all teaching hospitals. Though the rules them¬ 
selves are straightforward—they limit residents to an 8o-hour 
workweek and 24 continuous hours on call, and guarantee 
one day off each week—they have set off a sea change in 
American medical education and patient care. The traditional 
residency system was deeply ingrained in the educational 
structures of medical schools, and the presence of hardwork¬ 
ing, inexpensive house staff has long been taken for granted 
by hospitals in their day-to-day operations. 
Yale is no exception. Some 175 new residents in spe¬ 
cialties as diverse as anesthesiology and urology arrive in 
New Haven each year. Though most of these residents are 
technically employees of Yale-New Haven Hospital (ynhh), 
the dual educational and clinical missions of residency are 
reflected in the Graduate Medical Education Committee, 
which directly oversees the program and reports both to the 
chief of staff at ynhh and to the dean’s office at the School 
of Medicine. 
Some residency programs, such as pediatrics and psy¬ 
chiatry, have adapted fairly easily to the new rules, but for 
At the end of the morning, after 
work rounds, residents’ report 
and attending rounds, Charles Dela 
Cruz and Loida Viera (foreground) 
go over treatment plans for their 
patients, as do Francis Chan and 
Robert Bercovitch. 
A day in the life 
By 7:15 on a recent Monday morning, 
intern Loida Viera, M.D., and second- 
year resident Charles Dela Cruz, M.D., 
have been working for 24 hours 
straight in ynhh's new Acute Care 
for the Elderly (ace) unit. Viera 
admitted six patients to the unit dur¬ 
ing the night, and she and Dela Cruz 
are preparing for “work rounds,” dur¬ 
ing which they will convey all they 
know about the new patients to 
their counterparts on their residency 
team, intern Robert Bercovitch, M.D., 
and second-year resident Francis 
Chan, M.D. Medical student Robert 
McGlynn will join them. 
Along with attending physician 
Leo M. Cooney Jr., M.D. ’69, Humana 
Foundation Professor of Geriatric 
Medicine, the five move in a tight 
pack through the hallways before 
coming to rest in the hall outside 
the room of a newly admitted 
patient. By traditiop, interns pres¬ 
ent cases, and Viera, a freshly 
minted graduate of Tulane Uni¬ 
versity School of Medicine, 
betrays no fatigue Or uncertainty 
as she fashions clipped, efficient 
clinical narratives from the bliz¬ 
zard of acronyms, abbreviations 
and numerals that are the lingua 
franca of modern medicine. 
The truism that today’s patients 
are far sicker than those under resi¬ 
dents’ care 30 years ago is nowhere 
more true than in Cooney's ace 
unit. As Viera presents updates on 
the unit's more familiar cases, Chan 
and Bercovitch must keep track of 
multiple diagnoses, a litany of test 
results and combinations of several 
medications for each patient as 
they prepare for their shift. 
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others the regulations have forced a sweeping re-evaluation 
of both education and patient care. For example, the sheer 
size and complexity of the residency program in internal 
medicine, which shepherds 180 residents through 13 clinical 
rotations at four different hospitals each year, have required 
painstaking organizational and educational adjustments. 
“The structure of the program at Yale has been built 
over the last 50 years, and it has been built in pieces, so 
nobody knew when you changed one piece what the domino 
effect would be,” says Asghar Rastegar, m.d., professor 
of medicine (nephrology) and associate chair for academic 
affairs. “This is sort of like a spring cleaning. Every room 
in the house had to be looked at.” 
Institutions that skirt the new rules do so at their own 
peril. In 2002 the acgme threatened to withdraw accredita¬ 
tion of the surgical residency program at Yale for violations 
of its previous duty-hours guidelines, and the accrediting 
board has come down hard on other elite programs since 
July 2003. Residency programs at Johns Hopkins, Duke and 
the University of Rochester have been subjected to similar 
“adverse actions” by the acgme. However, just one year after 
the new rules took effect, Rosemarie L. Fisher, m.d., hs ’75, 
professor of medicine (digestive diseases) and director of 
graduate education at the School of Medicine, says that Yale 
has adapted well. According to Peter N. Herbert, m.d. ’67, 
hs ’69, chief of staff and senior vice president for medical 
affairs at ynhh, the close call with the surgical program’s 
accreditation may have been a blessing in disguise: the 
crisis led ynhh to take steps over the past two years—the 
Department of Surgery hired 12 physician assistants to 
lighten residents’ workloads, for example—that put Yale 
ahead of the curve for compliance. 
Herbert says that problems arising from the new regu¬ 
lations may loom large at the moment, but he is confident that 
the rules will present few difficulties for Yale or for graduate 
medical education in general in the long run. “I think all of 
these concerns will be history in two or three years,” Herbert 
says. “We will find a way to educate our residents and to give 
them all the necessary experiences, in and out of the operating 
room, and at the same time take good care of patients.” 
Education or service? 
has been a screenwriter’s staple since the earliest days of 
television medical dramas. A harried hospital resident, run¬ 
ning on empty after yet another all-nighter, slinks into a dark¬ 
ened storeroom during an unexpected lull. The young doctor 
lies down and closes her eyes. But after just a few seconds of 
blessed sleep, the door bursts open—emergency! Cut to our 
rudely awakened heroine, who shakes off her drowsiness and 
rushes off to slay whatever dragon may await. 
Any doctor knows that the relentlessly action-packed 
arena of ER only faintly resembles the everyday practice 
of medicine, but the stock character of the sleep-deprived 
resident is drawn from real life, and has been a familiar 
figure in hospital hallways for a century. 
The punishing life of the resident, like many other 
features of graduate medical education in America, was 
a product of innovations in medical education made by 
William Halsted, m.d., a Yale College graduate who founded 
the vastly influential surgical training program at the Johns 
Hopkins Hospital during the 1890s. 
For Halsted, who strongly admired the German medi¬ 
cal system of his day, “residency” was literal: he required 
doctors in training to live at the hospital, and he discouraged 
his charges from marrying to ensure that they gave their 
all to the profession. His residency system combined the 
rigor of boot camp, the asceticism of the monastery and the 
esprit de corps of a college fraternity. 
Senior physicians often speak of this system as if it had 
been in place since Hippocrates, but as Kenneth M. Ludmerer, 
m.d., professor of medicine and history at Washington 
University in St. Louis, says, residency was only one of many 
possible routes to medical specialization in Halsted’s time, 
and it did not become the dominant system in graduate medi¬ 
cal education until the 1920s. Moreover, says Ludmerer, 
author of Time to Heal: American Medical Education From the 
Turn of the Century to the Era of Managed Care, residency was 
originally considered a privilege reserved for a few students 
who had demonstrated promise for an academic career, and 
a high attrition rate was considered a virtue. 
“The concept was to start with a broad range of tal¬ 
ented individuals, and of those, to select the very best,” says 
Robert Udelsman, m.d., m.b.a., Lampman Professor of 
Surgery and Oncology, chair of the Department of Surgery 
and chief of surgery at ynhh. This model was known as 
the “pyramidal system,” because fewer residents remained 
in a program each year; only those at the top tier survived 
to become senior or chief residents. 
33 
After World War II, several trends converged to 
“democratize” residency, vastly increasing enrollments in 
residency programs. An explosion in medical knowledge 
made specialization increasingly necessary, and there was 
growing pressure on faculty at teaching hospitals to 
provide clinical care while pursuing research. The availabil¬ 
ity of more residents to care for patients freed faculty for 
laboratory work, and residents took on more responsibility 
for teaching medical students. By the 1950s, grueling 100- 
hour workweeks had become the norm for residents, but the 
system was remarkably efficient and cost-effective. As 
Udelsman says, residents “worked like the devil, didn’t com¬ 
plain too much and saved hospitals a fortune.” 
But according to medical historian Ludmerer, the 
educational mission of residency suffered greatly as hospi¬ 
tals increasingly relied on house staff for clinical care. “The 
dominant theme in the history of graduate medical educa¬ 
tion is the ongoing tension between education and service,” 
Ludmerer says. Graduate medical education still comes 
under fire for overemphasizing service and de-emphasizing 
education, a charge leveled since the 1930s, he says. 
If anything, the devaluing of residents’ educational 
experience has only increased in the era of managed care— 
patients admitted to the hospital are far sicker and require 
more medical care than inpatients of a generation ago. 
Moreover, in the face of the recent nursing shortage resi¬ 
dents have shouldered duties that have little or no relevance 
to the education of a physician. Because patient care must 
always take precedence over opportunities to teach medical 
students, medical school education has suffered as well. 
Nevertheless, Herbert says, arguments to reform residency 
to better meet educational goals have largely fallen on deaf 
ears, while the patient-safety crusade that grew out of the 
Zion case ultimately carried the day, leading directly to the 
acgme’s restrictions on duty hours. 
Unintended consequences 
Like military service or athletic competition, enduring the 
trials of traditional residency has been a source of great 
pride and camaraderie for generations of physicians and has 
undoubtedly burnished the profession’s mystique in the 
public mind. But whatever its romantic aspects, the intense 
schedule of the medical resident had a purely practical ben¬ 
efit known as “continuity of care”: by treating newly admit- 
As the intern who admitted 
patients overnight, it falls to 
Viera to present their cases 
at morning rounds. 
At 11 a.m. Leo Cooney leads 
attending rounds, an hour- 
long discussion of cases of 
interest from morning rounds. 
By 9 a.m., the handoff is com¬ 
plete, and Dela Cruz and Chan are 
free to attend residents’ report, an 
informal one-hour exchange of ideas 
among the chief resident, attending 
physicians and house staff, while 
Bercovitch keeps an eye on patients 
in the ace unit. Meanwhile, Viera 
huddles in front of a computer 
screen in a small ace workroom with 
McGlynn, using the six postcall 
hours that remain under Accredita¬ 
tion Council for Graduate Medical 
Education (acgme) rules to complete 
paperwork and order tests and 
medications for her patients. 
At 11 a.m., the four residents 
and interns are reunited for 
attending rounds, where Cooney 
compresses more than 30 years of 
clinical wisdom into a one-hour 
lecture based on cases of interest 
in the unit. Today’s topics: gout 
and pressure sores, two banes of 
geriatric medicine. Cooney seam¬ 
lessly weaves anecdotes from his 
hospital experiences and his days 
as a volunteer physician at a home- 
Recreating the residency l 
ted patients for long, uninterrupted stretches, budding doc¬ 
tors could see the natural course of disease and the effects of 
treatment unfold in ways no textbook could describe. 
The new limitations on duty hours inevitably create 
breaches in continuity of care. Under the acgme rules, 
residents must leave the hospital when their shift is over 
regardless of the clinical situation at hand, and the lack 
of flexibility in this regulation is the greatest source of dissat¬ 
isfaction among both faculty and residents. 
Robert J. Alpern, m.d., the Ensign Professor of 
Medicine (nephrology) and dean of the School of Medicine, 
says that “continuity of care was one of the best parts of the 
educational experience. Limiting continuity of care is espe¬ 
cially bad for education because you learn about a patient 
much better if you follow them through their whole treat¬ 
ment.” Surgery chair Udelsman agrees. “I don’t think there’s 
any question that the residents are sleeping more, are home 
more, and I think they basically like that,” he says. “There’s 
also no question that they’re not getting as much exposure 
to patient care as they used to. There’s no getting around it.” 
The same is true for medical students, whose schedules 
are tethered to resident teams’ shifts, says Herbert S. Chase 
Jr., m.d., professor of medicine (nephrology) and deputy dean 
for education at the medical school. “One learns by observing 
a patient live the natural history of an illness from beginning 
to end,” Chase says. “In the future, students are going to 
have to piece together the mosaic of a syndrome; they’re only 
going to see snippets of it. It will never be the same.” 
But the advantages of continuity of care are not just 
educational. Though it might seem obvious that better-rested 
physicians will improve patient safety, Rastegar says that 
rigorous studies on this question in a medical setting are 
sparse and inconclusive. David J. Leffell, m.d., hs ’86, pro¬ 
fessor of dermatology and surgery and associate dean for 
clinical affairs, has similar concerns. “I don’t know if there’s 
any evidence that an 8o-hour workweek is advantageous 
apropos risk,” says Leffell. “It seems like an arbitrary figure.” 
On the other hand, there were some clear advantages 
to the traditional residency’s longer hours. For one thing, 
longer schedules meant fewer “handoffs” of patient histories 
and test results from one resident to another when signing 
ut. Fisher used to warn residents to be especially vigilant 
about the possibility of medical errors during handoffs, 
' hich she says can come perilously close to the children’s 
game of “Telephone”—information passed from one person 
to another changes as it moves down the line. Though the 
pitfalls of handoffs are more subtle than resident fatigue and 
have largely escaped the notice of regulators, Rastegar says 
that two studies published in the 1990s in Annals of Internal 
Medicine and JAMA: The Journal of the American Medical 
Association presented convincing and worrisome data to 
back up Fisher’s concern. “There’s a trade-off between a 
rested team and handoffs,” he says. “Often handoffs have 
more negative impact on patient care than residents who 
have worked longer hours.” 
Herbert says that some of these problems should 
diminish over the next three years as ynhh becomes an 
increasingly “paperless” hospital. “We need exquisitely tight 
signoff systems from caregiver to caregiver when we have 
so many more individuals involved in the care of patients,” 
he says. “The handoff with index cards and paper sheets is 
still going on, but there’s a lot of effort on computerized 
formats for doing signout, so any caregiver can go into the 
computerized medical record and see the major concerns 
and things that need to be followed up in patient care.” 
Even as systems are put in place to alleviate proce¬ 
dural issues, many faculty worry that the new rules will 
create a “shift-worker” mentality in residents that will erode 
the absolute commitment to patient care so esteemed in tra¬ 
ditional residency. Reports of residents at other institutions 
being physically forced to leave hospitals at the moment 
their duty hours end are troubling to those trying to instill 
absolute dedication to patients’ welfare at Yale. “Those are 
the residents you want to be your doctor when they leave,” 
says Leffell, “because they’re the ones who care the most.” 
Meeting the challenge 
Whatever the shortcomings of the new rules, those entrusted 
with implementing them are convinced that they are here 
to stay. Instead of greeting the acgme ruling with a grudg¬ 
ing passivity, Yale faculty and ynhh administrators have 
seized the moment to examine the fine structure of the resi¬ 
dency system at Yale. Their ultimate aim is not rote compli¬ 
ance with the rules, but a reinvention of medical training 
that meets requirements but exceeds expectations in both 
education and clinical care. 
For example, surgical volume is sharply up in 
Udelsman’s department, which has added 22 surgeons to 
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the faculty in just the past two years. Because today’s hospi¬ 
tal patients need a great deal of care, the reduction in resi¬ 
dent duty hours has required junior faculty to perform many 
tasks formerly handled by interns; some assistant professors 
are logging in excess of 80 hours a week since the acgme 
rules were enacted, Udelsman says. 
His department has hired a dozen physician assis¬ 
tants to relieve residents and comply with the rules, but 
Udelsman suggests that tapping retired surgeons in the New 
Haven area would be a creative way to take up even more 
clinical slack. “What a waste to have these people sitting at 
home doing crossword puzzles when they could be in the 
operating room two or three days a week doing what they 
love to do,” he says. “It could be a win-win situation.” 
In the Department of Internal Medicine a hospitalist 
service has been formed to care for an increasing number of 
patients who cannot be cared for by the medical house staff. 
When it became clear that restrictions on duty hours 
were inevitable, Rastegar and his colleagues in the Depart¬ 
ment of Internal Medicine began to convene regular meet¬ 
ings of residents, chief residents and faculty to take a fresh 
look at house staff policies. “There was no blueprint to fol¬ 
low,” says Rastegar. “We had to develop it locally for our own 
hospital, and we knew we wouldn’t get it right the first time.” 
They didn’t. A system in place last year was deemed 
unworkable and was jettisoned in favor of the current model, 
which is based on teams of two senior residents and two interns 
(first-year residents) under the watchful eye of an attending 
physician. Two medical students are assigned to each team. 
One resident/intern pair in a team arrives for duty at 
about 7:30 a.m., working through the night and admitting 
new patients until 7:30 the next morning, when the other resi- 
dent/intem pair arrives. The first pair is now deemed to be 
“postcall”; according to the new acgme regulations, this pair 
may hand off patient care to the second team during rounds, 
but they may not admit new patients and they must refrain 
from any other clinical duties not crucial to continuity of care. 
After rounds, which start at 7:30 a.m. and last until 
about 9 a.m., responsibility for the unit’s patients is in the 
new pair’s hands, and with the medical student's help, the 
first team’s intern completes orders for tests and medica¬ 
tions and any other paperwork. The postcall pair are also 
permitted to use any of their remaining six hours for confer¬ 
ences or other educational activities. 
As they prepare to hand off their 
patients, Wendy Chen and 
Kathryn Hogan describe their 
cases to Viera. 
During breaks between meetings, 
residents, attendings and interns 
repair to a staff room to complete 
their notes and order tests and 
medications for their patients. 
less shelter together with precis 
of recent articles on molecular 
medicine, and delivers the whole 
package with warmth and humor. 
After a thorough review of 
Viera’s notes, Dela Cruz attends a 
lunch conference and leaves at 1 
p.m. On those days when her notes 
are complete, Viera leaves at noon. 
She may opt to spend her lunch 
hour at Fitkin Amphitheater, where 
a changing cast of faculty present 
intern-friendly lectures on various 
clinical concepts. 
Viera will return at 7:15 the 
following morning, but for now 
Chan and Bercovitch have taken 
the reins. 
For Asghar Rastegar, M.D., 
professor of medicine (nephrol¬ 
ogy) and associate chair for 
academic affairs, the key to pre¬ 
serving professionalism and a 
commitment to patient care 
under the new rules lies in a “cul¬ 
tural shift”: residents must be 
convinced, he says, that patients' 
interests will be best served 
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At i p.m., after a 30-hour shift, the first pair is offi¬ 
cially off duty until the next morning’s rounds. Each resi¬ 
dent/intern pair completes two such shifts per week, and 
puts in two days’ worth of more standard hours to approach 
the 8o-hour maximum. 
In the previous model, one resident supervised two 
interns, who could each admit five new patients and one 
patient transferred from another ward. Though interns can 
still admit the same number of patients, having two resi¬ 
dents on the team should significantly improve both patient 
care and education, says Cyrus R. Kapadia, m.d., fw ’78, 
professor of medicine (digestive diseases) and director of the 
residency training program. “Now the resident has time to 
read more about a couple of his or her patients, and to 
spend more time teaching the intern and the medical stu¬ 
dent,” Kapadia says. 
The acgme has been unwavering in its enforcement 
of the 8o-hour week, which faculty members say was 
probably necessary for hospitals to take the ruling seriously. 
And everyone agrees that they would much rather police 
their own programs in concert with the acgme than submit 
to auditing by a government agency in the event that federal 
restrictions on duty hours were passed. 
An unexpected gift 
“House staff and trainees are probably more conservative 
than faculty,” says Fisher. “They’ll tell you all the time that 
they’d love to see change, but when it comes to making 
major changes, ‘Well, maybe you can do it next year, when 
I’m gone.’” 
Perhaps, but Farshad Abir, m.d., a fifth-year adminis¬ 
trative chief resident in surgery who completed the first two 
years of his residency before the new rules took effect, has 
no doubt that the ACGME-mandated changes are all for the 
better. "Just like anything in life, when you start something 
new you’re going to have kinks that need to be ironed out,” 
Abir says. “But I think definitely we’re moving in the right 
direction—100 percent. 
“The way it used to be was awful,” says Abir, who 
regularly logged 120-hour weeks as a junior resident. The 
chance to straddle both systems has given him “perfect 
training,” he says, because having learned to budget his 
under the old rules, he views the new workweek as an 
unexpected gift of 40 extra hours. 
At the end of a day, with the 
entire night still ahead of her, Viera 
checks on a patient’s X-rays. 
when they scrupulously watch 
out for their teammates. He 
and his colleagues have taken 
pains to see that the handoff 
process is not only thorough, 
but sufficiently reassuring for 
dedicated residents to go off 
duty with a clear conscience. 
“It only works if you know that 
the team behind you is going to 
do everything possible to take care 
of the patient and take care of 
you, and if they know that you will 
do the same thing,” Rastegar 
says. “That you cannot write on 
a piece of paper.” 
Surgery chair Udelsman would understand. Recall¬ 
ing his own resident days, he says, “I saw my kids at 11 at 
night when I got home. My wife would wake them up so I’d 
actually see them once in a while!” Udelsman believes that 
the traditional residency, whatever its strengths, created “abu¬ 
sive” physicians, and Herbert agrees: “You can’t treat physi¬ 
cians like work animals and expect that they’ll come out of it 
with correct attitudes,” he says. “I think in the end we’ll have 
more humane surgeons.” 
Although Herbert’s ynhh desk sits squarely at the cen¬ 
ter of the fray in implementing the new acgme regulations, 
he exudes confidence when asked about the future. “It’s a 
radical change for those of us who are members of the old 
guard, and we can’t believe that we can play on this field, but 
in fact we will play on it,” Herbert says. “Patient care will be 
as good, and education will be as good as well.” ym 
Peter Farley is a freelance writer based in Boston. 
I Essay DONALD S. KORNFELD, M 
Are “bioethicists” really 
any wiser? 
A physician ponders the term and 
wonders who is qualified to make 
medical decisions. 
Last fall readers of this magazine were 
invited to present “thorny professional 
situations” to a panel of “bioethics 
experts,” who would discuss the dilem¬ 
mas raised in an article in Yale Medicine 
(“Two Alternatives, Each a Little 
Wrong,” Spring 2004). In that article, 
it was noted that the bioethics com¬ 
mittee at Yale-New Haven Hospital 
includes “ethicists” in addition to doc¬ 
tors, nurses, lawyers, social workers, 
clergy and members of the commu¬ 
nity. The initial inquiry, the discussion 
and the description of the committee 
prompted me to ask, what exactly is 
a “bioethicist" anyway? 
I have served on an ethics commit¬ 
tee at the Columbia-Presbyterian 
Medical Center for more than 20 years, 
as chair of two institutional review 
boards for 18 and as director of the 
psychiatric consultation service in 
a general hospital for 35. I have been 
involved in attempts to resolve scores 
of ethical dilemmas. Does this qualify 
me as a bioethicist? Apparently it 
does, if I choose to anoint myself as 
one. And therein lies the problem. 
In many situations the designation 
“bioethicist” grants individuals author¬ 
ity that they did not have the day before 
they assumed that role. In my opinion, 
studying bioethics as an academic dis¬ 
cipline does not provide any special 
wisdom in the resolution of a clinical 
ethical dilemma, and it is wisdom that 
is most needed. Before I begin to 
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sound like an academic Neanderthal, 
I want to make clear that I do believe 
such study is useful in identifying the 
basic principles that may underlie these 
clinical decisions. However, while the 
ability to identify paternalism, benefi¬ 
cence or autonomy as manifested in a 
particular decision may provide some 
clarity, it does not provide the analyst 
with any greater sagacity in making it. 
As a psychiatrist, I am also particu¬ 
larly troubled to observe that emotional 
conflicts, which are often at the root of 
such problems, can be ignored in a 
quest for an overriding ethical principle. 
Even when emotional conflicts are 
acknowledged, they are often framed 
using a legal/business model requiring 
negotiation, mediation or arbitration. 
The American Society for Bioethics and 
Humanities includes among its core 
competencies for a clinical ethicist the 
skills needed to identify the conflict 
that underlies a need for consultation 
and the ability to recognize and attend 
to various relational barriers in com¬ 
munication. These skills are not easily 
acquired in a classroom or a brief 
clinical assignment. 
In the examples presented in the 
Yale Medicine article, the bioethicists 
disagreed on an appropriate course of 
action or policy. This is not surprising, 
since such decisions are ultimately 
subjective and more likely to reflect 
personal beliefs than knowledge. For 
example, in the bioethics textbook 
Taking Sides: Clashing Views on Contro¬ 
versial Issues in Drugs and Society, 
opposing points of view are expressed 
on 21 out of 21 issues. At the sympo¬ 
sium on clinical ethics at the 2004 
Yale Medical School Reunion, Robert J. 
Levine, m.d., hs ’63, professor of 
medicine, co-founder of the hospital’s 
ethics committee and a leader in this 
field, stated that a medical decision 
should never rest on the advice of a 
single bioethicist, although hearing 
a pair of ethicists discuss their reason¬ 
ing can be illuminating. 
Therefore, it is particularly worri¬ 
some when bioethicists, especially 
those without clinical experience, influ¬ 
ence medical decisions. 
A similar problem, the influence of 
personal opinion rather than knowledge, 
also exists in the establishment of gov¬ 
ernmental health and research policy. 
A recent article in The New England 
Journal of Medicine written by a former 
member of President Bush’s Council on 
Bioethics describes her experience as a 
politically incorrect council member who 
was not reappointed, which illustrates 
this only too well. 
Nevertheless, I do believe that the 
discussion of ethical issues in clinical 
matters and public policy is useful. 
Scholars of bioethics add an intellec¬ 
tual dimension to such deliberations 
that can help participants arrive at 
useful consensus judgments. However, 
we should question the basis for 
attributing superior wisdom to bio¬ 
ethicists, thereby increasing their 
authority in finding resolutions to 
“thorny professional situations.” 
Donald S. Kornfeld, m.d. ’54, hs ’55, a psychia¬ 
trist, is an associate dean at the College of 
Physicians & Surgeons at Columbia University. 
WE WELCOME SUBMISSIONS 
Do you have an opinion to share on a vital 
topic in medicine, health or science? Send 
yours to Essay, Yale Medicine, P.O. Box 7612, 
New Haven, CT 06519-0612, or via e-mail to 
ymm@yale.edu. 
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Two appointed to 
Cancer Center posts 
Two Yale scientists named 
to new positions at 
the Yale Cancer Center. 
IRA MELLMAN, PH.D. ’78, chair 
and Sterling Professor of Cell 
Biology and professor of immuno¬ 
biology, has been named scientific 
director, edward chu, m.d., 
professor of medicine (medical 
oncology) and pharmacology, has 
been named chief of medical 
oncology. 
As scientific director Mellman 
will have a central role in the 
recruitment of cancer scientists 
and will collaborate closely with 
Chu and Jose Costa, m.d., the cen¬ 
ter’s deputy director. Mellman’s 
research combines cell biology and 
immunology to understand funda¬ 
mental mechanisms of antigen 
processing and presentation by 
cells. His leadership skills and 
familiarity with the Yale research 
community make him an ideal 
choice for the new position, said 
Richard L. Edeison, m.d. ’70, direc¬ 
tor of the Yale Cancer Center, who 
announced the appointments. 
“His seminal contributions 
to our understanding of how 
dendritic antigen-presenting cells 
trigger immune reactions have 
profound implications for the field 
of tumor immunotherapy, a major 
area of interest in the Cancer 
Center,” Edeison said. 
Chu plans to build on Yale’s 
strengths in several areas as he 
recruits new faculty and builds up 
translational clinical research as 
well as the cancer clinical pro¬ 
gram. "My challenge,” said Chu, “is 
to be able to recruit a large num¬ 
ber of new clinical faculty. Their 
main task, along with the current 
faculty, is to expand our clinical 
programs and really work with the 
scientists here on campus to trans¬ 
late the great discoveries from the 
laboratories into the clinic to treat 
cancer patients.” 
“Dr. Chu brings a special blend 
of clinical skills, major accomplish¬ 
ments as an innovative cancer 
researcher, familiarity with our 
school and hospital, and demon¬ 
strated leadership talents to the 




WILLIAM H. SLEDGE, M.D., HS’73, 
fw ’75, professor of psychiatry and 
master of Calhoun College, has 
been appointed the first George D. 
and Esther S. Gross Professor of 
Psychiatry. 
Sledge is the medical director 
of the Yale-New Haven Psychiatric 
Hospital and assistant chief of 
psychiatry at Yale-New Haven Hos¬ 
pital. He is the editor or co-editor 
of the Encyclopedia of Psychotherapy, 
Clinical Challenges in Psychiatry 
and Core Readings in Psychiatry: An 
Annotated Guide to the Literature 
(second edition). 
Among his professional inter¬ 
ests are research into schizophrenia, 
aviation psychiatry, community 
and public-sector psychiatry, the 
doctor-patient relationship, 
the education of psychiatrists and 
medical students and the efficacy 
of mental health services. 
Sledge came to the Depart¬ 
ment of Psychiatry as a resident 
in 1972, but upon completion of 
his residency he served in the Air 
Force, only to return to Yale as a 
member of the faculty in 1977. 
From 1987 to 1994 he was at the 
Connecticut Mental Health Center, 
as director of the outpatient divi¬ 
sion, clinical director and acting 
center director. Among his numer¬ 
ous honors is a listing since 2000 
in “Best Doctors in America.” 
The chair was established 
through the support of the 
Elizabeth K. Dollard Charitable 
Trust and the Esther S. Gross 
Trust. The Gross Trust was estab¬ 
lished by George D. Gross, m.d. ’36, 
and Esther S. Gross, m.d. Elizabeth 
K. Dollard, J.D. ’39, had a life¬ 
long interest in the interactions 
of psychiatry, law and medicine. 
Mary Warner 
Warner named 
director of Physician 
Associate Program 
MARY L. WARNER, M.M.SC., 
pa-C, interim director since last 
November, has been named 
assistant dean and director of the 
Physician Associate Program. 
Warner came to Yale in 2000 to 
oversee curriculum for the pro¬ 
gram’s first-year courses and was 
the program’s assistant director 
for didactic curriculum from 2001 
until 2003. She is a 1991 graduate 
of the Emory University School 
of Medicine’s Physician Assistant 
Program and has served in several 
roles at Ouinnipiac University 
and at Bridgeport Hospital, where 
she is a clinician in emergency 
medicine. She was appointed to 
the Connecticut State Board of 
Medical Examiners in 1999 and 
is a member of the Research 
Institute of the Association of 




Margaret Pisani Terri Fried Diane Callo- 
VanEss 
Akira Kugaya Bruce McClennan 
Sharon K. Inouye, m.d., m.p.h. ’89, 
professor of medicine and direc¬ 
tor of the Yale K12 Mentored 
Clinical Research Scholar Award 
Program, announced four award 
recipients for 2004-2005. The 
recipients are Karen B. Dorsey, 
m.d., postdoctoral fellow in 
medicine (clinical scholars pro¬ 
gram); Nina Kadan-Lottick, m.d., 
associate research scientist in 
pediatrics (hematology/oncol¬ 
ogy); Peter T. Morgan, PH.D., M.D., 
assistant professor of psychiatry; 
and Margaret A. Pisani, M.D., 
m.p.h. ’01, assistant professor of 
medicine (pulmonary and criti¬ 
cal care). The K12 Program, funded 
by the National Institutes of 
Health National Center for 
Research Resources, provides a 
stipend and a research and 
tuition allowance to physician- 
investigators pursuing careers 
in patient-oriented research. 
Terri R. Fried, m.d., associate pro¬ 
fessor of medicine (geriatrics), 
received the Outstanding Scien¬ 
tific Achievement for Clinical 
Investigation Award in May at 
the annual meeting of the 
American Geriatrics Society in Las 
Vegas. Fried studies the prefer¬ 
ences for care of older persons 
who are acutely and terminally ill. 
Diane M. Gallo-VanEss, m.d., clini¬ 
cal instructor of pediatrics at Yale 
and a senior staff member at 
Bridgeport Hospital, was elected 
to the board of trustees of the 
Fairfield County Medical Associa¬ 
tion (fcma) at its 212th semi¬ 
annual meeting. Gallo-VanEss 
has been a member of fcma, a 
professional membership organi¬ 
zation devoted to a healthier 
Fairfield County, since 1986. 
Ami J. Klin, PH.D., the Harris 
Associate Professor of Child 
Psychology and Psychiatry, and 
Fred R.Volkmar, M.D.,the Irving 
B. Harris Professor of Child 
Psychiatry, Psychology and 
Pediatrics, are principal investi¬ 
gators for a $2.6 million grant 
that will establish a new labora¬ 
tory at the Yale Child Study 
Center for infants at risk for 
autism.The grant was made by 
James and Marilyn Simons of 
The Simons Foundation, a pri¬ 
vate family foundation based in 
New York City. In this new proj¬ 
ect, babies at increased risk for 
autism will be examined monthly 
from birth through their first 
two years of life. The grant, 
said Volkmar,“will enable us to 
study infants with autism at a 
time when there is the greatest 
potential for change of behav¬ 
ior and brain development. 
We hope this will lead to more 
effective interventions.” 
The Department of Psychiatry 
announced this year's winners 
of the Seymour L. Lustman 
Research Award, which recog¬ 
nizes individuals who have 
achieved distinction in research 
and scholarship during their 
residencies.The first- and 
second-place winners, Akira 
Kugaya, M.D., ph.d., resident in 
psychiatry, and PeterT.Morgan, 
ph.d., m.d., assistant professor 
of psychiatry, presented their 
papers at departmental grand 
rounds in June. 
Nita J. Maihle, ph.d., professor 
of obstetrics and gynecology, 
was elected in June to a one- 
year term as the chair-elect of 
the Women in Cancer Research 
Council of the American Asso¬ 
ciation for Cancer Research. 
Maihle, a cancer biologist, will 
lead the council in promoting 
and increasing the professional 
development and achievements 
of women in the field of cancer 
research. 
Bruce L. McClennan, m.d., profes¬ 
sor of diagnostic radiology, has 
been named deputy editor of 
rsna News (Radiological Society 
of North America) and vice¬ 
chair of the rsna News Editorial 
Board. McClennan has been a 
member of the rsna since 1975 
and is currently chair of the pub¬ 
lic relations committee for the 
rsna Research and Education 
Foundation. 
Curtis L. Patton, ph.d., professor 
of epidemiology and public 
health and head of the Division 
of Global Health, received the 
Edward A. Bouchet Leadership 
Award at the Graduate School’s 
May 23 Convocation. The 
Bouchet Leadership Award, 
established in 2002, honors 
Edward Bouchet, the first 
African-American graduate of 
Yale College. The son of a Yale 
porter, Bouchet graduated sixth 
in his class in 1874, and in 1876, 
when he earned his ph.d. in 
physics, he became the first 
African-American in the United 
States to earn a doctorate. The 
Bouchet Leadership Award is 
a national award given to lead¬ 
ers in academia who have 
played a critical role in diversify¬ 
ing higher education, who are 
outstanding in their own fields 
of study and who serve as role 
models to students of all ages. 
Clarence Sasaki Hui Zhang 
Sara C. Rockwell, ph.d., professor 
of therapeutic radiology and 
pharmacology, was honored in 
May as the second Virginia 
Logan Lecturer at the Department 
of Radiation Oncology and 
Kimmel Cancer Center at Jefferson 
Medical College/Thomas 
Jefferson University.The award 
recognizes her contributions to 
the field of tumor biology. She 
presented two lectures, "Micro¬ 
environmental Heterogeneity in 
Solid Tumors: Problems and 
Targets for Therapy” and "Adverse 
Microenvironments in Solid 
Tumors: Their Role in Tumor 
Resistance,Tumor Evolution and 
Tumor Progression.” 
Clarence T. Sasaki, M.D. '66, HS 
’73, the Charles W. Ohse 
Professor of Surgery and director 
of the Yale Head and Neck Unit, 
received the Broyles-Maloney 
Award in April from the American 
Broncho-Esophagological Asso¬ 
ciation at its annual meeting in 
Phoenix. He was honored for his 
accomplishments in broncho- 
esophagology and laryngology. 
Hui Zhang, ph.d., associate pro¬ 
fessor of genetics, received the 
Department of Defense Prostate 
Cancer Research Program Idea 
Development Award in June 
for a study of a mouse model of 
prostate cancer progression. 
Zhang and his colleagues created 
a genetic mouse model that will 
allow them to study pathways 
of tumor progression and the 
relationship between dietary 
and genetic contribution factors. 
SEND FACULTY NEWS TO 
Claire M. Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
























40 | students 
Finding a way to do 
the right thing 
Physicians must go the extra mile 
for patients, surgeon and writer Atul 
Gawande tells the Class of 2004. 
As a medical student on an internal 
medicine rotation, Atul Gawande, 
m.d., m.p.h., wasn’t particularly wor¬ 
ried about the elderly woman with a 
low-grade fever who was being 
watched for signs of pneumonia. She 
was one of the last patients he’d cover 
as a fourth-year student at Harvard, 
and his mind was on the surgery resi¬ 
dency he’d soon begin. After rounding 
in the morning, he decided not to 
check in again with the patient after 
lunch, recalled Gawande, a surgeon 
and writer for The New Yorker, speak¬ 
ing at the School of Medicine 
Commencement in May. 
Luckily, the woman’s chief resi¬ 
dent was more vigilant. By the time 
Gawande stopped in to see her, the 
patient was gone—gone to the icu 
in the throes of a rapidly progressing 
fulminant pneumonia. 
The lesson, Gawande told the 109 
graduates gathered on Harkness Lawn, 
is that being a physician requires “a 
particular kind of strength. ... Doing 
the right thing is often painful, and yet 
you find the way to do it anyway,” 
said Gawande, whose essay collection, 
Complications, was nominated for a 
2002 National Book Award. Gawande 
said that physicians must go the extra 
mile for patients, even if doing so is a 
hassle, even if it’s humiliating, even 
though one might make a bad decision 
and unintentionally do harm. He 
urged new graduates to do the right 
thing “because you said you would; 
because it’s what you chose to do.” 
The graduates listening to 
Gawande’s address had processed 
into the tent led by piper Glenn H. 
Pryor playing “The Athol High¬ 
landers.” Former opera singer (and 
2004 graduate) Nduka M. Amankulor 
opened the ceremonies by singing 
“The Star Spangled Banner” in his 
bass-baritone. 
The Class of 2004 honored Barry J. 
Wu, m.d., hs ’92, associate clinical 
professor of medicine and “the nicest 
doctor in New Haven,” with the 
Francis Gilman Blake Award for out¬ 
standing teacher. They gave the Betsy 
Winters House Staff Award to Ashwin 
Balagopal, m.d., chief resident in 
medicine, for his “Zen-like brilliance.” 
The class donated $1,000 to the School 
of Medicine’s Society of Distinguished 
Teachers to “underscore symbolically 
our commitment to superlative teach- 
OPPOSITE Kavita Mariwalla was the banner 
bearer during the procession to Commencement 
on Old Campus. 
top Zachary Goldberg, Allyson Bloom, 
Rupali Gandhi and Elizabeth Arleo before the 
procession to Old Campus. 
above Physician and writer Atul Gawande 
told the graduates that to be a physician 




























ing at the School of Medicine,” said 
class co-president Michael Shapiro. 
Joseph E. Craft, m.d., hs ’77, pro¬ 
fessor of medicine (rheumatology), and 
Auguste H. Fortin VI, m.d., m.p.h., 
assistant professor of medicine, won 
the Bohmfalk Prizes for teaching. 
James M. Perlotto, m.d., associate 
clinical professor of medicine, won the 
Leonard Tow Humanism in Medicine 
Awards. The Leah M. Lowenstein 
Award went to Eve R. Colson, m.d. ’89, 
assistant professor of pediatrics, and to 
Rajlakshmi Krishnamurthy, m.d., 
assistant professor of medicine. 
Outgoing Interim Dean Dennis D. 
Spencer, m.d., hs ’77, encouraged the 
new graduates to adopt a multidiscipli¬ 
nary approach to medicine that incor¬ 
porates the continuum from basic 
research to patient care. Although his¬ 
torically scientists have spoken of medi¬ 
cine in militaristic terms—“conquering 
disease”—Spencer suggested that the 
new generation “will adopt metaphors 
other than war: metaphors of growth, 
and exploration and evolution.” 
—Cathy Shufro 
top Darlene Cabeau was joined at 
Commencement by her husband, Jean Lacet, 
and two of her children, Srina Lacet, 3, 
and Asha Lacet, 4 months. 
middle Jessica Newman attended 
Commencement with her daughter, Miko, 3. 
above The Class of 2004 donned toy 
stethoscopes as a symbol of medicine. 
“Healthy people are the 
foundation on which we 
build," Gates speaker says 
Helene D. Gayle, m.d., m.p.h., didn’t 
start out wanting a career in medicine 
or public health. She simply went to col¬ 
lege to leam how to change the world. 
When she realized that a career in 
health was an avenue to social change, 
she knew she had made the right 
choice. Formerly director of the National 
Center for hiv, std and TB Prevention 
at the Centers for Disease Control and 
Prevention in Atlanta, Gayle is now 
director of the hiv, TB and Reproduc¬ 
tive Health Program for the Bill & 
Melinda Gates Foundation. “The chal¬ 
lenge we all face in our role as public 
health professionals is finding a way 
to use the tools we have to reduce the 
inequities at home and around the 
world,” she told graduates during her 
Commencement address at the School 
of Public Health on May 24. 
Events of the last few years have 
brought an extraordinary pace of 
change and challenges to our world 
and our nation, Gayle said, and have 
highlighted public health in unex¬ 
pected ways. The terrorist attacks on 
September n, 2001, the anthrax threat 
and the sars outbreak have under¬ 
scored our connections to the world 
community and taught us that we’re 
not as independent or as isolated as we 
once believed. “We can no longer 
afford to pretend that actions taken in 
one part of the world have no impact 
in other parts of the world, or that 
inaction does not have its own dire 
consequences,” Gayle told the 123 men 
and women receiving either a master’s 
or a doctoral degree in public health. 
While key health indicators such as I life expectancy and infant mortality 
have long been important measures of 
societal development, Gayle said that 
health is now considered a fundamen¬ 
tal component of economic and soci¬ 
etal development, human rights and 
social justice. “Healthy people are 
the foundation on which we build 
economies, education systems and, 
ultimately, a strong and stable civil 
society,” she said. 
Noting that individuals can change 
society, Gayle also spoke of obstacles 
ahead. “We spend more on health than 
any other nation, but rank 37th in over¬ 
all health system effectiveness,” she told 
the crowd, adding that the disparities 
in health among different segments of 
society are “not-so-gentle reminders 
that we still have unfinished business in 
our own social and health agenda.” 
Stephen Vindigni gave the student 
address, in which he spoke of the diver¬ 
sity of the Class of 2004 and of the 
graduates’ shared desire to improve 
public health. Citing the variety of 
internships undertaken by his fellow 
students around the world, he said, 
“What an amazing contribution this 
class has made, while simultaneously 
gaining valuable experience and giv¬ 
ing back to the communities in which 
we worked.” Vindigni encouraged 
his classmates to use what they learned 
at Yale to generate interventions in 
public health that would benefit both 
individuals and communities. “Trust 
your power to influence,” he urged 
the graduates. “All of us are capable of 
initiating change.” 
—Jill Max 
top Sharmi Majahan gets a hug from Bonnie 
Pau (back to camera) at the Commencement for 
Epidemiology and Public Health. 
above left Linda Niccolai,an assistant 
professor of epidemiology, received the Award 
for Excellence in Teaching. 
above right Commencement speaker 
Helene Gayle, director of the hiv,TB and 
Reproductive Health Program at the Bill & 
Melinda Gates Foundation, told graduates 
that “we still have unfinished business in 

































At Student Research Day, 
encouraging a new cadre of 
physician-scientists 
Among the 68 students presenting 
posters at Student Research Day in 
May were three who spent the past 
year doing research under seemingly 
ideal conditions. They each received 
a $20,000 stipend and a travel budget, 
worked under the tutelage of expert 
mentors and pursued research that 
excited them. 
“I am basically learning how to do 
research,” said Sharon K. Gill, who 
studied patients with coronary artery 
disease a year after their hospitaliza¬ 
tions in a project designed to improve 
clinical decision making. “If I want to 
look into a question I am passionate 
about, I think I have the tools to do it.” 
She was one of seven students at 
Yale during the last academic year 
supported by the Doris Duke Clinical 
Research Fellowship Program for 
Medical Students. The Doris Duke 
Charitable Foundation (ddcf) started 
the national program in the fall of 
2001, and Yale has been one of io par¬ 
ticipating universities since last year. The 
yearlong program starts in July with 
three classroom courses—“Principles of 
Clinical Reasoning,” “Introduction to 
Biostatistics” and “Practical and Ethical 
Issues in Clinical Investigation”—before 
students embark on their own research 
projects. According to John N. Forrest 
Jr., m.d. ’67, hs ’71, director of student 
research, there must be a clinical element 
to the project and involvement with a 
patient. “Someone in the research group 
touches the patient,” he said. “It can’t be 
a mouse model of diabetes.” 
Students describe their research 
goals in presentations at the beginning 
of the program and discuss their results 
at the end. They also attend three din¬ 
ners with faculty who describe both per¬ 
sonal and professional aspects of life 
as a physician-scientist. Encouraging 
medical students to pursue careers as 
physician-scientists is the primary goal 
of the fellowship. Students from any 
medical school may apply to study at 
any of the 10 participating schools. 
During the past two years two students 
at Yale have gone elsewhere for research 
and three students have come to Yale. 
Presenting at Student Research 
Day this year was Paul M. Weinberger, 
from the Medical College of Georgia, 
who worked with Amanda Psyrri, 
m.d., fw ’02, assistant professor of 
medicine (medical oncology). 
“We are both interested in new 
molecular therapeutics for cancer and 
why some people with cancer die and 
others don’t,” Weinberger said. “You 
look at stage 4 patients, and there are 
some who 20 years later have no can¬ 
cer and they are still alive. Some stage 
1 patients are dead a year later. We 
have no idea why.” 
Brian V. Nahed spent his year using 
a novel approach to identify the genetic 
basis of intracranial aneurysms. “This 
is a perfect opportunity to contribute to 
the field I wish to pursue—academic 
neurosurgery,” said Nahed. 
Echoing the importance of train¬ 
ing a new generation of physician- 
scientists was the keynote speaker at 
Student Research Day, Story C. Landis, 
ph.d., director of the National Institute 
of Neurological Disorders and Stroke. 
“We will only be able to take advantage 
of the opportunities that exist if there 
are physicians, physician-scientists 
and scientists who are able to move 
the field forward,” she said. “We don’t 
know what we need to know. Who 
would have guessed that much of our 
understanding of the biochemistry 
of cell death came out of studies of 
C. elegans? Who would have guessed 
that research funding for coronavirus 
for 15 years ... turned out to be abso¬ 
lutely critical when the sars epidemic 
started in China?” 
—John Curtis 
Rachel Willner described her research at 
Student Research Day in May. 
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Integrative medicine: 
student group bridges a gap 
in medical education 
Medical students have a lot to learn, 
and not all of it is in today’s textbooks. 
One glaring omission in the curricu¬ 
lum, according to second-year student 
Rachel Friedman and third-year 
student Joey Cousin, is exposure to 
alternative therapies such as acupunc¬ 
ture, herbal remedies, massage and 
homeopathy. As co-organizers of the 
Yale Integrative Medicine Student 
Association (yimsa), that’s something 
the two are working to change. 
Originally naming the group the 
Yale Alternative Medicine Student 
Association, the handful of students 
who founded it two years ago soon 
replaced “alternative” with “integrative” 
to reflect their intentions more accu¬ 
rately. “We’re not exploring alternatives 
to our profession,” said Friedman. 
“What we’re interested in is having one 
medicine that is open-minded and 
that looks at anything that can possibly 
help patients.” 
Although integrative medicine still 
has quack status in the minds of some 
physicians, the tide is turning. With 
research programs in major medical 
schools across the country investigating 
treatment efficacy, often with funding 
from the National Center for Comple¬ 
mentary and Alternative Medicine at the 
National Institutes of Health, the field 
is beginning to gain validity. But part of 
the problem, Friedman and Cousin say, 
is that the definition of these therapies 
is still nebulous. “Basically, it’s anything 
that isn’t currently taught in medical 
school," said Friedman, which means 
that acupuncture is lumped together 
with crystals, psychic healers and the 
latest vitamin fad. 
Still, patients are turning to such 
treatments with increasing frequency. 
“Outside of whether these therapies 
work or not,” said Friedman, “our first 
goal is to educate students on what’s 
out there—what kinds of practitioners 
we’re going to encounter who are treat¬ 
ing our patients, and what we need to 
know about those treatments.” 
To that end, yimsa organizes a 
monthly lecture series at which differ¬ 
ent practitioners present not just the 
backgrounds of their modalities, but 
also what a doctor needs to know 
about them. The idea, said Margaret A. 
Drickamer, m.d., associate professor 
of medicine (geriatrics) and the group’s 
faculty advisor, is “not to destroy alter¬ 
native medicine or to promote it, but 
simply to look at it. ... They’re learning 
to look at nontraditional medicine, 
and to see that there are both value 
and problems in that.” 
The series was well-attended last 
year, Cousin said, with 20 to 30 stu¬ 
dents coming to each talk. This year 
Cousin and Friedman plan to publi¬ 
cize the talks more widely to encourage 
broader participation by students 
across health disciplines. Other events 
have been more interactive. Friedman, 
who is licensed as a massage practi¬ 
tioner in California, organized a six- 
week medical massage course to run 
concurrently with first-year gross 
anatomy, hoping that massaging each 
other will strengthen students’ memo¬ 
rization of muscle groups. The semes¬ 
ter finished with a full day dedicated 
to a topic universally known to medical 
students: stress. Students were invited 
to experience massage, Reiki, reflex¬ 
ology and other therapies during a 
drop-in health fair. After dinner, yimsa 
hosted an expert panel, the “Science 
of Stress,” in which doctors and inte¬ 
grative medicine practitioners offered 
a healer’s perspective on the biology 
and psychology of stress. 
Ultimately, yimsa’s goal is to change 
the curriculum to incorporate train¬ 
ing in integrative therapies. Progress on 
this front has been slow, but Friedman 
is trying to build a faculty advisory 
committee to steer the process. “My 
sense is that there are many individuals 
among the faculty who support change, 
but there hasn’t been any umbrella” 
to unite them, she said. 
—Alla Katsnelson 
Clinical practice suites 
open in Harkness 
Students have a new place to practice patient 
interviews and physical exams with the 
opening of seven clinical suites in the base¬ 
ment of Harkness Dormitory. The suites, 
which opened early this year, have exam tables 
and computers, and will be equipped with 
video cameras so students can review their 
training sessions, which often involve 
standardized patients. 
top First-year student Karen Shoebotham 
interviews standardized patient Barbara Webb. 
above First-year students Barbara Wexeiman 
and Roger Goldberg interview standardized 

































46 Alumni REUNION 2004 
Reunion 2004 
With a new dean, a new venue and new programs, 
alumni catch up at reunion. 
Photographs by John Curtis and Terry Dagradi 
Dean Robert Alpern, right, pictured with 
Frank Coughlin, past president of the 
Association of Yale Alumni in Medicine. 
Even as all the traditional trappings 
of reunion—the Friday evening 
clambake, the Saturday morning sym¬ 
posium and the dean’s welcoming 
reception—remained in place, change 
was in the air this year. At the tradi¬ 
tional Friday afternoon welcome in the 
Starr Atrium of the Anlyan Center, 
the medical school’s new dean made 
his first appearance before alumni. 
“This is my fourth day as dean 
here,” said Robert J. Alpern, m.d., who 
arrived from his post as dean of the 
University of Texas Southwestern Medi¬ 
cal Center on June i. Alpern lauded the 
alumni for their support of the school 
and said that he views serving as dean 
as “an incredible opportunity." 
For those willing to come to New 
Haven a day early, a reinvigorated Yale 
Surgical Society offered a Thursday 
afternoon roundtable, “The Surgeon 
as Writer,” by three of its veterans. 
And this year’s reunion included not 
one, but two scientific symposia, 
starting with a Friday afternoon panel 
on cardiovascular disease. The tradi¬ 
tional Saturday morning panel dis¬ 
cussed ethical issues facing physicians. 
At the annual Saturday morning 
meeting of the Association of Yale 
Alumni in Medicine (ayam), two 
appointments were made to the execu¬ 
tive committee. Richard D. Kayne, 
m.d. ’76, hs ’79, was appointed to his 
first two-year term. Irving G. Raphael, 
m.d. ’71, was elected to a second two- 
year term. In addition, Ercem S. Atillasoy, 
m.d. ’91, and Frank L. Gruskay, m.d. ’54, 
hs ’56, were named representatives to 
the Association of Yale Alumni. 
Arthur C. Crovatto, m.d. ’54, hs ’61, 
and Joseph F.J. Curi, m.d. ’64, each 
received the Distinguished Alumni 
47 
Service Award. Of Crovatto, a class¬ 
mate wrote, “It is reported that when 
you cut yourself shaving, you bleed 
Yale blue. We thank you for your 
energy and your dedication to the Yale 
School of Medicine.” To Curi, said 
Donald E. Moore, m.d. ’8i, m.p.h. ’8i, 
president of the ayam, “You have been 
a tireless worker and loyal alumnus.” 
Over lunch, talk about obesity 
On Friday, at the New Haven Lawn 
Club, the topic at the School of Public 
Health’s Alumni Day was obesity. 
During a panel discussion, a keynote 
speech by Kelly D. Brownell, ph.d., 
professor and chair of psychology and 
director of the Yale Center for Eating 
and Weight Disorders, and a luncheon 
talk by J. Michael McGinnis, m.d., Yale 
faculty and alumni discussed the impli¬ 
cations of the national epidemic of 
obesity and its related health problems. 
Elaine P. Anderson, m.p.h. ’76, 
director of alumni and community 
affairs, joked that organizing a confer¬ 
ence on obesity presented a new prob¬ 
lem. “This year,” she said, “the challenge 
was lunch. We had some food fights 
and we had some disagreements. The 
entrees will meet the requirements 
of Atkins, the South Beach diet and 
Carboholics Anonymous.” 
“I was planning to stay for lunch 
until I heard what it was going to be,” 
Brownell quipped. “If it meets all those 
criteria it’s going to be awful.” 
In a more serious vein, Brownell 
said that the nation’s obesity crisis has 
many roots. “Interwoven are complex 
social issues, political beliefs, large- 
scale economic forces and, of course, 
science,” he said. “What we are find¬ 
ing with the approach our govern¬ 
ment is taking, as well as the food 
industry’s, is that science is becom¬ 
ing almost irrelevant. That approach 
is driven by money and it leads to 
a focus on personal responsibility 
instead of the global environmental 
ABOVE Dean Robert Alpern visited with 
members of the Class of 1949 at the opening 
reception in the Anlyan Center. 
below left Arthur Crovatto (top photo with 
his wife, Janet) and Joseph Curi (bottom photo), 
each received the Distinguished Alumni Service 
Award at this year’s reunion. 
below right Donald Moore, president 
of the ayam, welcomed alumni to the reunion 




















448 Alumni REUNION 
to p In his keynote speech at the reunion of 
public health alumni, Kelly Brownell, director of 
the Yale Center for Eating and Weight Disorders, 
described the rise in obesity rates and its causes 
in the United States. 
middle Loretta DiPietro and Marlene 
Schwartz were on the panel that discussed 
obesity and its implications. 
above Alumni spent time catching up 
between talks at the New Haven Lawn Club. 
causes that are creating this problem 
in the first place.” 
Following Brownell’s keynote talk, 
a panel discussed various aspects of 
the obesity crisis. Participants included 
Loretta DiPietro, m.p.h. ’85, ph.d. ’88, 
associate professor of epidemiology 
(environmental health); Susan T. 
Mayne, ph.d., associate professor of epi¬ 
demiology and public health; Marlene 
B. Schwartz, ph.d. ’96, co-director of 
the Yale Center for Eating and Weight 
Disorders; and Derek Yach, m.p.h., rep¬ 
resentative of the director-general of the 
World Health Organization. 
Luncheon speaker McGinnis of the 
Robert Wood Johnson Foundation 
(rwjf) said that the current focus on 
counting carbs may help mitigate 
obesity, but it diverts attention from 
the key issues. “There’s no point 
arguing whether it’s fat or carbs that 
matter,” he said. “It’s both.” 
McGinnis laid part of the blame 
for America’s sugar- and starch-laden 
diet at his own doorstep. In addition 
to being the principal architect of 
the Healthy People process that elevat¬ 
ed nutrition on the national agenda, 
he was a key contributor to the Dietary 
Guidelines for Americans. The Guide¬ 
lines lay out central nutritional con¬ 
cepts that still pertain, but when the 
United States Department of Agricul¬ 
ture (usda) developed the accompany¬ 
ing food pyramid many people look¬ 
ing at recommendations for six to 11 
daily servings of bread, cereal, rice 
and pasta failed to distinguish between 
simple and complex carbohydrates. 
“We in public health were so happy 
to have buy-in from the usda, with 
its sizable food-industry constituency, 
that the potential for misunderstand¬ 
ing when it came to carbohydrates 
didn’t receive the emphasis it deserved. 
We meant clearly to focus on high- 
fiber carbs, and the fact is I didn’t pay 
enough attention to how the graphic 
might be misrepresented or to the 
appropriateness of the number of serv¬ 
ings,” McGinnis said. But he added: 
“The good news is we have the oppor¬ 
tunity now to get it right.” 
Getting it right is important, given 
that Americans consume 150 pounds 
of sugar a year (compared to 7.5 
pounds 200 years ago), McGinnis said, 
adding that diet and activity patterns 
are now responsible for more than 
500,000 premature deaths each year 
in the United States, ranking at the 
top of the list of preventable causes of 
death. Because of the stakes involved, 
the rwjf has made childhood obesity 
its top priority. “The vision,” he said, 
“is not for everyone to be slim. Instead, 
we want society’s signals to promote a 
healthy diet and healthy living.” 
At lunch the Distinguished Alumni 
Service Award was presented to James 
M. Malloy, m.p.h. ’67, president of 
Malloy Associates, a health care man¬ 
agement consulting firm in Missis¬ 
sippi. James Rawlings, m.p.h. ’80, and 
Patti Harvey Rose, m.p.h. ’85, ed.d., 
were inducted into the Alumni Public 
Service Honor Roll. 
Finding the genes that cause disease 
From the two photographs, it seemed 
obvious who would live longer. One 
showed a jogger, looking fit at 5’io” 
and 150 pounds. The other showed 
a seated man with a double chin, 5’8” 
and 270 pounds—a cigar smoker. 
Ironically, the jogger fared far worse 
than did his counterpart, reported 
from left James Malloy received the 
Distinguished Alumni Service Award at the 
public health reunion. Patti Harvey Rose 
and James Rawlings were inducted into the 
Alumni Public Service Honor Roll. Michael 
McGinnis, a key contributor to the Dietary 
Guidelines for Americans, gave the day's 
luncheon speech. 
Richard P. Lifton, m.d., ph.d., chair 
and Sterling Professor of Genetics, 
speaking at the symposium titled 
“Cardiovascular Disease: From Bedside 
to Bench and Back Again.” The first 
man, running guru James F. Fixx, died 
of a heart attack at 52. The other, 
Winston Churchill, lived to be 90. The 
probable cause for the difference— 
genes—is increasingly the subject of 
research at Yale into the leading cause 
of death in the United States, said Lifton. 
Liftorfs research has led him to 
“scour the globe” for families with 
extreme phenotypes, such as severe 
hypertension, which develops as early 
as adolescence. Lifton and his team 
identify the genetic mutations affecting 
the families and show, on the molecu¬ 
lar level, how the mutations cause 
disease. Understanding these mecha¬ 
nisms could suggest ways to manipu¬ 
late gene products and pathways to 
fight diseases in the general population. 
Other speakers included Jeffrey R. 
Bender, m.d., hs ’83, the Robert I. Levy 
Professor of Preventive Cardiology, 
who discussed the effects of hormone 
replacement therapy on vascular 
inflammation; William C. Sessa, ph.d., 
professor of pharmacology, who 
described his research on improving 
peripheral circulation; and Stuart D. 
Katz, m.d., associate professor of medi¬ 
cine, who discussed his hypothesis 
that lower serum iron levels reduce the 
risk of endothelial disease. 
The ethics of modern medicine 
At the Saturday morning symposium 
four panelists described ethical issues 
facing physicians and society. Thomas 
P. Duffy, m.d., explored “how it is that 
we live our daily lives as physicians.” 
Rupali Gandhi, j.d. ’00, m.d. ’04, 
discussed rules that protect children 
in clinical trials. Patricia T. Powell, 
m.d. ’87, described the Japanese 
practice of physicians informing fam¬ 
ilies, rather than individuals, of 
bad news. Philip R. Reilly, m.d. ’81, 
j.d., discussed the impact of the 
genomic revolution. 
For Duffy, the image of the physician 
has taken a beating. The New York Times, 
he said, was having a field day with arti¬ 
cles about alcoholic practitioners, Botox 
queens of Park Avenue and “boutique” 
doctors catering to the elite. On top of 
depictions of physicians as something 
less than selfless healers, the demands 
of practice compete with those of family, 
and physicians find themselves involun¬ 
tary partners with insurance companies 
that want a say in medical decisions. 
“Our profession is a house divided, 
almost a house conquered. It is time to 
come together to reflect on our moral 
dilemmas,” Duffy said. 
Gandhi reviewed the issues con¬ 
cerning children as research subjects. 
In 1789, she noted, Edward Jenner 
made the questionable decision to test 
the worth of cowpox as a smallpox 
vaccination by inoculating his son. 
“Children,” Gandhi said, “lack the 
maturity and the information base to 
make a truly informed decision. The 
regulations [governing clinical trials] 
provide children with additional pro¬ 
tections because they are a vulnerable 
group. Nevertheless, although regula¬ 
tions limit the participation of children 
in research trials, problems—such 
as ambiguous and inconsistent termi¬ 
nology—persist.” 
During the four years she lived in 
Japan, Powell was at first appalled by 
from top Tia Powell, Philip Reilly and Rupali 
Gandhi were among panelists at the medical 
school reunion who discussed ethical issues fac¬ 
ing physicians. Powell described doctor-patient 
relations in Japan; Reilly pondered the question 
of genetic disorders and the physician’s obliga¬ 
tion to inform family members who might be at 
risk; and Gandhi described the regulations that 




















5° Alumni REUNION 
At a panel sponsored by the Yale Surgical 
Society, authors and surgeons (top to bottom) 
Sherwin Nuland, Bernie Siegel and Richard 
Selzer described how they moved from 
operating to writing. 
physicians’ reluctance to share bad 
news with a patient. “I could not imag¬ 
ine any principled reason for not 
revealing to patients their diagnoses,” 
she said. Yet in Japan physicians 
are more likely to relay the information 
to a family member and, with the 
patient’s family, invent a fiction about 
the illness and find a way to continue 
treatment. However, a shift is under 
way and disclosure has become accept¬ 
able if the patient is psychologically 
stable and capable of making a deci¬ 
sion regarding treatment; there are 
good relations between the doctor, 
patient and family; and the patient has 
a strong support network. 
Family relations are also of concern 
to Reilly, ceo and chair of the board 
of Interleukin Genetics. If a patient 
has a genetic disorder, does the physi¬ 
cian have an obligation to inform 
family members who might also be 
vulnerable? And how can a physician 
inform others without violating patient 
confidentiality? Pharmacogenetics, he 
added, “will change everything about 
patient care.” 
Reilly also worries about genetic 
testing of fetuses. A survey of preg¬ 
nant American women conducted in 
the mid-1990s found that many con¬ 
sidered gene variants that predispose 
to obesity as serious as genetic muta¬ 
tions that cause cystic fibrosis. “I worry 
about a culture that is more interested 
in perfection,” Reilly said. 
The surgeon as writer 
Richard A. Selzer, m.d., hs ’61, gave 
up surgery, but he cannot give up writ¬ 
ing. "Once you have become an artist 
and that third eye of the artist is open, 
it can never be closed,” he said. 
At the ninth annual spring reunion 
of the Yale Surgical Society, Selzer and 
fellow writers and surgeons Sherwin 
B. Nuland, m.d. ’55, hs ’61, and Bernie 
S. Siegel, m.d., hs ’61, discussed the 
paths that led them away from surgery, 
even while drawing heavily on their 
experiences as physicians. 
For Siegel, the act of writing was 
self-preservation as he struggled emo¬ 
tionally with death and dying. “The 
training we don’t have is: How do you 
deal with loss?” he explained. He 
coped by keeping a journal. Impres¬ 
sions grew in complexity and Siegel 
found himself writing books. He 
divided his calendar between medicine 
and writing until he noticed that he 
had colored all his days in surgery 
black—he had come to prefer writing. 
Nuland’s entry into literature was 
less deliberate. A literary agent asked 
him to write a book called How We 
Die. Nuland declined until it dawned 
on him that the book would be an 
opportunity “to write about my entire 
career, indeed my entire life.” 
How We Die was not what the agent 
envisioned. It was also a surprise to 
the author, who uncovered, “an entire 
philosophy about death and dying that 
I didn’t know I had.” 
Like Selzer, who teaches creative 
writing to Yale medical and nursing 
students, Nuland believes medicine 
provides rich material for literature. 
“Please do write,” Nuland told his col¬ 
leagues in the audience, before adding, 
to laughter, “but whatever you write, 
don’t send it to me.” 
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1944 
60th reunion 
Our 60th reunion was like a 
family holiday gathering. All of 
us are in our 80s, and 18 of our 
original 42 classmates are alive. 
Eight were at this reunion, plus 
several wives, and 14 have sent 
letters and news to our class 
reunion news journal. This jour¬ 
nal is one reason why we have 
stayed a family for so many 
years. Our class was half the size 
of current classes and every 
five years we have circulated a 
journal with news of everyone, 
largely from letters to each 
other. In earlier years it would be 
25 pages; five years ago it was 
11 pages. Several of us are still in 
practice. Bob Frelick is active on 
the cancer committees of four 
hospitals, as well as in adminis¬ 
tration, and has received several 
awards. He and Jane keep busy 
with a widely distributed family 
of children and grandchildren. 
Larry Crowley has been dean of 
the Stanford School of Medicine. 
Edith Jurka is listed in Who's Who 
in America and Who’s Who in 
Medicine and Healthcare. Nick 
Spinelli has been active with 
the Association of Yale Alumni 
in Medicine. 
For years, 100 percent of us 
donated to the School of Medi¬ 
cine. This year it was 72 percent 
and totaled $74,272. Carol 
Goldenthal, Larry Crowley and 
Nick Spinelli worked on the fund¬ 
raising, and we are supplying 
scholarships for three current 
medical students. 
At this year’s reunion we 
enjoyed touring the new Anlyan 
building. It is amazing that it 
has laboratory facilities for 700 
researchers, huge places for 
class anatomy dissections and 
457,000 square feet of space. 
We sat together at a table for 12 
at the Saturday evening dinner 
for 50+ reunion classes, and it 
provided the happy time that a 




Our 55th reunion was great 
fun as well as educational. Yale 
Medical School continues to 
offer its students and faculty 
exciting new opportunities in 
education, research and service. 
The guided tour of research and 
teaching labs in the new Anlyan 
Center for Medical Research and 
Education showed us not only 
the huge investment in bricks 
and mortar Yale is making, but 
also some of the innovative 
approaches to student teaching 
introduced in this new facility. 
In this regard, we were pleased 
to see that the truly innovative 
Yale System of Medical Educa¬ 
tion is thriving. At the annual 
meeting of the Association of 
Yale Alumni in Medicine we 
heard presentations by two stu¬ 
dents (Sharon Gill and Jessica 
Yager) who had taken time off 
to carry out research/service 
projects, one in Africa, and were 
astounded that roughly half the 
class now takes such an addi¬ 
tional year off in order to pursue 
a particular interest. In our time, 
only about 10 percent did. 
One of our classmates, Frank 
Dana Law, died earlier this year, 
so our number now stands at 
31. Eight attended the reunion, 
most with their wives: Bill Anlyan, 
Bud Baldwin (still hard at work 
for the ama), Bill Bevis and 
Dorothy, Dan Elliott and Betty, 
Paul Goldstein and Betty, Jack 
Miller and Anne, Julian Pichel and 
Cecile, and Larry Shulman and 
Reni. Few of our classmates are 
still working full time, but Hal 
Holman does, at Stanford. A few 
still work part time, but most 
are actively retired. Gordon 
Jensen has just finished writing 
another book, his first novel. Carl 
Russell is busy with his oil paint¬ 
ing and watercolors. He attends 
painting workshops in places 
like Chattanooga, Sedona and 
Taos, where he fancies a golf 
course nearby. It is at 9,000 feet 
and facilitates long drives! Nora 
Gordon Baird continues her 
translations of ancient Greek 
classics. Nora skipped the 
reunion in order to attend the 
high school graduation of one of 
her five grandchildren. 
The luncheon and wonderful 
clambake at Harkness provided 
opportunities to chat with old 
friends from other classes as 
well as our own. Breakfast in the 
Beaumont room held a special 
significance for Jack and Anne 
Miller, who held their wedding 
reception there 50 years ago. 
Dinner at the Graduate Club had 
to await the running of the 
Belmont. The disappointment 
of the enthusiastic supporters of 
Smarty Jones when he lost in 
the last few seconds was quickly 
erased by the animated conver¬ 





The Class of 1954 celebrated the 
50th anniversary of our gradu¬ 
ation. An outstanding reunion 
celebration was planned and 
supervised by our local arrange¬ 
ments committee: Frank Gruskay 
(chair), Tony Picciriilo and Lowell 
Olson. A reunion record was set, 
as 33 classmates were present. 
Adding to the success was the 
50th Reunion Album, edited by 
Bob Hatch and Harry Miller; Kitty 
Halloran, Dick Pullen and Don 
Davis contributed. Eva Henriksen’s 
diary of her four years at ysm 
formed the framework for the 
chronology of the event. 
The exhibition cases in the 
Ogilvie Lobby are filled with 
books written by Freeman, 
Hustead, Kornfeld, Lamb, Miller 
and Nora, members of the Class 
of ’54, donated as a permanent 
collection. Also shown was a 
montage of memorabilia from 
the dedication ceremony nam¬ 
ing the laboratory at the 
University of California, San 
Diego, the Nicholas A. Halasz, 
m.d., Student Laboratory. 
On Thursday, early arrivals 
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party, where the rebonding 
began. Friday we attended gen¬ 
eral reunion events, followed 
by the clambake. Sam Hunter 
played the grand piano in 
Harkness Hall for us and all 
the alumni—over the sound 
system. Sam was terrific. On 
Saturday we took advantage of 
the cme program, the ayam 
annual meeting and the tradi¬ 
tional sherry luncheon at 
Harkness Hall. 
On Saturday evening we 
were honored at the “Friends of 
the 50th” dinner at the Graduate 
Club. After dinner we observed 
a moment of silence for those 
no longer with us. Special men¬ 
tion was made of those who 
died since our last reunion— 
Nick Halasz, Paul Neufeld and 
Lowell Olson. 
Bob Hatch and Harry Miller 
were thanked for the superb 
reunion album. They rated a 
standing ovation. 
Of 61 graduates, 33 attended 
the reunion. This (73 percent 
of surviving classmates) sets a 
record for attendance at a 50th 
reunion. Most members of 
the class and their spouses have 
retired from practice and are 
traveling for pleasure, visiting 
children/grandchildren and 
occupying themselves with vol¬ 
unteer work and hobbies.These 
include George and Mary 
Bostwick, Richard and Cleone 
Bouchard, John and Cynthia Cole, 
Don and Jeanne Davis, Jack and 
Elaine Gariepy, Kitty Halloran, 
Bob and Mary Hatch, Walker and 
Sylvia Heap, Sam and Lynn 
Hunter, Eva Henriksen, Bob and 
Joy Hustead, Lowell and Shirley 
Kristensen, Richard and Doris 
Lamb, Harry and Kari Miller, Jim 
and Audrey Nora, Dick and 
Barbara Pullen, Jacques Ouen, 
and Jack and Jo Ann Vosskuhler. 
George and Myra Bowers 
enjoyed the reunion so much 
they promised to return. Alan 
Covey, who came with wife 
Sylvia, remains in part-time 
practice with their son on Long 
Island. Art and Janet Crovatto 
have happily returned to York, 
Pa., and continue to summer on 
Martha’s Vineyard. Mike and 
Jeanne DeNicola attended the 
Saturday luncheon but missed 
the banquet. Fred Fiederlein 
attended with his son. Fred has 
retired from his neurology prac¬ 
tice, where he specialized in the 
diagnosis and treatment of 
headaches. Dick Foster returned 
to our fold—he graduated in 
1955 but is affiliated with our 
class. He retired from an ob/gyn 
practice in upstate New York. 
Walter Freeman and Do were 
energetically involved in a dis¬ 
cussion of medical politics. 
Orlando and Denise Gabriele 
returned for a pleasant week¬ 
end. The department of radiol¬ 
ogy at the University of West 
Virginia has been named for 
him. He is said to be fabulous. 
Denise was a former resident. 
Frank and Bette Gruskay com¬ 
mute between New Haven and 
Watch Hill, R.l. Kudos to them 
for arranging our reunion. Don 
Kornfeld continues to report 
to the College of Physicians and 
Surgeons at Columbia, where 
he was once acting dean and 
rumored to be outstanding. Herb 
Lubs and Dr. Betty Lou Lubs have 
tied the knot—congratulations 
and good luck. Tony and Jeanne 
Piccirillo are living at the Masonic 
Home in Wallingford. They 
attended the luncheon but did 
not return for dinner. Len and 
Gail Silverman have found Ponce 
de Leon’s fountain. Len looks 
younger than he did in 1954. 
Barbara Olson and daughters 
Kristi and Kari represented Lowell, 
who had worked hard as a mem¬ 
ber of the reunion arrangements 
committee, and died just before 
the reunion. Erika Hurwitz 
attended in her husband’s place. 
She is doing well. 
Two classmates cancelled 
because of emergency medical 
problems. Bob Keith had an 
operation and Bob Joy spent the 
weekend in the intensive care 
unit of his hospital. Both are 
recovering well. Marty Vita had 
family obligations that precluded 
attendance. Lee Hilburg can¬ 
celled. Ralph Campbell’s grand¬ 
daughter was being married 
during the weekend. Eli Schimmel 
sent his regards to all—but he 
could not attend. Mano Shirodkar 
intended to come, but was 
advised by his physician not to 
travel. He sent a letter, a tape 
and a review of his work in virol¬ 
ogy for our class records. 
We’ll meet again in 2009— 
maybe sooner if there is demand. 
Finally, we must thank Harry 
Miller for his leadership in 
establishing the medical school’s 
newest endowed class scholar¬ 
ship fund. The effort began five 
years ago and the participation 
of 75 percent of the class has 
made it a success. 
Arthur C. Crovatto 
1959 
45th reunion 
Two score and five years after 
graduation the Class of ’59 
gathered to celebrate the 
advances in medicine, such as 
artificial joints, improved diets 
and the cardiovascular benefits 
of shuffleboard, that made our 
attendance possible. Friday night 
at Dave and Joan Reed’s mega¬ 
home there was a silver sea of 
gray heads with a few shining 
domes bobbing up in their 
midst, all gathered around the 
lobster pot. A debate raged 
among our chronologically 
gifted group on the pros and 
cons of retirement. The advo¬ 
cates, led by Herb Kaufmann, held 
that even if you win the rat 
race, you are still a rat, while the 
cons discussed "phased retire¬ 
ment” and elder mentoring. Ace 
Barnes pointed out that being 
antiquated is an asset in some 
third-world countries. Mimi Wolf 
and Bob Amick’s wife Carol con¬ 
tinued discussing artificial joints, 
both anticipating hip replace¬ 
ment soon (Mimi by Kris Keggi 
the following week). 
Saturday night Nick Passareili 
arranged for us to enjoy the 
imaginative productions of 
world-class chefs as well as the 
air conditioning at the New 
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Haven Lawn Club. (Remember 
the heat wave of ’94?) It was 
really cool—and tasty. Bob Fisher 
announced that contributions of 
the Class of ’59 were outstand¬ 
ing during this past reunion year. 
Our class contributed $93,623 
in gifts and pledges to the 
School, and our class scholar¬ 
ship fund now has a market 
value of $364,594. Bob is now a 
High Poobah at the Alumni 
Giving office. 
Nick reported that we had 
broken the record at 72 percent 
attendance and he brought us 
up to date, not unkindly, on 
some of the nonattendees. Then 
the band struck up a tango and 
we danced away a beautiful 
evening. 
All of us were pleased that 
two special ladies, Ellie Skinner 
(Dave) and Bunny Prokop (Jim) 
attended. Bill Heydorn did not 
attend because of the recent 
death of Joan. First-time atten¬ 
dees included Mark Bitensky, 
Line Potter and Kent Morest. 
Others present were Bob 
Amick, Frank Beer, Jack Bowers, Ed 
Clayton, Sid Cohen, Bud Dawson, 
Ron De Conti, Gerry Fenichel, Bob 
Gonyea, Gerry Gordon, Rod 
Hartmann, Len Inker, John Jasaitis, 
Ed Kaminskas, Kris Keggi, Mike 
Lee, Ray Mark, John Marsh, Brian 
McGrath, Pete Molloy, Ron Morris, 
Jack Poglinco, Joe Saccio, Mark 
Schwartz, Dick Senfield, Sandy 
Solomon and Jim Stagnone. 




Our 40th gala at New Haven’s 
Polo Grille had spirit and reason¬ 
able number as 15 classmates and 
nine spouses returned to Yale. 
Bob and Becky Mitchell 
traveled from northern Califor¬ 
nia, where he still practices car¬ 
diovascular surgery. Lew (dean at 
Northwestern) and Jill Landsberg 
flew in from Chicago en route to 
Nice, France. Skip and Joyce Stilp 
from Wisconsin appeared to be 
more than enjoying retirement. 
Other Wisconsonites included 
Bill and Mary Alice (m.D. ’66) 
Houghton. Their daughter, 
Shelagh, was Class of ’98. Stan 
and Maxine Rosenberg came 
down from Boston and provided 
free antacids. Steve and Gillian 
Waltman from St. Louis punctu¬ 
ated the evening with subtle 
one-liners and critical ecopoliti- 
cal wisdom. Tom and Claire 
Cardella added a nice Washington, 
D.C., touch. Remo and Christiane 
Fabbri, psychiatrist extraordi¬ 
naire and lay minister, were the 
only locals. 
Class treasurer Bob and 
Wendy Lyons had flowchart and 
charge card machine in hand. 
Mary Digangi and Diane Shrier, 
while not discussing mental 
health issues, debated the 
virtues of comfortable fashions 
and long-stemmed footwear. 
Tony Bravo looked the picture 
of health and wealth and will 
someday be the fourth great 
tenor. Bob Briggs had brief lapses 
of memory and reaffirmed that 
fantasies have no boundaries. 
Tom Lentz, presently associate 
dean of admissions, concluded 
that we were most fortunate to 
have applied to Yale Medical 
School in i960 and not later. 
Joseph F.J. Curi 
1969 
35th reunion 
The oysters, corn fritters, huge 
shrimp and liquid refreshment 
compensated a bit for the chill 
of Friday night as we greeted 
Arnie and Nancy Mazur and Jody 
Robinson. We then moved into 
the warmth of the old Harkness 
dining room and joined the 1969 
table filled with Ellen and Len 
Milstone, the Lionel Nelsons, Sandy 
Genser, Steve and Lyn Krant, John 
and Patty Kelly, Rob and Joanne 
Marier, Larry and Sally Yeatman, 
and Jonelle Carey Rowe. 
The Saturday morning ethics 
seminar was well-received. We 
were joined at lunch by Joel and 
Janet Kaufman, Lee Jampol, and 
David Schulak and his fiancee. 
We moved on to the historic 
Beaumont Room for a special 
memorial discussion of David 
Barry, whose achievements we 
celebrated in 1999. We watched 
some very touching and illumi¬ 
nating portions of David’s memo¬ 
rial service from Chapel Hill, 
kindly provided by Gracia Barry. 
We then discussed how we 
might memorialize David, as well 
as John Meehan and Eric Otobo, 
who also left us far too early. A 
small group agreed to work on an 
appropriate memorial process for 
departed class members. 
The evening at the Ouinni- 
piack Club brought Chuck and 
Sandra Angell, Tom Ciesielski, the 
Robert Gordons, Stephen Webb 
and Ralph Falkenstein. The class 
photograph had to be delayed 
as we watched Smarty Jones 
lose his attempt at the Triple 
Crown. Rob Marier and the devel¬ 
opment office provided memo¬ 
ries of lost youth with 1965 
entrance photographs and a 
1969 class photo in front of the 
Brady building. 
We did our traditional "lam¬ 
pooning” of all absent class¬ 
mates, which should inspire 
them to attend future reunions 
to defend their reputations. 
Our gathering appears to 
expand reunion by reunion. 
Nearing or passing 60 certainly 
does bring on a good deal of 
reflection. Several classmates 
who hadn’t returned to New 
Haven since 1969 found it par¬ 
ticularly enjoyable to be back. 
We all found that the opportu¬ 
nity to remember and reflect 
with classmates gave us a 
renewed vision to carry back to 
our professional and personal 
lives. We look forward to 2009. 
Leo M. Cooney Jr. 
1974 
30th reunion 
Our reunion weekend flew by 
too quickly. We participated in 
provocative symposia and tours 
of the campus, but the high¬ 
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with lots of shared memories 
and time to catch up. We saw 
people we had not seen in 30 
years. Both nights we stayed 
until closing and we all felt we 
could have stayed longer. 
Early birds were treated to a 
symposium on obesity presented 
by the Department of Epidemi¬ 
ology and Public Health. Kelly 
Brownell, professor and chair of 
the Department of Psychology 
and director of the Yale Center 
for Eating and Weight Disorders, 
told us that obesity results as 
much from societal pressures 
and national policies as from per¬ 
sonal failures. 
Friday night my wife, Cheryl, 
son David (age 20) and daughter 
Julia (age 11) joined me at the 
New England clambake, where 
we found Dahlia Kirkpatrick, Tony 
Demorizi and son Eliseo (junior 
in college), Ralph Binder and wife 
Barbara, and Rob Kolodner. Ralph 
is practicing pulmonary medi¬ 
cine in New Rochelle, N.Y. He has 
continued his world travels, 
including backpacking trips to 
the Amazon and Alaska. Rob is 
the acting chief information 
officer for the Veterans Health 
Administration. At our last 
reunion Rob had told me that he 
was working on a project that 
was going to “change the way 
we all practice medicine.” He 
elaborated this year by showing 
us the VA’s electronic charting 
system that will revolutionize 
the way medicine is practiced. 
Both Tony and Dahlia have had 
hard luck with medical prob¬ 
lems. Tony uses a wheelchair 
because of a spinal cord prob¬ 
lem of unknown origin that is 
still being investigated. Tony 
commented that he was “so 
impressed and happy to find 
that the warmth of old friends is 
still there after so many years." 
Dahlia has been a bone marrow 
transplant specialist at Sloan 
Kettering and Tulane Medical 
School. She has had problems 
with multiple hip replacements 
and has changed her practice to 
physical medicine for the time 
being. Dahlia spent most of her 
professional life in academic 
medicine and she misses con¬ 
tact with students. She encour¬ 
ages young graduates to go 
into academic medicine because 
mentoring students is so 
rewarding. 
Those of us who toured the 
new Anlyan Center were awed by 
the combination of beautiful 
architecture, huge size and mod¬ 
ern lab facilities. The student 
anatomy rooms are quite differ¬ 
ent from the dissecting rooms of 
our time. Each station has touch- 
sensitive screens showing the 
anatomy in rich colorful detail. 
At Zinc Restaurant I talked 
with Irv and Marina Asher. Irv is 
practicing neurology with a spe¬ 
cialty in movement disorder, in 
Columbia, Mo. We shared our 
memories of working in the labs 
at Connecticut Mental Health 
Center. Len and Liz Banco came 
down from Hartford, where Len 
is professor of pediatrics at the 
University of Connecticut School 
of Medicine and vice president 
of strategy and regional devel¬ 
opment at Connecticut 
Children’s Medical Center. Len 
noted, "When not doing medi¬ 
cine my hobbies include collect¬ 
ing rare books (early American 
history), traveling and enjoying 
wine and food.The reunion at 
Zinc was a lot of fun; the dinner 
was excellent, as was the con¬ 
versation. I only wish that more 
classmates would attend the 
next reunion.” In addition to 
practicing pulmonary medicine 
in Basking Ridge, N.J., Harvey 
Gerhard has written scientific 
articles and three novels, includ¬ 
ing the bestselling medical 
thriller The Donors. Harvey is 
married and has two children in 
high school. 
Our conversation at Zinc was 
filled with warmth, laughter and 
surprisingly close feelings. While 
we had not seen each other for 
30 years, we had a history of 
four intense years together and, 
as Ralph noted, a very strong 
bond because of our shared 
experiences in medicine. While 
we live in different places and 
practice different specialties, we 
had many things in common. 
We reminisced and shared our 
life’s experiences, good and bad. 
We talked about career choices, 
politics (right, left and middle 
were represented), managed 
care, family, malpractice. Most 
of us have been victimized by 
frivolous lawsuits. We agreed 
that the best solution to the 
malpractice crisis is a no-fault 
system for patients combined 
with an educationally focused 
program for doctors. When 
someone asked,"Would you 
want your child to be a doctor?" 
our group was evenly split. 
Several classmates who were 
not able to attend wrote me: 
Carol Teitz is professor of 
orthopaedics at the University of 
Washington in Seattle. She could 
not attend the reunion because 
she was going to Asia with three 
traveling fellows from the 
American Orthopaedic Society 
for Sports Medicine. Carol wrote, 
"I remarried in 2000 to Craig 
Keebler, who is a bariatric medi¬ 
cine physician (not surgical). My 
twins are almost 21. One is at 
Stanford and one is at U. Miami. 
Craig has a 25-year-old married 
daughter (and we have one 
grandchild), another daughter 
who is 22 and here at UW and a 
son, 19, who is spending a year 
studying in Israel before starting 
university. It’s pretty noisy when 
everyone is home!" 
Jerry Orlin sends regards from 
the Hasharon Hospital Blood 
Bank in Petah Tiqwa, Israel. Dave 
Collier has recently returned 
from an adventure serving as 
chief of nuclear medicine at the 
Kuwait University Medical 
School where, prior to the Iraq 
War, he lectured on nuclear ter¬ 
rorism. Dave Ritvo is practicing 
psychoanalysis in the Bay Area. 
Ross Tonkens almost made it to 
the reunion but had to travel 
to Helsinki for business. He is 
the director of medical and sci¬ 
entific services and global scien¬ 
tific head of the cardiovascular 
therapeutics division at Quintiles. 
Paul David lives outside Boston 
with his wife and three children 
55 
(ages 21,17,13). Paul worked for 
15 years at Beth Israel Hospital 
on the psychiatry consultation 
service and in the ER and ran the 
medical student clerkship. He is 
now in full-time private practice. 
Ron Neumann sends his best 
wishes to everyone from Mary¬ 
land. He is head of the nuclear 
medicine department at the 
nih, where he does research on 
dna damage and repair follow¬ 
ing radionuclide treatment of 
cancers. He notes that he still 
lunches with his wife after 25 
years. She is the head of the 
surgical pathology group in 
the pathology branch of the 
National Cancer Institute. Amy 
Starr sends her best wishes 
from Los Angeles, where she is 
a pediatrician. Her daughter 
is a sophomore at Yale, in the 
same college as my son. 
The reunion was a great 
time. Mark your calendars now 




A very small group of the Class 
of ’79 gathered for the clambake 
on the Harkness lawn on Friday 
night, including Lloyd Friedman, 
vice president of medical affairs 
(pulmonary diseases), Milford 
Hospital (Conn.), with his wife, 
Kai Yang, and kids (one of whom 
was braving an abscessed tooth!); 
Jeff Dornbusch, picu Presbyterian 
Hospital, Albuquerque; Mike 
Young, assistant professor (al¬ 
lergy and immunology), Harvard 
Medical School; Cindy Sherman, 
gastroenterologist, Minneapolis; 
and me. Ed Shultz, associate pro¬ 
fessor (biomedical informatics), 
Vanderbilt University Medical 
Center, Nashville, and his wife, 
Patty, joined us briefly, though 
they had to leave before the 
Saturday festivities, because Ed’s 
band had a gig in Washington, 
D.C.They are apparently much 
sought after at medical gather¬ 
ings to get the dancing going— 
maybe next reunion? 
Our dinner on Saturday was 
in the library of the Graduate 
Club, where the group from the 
night before was expanded to 
include a respectable dozen or 
so of our classmates, including 
Kerry Cooper, nephrology, Scotts¬ 
dale, Ariz.; Bonnie Cunningham, 
associate professor/attending 
physician (hematology), Albert 
Einstein College of Medicine, 
Jacobi Medical Center, New York; 
Dave Golan, biological chemistry, 
Harvard Medical School; Jonathan 
Holt, consultation, liaison, 
(psychiatry), University at Buffalo- 
Department of Psychiatry, suny- 
Buffalo, N.Y., and his wife, Karen; 
Liz Moore, radiology, Univer¬ 
sity of California-Davis Medical 
Center, Sacramento; Eddie 
Reed, director of the cancer cen¬ 
ter at West Virginia University 
(oncology-internal medicine) 
and his wife, Meenakshi; my 
husband, Alan Plattus, and me, 
as well as Jeff, Mike, Cindy and 
Lloyd from the night before. 
Shirley McCarthy, professor of 
radiology at Yale, sent her regrets, 
having been called away on a 
family emergency. Lynn Rudich, 
pediatrics, Woodbridge, Conn., 
and her husband, Alan Klein- 
man, made a surprise appear¬ 
ance during dessert and coffee. 
We lingered over cocktails and 
then had a class picture taken 
before moving on to dinner. We 
all clustered around a board with 
our first-year "mug shots”—and 
agreed that none of us had 
changed a bit! Conversation was 
lively, catching up on our lives, 
children and the past, recent or 
upcoming college searches for 
the next generation. It was a very 
relaxed and enjoyable evening, 
and we hope to garner a bigger 




Our class dinner was held at 
Peter Glazer’s (therapeutic 
radiology at Yale) and my 
(molecular biophysics and bio¬ 
chemistry, Yale) house in 
Guilford.The weather was cold 
and rainy for June, so we 
brought the tables inside and 
lit a fire in the fireplace. We 
were joined by David (ent, New 
Haven) and Karen Astrachan; 
Lenny (founder of biotech com¬ 
pany, Alexion, in Cheshire, Conn.) 
and Linda Bell and two of their 
children; Jan Blustein (health 
policy, nyu) and Leslie 
Greengard; Joe Chambers (cardi¬ 
ology) and Barbara Coda (anes¬ 
thesia), who are living in 
Oregon; Rich (AstraZeneca in 
Delaware) and Sara Leff; and 
Paul Rothman and Frances Meyer 
and their three children. Paul is 
at Columbia University but is 
moving to the University of 
Iowa this summer to be chair of 
medicine. John Krystal (psychia¬ 
try, Yale) and Bonnie Becker and 
their twins attended, and Mark 
Stein (urology in New York) and 
Andy Sternlicht (antibiotic bio¬ 
tech in Boston) were there. Ken 
Rosenblum has a new undertak¬ 
ing: machines that dispense pre¬ 
scriptions in doctors’offices 
(InstyMeds). Look for them. 
On Friday night at the clam¬ 
bake we were joined by Dave 
Shrier, who is in diagnostic 
imaging at Rochester, and Josh 
Schor, who is the medical direc¬ 
tor of a Jewish nursing home in 
New Jersey. Michael Caplan, who 
is in the physiology department 
at Yale, and Mamin Merrick, who 
is a radiation oncologist in New 
York City, also joined us. I was 
very happy that our son, Sam, 
kept himself occupied playing 
football in front of Harkness 
with David and Karen Astrachan’s 
two very congenial boys. 
Several of our classmates 
sent their regrets: Aron and 
Peggy Wahrman had a baby in 
May, Hope Francesca, and so 
could not come; Ana and Dan 
Kolansky had a family matter to 
attend to; Bruce Haffty (thera¬ 
peutic radiology, Yale) was giv¬ 
ing the radiation oncology 
boards; and Kim Gutner was tak- 
56 Alumni REUNION REPORTS 
ing her children to Europe and 
so could not attend. 
All of us greatly missed our 
friend and classmate, Sabra 
Jones, who died in a rock climb¬ 





The reunion was very disap¬ 
pointing—of a class of more 
than 100 people, many of whom 
live in the tri-state area, only 
three showed up. Besides me, 
there was Anita Licata (formerly 
Anita Goodrich), who came down 
from Vermont, and Dora Wang, 
who came all the way from New 
Mexico. It was nice to see Anita 
and Dora again (they were at the 
10th reunion as well). 
Anita is married to Tom Licata 
and is a dermatologist at the 
University of Vermont. They have 
two children, Thomas and Isabel. 
Dora came with her husband, 
Chris Calott, who is an architect 
in New Mexico, and their new 
baby. Dora is a psychiatrist at the 
University of New Mexico and is 
writing a book. 
As for me, I am a neurologist 
at the College of Physicians and 
Surgeons, Columbia University, 
where I recently received tenure. 
I spend about 80 percent of 
my time in research and 20 per¬ 
cent seeing patients with move¬ 
ment disorders, and have built 
a research program on the epi¬ 
demiology, genetics and patho¬ 
physiology of tremor disorders. 
In my spare time, I play the bag¬ 
pipes with the Kearny Pipe band 
(we wear the MacBeth kilt), 
and have recently begun show¬ 
ing some of my artwork (pas¬ 
tels) and had my first solo show 
in Manhattan in October. I am 
married (Vinita Seghal, m.d. ’90) 
and have two children, Devin 
and Ravi, ages 8 and 6, and we 
live in Westchester. I would love 
to hear from old friends. My e- 




It is hard to imagine that 10 
years have already passed since 
we left (OK, since most of us 
left) en masse from New Haven. 
To celebrate the occasion, a 
strong contingent from the 
Class of 1994 gathered in New 
Haven to reminisce. Constantino 
Pena, positioning himself at the 
top stair in the Starr Atrium of 
the newly built Anlyan Center 
(can you believe the new anato¬ 
my labs are ventilated so that 
first-years don’t constantly smell 
of formaldehyde?), offered a big 
hearty welcoming wave to all 
classmates as they entered the 
opening reception. Tin©, an 
interventional radiologist in 
Florida, traveled solo to New 
Haven. His two daughters 
stayed home with wife Barbara 
(m.d. ’95), an ER doc, who is 
expecting their third this fall. 
Tin© has been in touch with Jae 
Urn, who is a neurosurgeon in 
Spokane, Wash. 
Other classmates attending 
the Friday evening clambake 
included Victoria Holloway, 
assistant vice president of R&tD, 
L’Oreal Institute; Marsha Roberts, 
a California-based radiologist; 
and Marie Eason. Marsha and 
Marie, unfortunately, could not 
stay for Saturday, as they had 
more social calls to make in the 
D.C. area. Also traveling from 
California was Kirk Essenmacher, 
director of marketing strategy 
for Genentech’s oncology port¬ 
folio, his wife, Kirsten, and their 
11-month-old daughter Stella. 
Kirk reports news from Joetta 
(Davis) Maier and Alexa (Boer) 
Kimball, neither of whom could 
make the trip east, and from 
Dov Goldstein, who is back in 
Philadelphia as the cfo of 
Vicuron Pharmaceuticals. Kirk, 
who still makes his famous 
daiquiris, is not sure of the 
proper method for putting 
kumquats in the beverage. 
Kevin (Bishoff) Carlson and 
Nancy Christmas, each with 
a baby in tow, carpooled up 
from D.C. Kevin is an internist- 
geriatrician in Maryland and 
has three kids all under the age 
of 5. Still as energetic as ever, 
she left many of us thinking 
“I don't know how she does it.” 
Nancy is a retinal surgeon in 
Alexandria, Va. My daughters, 
after playing with Nancy’s son 
Abbott, started lobbying for a 
new baby brother. 
Len Landesberg arrived 
Saturday in time for the sherry 
luncheon where he, Tino and 
Kirk finally concluded that, after 
10 years, they still looked the 
same (and very different from 
the other luncheoners who 
mostly hailed from classes in 
the 1960s). 
The Saturday evening class 
dinner was held at my house in 
Guilford, Conn. Interestingly, we 
had more children in attendance 
than adults. Debbie Schussheim, 
her husband, Adam, and their 
two children drove up from 
Westport, Conn., where Debbie 
practices endocrinology. Belinda 
Chan arrived with her two boys, 
who very quickly bonded with 
my son, Noah. Kudos to Belinda, 
who recently went into a solo 
internal medicine practice and 
hung her shingle in Branford, 
Conn. Kirk Essenmacher, Nancy 
Christmas and their families 
completed the dinner crowd. 
Many other classmates sent 
me e-mail offering their regrets 
for not being able to attend, 
Melissa Berhow just started a 
new anesthesiology position in 
Palo Alto. Scott Dessain, a proud 
dad to two lovely daughters, is 
an assistant professor of hema¬ 
tology at Thomas Jefferson 
Medical College and conducts 
research to develop fully human 
monoclonal antibodies. Beverly 
Naiman and Brian Lee live with 
their two boys in Virginia, where 
Bev is a pediatric ER physician 
and Brian is a critical-care physi¬ 
cian who is double-boarded in 
ER as well. Bandy Lee is back in 
New Haven as an assistant clini¬ 
cal professor of psychiatry at 
Yale. Greg Licholai does venture 
capital investing and speaks 
regularly with Stephen Jackman. 
Dave Aghassi is practicing der¬ 
matology in Boston. 
I look forward to seeing 
everyone back in New Haven for 
our 15th year celebration in 
June 2009! 
Bonnie E. Gould Rothberg 
1999 
5th reunion 
After five years away from 
New Haven, the Class of 1999 
gathered once again on the 
Yale campus for our first 
reunion. While there are a few 
things that have changed, it was 
nice to see some old standbys 
(Bar, Louis’ Lunch) and some 
friendly faces from the past (Eric 
Schonewald is still there!). 
Our class gathered on Friday 
evening, amidst an endless 
spread of fantastic seafood and 
the sounds of Dixieland music 
in the background. Our group 
included Ken Baum and his wife, 
Julie. Ken is practicing law in 
New Haven and Julie is a fifth- 
year medical student at Yale, 
planning a career in dermatol¬ 
ogy. They plan on finally leaving 
New Haven in one year, when 
Julie begins her residency. 
Deborah Steinbaum also joined 
us. Deb is practicing general 
pediatrics at Mount Sinai 
Hospital in New York City. Alison 
Days came with her husband, 
Sergio. Alison is practicing aca¬ 
demic pediatrics in El Paso, 
Texas. Our group also included 
Sherri Sandifer, Debby Lin, Obi 
Ugwonali and Joy Weinberg. 
Sherri is practicing general pedi¬ 
atrics in Houston. Debby is a 
second-year immunology fellow 
at Brigham and Women’s 
Hospital in Boston. Obi is finish¬ 
ing an orthopaedics residency at 
Columbia-Presbyterian Hospital 
in New York, and will be moving 
to Boston next year for a hand/ 
shoulder fellowship at Brigham 
and Women’s Hospital. Joy is 
finishing an internal medicine 
residency at North Shore Medi¬ 
cal Center and plans on doing 
a fellowship in nephrology and 
hypertension at Lenox Hill 
Hospital in New York City. 
On Saturday evening, we 
gathered at the Graduate Club, 
the site of our last evening out¬ 
ing as a class back in 1999. We 
had a great turnout, with close 
to 20 class members present 
(and had our own "kiddie” room 
set aside by the Alumni 
Association, to keep us separate 
from the rowdy Class of 1954). 
We were joined by Lifei Guo, who 
is in the midst of a residency in 
plastic surgery in Boston. Deanna 
Chin and her husband, John 
(married in September 2003), 
also attended. Deanna is finish¬ 
ing her fourth year of a radiol¬ 
ogy residency at Weill-Cornell 
Medical Center and will be 
doing an mri fellowship at nyu 
next year. Also present were 
Kathryn Cunningham, Ara 
Feinstein, Andrew Resnick, Aaron 
Milstone, Zach Leitze, Johnathan 
Henderson, and Grey Maher and 
her husband, Aaron. Kathryn is 
practicing internal medicine at 
Mass General. Ara is in a general 
surgery residency at Mass General 
and is spending his research years 
getting an m.p.h. from the 
University of Miami. Andy, who is 
finishing a general surgery resi¬ 
dency at UPenn, is spending his 
research years getting an m.b.a. 
from Wharton. Aaron finished his 
pediatric residency at Children’s 
Hospital of Philadelphia (chop), 
and is currently working in a 
private practice for one year, 
before moving on to Baltimore 
to do a fellowship in infectious 
disease at Johns Hopkins. His 
wife, Amy, who got her medical 
degree at Yale in 2000, is now a 
chief resident at chop, and is 
expecting their first baby. Zach is 
at Yale-New Haven Hospital 
doing orthopaedics. He is plan¬ 
ning to move to Texas next 
year to do a fellowship in hand/ 
shoulder surgery. Johnathan is in 
private practice at Dorchester 
House Community Health 
Center in Boston. His wife, Keba, 
is finishing her ob/gyn residency 
in Boston this year, after which 
they will be moving to Atlanta. 
Johnathan and Keba are expect¬ 
ing their first baby as well. Grey 
is currently doing a chief resi¬ 
dency year in urology at the VA 
hospital in West Haven, and 
then plans on doing a female 
pelvic reconstructive surgery fel¬ 
lowship in California next year. 
After that, she plans on return¬ 
ing to New Haven and joining a 
private practice group. Lastly, I 
am in the middle of a fellow¬ 
ship in pediatric hematology- 
oncology at Boston Children’s 
Hospital/Dana- Farber Cancer 
Institute, and recently married 
as well. 
We had a fantastic time remi¬ 
niscing about all of our class¬ 
mates, and look forward to doing 
it again in another five years. 
Elly Falzarano Barry 
2004-2005 
Association of Yale Alumni 
in Medicine 
Officers 
Donald E. Moore, m.d. ’81, m.p.h. '81 
President 
Francis M. Lobo, m.d. ’92 
Vice President 
Christine A. Walsh, m.d. '73 
Secretary 
Francis R. Coughlin Jr., m.d. '52 
Past President 
Executive Committee 
Cynthia B. Aten, m.d. '81 
Sharon L. Bonney, m.d. '76 
Joseph F.J. Curi, m.d.'64 
Louis R.M. Del Cuercio, m.d. '53 
Victoria L. Holloway, m.d. '94 
Richard D. Kayne, m.d. '76, hs '79 
David H. Lippman, m.d. '71 
Robert Lyons, m.d. '64, hs '68 
Harold R. Mancusi-Ungaro Jr., 
m.d. '73, hs '76 
Irving G. Raphael, m.d. '71 
Ex officio 
Robert J. Alpern, m.d. 
Dean 
Martha Schall 
Associate Vice President for Development; 
Director of Medical Development 
Sharon R. McManus 
Director, Alumni Affairs 
Howard A. Minners, m.d. '57 
Chair, Medical School Alumni Fund 
Samuel D. Kushlan, m.d. '35, hs '37 
VSM Bequest and Endowment Officer 
Representatives to the 
Association of Yale Alumni 
Ercem S. Atillasoy, m.d. '91 
Harold D. Bornstein Jr., m.d. ’53, HS '56 
Arthur C. Crovatto, m.d. '54, hs '61 
Frank L. Gruskay., m.d. '54, hs '56 
Gilbert F. Hogan, m.d. '57 
Donald L. Kent, m.d. 72, hs '78 
ayam Representative, 
Medical School Council 




















s8 Alumni faces 
What makes a tyrant tick? 
Ask a political psychologist 
How one medical school graduate’s 
“career in the shadows” began with 
an unexpected job offer. 
In 1965, the cia presented an unusual 
job opportunity to the young psychia¬ 
trist, then completing his residency at 
the National Institute of Mental Health, 
that was enticing enough for him to 
turn down a faculty position at Harvard. 
Asked to develop a pilot program for 
what he described as “assessing at a 
distance the personality and political 
behavior of foreign leaders,” Jerrold M. 
Post, m.d. ’60, decided this diversion 
justified delaying a trip into academia. 
Little did he suspect in 1965 that some 
of the world’s most important leaders 
would soon be stretched out on his ana¬ 
lyst’s couch—figuratively speaking— 
and that his cia side trip would last 
until 1986. 
As founding director of the Center 
for the Analysis of Personality and 
Political Behavior (cappb) at the cia, 
Post led an interdisciplinary behavioral 
science unit composed of clinical and 
research psychiatrists, social psycholo¬ 
gists, political sociologists, anthropolo¬ 
gists and political scientists. Their job 
was to develop political personality pro¬ 
files of foreign leaders. 
“We looked at foreign leaders in 
their cultural and political context and 
gauged to what degree they were play¬ 
ing out personal conflicts on an inter¬ 
national stage,” says Post, who today is 
frequently quoted on television and in 
newspapers and magazines. 
During 21 years at the cia, psychiatrist Jerrold 
Post developed personal and political profiles 
of world leaders, including Saddam Hussein, 
Menachem Begin and Anwar Sadat, as well as 
al-Oaeda leader Osama bin Laden. 
During what he calls his 21-year 
“career in the shadows," Post probed 
the pathologies and personalities of 
some of the world’s most dangerous 
minds. He continued to develop politi¬ 
cal personality profiles after joining the 
faculty at George Washington 
University in Washington, where he is 
professor of psychiatry, political psy¬ 
chology and international affairs and 
director of the political psychology pro¬ 
gram. Among the contemporary lead¬ 
ers he has profiled are Slobodan 
Milosevic, North Korea’s Kim Jong-Il, 
Osama bin Laden and, most famously, 
Saddam Hussein. His analysis of the 
Iraqi leader was presented in testi¬ 
mony in December 1990 to the House 
Armed Services and Foreign Affairs 
committees. Post’s intimate knowledge 
of the Iraqi leader was called upon 
again by national media in March 
2003, when war with Iraq began, and 
again last December, when the Iraqi 
leader was captured. 
“No worse beginning is imaginable,” 
Post says of the dictator’s formative 
years. “His father and 12-year-old 
brother died during his mother’s preg¬ 
nancy. She tried to kill herself and then 
tried to abort Saddam. She wouldn’t 
even look at him when he was bom in 
a mud hut in Tikrit.” 
According to Post, Saddam was 
passed off to an uncle, who took care 
of him, then returned him to his 
mother after she’d remarried. His step¬ 
father abused him physically and 
psychologically. But when he was eight, 
wanting an education that his parents 
refused, he went back to his uncle, 
who filled his head with dreams of 
glory. “As he accumulated power,” 
Post says, “Saddam created these mar¬ 
velous palaces, and yet they all had 
enormous bunkers down below, like 
the defiant paranoid self beneath 
his grandiose facade. When he was 
captured in Tikrit, he wasn’t just back 
in the mud hut. He was in a hole 
underneath the mud hut, as low as 
anyone could go, representing 
Saddam’s shattered self.” 
Among Post’s proudest cia achieve¬ 
ments were the Camp David profiles 
his unit prepared of Menachem Begin 
and Anwar Sadat for President Carter 
in 1978. Using these assessments, 
the president was able to ready himself 
for that groundbreaking summit. In 
his book, Keeping Faith (1982), Carter 
acknowledged that these analyses 
influenced his negotiating strategy and 
paid rich dividends. 
“After Camp David, there was 
scarcely a major summit without our 
being asked to prepare profiles and 
assessments of the foreign leaders,” 
Post says. “Part of my pride was in 
crafting an entirely new field of intelli¬ 
gence at the cia.” Post was awarded the 
Intelligence Medal of Merit in 1979. 
Since leaving the cia in 1986, Post 
has established himself as an expert on 
“the mind of the terrorist,” which is, in 
fact, the title of the book he’s currently 
writing. In addition to consulting for 
the departments of defense and home¬ 
land security, Post was an expert wit¬ 
ness at the 1997 trial of an Abu Nidal 
operative and the Judy 2001 trial of an 
al-Qaeda member for the bombing of 
the U.S. embassy in Tanzania. 
He is the author of several widely 
cited books, including When Illness 
Strikes the Leader (Yale University Press, 
1993) and Leaders and Their Followers in 
a Dangerous World (Cornell University 
Press, 2004). Post is often quoted on 
matters related to Saddam Hussein, 
Osama bin Laden and the psychology 
of suicide terrorism. 
“I have always seen my role, in gov¬ 
ernment and outside it, as communi¬ 
cating complicated concepts in a way 
that is useful for intelligence profes¬ 
sionals, policy officials and the general 
public,” says Post. “I’m not always 
reassuring, but I am trying to facilitate 
understanding.” 
—Alan Bishort 
Looking to mechanics to 
explain what cells do and 
how they develop 
Mavericks start out young, it seems. 
Once, after performing an advanced 
earth science experiment with other 
ninth-graders, Donald E. Ingber, m.d. 
’84, ph.d. ’84, arrived at a different 
result. “I wrote down 12,” he says, 
“even though they all wrote down 88.” 
The instructors informed the class that 
there were indeed two correct answers, 
but that among the few students who 
had discovered the less obvious solu¬ 
tion, only one—Ingber—hadn’t 
scratched it out in favor of the more 
popular result. 
“That was incredible feedback from 
a teacher,” Ingber says, “for people to 
do what they believe in and what they 
think is right.” 
Ingber has found this message use¬ 
ful in the years since as he forged an 
offen-controversial career. While most 
cell biologists use molecular techniques 
to tease out the genes at work in health 
and disease, Ingber, now the Judah 
Folkman Professor of Vascular Biology 
at Harvard Medical School and 
Children’s Hospital in Boston, has 
championed the more radical notion 
that minute mechanical forces acting 
on cells—pushing and pulling, com¬ 
pression and tension—are crucial to 
their normal growth and function, and 
that disturbances in these forces can 
lead to disease. 
“I’m a person who has always had 
a strong sense of how things work 
by looking at them,” Ingber says. “I’m 
very mechanically minded.” Ingber’s 
mechanical bent led to an early fasci¬ 
nation with the work of ano ther 
rugged individualist, R. Buckminster 
Fuller, in particular the concept of 
“tensegrity,” the complementary inter¬ 
play of compression and tension that 
underlies the elegance and strength of 
Fuller’s geodesic domes. 
While a Yale undergraduate, Ingber 
encountered in an art class the sculp¬ 
tures of Kenneth Snelson, in which 
pipes and wires, intricately arranged 
according to principles of tensegrity, 
create airy yet rigid forms that rise 
improbably into space. For Ingber, who 
was doing tissue culture experiments 
on metastasis with Alan C. Sartorelli, 
ph.d., in the Department of Pharma¬ 
cology at the time, Snelsorfs pipes 
and wires called to mind the actin fila¬ 
ments and microtubules that make up 
the cytoskeleton—the internal scaffold¬ 
ing of the cell. 
Seeing Snelson’s work had the 
force of a revelation, Ingber says. “I 
spent multiple two-week vacations in 
every library at Yale—the art library, 
the chemistry library, the physics 
library,” he says. “I bought every book 
in Atticus Bookstore related to tensile 
membranes or patterns in nature.” 
Ingber gradually became convinced 
that mechanical forces, largely ignored 
since the rise of molecular biology, 
must play crucial roles in the develop¬ 
ment and behavior of cells. However, 
when he suggested to a postdoctoral 
fellow that cells might change their 
shape because of changes in tensegrity, 
he received a less than encouraging 
response. “He told me, ‘Don’t ever say 
that again!”’ Ingber recalls. 
But Ingber isn’t one to give up easi¬ 
ly. As a graduate student in Yale’s 
m.d./ph.d. Program, he sought out a 
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ideas, which he found in the laboratory 
of James D. Jamieson, m.d., ph.d., 
professor of cell biology and director 
of the program. With Jamieson’s bless¬ 
ing, Ingber devoted a chapter of his 
thesis to tensegrity, and he is particu¬ 
larly grateful that one of his thesis 
advisors, the pioneering cell biologist 
and Nobel laureate George E. Palade, 
m.d., entertained his unconventional 
views with an open mind. “Instead 
of laughing, he gave me Buckminster 
Fuller’s book Synergetics, which he 
had received as a gift when he won the 
Nobel,” Ingber says. 
When it came time for his resi¬ 
dency, Ingber made the decision to 
stop his medical training to do 
research in the laboratory of M. Judah 
Folkman, m.d., at Children’s Hospital 
in Boston. No stranger to controversy, 
Folkman has fought his own long and 
lonely battle to prove his theory that 
blocking angiogenesis—the body’s 
recruitment of new blood vessels—is 
the key to treating cancer and a host 
of other diseases. 
Shortly after Ingber joined the 
Folkman lab, a fungus contaminated 
a tissue culture experiment he was 
working on. Before pitching his dishes 
into the trash, Ingber decided to see 
whether the fungus had any noteworthy 
effects on the endothelial cells that 
were being used in the studies. It was 
a wise decision: the cells had retracted 
av from the fungus, and Ingber 
sed that the fungus was secreting 
some substance that inhibited their 
growth. To Folkmarfs delight, Ingber 
had happened upon a substance that 
led to the development of TNP-470, 
one of the most promising angiogen¬ 
esis inhibitors ever discovered. TNP- 
470 showed potent antitumor activity, 
but it was shelved when Phase II 
trials revealed serious neurotoxicity. 
However, a young scientist now 
working in Folkman’s lab has recently 
modified the compound, and Ingber’s 
chance discovery may yet find its way 
into the clinic. 
In a lab at Children’s Hospital 
where Ingber continues his study of 
tensegrity, the walls are lined with 
framed micrographs of such stunning 
beauty that they could hang in the 
upscale galleries of nearby Back Bay. 
In one, cells cultured on a surface 
designed to constrain various forces 
on the cytoskeleton have assumed a 
number of brilliant shapes, including 
multihued squares and lozenges 
reminiscent of Paul Klee. 
Ingber believes he has finally 
homed in on the interface between 
physical forces and cell physiology. 
Many regulatory and signaling mol¬ 
ecules cluster on the cell membrane 
around proteins called integrins, which 
anchor the cytoskeleton of cells to the 
extracellular matrix. In recent work, 
using miniscule magnetic beads that 
lock onto integrins like a molecular 
wrench, Ingber has shown that twist¬ 
ing integrins in different ways causes 
distinctive shape changes in the 
cytoskeleton, which in turn cause pre¬ 
dictable patterns of gene expression. 
He also can switch cells between 
growth, death and differentiation by 
varying the degree to which cells physi¬ 
cally distort when bound to a matrix 
through integrins. 
To investigate these processes more 
deeply, Ingber has developed a femto¬ 
second laser technique along with 
Harvard physicist Eric Mazur, ph.d., 
Donald Ingber applied Buckminster Fuller’s 
concept of tensegrity—the interplay 
of compression and tension underlying 
structures—to the study of cell biology. 
that will allow him to perform highly 
selective nanosurgery on cells. Ingber 
says that the ability to obliterate some 
structures while retaining cells’ overall 
function will open completely new 
avenues to test his theories. 
Ingber is confident that the rigor of 
his experimental work will eventually 
overcome the skepticism he has long 
faced, and that his ideas will slowly 
but surely enter the mainstream of cell 
biology. “A couple of big Science and 
Nature papers convinced a hell of a lot 
of people,” he says. “In science, even 
if it’s a wild idea, if other people start 
using it and find it valuable—if it 
works—it builds momentum.” 
—Peter Farley 
"When we cast all medical accidents ... 
in terms of negligence, doctors are 
loathe to come forward.” 
Straddling law and medicine, 
and looking for an answer to 
the malpractice crisis 
When health policy guru Troyen A. 
Brennan, m.p.h. ’84, j.d. ’84, m.d. ’84, 
began his studies at the School of 
Medicine in 1978, fresh from a Rhodes 
Scholarship at Oxford, he “wandered 
around,” he says, liberally sampling 
the range of courses Yale had to offer, 
particularly in public health and law. 
Brennan already had a strong interest 
in policy research, and he found the 
classes at the Law School to be so 
stimulating that he donned a second 
hat during his second year of medical 
school and became a law student 
as well. 
But while Brennan still believes 
that his immersion in the world of law 
has been invaluable in his career as 
a policy-maker, he never doubted that 
he would spend his working life as a 
physician. “I always knew I’d practice 
medicine, not practice law,” he says. 
“I’ve never taken a bar exam.” 
Lawyering is too solitary for 
Brennan, who prefers the social and 
intellectual give-and-take of medicine. 
“The practice of law is pretty isolating, 
whereas medicine’s just the opposite— 
it’s always dealing with people,” says 
Brennan, now professor of medicine at 
Harvard Medical School and professor 
of law and public health at the Harvard 
School of Public Health. “It’s much 
more interpersonally satisfying.” 
So if s no surprise that Brennan 
chose a very public way of doctoring. He 
has been front-and-center in national 
debates on health care policy for two 
decades; his research group now focuses 
on the interwoven issues of improving 
patient safety and addressing the crisis 
in medical malpractice. 
“Until very recently, the major way in 
which our health care system dealt with 
deterring medical injuries and improv¬ 
ing safety was through medical malprac¬ 
tice. That was the social mechanism,” 
Brennan says. “We think those should 
be tom apart, and that patient safety 
should be addressed through an entirely 
different mechanism.” 
Brennan argues that both doctors 
and patients would be far better off 
with an administrative compensation 
scheme or mandatory arbitration of 
claims of medical injury. He envisions 
a system similar to Workers’ Compen¬ 
sation, where an administrative-law 
judge would render verdicts after 
advice from experts and with the help 
of specifically defined criteria on how 
avoidable a given patient’s injuries 
were under present standards of care. 
Any damages would be awarded 
according to strict guidelines. 
As it stands, state common law gov¬ 
erning medical injury claims is a 
patchwork of wildly varying standards 
and precedents. A few states—Nevada, 
Oregon, Pennsylvania, Texas and 
Illinois, for example—are malpractice 
hotspots where skyrocketing insurance 
premiums are leading to a shortage of 
specialists. The American Medical 
Association has said that as many as 
20 other states are also in “malpractice 
crisis.” And Brennan says that 50 to 
60 percent of insurance premiums 
now pay attorneys’ fees rather than 
compensating patients who have been 
injured in avoidable medical accidents. 
Brennan also endorses a greater 
embrace of “enterprise liability,” where 
hospitals, rather than individual doc¬ 
tors, are held liable when accidents 
occur. “In plane crashes, it’s not like 
everybody goes and sues the pilot,” he 
says. “They sue the airline, because it’s 
a big enterprise. The pilot’s part of it, 
but he’s got to be informed by the sys¬ 
tems and processes that are going to 
make that flight safe. A doctor in a 
hospital is part of a much larger sys¬ 
tem, and that system’s got to function 
well to prevent these types of injuries 
in the future.” 
Brennan says that the simple substi¬ 
tution of “avoidable” for “negligent” 
under his scheme would represent a 
major cultural shift away from the sim¬ 
mering cauldron of the malpractice 
courtroom. When we cast all medical 
accidents, even some that may have been 
unavoidable, in terms of negligence, he 
says, doctors are loathe to come forward 
when they have made an error. 
“If doctors could say, ‘This was an 
avoidable injury, and we should go 
ahead and report this,’ Brennan says, 
“they don’t have to feel as though 
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a difference in medicine or public 
health or has followed an unusual path 
since leaving Yale? We’d like to hear 
about alumni of the School of Medicine, 
School of Public Health, Physician 
Associate Program and the medical 
school’s doctoral, fellowship and 
residency programs. Drop us a line at 
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I94OS 
Morris A. Wessel, M.D. ’43, clinical 
professor of pediatrics at Yale, 
is spending two days a week as 
a developmental pediatrician 
at the Clifford W. Beers Child 
Guidance Clinic in New Haven. 
Throughout his career Wessel 
has focused on pediatric 
bereavement, prenatal counsel¬ 
ing for parents, neonatal death 
and guidance for adolescents. In 
June 2003 his article on helping 
children and families cope with 
the loss of a loved one was pub¬ 
lished in Pediatrics in Review. 
195OS 
Joseph 0. Robinson Jr., M.D. '59, 
professor emeritus of pharma¬ 
cology at the Syracuse campus 
of the State University of New 
York, retired to Charlottesville, 
Va., after four decades of bio¬ 
medical research (membrane 
transport) and teaching (neuro¬ 
pharmacology). For the past two 
decades he has been indulging 
his enthusiasm for the history 
and philosophy of science, and 
his most recent book, Mechanisms 
of Synaptic Transmission: Bridging 
the Caps (1890-1990), just 
received the biennial award for 
Outstanding Book in the History 
of the Neurosciences from the 
International Society for the 
History of the Neurosciences. 
196OS 
Jack D. Barchas, M.D. ’61, the 
Barklie McKee Henry Professor 
and chair of psychiatry at the 
Weill Medical College of Cornell 
University and psychiatrist-in¬ 
chief at the Weill-Cornell 
Medical Center of the New York- 
Presbyterian Hospital, received 
the American Psychiatric 
Association (apa) Award for 
Research in May at its annual 
meeting in New York. This honor, 
the oldest and most prestigious 
of the apa’s research awards, 
was shared with J. Christian 
Gillin, m.d., who received the 
award posthumously. Barchas’ 
Award for Research lecture was 
titled "Adventures in Psychiatric 
Research: From Neurobiology 
to Public Policy.” 
Gerald R. Fink, ph.d. ’65, Ameri¬ 
can Cancer Society Professor of 
Genetics at the Massachusetts 
Institute of Technology (mit) 
and former director and found¬ 
ing member of the Whitehead 
Institute, has joined the scien¬ 
tific advisory board of Dyadic 
International, a biotechnology 
company that bases its prod¬ 
ucts and solutions on its protein 
expression technology. 
Robert G. Luke, M.D., FW ’65, 
director of internal medicine at 
the University of Cincinnati 
Medical Center, was elected to 
the board of regents of the 
American College of Physicians 
(acp) during its annual meeting 
in New Orleans in April. Luke, a 
member of the acp since 1970, 
will serve as regent for a three- 
year term. 
197OS 
Eliot Sorel, m.d., fw ’75, watched 
his son, Marc, graduate from 
Yale this year. Sorel recently 
chaired the scientific committee 
of the First African Congress on 
Social Psychiatry in Johannesburg, 
South Africa, on "Brain, Behavior 
and Molecules in Social 
Contexts.” 
198OS 
Eugene J. Barrett, M.D., ph.d., FW 
’80, professor of pediatrics and 
medicine at the University of 
Virginia School of Medicine in 
Charlottesville and president of 
the American Diabetes Associa¬ 
tion, spoke about the increasing 
hope for treatment and preven¬ 
tion of type 2 diabetes at the 
Trinity Mother Frances Health 
System Diabetes Seminar in 
March in Tyler, Texas. 
Marc F. Glickstein, M.D. ’80, HS 
’83, a radiologist at Hartford 
Hospital and Jefferson X-Ray 
Group and president of the 
Radiological Society of Con¬ 
necticut, was inducted as a fel¬ 
low of the American College 
of Radiology at its annual meet¬ 
ing in Washington, D.C., in May. 
199OS 
Andrew J. Griffith, M.D. ’92, PH.D. 
’92, who resides in Rockville, Md., 
with his wife and three daugh¬ 
ters, received a 2002 Presidential 
Early Career Award for Scientists 
and Engineers, the highest gov¬ 
ernment honor for scientists and 
engineers beginning independ¬ 
ent careers. The award was pre¬ 
sented in May 2004. Griffith is 
part of the intramural research 
program of the National Institute 
on Deafness and Other Commu¬ 
nication Disorders at the National 
Institutes of Health. His research 
group studies the clinical mani¬ 
festations and the molecular 
basis of hereditary deafness. 
Gina M. Solomon, M.D. '91, M.P.H., 
assistant clinical professor of 
medicine at the University of 
California, San Francisco, and a 
senior scientist in the Health 
and Environment Program of 
Gina Solomon 
the National Resources Defense 
Council, received the Clean Air 
Award for her research on a direct 
relationship between diesel 
exhaust and respiratory disease. 
The award was presented in April 
at the American Lung Associa¬ 
tion’s annual luncheon in San 
Francisco. 
Nirit Weiss, M.D. ’98, and Stephen 
B. Solomon, m.d. ’93, were mar¬ 
ried on May 16 at the Harvard 
Club in New York. Weiss is the 
chief resident in neurosurgery at 
Johns Hopkins Hospital and 
Solomon is an assistant profes¬ 
sor of radiology and urology at 
the Johns Hopkins University 
School of Medicine in Baltimore, 
where the two met. 
2000S 
Barbara Ellen Latunik, M.M.SC. ’03, 
was married on June 7 to 
Theodore Walter Esders Jr. at St. 
Josaphat’s Ukrainian Catholic 
Church in Irondequiot, N.Y. 
Latunik works at Park Ridge 
Hospital, Rochester, N.Y., as a 
physician assistant. Her husband 
is a special education teacher. 
Anita Reddy, PH.D. ’02, FW ’02, 
and Steven Harrison Williams, 
m.d. ’99, were married on May 
30 at Pier Sixty in Manhattan. 
Reddy is a staff scientist at 
Alexion Pharmaceuticals and 
Williams is a resident in plastic 
and reconstructive surgery 
at Yale-New Haven Hospital. 
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James R. Brayshaw, M.D., HS ’57, a 
retired internist from Deltaville, 
Va., died on May 15 at the age of 
75. During his career, Brayshaw 
was president of Alexandria 
Hospital; medical director of 
Goodwin House East and West, 
a continuing care retirement 
community; and resident physi¬ 
cian at Episcopal High School. 
Jonathan M. Clive, PH.D. ’73, a bio¬ 
statistician from Farmington, 
Conn., died on February 27 at the 
age of 58. In the 1970s Clive was 
on the faculty at Duke University. 
He later served as director of 
biostatistical research at the 
University of Connecticut Health 
Center, where he helped medi¬ 
cal and dental researchers design 
studies and interpret data. 
Edmund S. Crelin Jr., PH.D. '51, 
professor emeritus of surgery 
(anatomy) at Yale, who was 
instrumental in creating the 
neonatal and ultrasound units 
at Yale-New Haven Hospital, 
died on June 21 in Branford, 
Conn., at the age of 8i. Crelin 
also pioneered the Physician 
Associate Program at the school 
and was chair of the Human 
Growth and Development Study 
Unit. After his retirement in 
1991, he received an honorary 
appointment to the Yale Society 
of Distinguished Teachers. 
Donald J. Ferguson, M.D. ’42, of 
Minneapolis, died on January 9 
at the age of 87. Ferguson was 
an Army captain in the European 
Theater of Operations during 
World War II. A professor of sur¬ 
gery at the University of Chicago 
until 1987 and former chief 
of surgery at the Minneapolis 
Veteran's Hospital, he researched 
and wrote papers on surgery 
and breast cancer. 
Ann Gomez, M.P.h. ’67, of Largo, 
Fla., died on May 22 in Naper¬ 
ville, III. Born in Brooklyn, N.Y., 
Gomez was a retired administra¬ 
tor at Bridgeport Hospital in 
Connecticut. She was also execu¬ 
tive director of Presbyterian 
Village North, a continuing care 
retirement community in Dallas. 
James N. Harten, M.D. ’46, of 
Wareham, Mass., died on May 4 
at the age of 81. Harten had a 
family practice for 54years and 
was a diplomate of the Ameri¬ 
can Board of Family Practice. 
During World War II and the 
Korean Conflict, he served as an 
officer and general surgeon in 
the U.S. Army and as a major in 
the U.S. Air Force. 
Robert D. King, M.D. ’51, hs ’53, of 
Indianapolis, died on April 25 at 
the age of 79. King served as a 
surgeon for the Reserve Corps of 
the U.S. Public Health Service in 
Seattle. He was a professor of 
surgery and a cardiothoracic sur¬ 
geon at the Indiana University 
Medical Center until he retired 
in 1995- 
William McBride, M.D. ’73, medi¬ 
cal director of Merck & Co., died 
on April 17 of kidney cancer at 
home in Radnor, Pa. He was 56. 
McBride was a gastroenterolo¬ 
gist at Downstate Medical 
Center in Brooklyn, N.Y., until 
1983, when he started a private 
practice in Atlanta. He was also 
a professor at the medical 
schools at Morehouse College 
and Emory University. 
Lowell E. Olson, m.d. ’54, of North 
Haven, Conn., died on March 23 
at the age of 75. Early in his 
career Olson joined the faculty 
at Yale as an instructor in 
obstetrics and gynecology. He 
stayed for 41 years and at his 
death was an associate clinical 
professor. From 1965 until his 
retirement in 1998, he was also 
in private practice. 
Frederick L. Richardson, M.D., of 
North Baltimore, Md., died on 
March 5 in an automobile acci¬ 
dent in Maryland at the age of 
77. Richardson was a lecturer in 
neurology on the Yale faculty 
from 1993 until 2003. As a medi¬ 
cal student he was stricken with 
polio but recovered after one 
year. He devoted his life to help¬ 
ing sick children in countries all 
over the world. 
William B. Seaman, M.D., HS ’47, of 
Tequesta, Fla., died at home on 
June 7 at the age of 88. Seaman 
was a major and flight surgeon 
in the U.S. Army Air Corps during 
World War II. He was professor 
of radiology at Washington 
University School of Medicine in 
St. Louis, and later became chair 
and director of radiology at 
the College of Physicians and 
Surgeons at Columbia University. 
John M. Sherwin, M.D., HS ’65, of 
Manchester, N.H., died of cancer 
on February 11 at the age of 74. 
Sherwin joined the staff at Elliot 
Hospital in Manchester in 1965 
and founded New Hampshire 
Orthopaedic Surgery, P.A. He 
performed the first total hip 
replacement surgery at Elliot 
Hospital and holds a U.S. patent 
for the Sherwin Knee Retractor. 
A.Thomas Snoke, M.D. ’64, of 
Glendale, Ariz., died on February 
28 at the age of 65. Snoke served 
in the Commissioned Corps of 
the U.S. Public Health Service 
(phs) from 1965 to 1989. He was 
the general medical officer at the 
phs Indian Hospital and was later 
promoted to service unit director. 
He also worked as a staff physi¬ 
cian in family practice at the 
Phoenix Indian Medical Center. 
Nicholas M. Stahl, M.D. ’43, of 
Charlestown, R.I., died on April 13 
at the Westerly Nursing Home. 
He was 87. Stahl had a private 
practice in pediatric surgery in 
Syracuse, N.Y., and was an instruc¬ 
tor at Syracuse University Medical 
School. He served as a lieutenant 
in the Army Medical Corps dur¬ 
ing World War II and attained the 
rank of major in 1947. 
Howard W.Telson, M.D. ’80, died 
of cancer on April 5 at the age of 
49.Telson was a clinical associ¬ 
ate professor of psychiatry and 
a faculty member for 20 years at 
New York University School of 
Medicine. He developed innova¬ 
tive programs at Bellevue 
Hospital to improve the mental 
health systems and New York’s 
outpatient commitment pro¬ 
gram that was expanded 
by Kendra’s Law, which allows 
courts to order some people 
with brain disorders to adhere 
to treatment while they live 
in the community. 
Herbert P. Ungricht, M.D. '51, of 
Salt Lake City, died on March 14 
at the age of 86. Ungricht was a 
pilot with the rank of lieutenant 
colonel in the U.S. Army Air Corps 
during World War II. He prac¬ 
ticed ophthalmology in Salt Lake 
City until he was 82. 
SEND OBITUARY NOTICES TO 
Claire M. Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
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Wednesday night at the clinic 
As schools around the country rethink medical education and 
look for ways to enhance clinical experiences for students, the 
Wednesday Evening Clinic can look back on almost three 
decades of a unique experiment [“Learning for the Long Run,” 
Spring 2001]. Since the mid-1970s about 15 students each year 
have enjoyed a rare opportunity in medical school—the 
chance to see the same patient over and over again—and 
learned how to manage long-term clinical care. Working under 
the supervision of attending physicians, medical students 
interview patients, conduct physical exams, make diagnoses 
and recommend treatment. 
For G. Morris Dillard, m.d., ph.d., who founded the clinic, 
the clinic’s value is not in the information that students 
acquire, but the ability to think clinically. 
"It is the logical reasoning with the material you have 
at hand that is the most important thing the clinic can accom¬ 
plish,” he said. 
The clinic serves as an example of how to expose stu¬ 
dents to long-term clinical experiences at a time when the 
medical school is exploring ways to teach universal, as 
opposed to discipline-specific, skills.“There is an interest in a 
longitudinal experience,” said Herbert S. Chase Jr., m.d., deputy 
dean for education. “To that extent, the Wednesday Evening 
Clinic was really a pioneer.” 
Kathleen P. White, m.d., the clinic’s director, said 
the clinic has seen a few changes in recent years. Spanish¬ 
speaking first- and second-year students are on hand to 
interpret for patients. Undergraduates interested in medicine 
provide clerical support. Four more attending physicians have 
joined the roster of volunteers, and the clinic has recruited 
community doctors. Clinic files are now computerized so pre¬ 
ceptors can review student notes on their cases online. 
And this year, said White, two students found long-term 
preceptorships outside the clinic, in reproductive gynecology 
and vascular surgery. “They got longitudinal experience in 
'eir interests,” White said. 
—John Curtis 
THt SCHOOL Of MEDICINE 
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Alumni Bulletin 
Wanted: Books for General 
Reading 
“A small bookplate indicating own¬ 
ership of the Yale Medical Library 
and bearing the tag from Marital’s 
[sic] Epigrams,‘Those books they 
praise, but these they read’ is used 
in a collection of books that have 
nothing to do with medicine—not 
only volumes classified as ‘light 
reading’ but also books in other 
fields of endeavor which represent 
good general reading. This collec¬ 
tion was started when a member of 
the Library Committee suggested 
the possibility of having a non¬ 
medical section in the Library. It was 
indicated that such volumes were 
to be added by gift only. 
“Dr. Samuel C. Harvey made 
the initial donation of some 
thirty-odd volumes, and donations 
have been added subsequently. 
These books have circulated many 
times throughout the year. They 
are not catalogued in any way and 
are located in the Historical Library 
near the main door. 
“The Library would be most 
grateful to receive from members 
of the Alumni Association and 
other interested persons any good 
books published since World War II 
to add to this collection.” 
WINTER 1979 
Yale Medicine 
A Special Program to Help 
Juvenile Diabetics 
"... Last year, Connecticut became 
the second state (after Florida) to 
establish a program for children 
with diabetes, when the State 
Legislature authorized an appropri¬ 
ation of $130,000 to the State 
Department of Health to establish 
and administer two regional centers 
to provide counseling and health 
services to the estimated 1,500 to 
2,500 diabetic children in Connecti¬ 
cut and their families. The centers 
are at the Yale School of Medicine, 
under the direction of Dr. Myron 
Genel and Dr. William V.Tamborlane 
Jr., and at the University of Connecti¬ 
cut School of Medicine, under the 
direction of Dr. David Rowe and Dr. 
Susan Ratzan. 
“The program was developed in 
the Yale Section of Pediatric 
Endocrinology by Dr. Genel, who is 
program director of the Children’s 
Clinical Research center at Yale. 
Modeled in part on the Florida pro¬ 
gram, it consists of a team at each 
center of three physicians, a nurse 
specialist, social worker, dietician, 
lab technician, and administrative 
coordinator. Their objective is to 
educate the young diabetics and 
their families, with the ultimate 
goal of helping the patients to care 
for themselves.” 
Stay connected 
Yale Medicine can help you stay connected with fellow alumni 
of the School of Medicine, School of Public Health, Physician 
Associate Program and the medical school's doctoral, fellowship 
and residency training programs. Share your personal and pro¬ 
fessional news for publication in the Alumni Notes department 
of Yale Medicine and on the Web, using this card or the online 
form at info.med.yale.edu/ayam. 
□ _ 
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Chinese University leaders listen as 
Lawrence Rizzolo, associate professor of 
surgery (anatomy), gives a tour of new 
teaching facilities in the Anlyan Center. 
Below, the chop designed for the China-Yale 
Advanced University Leadership Program. 
CHINESE UNIVERSITY LEADERS VISIT YALE 
Leaders of 12 of China’s most prestigious universities spent two 
weeks at Yale in August, including one day at the medical school. 
The purpose of their visit, the first of its kind sponsored by China’s 
Ministry of Education outside the country, was to study Yale's 
structure, organization and administrative practices. 
At the medical school Dean Robert J. Alpern, m.d., and others 
described medical education at Yale and in the United States. 
(In China students go straight from secondary school to medical 
school.) The visitors also toured research laboratories and teach¬ 
ing laboratories and classrooms for histology and anatomy. 
Yale began a series of educational exchanges with Chinese 
universities in 1996, and earlier this year Yale concluded an agree¬ 
ment with Fudan University in Shanghai to promote exchanges 
among scholars in history, East Asian languages and literature, 
genetics, biology, law, medicine and management. 
“Will this visit cause changes to be made?” asked Tian Xu, 
p.h.d. ’90, professor and vice chair of genetics at Yale and 
special advisor to President Richard C. Levin on science and higher 
education in China. “Definitely. It’s a question of how much 
and how fast.” 
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ON THE COVER 
Zebrafish, usually found swimming 
in rice paddies along the Ganges 
River, peer out from a tank in the 
laboratory of Zhaoxia Sun, one 
of two scientists at Yale who use 











Zebrafish grow quickly, progressing 
from egg to fish in a day. The eggs 
are transparent and develop out¬ 
side the mother’s body, allowing 
scientists to observe development 
as it occurs. 
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Capsule 
Lessons from the depths 
Scientists are increasingly turning to aquatic organisms as 
they seek clues to human physiology and disease. Zebrafish, 
coral and sea hares are becoming model organisms on a 
par with Drosophila, mice and yeast. 
By Jennifer Kay I'm 
Leaving no child behind 
In a memoir of his formative years, child psychiatrist 
James Comer describes what he learned from his family and 
neighbors—and how he sought to make tholpvalues the 
linchpin of an educational philosophy. 
By James Comer 
In the anatomy lab, a new way of thinking 
Scarce instructors, new tools and a boom in knowledge lead 
to an ongoing experiment in anatomy teaching. Structure 
remains important, but the new paradigm is functionality. 
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On our website, readers can submit class notes or a change of address, 
check the alumni events calendar, arrange for a lifelong Yale e-mail alias 
through the virtual Yale Station and search our etfcgtronic archive. 
Letters 
The 8o-hour week, 
and its aftermath 
I read with interest your recent 
article on resident hours ["Re¬ 
creating the Residency,” Fall/ 
Winter 2004]. I was among the 
physicians who testified at 
the grand jury that investigated 
the Libby Zion case. While it is 
true that the grand jury did not 
indict anyone, they did find that 
there was a significant cause 
for concern and issued a report 
to the New York state legisla¬ 
ture. This led to the formation of 
the Bell Commission, which rec¬ 
ommended the 8o-hour work¬ 
week and increased supervision 
of house staff. It was this report 
that ultimately led to the pas¬ 
sage of the 8o-hour limit for 
house staff in New York. 
The invective from organized 
medicine against these rules 
was ferocious. It put medicine 
at direct odds with the public, 
for whom these rules were 
self-evident and made unques¬ 
tionable common sense. They 
believed that no one could work 
ioo to 120 hours a week and 
still provide the level of care and 
cognitive functioning that the 
public required of their physi¬ 
cians. They also intuitively under¬ 
stood that the more physicians 
were asked to deny their own 
needs while in training, the less 
they would be able to cater to 
the needs of their patients while 
in practice.The more medicine 
railed against the rules, the more 
the public began to question 
its judgment. As you correctly 
pointed out, in many ways this 
was one of the strong impetuses 
for the patient safety movement. 
In addition, as medicine chose to 
specifically break the law in New 
York by not adhering to the 
hours limit, the public perceived 
medicine as viewing itself as 
being above the law, as being 
paternalistic and as acting in its 
own financial best interests.The 
resulting furor has led, in part, 
to the distrust that has been 
increasingly seen in the public's 
opinion of American medicine. 
Yale has now taken a lead¬ 
ing position in the intelligent 
implementation of these rules. 
Yale’s leaders assessed the prob¬ 
lems for patient care that the 
rules raised and put into effect 
specific solutions that addressed 
them. They committed them¬ 
selves to an ongoing look at the 
process and continued improve¬ 
ment as problems arise. The 
resulting system of training will 
be good for patient care, house 
staff training and the view of 
medicine by the public. 
Gerald M. Brody, m.d. '77 
Tuckahoe, N.Y. 
Enlightened hmos 
make time for cme 
Writer Jill Max quoted Lawrence 
5. Cohen, m.d., as saying: “One 
of the challenges in the environ¬ 
ment is that physicians, because 
of managed care, find it increas¬ 
ingly difficult to leave the 
practice and go to a meeting.” 
[“Yale cme Gets a New Lease on 
Lifelong Learning,” Fall/Winter 
2004.] I find this statement con¬ 
trary to my experience with the 
Southern California Permanente 
Medical Group (scpmg), a part 
of Kaiser-Permanente. 
I joined scpmg in July 1967 
and became chief of ob/gyn. 
From the beginning, my depart¬ 
ment had weekly, mandatory, 
half-day cme meetings plus a 
weekly Friday morning hour for 
quality review. Speakers from 
the Department of Reproductive 
Medicine at the University of 
California, San Diego, were often 
present. Later, when the ucsd 
residency began, our hospital 
was the first in San Diego to 
have a resident. 
Our partnership agreement 
specifies a half-day weekly of 
paid education time plus one 
week paid yearly to attend an 
educational meeting. I never 
had these benefits when I was 
in solo practice in Brockton, 
Mass. Because of these educa¬ 
tional opportunities, as regional 
clinical coordinator for scpmg, 
I was involved in improving the 
quality of practice. Two of our 
hospitals, in San Diego and Los 
Angeles, became No. 1 and No. 2 
in the state for quality. 
Myron K. Nobile, m.d. ’47, HS '54 
La Jolla, Calif. 
Dr. Cohen responds: "My com¬ 
ments did not apply to groups 
such as yours, but they do apply 
to the average practitioner 
who is in a solo or group practice. 
In that instance, time away 
at conferences that award cme 
credits are not easily come by. 
It is true that grand rounds and 
specialty conferences are often 
given at the hospitals, but many 
physicians are not encouraged 
to attend; I applaud the success 
of your program at Kaiser- 
Permanente." 
HOW TO REACH US 
Yale Medicine welcomes news and 
commentary. Please send letters 
to the editor (250 words or less) 
and news items to Yale Medicine, 
P.O. Box 7612, New Haven. 
CT 06519-0612, or via electronic 
mail to ymm@yale.edu, and 
include a daytime telephone num¬ 
ber. Submissions may be edited 
for length, style and content. 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
Merson steps down as 
dean of public health 
As this issue of Yale Medicine 
was being prepared, we learned 
that Michael H. Merson, m.d., 
the Anna M.R. Lauder Professor 
of Public Health, would step 
down as dean of public health 
and chair of the Department of 
Epidemiology and Public Health 
(eph), as of December 31,2004. 
Brian P. Leaderer, m.p.h. ’71, ph.d. 
’75, the Susan Dwight Bliss 
Professor of Public Health, was 
named interim dean and chair 
during a search for a successor 
to Merson. Nancy H. Ruddle, 
ph.d. ’68, the John Rodman Paul 
Professor of Epidemiology and 
Public Health, will serve as in¬ 
terim deputy dean and vice chair. 
Merson came to Yale in 1995 
from the World Health Organiza¬ 
tion in Geneva, where he directed 
the Global Programme on aids. 
At Yale he continued his efforts 
to stem the pandemic, forming 
the Center for Interdisciplinary 
Research on aids (cira), which 
undertakes research and pre¬ 
vention programs in the United 
States, Russia, China, India and 
South Africa. 
He has also raised the profile 
of the public health school 
and has fostered joint-degree 
programs with other profes¬ 
sional schools at Yale, including 
nursing, law, management, 
forestry and environmental 
studies, and divinity. 
After a sabbatical, Merson 
will return to the public health 
faculty later this year. He will 
also continue as director of cira. 
Leaderer joined the eph 
faculty in 1976 and is the princi¬ 
pal investigator of studies that 
examine environmental and 
genetic factors of asthma in 
children. Ruddle directs gradu¬ 
ate studies in public health. 
She studies cell trafficking and 
inflammation, particularly with 
regard to the lymphotoxin/ 
tumor necrosis factor family. 
She has been on the Yale faculty 
since 1975. 
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Fish tales, on the up and up 
Last September, I was listening to a lecture in the Anlyan Center when a fascinating bit of 
data flashed on the screen. Assistant Professor of Genetics Zhaoxia Sun, ph.d. ’98, was 
describing her use of zebrafish as a model organism for the study of polycystic kidney dis¬ 
ease and alluded to how compact and convenient they are for laboratory work. The 600 small 
tanks on racks in her lab at the medical school can hold as many as 15,000 zebrafish, a 
species whose dna bears a remarkable similarity to our own genetic code. Given the rapidity 
with which zebrafish develop (from egg to fish in a day), Sun has a powerful resource for 
conducting genetic studies relevant to human illness. 
We wondered what other aquatic organisms were assisting scientists at the School of 
Medicine as they explore the dimensions of normal biology and disease. Sea hares, with their 
elongated neurons, and sea squid, with synapses so wide they can be seen without a micro¬ 
scope, are among the creatures writer Jennifer Kaylin encountered while reporting this 
issue’s cover story (“Lessons From the Depths,” page 18). She also learned how knowledge of 
chloride transport in dogfish sharks may one day help solve the riddle of cystic fibrosis and 
how a professor of physiology and neurobiology is exploring Australia’s Great Barrier Reef to 
discover and clone new fluorescent proteins from coral. These molecules may prove useful 
for tagging cells and exposing what happens inside them—in real time and brilliant color. 
Science and medicine are always changing, and it’s gratifying to know that Yale 
faculty are leading the way in areas such as these, asking the questions that open doors to 
new knowledge. That curiosity and sense of adventure can only benefit doctors and patients 
around the world—and across the seven seas—for years to come. 
Michael Fitzsousa 
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chronicle news from cedar street 
The molecule meets 
the computer chip 
Harnessing the power of computers 
is essential as biologists work to 
decipher mountains of new data. 
It is difficult to imagine two places 
more different than The Eagle Pub and 
Celera Genomics, each of which pro¬ 
vided the setting for signal events in 
modern biology. The cozy Eagle, in 
Cambridge, England, was already a 
smoky anachronism fitted with bur¬ 
nished brass and dark wood in Feb¬ 
ruary 1953, when Francis H.C. Crick 
famously burst through the door to 
inform James D. Watson that they had 
jointly deciphered “the secret of life”— 
the structure of dna. Nearly 50 years 
later, in Celera’s sterile, starkly lit 
“sequencing rooms,” and in similar 
rooms at institutions responsible for 
the government-sponsored Human 
Genome Project, the complete human 
genome was painstakingly unraveled by 
row upon row of humming computers. 
The pub and the sequencing room 
are apt metaphors for the vast changes 
wrought by Watson and Crick’s dis¬ 
covery, which unleashed a torrent of 
research in molecular biology that 
has revolutionized our understanding 
of evolution, physiology and disease. 
Watson and Crick confronted a blank 
slate, but today’s scientists are awash in 
a fast-moving river of information so 
thick with possibility that the American 
Association for the Advancement of 
Science recently felt compelled to spon¬ 
sor a symposium for biologists called 
“Inundated With Data.” 
The collective efforts of the world’s 
scientists have allowed us to construct 
diagrams of intracellular signaling 
pathways that would make a New York 
subway official blanch, and the com¬ 
plete genomes of over 100 organisms 
are now in hand. However, biologists 
have been so busy amassing fine 
details that they have had little time or 
incentive to step back from the bench, 
take a breath and begin to grasp the 
essential patterns in the big picture. 
Luckily, computing power has 
increased in tandem with biological 
knowledge at an exponential rate, 
setting the stage for the recent emer¬ 
gence of the cutting-edge, multidisci¬ 
plinary field of computational biology. 
The field embraces genomics and 
proteomics (the latter aims to catalog 
the complete inventory of proteins 
encoded by genomes), but also pro¬ 
motes computational modeling of 
intracellular processes and cell-cell 
interactions, as well as the “high- 
throughput" data-mining techniques of 
bioinformatics, which can unveil com¬ 
mon mechanisms underlying seem¬ 
ingly diverse diseases and compare 
genomes to discern subtle evolutionary 
relationships among organisms. 
In 2003, Yale established an inter¬ 
disciplinary ph.d. program in com¬ 
putational biology and bioinformatics. 
That same year, the university’s 
Biological Sciences Advisory Commit¬ 
tee (bsac), under the leadership of 
H. Kim Bottomly, ph.d., professor of 
immunobiology, began a study 
which concluded that computational 
approaches would play a central role 
in 21st-century biology. The committee 
has just produced its final report, a 
blueprint for Yale to stay ahead of the 
curve in faculty recruitment, funding 
and facilities. 
The committee’s efforts also led to 
“A Look to the Future,” an October sym¬ 
posium at the medical school’s Anlyan 
Center chaired by Perry L. Miller, m.d., 
ph.d., professor of anesthesiology and 
director of the Center for Medical 
Informatics; Mark B. Gerstein, ph.d., 
the Albert L. Williams Associate 
Professor of Biomedical Informatics 
and associate professor of molecular 
biophysics and biochemistry; and 
William L. Jorgensen, ph.d., the Conkey 
P. Whitehead Professor of Chemistry. 
The symposium assembled seven 
top researchers from around the world 
who use computational approaches to 
attack a variety of biological problems, 
from untangling phylogenetic relation¬ 
ships between species to manipulating 
gene sequences to create completely 
new proteins and enzymes with cus¬ 
tomized biological functions. 
In addition to providing a forum for 
these scientists to present their latest 
work, the symposium also included 
several informal brainstorming ses¬ 
sions where Yale scientists and admin¬ 
istrators learned how the speakers’ 
home institutions have risen to the 
structural and organizational chal¬ 
lenges of integrating computational 
biology into teaching and research. 
The bsac report argues that Yale 
must increase its research and teaching 
strengths in computational biology 
and bioinformatics. It recommends the 
creation of thematically oriented clus¬ 
ters of faculty at the medical school and 
on Science Hill. And it proposes the 
formation of a universitywide center 
for computational biology and bioinfor¬ 
matics that would foster campuswide 
interactions of faculty and trainees and 
provide administrative support. 
No one doubts that computational 
biology is here to stay. “The old view was 
that biologists were the scientists who 
didn’t like to think quantitatively,” said 
Carolyn W. Slayman, ph.d., Sterling 
Professor of Genetics and deputy dean 
for academic and scientific affairs. “Now, 
biologists must face up to the fact that 
there’s going to be a demand for greater 
computational skill and greater expertise 
in informatics than ever before—it’s 
the future of the field." 
—Peter Farley 
A new hospital pavilion, set 
to open in 2008, will house 
$430 million cancer facility 
Services for cancer patients are cur¬ 
rently scattered at six sites across 
the Yale-New Haven Medical Center, 
but that will change by 2008 with 
the planned opening of a new hospital 
facility that will offer all cancer serv¬ 
ices under one roof and significantly 
enhance the medical school’s ability to 
conduct clinical research. 
At a press conference on November 
30, Yale-New Haven Hospital (ynhh) 
President and ceo Joseph A. Zaccagnino, 
m.p.h. ’70, announced that ynhh 
would add a 497,000-square-foot 
north pavilion to the ynhh complex 
that will house a comprehensive 
clinical cancer center. The plan will 
add 112 inpatient hospital beds and 
an estimated 400 permanent jobs. 
The proposed $430 million center 
is a 14-story facility with space for 
operating rooms; infusion suites; radia¬ 
tion treatment rooms; adult inpatient 
facilities for surgical, medical and 
gynecologic oncology; and an outpa¬ 
tient women’s cancer center. It will 
be connected to the Yale-New Haven 
Children’s Hospital by way of a five- 
story bridge across the upper floors, 
so that pediatric patients will be able 
to receive treatment at the new center 
while remaining hospitalized in the 
children’s facility. 
“I cannot overstate our level of 
enthusiasm and excitement about this 
project,” Dean Robert J. Alpern, m.d., 
said at the press conference, attended 
by city officials, patients, employees 
and community, hospital and medical 
school leaders. “Now that we’ve seen 
the drawings, we’re impatiently ready 
to move into the building. We’re 
going to have to control ourselves.” 
Yale Cancer Center Director Richard 
Edelson, m.d. ’70, called the move 
“a huge step forward.” 
Alpern and Yale President Richard 
C. Levin both stressed the opportunities 
the new center opens up for conduct¬ 
ing additional clinical trials, which are 
a source of promising new treatments 
for patients and an important revenue 
stream for academic medical centers. 
Levin noted that Yale is already one of 
the top biomedical research institutions 
in the world and does excellent cancer 
research in the laboratory. 
“With expanded capabilities to 
treat cancer patients and to do research 
on the efficacy of new therapies, we 
can do much more,” Levin said. “We 
can establish ourselves as one of the 
world’s great centers for the treatment 
of cancer.” 
The new center will be built on 
existing hospital property at the site of 
the Grace Building on Park Street, a 
former nursing hall now given over to 
offices, which is slated for demolition 
this spring. The hospital’s board of 
trustees approved plans for the center 
in November, following state approval 
of the preliminary site plan last July. 
Pending approval of the plans by the 
city and state, groundbreaking is 
expected in the fall. 
—Michael Fitzsousa 
An artist’s rendering shows a new pavilion at 
Yale-New Haven Hospital, which will house all 
cancer services under one roof. It is expected 
to open by 2008. 
chronicle 
New mba program to help 
health professions with 
the business of medicine 
At some point in the 1980s, according 
to Howard P. Forman, m.d., m.b.a., 
vice chair and associate professor of 
diagnostic radiology, the practice 
of medicine became more pain than 
gain for many physicians. 
“Health care costs were skyrocket¬ 
ing and cost containment measures 
gained importance,” said Forman. 
“Physicians were targeted as the cause 
of the problems and were counted 
on to bring down costs.” 
Forman and others at Yale’s schools 
of medicine, management and public 
health may have a prescription for this 
malaise—the Yale mba for Executives: 
Leadership in Healthcare. This new 
program, which Forman co-directs 
with Stanley J. Garstka, ph.d., deputy 
dean of the School of Management, 
and Dick R. Wittink, ph.d., tire George 
Rogers Clark Professor of Management 
and Marketing, will enroll a charter 
class of up to 30 students in August. 
The 22-month program’s goals— 
besides providing a second set of skills 
without career disruption—are to 
turn the classroom into a cross section 
of the contemporary health care field 
and to train what Forman calls “change 
agents capable of making a positive 
difference in the practice of health 
care.” By enrolling students with a 
broad range of background and experi¬ 
ence—professionals from hospitals, 
clinics, insurance and managed-care 
organizations and pharmaceutical, 
biotechnology and financial service 
firms—the program aims to change 
perceptions that these fields are adver¬ 
saries. Then, through two intense 
residences, weekend classes and semi¬ 
nars with visiting scholars, the curricu¬ 
lum provides the management skills 
needed to navigate the complexities of 
health care, which is itself constantly 
changing due to medical and techno¬ 
logical breakthroughs, new laws and 
government policies. 
The seed for the executive program 
was planted in 1996 when medical 
students expressed interest in an m.d./ 
m.b.a. program. That joint-degree pro¬ 
gram, though geared toward medical 
students, has also attracted faculty and 
working physicians. Among the latter, 
Michael Apkon, m.d., ph.d., fw ’94, 
m.b.a. ’02, was one of the four m.d./ 
m.b.a.s produced by the first graduat¬ 
ing class in 2002. A former assistant 
professor in the medical school, he is 
now medical director of the pediatric 
icu and a vice president at the Yale- 
New Haven Children’s Hospital. 
Although that program worked 
for medical students, who could add a 
year to their studies, it was not ideal 
for practicing professionals. “Surgeons 
came to me and said, ‘I'd have to give 
up my career if I’m going to do this 
joint-degree program because I can’t 
do four days a week and not be in the 
OR.’ So we started work on an execu¬ 
tive program targeted to health care 
professionals,” said Forman. 
Not so long ago, even the idea of an 
m.d./m.b.a. was a tough sell. “There 
was the fear that you were either sell¬ 
ing out to the enemy or selling your 
soul,” said Forman. That negative per¬ 
ception was changed, in part, by the 
University of Pennsylvania’s Wharton 
School, where William L. Kissick, 
m.d. ’57, m.p.h. ’59, dr.ph. ’61, led an 
m.d./m.b.a. program that produced 
some of today’s health care leaders 
(See Alumni Faces, p. 38). 
“By the 1990s, it was apparent that 
for those who want to be leaders this 
is an appropriate path—that you’re not 
selling out,” said Forman. “You’re ful¬ 
filling your mission to improve health 
care for larger numbers than you could 
as a pure clinician.” 
—Alan Bisbort 
Yale and New Haven join 
in pilot program for treating 
hiv/aids in Russia 
Russia today is where the United States 
was 20 years ago in dealing with hiv/ 
aids: denial and prejudice are almost 
as widespread as the disease itself. 
In an effort to help, last July in 
St. Petersburg Health and Human 
Services Secretary Tommy G. Thompson 
announced a major grant to fight 
the aids epidemic. A Yale doctor and 
epidemiologist were by his side, and 
at an October news conference in New 
Haven’s City Hall, they announced 
their own role in the initiative. The 
School of Medicine was one of four 
U.S. organizations chosen to receive 
$320,000 each from the U.S. Agency 
for International Development to pro¬ 
vide training in care, treatment and 
support services to people living with 
hiv/aids in Russia. 
The School of Public Health, 
through its Center for Interdisciplinary 
Research on aids, has worked on 
training and prevention programs with 
colleagues in St. Petersburg since 
1998. But this marks the first collabo¬ 
ration between the two cities to 
address hiv/aids care and treatment. 
The 30-month program calls for 
Yale, along with state and city agencies, 
to share information and strategies 
with colleagues in St. Petersburg. The 
grant will fund four exchanges each 
year; the first group of Russian trainees 
arrived in New Haven in early October. 
Yale faculty and representatives from 
community-based hiv/aids organiza¬ 
tions will also travel to St. Petersburg 
to train Russian health professionals 
and to observe how they are managing 
the epidemic. 
In Russia, a major obstacle is the 
prejudice against hiv/aids patients, 
typically young, male intravenous drug 
users. As part of the program, Russian 
visitors will observe services provided 
by the Yale aids Program and organi¬ 
zations in New Haven, and they will 
visit a methadone clinic and needle 
exchange program. Krystn R. Wagner, 
ph.d. ’89, m.d. ’96, assistant profes¬ 
sor of medicine and project coordi¬ 
nator of the New Haven-St. Petersburg 
partnership, said she hopes that 
“observing drug treatment here will 
help catalyze new thinking about 
substance abuse management and 
the care of drug users.” 
The problem in Russia, said 
Robert Heimer, ph.d. ’88, associate 
professor of epidemiology and public 
health and co-coordinator of the 
project, is the lack of a multidiscipli¬ 
nary, integrated system for managing 
hiv/aids. “Someone walks into a 
hospital and is treated for hiv,” said 
Heimer, “but what about his drug 
addiction, or the fact that he has 
tuberculosis or that he’s homeless? 
There’s no coordination, no system 
that allows them to deal with the 
complexities of this illness in a way 
that crosses traditional medical 
boundaries.” 
The impetus for this initiative is the 
soaring number of hiv infections in 
Russia, hiv/aids didn’t surface in 
the countries of the former Soviet 
Union until the early 1990s, but they 
now report some of the world’s fastest- 
growing rates of new infections. 
Although there are 300,000 reported 
cases in Russia, the United Nations 
and Russian aids officials put the 
number at 1 million or more. Wagner, 
medical director of the Nathan Smith 
Clinic, the hiv clinic affiliated with 
Yale-New Haven Hospital, said this is 
due to many factors, including relaxed 
border controls after the dissolution 
of the Soviet Union, rising unemploy¬ 
ment and drug trafficking. Most new 
hiv cases were initially among IV drug 
users, but now cases caused by sexual 
transmission are on the rise. 
Heimer called the collaboration 
“remarkably exciting. ... If we can 
create and implement an integrated 
system on a pilot basis in one small 
region of St. Petersburg, and if it’s suc¬ 
cessful, it can be replicated elsewhere 
in Russia.” 
—Jennifer Kaylin 
KAPLAN NAMED TO IOM 
Edward H. Kaplan, ph.d., the William N. and 
Marie A. Beach Professor of Management 
Sciences at the School of Management and 
professor of public health, has been elected 
to the institute of Medicine. Kaplan, the only 
Yale faculty member named to the institute 
this year (see Alumni on page 42 for more on 
this topic), is an operations research and sta¬ 
tistics expert who studies problems in public 
policy and management. His recent research 
has focused on counterterror topics such as 
the tactical prevention of suicide bombings, 
bioterror preparedness and response logis¬ 
tics in the event of a smallpox or anthrax 
attack. In the early 1990s, he was the princi¬ 
pal investigator of a landmark project that 
evaluated the efficacy of New Haven’s nee¬ 
dle exchange program. 
Membership, one of the highest honors 
in medicine, is awarded for contributions to 
medical science, health care and public 
health. The institute was established in 1970 
by the National Academy of Sciences and 
provides independent, scientifically informed 
analysis and recommendations on human 
health issues. 
—John Curtis 
YALE JOINS NATIONAL EPILEPSY STUDY 
Yale has been named a key member of a 
national group of medical centers that has 
received the largest grant ever for a study of 
epilepsy in children. The $17 million award 
from the National Institute of Neurological 
Disorders and Stroke will fund a study of the 
three most-used drugs for treating childhood 
absence (petit mal) epilepsy. The five-year 
study at 20 sites across the country will 
attempt to determine the best initial medi¬ 
cine for childhood absence epilepsy, which 
involves seizures marked by nonconvulsive 
staring spells. 
At Yale researchers will try to identify 
why some treatments work, why some have 
side effects and what effects they have on 
cognition, behavior and learning. “This is the 
first step toward our goal of making it possi¬ 
ble for physicians to predict patient response 
and tailor therapies for individual needs,” 
said Edward J. Novotny Jr., m.d., fw ’89, who 
is leading the study with colleague Susan R. 
Levy, m.d. 
—J.C. 
Health officials in the 300-year-old city of 
St. Petersburg have joined with New Haven 
and Yale in a new effort to coordinate medi¬ 
cal and social services for people infected 
with hiv/aids. The epidemic in Russia, origi¬ 
nally prevalent in drug users, is poised to 
spread through sexual transmission. 
ROUnds MEDICINE AND HEALTH AT YALE 
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Minority patients wait 
longer for angioplasty 
Researchers say the choice of hospital 
is a bigger factor than differential 
treatment in the hospital. 
Minority patients with heart attack 
symptoms wait longer for treatment 
than whites do, according to a recent 
study led by Harlan M. Krumholz, 
Q m.d., m.sc., professor of medicine (car- 
£ diology), and Elizabeth H. Bradley, 
| ph.d. ’96, associate professor of public 
health (health policy and administra¬ 
tion). But waiting time appears to have 
more to do with the choice of hospital 
than any conscious decision by health 
care providers to discriminate based on 
race or ethnicity. 
For the study, published in the 
October 6 issue of JAMA: The Journal 
of the American Medical Association, 
researchers examined data from the 
National Registry of Myocardial 
Infarction (nrmi) to determine how 
much time elapsed between a patient’s 
arrival at the hospital and the start of 
either drug therapy or balloon angio¬ 
plasty. Records of more than 110,000 
heart attack patients treated between 
January 1999 and December 2002 
were analyzed. 
At first glance, the results showed 
that door-to-drug times for minority 
patients were significantly longer— 
up to seven minutes for African- 
Americans—than for white patients, 
while door-to-balloon times for this 
group were almost 19 minutes longer. 
However, once the study factored in 
the hospitals that were offering treat¬ 
ment, these differences were substan¬ 
tially reduced: it took about five 
minutes more for African-Americans 
to receive drugs and nine minutes 
more for balloon intervention. For 
other ethnic groups, the differences 
were reduced even further. 
“People who get care quicker when 
they are having a heart attack are more 
likely to live, so this is an important 
difference to understand and address,” 
said Bradley. “The biggest insight from 
this paper was that it seems as if there 
were two levels of difference going 
on,” said Krumholz. “There’s the level 
where race/ethnicity differences exist, 
and although they’re small, they’re 
disturbing and need to be understood. 
But a bigger part of the overall differ¬ 
ence in treatment by race and ethnicity 
seems to be explained by the hospitals 
that people are going to.” 
Previously, researchers assumed 
that racial and ethnic disparities were 
due to differential treatment inside the 
hospital, without considering the pos¬ 
sibility that hospitals that treat greater 
numbers of minority patients do not 
offer the same level of care as hospitals 
that treat fewer minority patients. “Our 
finding suggests that the issue is bigger 
than differential treatment inside the 
hospital. Minority patients tend to be 
treated at hospitals with poorer quality 
in this area generally,” Bradley said. 
The study suggests that efforts 
focusing solely on racial and ethnic 
disparities will fall short in improving 
patient care. Hospitals need to 
examine how they’re delivering care 
and formulate systems that address 
inadequacies. “As one solution, we 
should really identify the characteris¬ 
tics and key processes that raise the 
quality of hospitals generally and 
ensure that we target these kinds of 
improvement efforts in hospitals that 
have poorer quality indicators, many 
of which are hospitals where minori¬ 
ties receive their care,” Bradley said. 
—Jill Max 
Camera in a pill gives 
an unprecedented view 
of the small intestine 
When the White Queen assured Alice in 
Wonderland that she was able to believe 
“as many as six impossible things before 
breakfast,” the idea of swallowing a tiny 
camera first thing in the morning was 
probably not on her list. 
But thanks to a new procedure 
called video capsule endoscopy, 
some patients with gastroenterological 
symptoms are doing just that. The 
camera, enclosed in a pill about the 
size of a large vitamin supplement, 
is swallowed early in the morning on 
an empty stomach; the patient drinks 
water two hours later and eats a light 
lunch two hours after that to encour¬ 
age the gastric and intestinal contrac¬ 
tions that move the video capsule 
along. During its eight-hour passage 
through the digestive tract, the camera 
transmits images of the small intes¬ 
tine to a monitoring device around the 
patient’s waist. The resulting pictures, 
downloaded into a computer, allow 
the clinician to see parts of the small 
intestine that are not visible through 
a regular endoscope. 
According to Deborah D. Proctor, 
m.d., associate professor of medicine 
(digestive diseases), who has been 
using the technique since it was intro¬ 
duced at Yale last spring, it is helpful 
in diagnosing hidden gastrointestinal 
bleeding where upper endoscopy and 
colonoscopy are inconclusive. It is 
also useful in obtaining information 
about management of chronic prob¬ 
lems such as Crohn’s disease, which 
depends on the degree to which the 
disease is located in the small intes¬ 
tine. “Upper endoscopy shows only 
about a foot of small intestine,” Proctor 
noted. “The enteroscope shows only 
about another 6 to 8 feet—a total of 
about one-third to one-half of the small 
intestine. With the camera we can 
see the entire small intestine in about 
85 percent of patients who undergo 
the procedure.” 
Scanning technology—using a 
camera at the end of a scope to trans¬ 
mit data, as is done with an endo¬ 
scope—has been around for about 15 
years, while fiber optic technology has 
been around for about 30 years. What 
is new here is the camera-inside-the- 
pill—a technique that originated in 
Israel four years ago and is currently 
in use at Yale and 250 other facilities 
around the country. 
"The procedure is totally noninva- 
sive; no radiation is involved, there is 
no discomfort and no need for seda¬ 
tion,” she said. "Once the camera and 
belt are in place, patients can go about 
their normal day.” 
The only contraindication is for 
those patients whose GI tracts might 
be obstructed, preventing the capsule 
from moving through. For all others 
the capsule moves painlessly through 
the GI tract and is excreted. 
“This is so safe that we’ve started 
using it with children—as long as they 
weigh over about 50 pounds,” Proctor 
said. “Being able, for instance, to see 
active bleeding and know exactly where 
it is coming from has great potential 
to improve GI disease diagnosis and 
management.” 
—Rhea Hirshman 
MELANIN CAN BE GOOD, OR BAD 
It’s common knowledge that blondes and 
redheads need more protection from the sun 
to prevent skin cancer, but a Yale scientist 
may have discovered why. The culprit may be 
the melanin in the follicles of light-colored 
skin, Douglas E. Brash, ph.d., professor of 
therapeutic radiology and genetics, reported 
in a study published in the Proceedings of 
the National Academy of Sciences in October. 
Brash began his research to determine 
why fair-skinned but dark-haired people 
were less vulnerable to skin cancer than 
blondes or redheads. He found that among 
the fair-haired, melanin, the source of skin 
and hair color which usually protects the 
skin from ultraviolet (UV) rays, actually mag¬ 
nifies the rays’ damaging effects. For the 
study, he irradiated mice of various hair 
colors with UV rays and found pronounced 
cell death in yellow-haired mice. 
"What this tells us is that melanin is 
not just good for you, it can also be bad,” 
Brash said. “It depends on the color of your 
particular melanin.” 
—John Curtis 
GAMBLING AND ELDER HEALTH 
A study by Yale researchers published in The 
American Journal of Psychiatry in September 
has found a link between good health and 
gambling among the elderly. Younger gam¬ 
blers, however, show high rates of alcohol 
use and abuse, substance abuse, depression, 
incarceration and bankruptcy. 
In a telephone survey of 2,417 adults, 
gamblers 65 and older were far more likely 
to describe their health as excellent or good, 
but the researchers haven’t determined why. 
One theory is that better health enables 
older people to take part in activities includ¬ 
ing gambling. 
“Although the underlying reasons remain 
hypothetical, proposed reasons included the 
increased activity, socialization and cognitive 
stimulation that are related to engaging in 
gambling,” said Rani Desai, m.p.h. ’91, ph.d. 
’94, associate professor of psychiatry and 
public health and one of the authors of the 
report. “Such a mechanism would be consis¬ 
tent with the literature on healthy aging, 
which indicates that more socially and cogni¬ 
tively active elders are, in general, healthier.” 
—J.C. 
Findings from the bench 
A new role for “good” 
microorganisms 
Findings at Yale question the 
consensus on how the immune 
system interacts with bacteria. 
The human immune system is a finely 
honed defense mechanism that quickly 
detects and destroys bacterial and viral 
invaders. But so-called “good" bacte¬ 
ria—which perform useful physiologi¬ 
cal roles—are a puzzling exception: 
they somehow slip under the immuno¬ 
logical radar and form flourishing 
colonies on or in our bodies. Such 
“commensal microflora” are particu¬ 
larly abundant in the colon, which 
teems with some io trillion bacteria 
that help to metabolize nutrients and 
guide normal tissue development. 
The scientific consensus has been 
that the immune system overlooks the 
colon’s commensal microbes because 
they remain “sequestered” within a 
layer of epithelial cells. However, the 
immune system does sometimes attack 
the colon’s commensal bacteria, causing 
inflammatory bowel diseases such as 
Crohn’s disease and ulcerative colitis. 
In 1997, in collaboration with the 
late Charles A. Janeway Jr., m.d., 
Ruslan M. Medzhitov, ph.d., professor 
of immunobiology, discovered toll-like 
receptors (tlrs), a new class of mol¬ 
ecules in the innate immune system 
[“The Toll Road,” Spring 2002], and 
he suspected that they might be 
involved in inflammatory bowel dis¬ 
eases. To find out, he and his col¬ 
leagues injected dss, a substance that 
kills colonic epithelial cells, into 
both normal mice and mice with non¬ 
functional tlrs. Because of the tlrs’ 
assumed role in inflammatory bowel 
diseases as attackers of good bacteria, 
the researchers fully expected that 
there would be no inflammation in the 
mice with the disabled tlrs. 
But to Medzhitov’s amazement, the 
opposite occurred. As reported last July 
in the journal Cell, even the smallest 
doses of dss had no effect on normal 
mice, but in the mice with compro¬ 
mised tlrs they caused marked weight 
loss, severe colonic bleeding and death. 
Moreover, tissue samples from the 
colons of these mice showed that the 
normal cell cycle was profoundly dis¬ 
rupted. In short, tlrs looked more 
like defenders than attackers. 
These startling findings led Medzhi¬ 
tov to question tire long-held view that 
commensal microbes are fully shielded 
from the immune system. Instead he 
surmised that commensal bacteria may 
be only partially sequestered, and that 
recognition of these bacteria by tlrs 
triggers the production of molecules that 
protect the colon. In the case of acute 
epithelial injury, a tlr response to 
exposed microflora might efficiently 
recruit and direct healing molecules. 
To test these wholly new ideas, 
Medzhitov and his colleagues turned 
their original procedure on its head. 
Instead of knocking out tlrs geneti¬ 
cally, they used antibiotics to eliminate 
good bacteria from mice with normal 
tlr activity. Doses of dss caused the 
same profuse intestinal bleeding and 
high mortality rate found in mice with 
faulty tlrs. But dss caused no ill 
effects in mice that had received bacte¬ 
rial fragments known to activate tlrs. 
“Because this all was so unexpected, 
it brought up a lot of questions that 
we’re following up now and finding a lot 
of interesting and surprising results,” 
said Medzhitov. But he believes that the 
studies have one immediate implication 
for clinical practice. Patients at risk for 
opportunistic infections, including those 
undergoing treatment with radiation or 
chemotherapy, routinely receive power¬ 
ful antibiotics that kill off commensal 
intestinal flora. By combining antibiotics 
with TLR-activating compounds such 
as the bacterial fragments used in his 
mouse studies, Medzhitov says, it may 
be possible to prevent infection while 
triggering tissue protective responses 
needed to repair damage induced by 
radiation and chemotherapy. 
“This idea could be directly rele¬ 
vant, and could be tested in clinical 
trials and used in patients—if not the 
precise regimen, the basic approach,” 
Medzhitov said. “That would be very 
exciting.” 
—Peter Farley 
ALZHEIMER’S PROTEIN SOLVED 
Lipid found to play key role 
in transmitting information 
between synapses 
Yale researchers have found that a 
membrane lipid plays a crucial role in 
communicating information between 
synapses in the brain, according to a 
study published in Nature in September. 
“This study is the first to show that 
lowering the levels of this lipid in 
nerve terminals affects the efficiency 
of neurotransmission,” said senior 
author Pietro De Camilli, m.d., fw ’79, 
the Eugene Higgins Professor of Cell 
Biology and a Howard Hughes Medical 
Institute investigator. 
De Camilli and his team started by 
genetically engineering laboratory mice 
that lacked an enzyme, PiPio-gamma, 
which in turn plays a role in synthesiz¬ 
ing the lipid under investigation, phos- 
phatidylinositol-4,5 -bisphosphate— 
or PtdIns(4,5)P2—a member of a class 
of lipids called phosphoinositides. 
The mice born without pi pic 1-gamma 
were apparently normal, but they 
were unable to feed and died quickly. 
Studies of their nervous systems 
revealed lower levels of PtdIns(4,5)P, 
and a partial impairment both of the 
process of fusion of synaptic vesicles 
and of their recycling. 
De Camilli’s laboratory has studied 
extensively the mechanism underlying 
cycling of synaptic vesicles, small sacs 
that contain neurotransmitters that 
exchange information between neu¬ 
rons. Synaptic vesicles release their 
contents at junctions between nerve 
terminals by fusing with the plasma 
membrane, where they rapidly reinter¬ 
nalize, reload with neurotransmitter 
and are reused. 
Using X-ray crystallography, Yale scientists 
have discerned, for the first time, the atomic 
structure of a protein that is linked to 
Alzheimer’s disease. 
Ya Ha, ph.d., assistant professor of phar¬ 
macology, reported in August in Molecular 
Cell that he had observed an unusual feature 
of human amyloid precursor protein (app). 
Rare mutations of app cause Alzheimer’s at 
an early age in a small number of people. 
Researchers have been trying to determine 
what app does and how it converts to a 
smaller protein, amyloid beta-peptide, 
which forms neuronal and vascular amyloid 
deposits typical of Alzheimer’s disease. 
Ha and Yongcheng Wang, ph.d., a post¬ 
doc in his laboratory, found that app consists 
of two long rodlike molecules that form a 
tight complex, with the head of one mol¬ 
ecule touching the tail of the other. 
“That observation suggested a novel pos¬ 
sibility,” said Ha, “that app may function 
to mediate cell-to-cell contact by interacting 
with itself.” 
—John Curtis 
GROWTH FACTOR LINKED TO ASTHMA 
Yale scientists have found that a molecule 
normally associated with the growth of new 
blood vessels in the lungs probably plays a 
role in asthma, raising the possibility of 
developing drugs that block the molecule’s 
receptors and signaling pathways. 
The molecule, vascular endothelial 
growth factor (vegf), induced asthmalike 
abnormalities when it was expressed 
in the lungs of transgenic mice, according 
to a report published in the journal Nature 
Medicine in September. 
“To our surprise, in addition to growing 
new blood vessels, many features of asthma 
were also seen in these mice,” said principal 
investigator Jack A. Elias, m.d., the Waldemar 
Von Zedtwitz Professor of Medicine. “We 
saw mucus formation, airway fibrosis and 
asthmalike pulmonary function abnormali¬ 
ties. We also found that if you block vegf, 
you block the asthmalike manifestations in 
other mouse asthma models.” 
Elias and his team are currently examin¬ 
ing how vegf works at the cellular and 
molecular levels. 
—Karen Peart 
These studies not only provide new 
insight into basic mechanisms in 
synaptic transmission, said De Camilli, 
a member of the Kavli Institute for 
Neuroscience at Yale, but also have 
implications for medicine. For exam¬ 
ple, Down syndrome patients have 
an extra copy of the gene encoding the 
enzyme synaptojanin 1, which degrades 
PtdIns(4,5)P2 in the brain. Patients 
with Lowe syndrome, who also have 
mental retardation, lack another 
PtdIns(4,5)P2-degrading enzyme. 
Cancer and diabetes also can result 
from abnormal metabolism of phos¬ 
phoinositides, De Camilli said. 
“Typically, studies of synaptic trans¬ 
mission have focused on membrane 
proteins,” he said. “Only recently has 
the importance of the chemistry of 
membrane lipids and of their metabo¬ 
lism started to be fully appreciated. 
The field is still in its infancy, but 
rapid advancements in the methodol¬ 
ogy for the analysis of lipids promise 
major progress in the field and the 
possibility of identifying new targets 
for therapeutic interventions in 
human diseases.” 
—Jacqueline Weaver 
12 Books & ideas bookshelf 
Flashcards for 
the boards 
How two frustrated students decided to make 
studying for the Step i exam easier. 
The project began after a 
bridge game in mid-January 
2003, when two medical 
students were commiserat¬ 
ing about preparing for the 
board exam. Bridge partners 
Suzanne J. Baron and 
Christoph 1. Lee were frus¬ 
trated by studying for Step 1 
of the United States Medical Licensing Examination— 
no single source seemed to provide the information they 
needed about pathology. 
To assemble the basic facts about more than 300 dis¬ 
eases covered in the pathology section of the exam, the two 
second-year students leafed through a half-dozen review 
books and textbooks. Somebody ought to make the job easi¬ 
er, they reasoned. And so, although they don’t bet on their 
bridge games, Baron and Lee decided to gamble: they would 
develop a study aid, a set of flashcards, and they would sell 
it to a publisher. 
Their efforts paid off. McGraw-Hill liked the idea, 
and three months after Lange FlashCards: Pathology came on 
the market last summer, more than 3,000 sets had sold. 
McGraw-Hill may translate the cards into Chinese, Greek, 
Italian, Spanish and Turkish for students in international 
medical schools who will take the Step 1 before applying for 
residencies in the United States. 
!i -*N 
Ironically, preparing the manuscript meant even more 
of the hard work that Baron and Lee had complained about. 
I have a stack of review books this high in my apartment,” 
says Baron with a laugh, holding her hand waist high. 
The flashcards cover disorders in 13 systems in the 
human body, from the heart to the immune system. To put 
LANGE ‘r HASH CARDS 
PATHOLOGY 
. i 296 cards for course review 
p [ and USMLE preparation 
Dr. FLASH 
Suzanne J. Baron Christoph 1. Leo 
Christoph Lee and Suzanne Baron 
delayed their clinical clerkships in 
order to develop a set of flashcards 
to help medical students prepare 
for Step 1 of the Medical Licensing 
Exam. The cards are now being 
marketed by McGraw-Hill. 
the facts in context, Lee and Baron wrote a clinical vignette 
for the front of each card, and facts about the disease on the 
back. As Lee and Baron worked, they realized that students 
would find the cards useful not only in preparing for the 
boards, but also for studying pathology when it was taught 
in class. Two of their professors, John H. Sinard, m.d., 
ph.d., hs ’93, fw ’94, associate professor of pathology and 
ophthalmology, and Deborah Dillon, m.d. ’92, associate 
research scientist in pathology (now at Harvard), checked 
their manuscript for accuracy. 
To find time for the project, Lee and Baron asked 
Nancy R. Angoff, m.p.h. ’81, m.d. ’90, hs ’93, associate 
dean for student affairs, for permission to postpone their 
clinical clerkships, which their classmates began in June 
2003. Angoff agreed that the project was consistent with the 
philosophy of the Yale System. “Students are encouraged 
to find the things they’re passionate about and explore them 
in depth,” she said. “I love the fact that they saw a need and 
they were going to be the ones to fill it.” (This was not the 
first effort by Yale students or residents to prepare a study 
guide. Tao Le, m.d., hs ’03, co-wrote First Aid for the USMLE 
Step 1 while a Yale resident, with the help of students Antony 
Chu, m.d. ’02, and Esther Choo, m.d. ’01, who worked on 
the 1999 edition of the study guide.) 
“We owe a lot to the Yale System,” says Lee. Still, 
when they saw their friends begin work in the hospital, 
Baron recalls, “we felt a little left behind.” 
They have something to show for their time: a stack 
of 286 four-by-six flashcards, which retail for $29.99. (The 
authors receive royalties of 10 percent.) As they apply for 
residencies in internal medicine (Baron) and diagnostic radi¬ 
ology (Lee), they’re also working on flashcards for pharma¬ 
cology and for biochemistry and genetics. 
Recently, Baron spotted the cards on a shelf at the 
Barnes & Noble bookstore near her home in suburban Boston. 
“I said, ‘That’s me!’ That was a huge thrill.” 
—Cathy Shufro 
Bookshelf is a column focusing on matters related to books and 
authors at the School of Medicine. Send ideas to Cathy Shufro at 
cathy. shufro @yale.edu. 
BOOK NOTES iB 
The Optimist: Meditations 
on Medicine 
by Howard M. Spiro, M.D., pro¬ 
fessor emeritus of medicine 
(Science e[ Medicine) This compi¬ 
lation of essays by Spiro, which 
have appeared regularly in 
the pages of Science & Medicine 
since 1994, ranges broadly in 
subject from patients to tech¬ 
nology to the state of medicine. 
Spiro addresses some recurrent 
themes: the importance of lis¬ 
tening to the patient, consola¬ 
tion of the patient and the role 
of the physician as mediator 
between technology and patient. 
A Doctor’s Visit: Three Novellas 
& Five Short Stories 
by Siegfried J. Kra, m.d., associ¬ 
ate clinical professor of medicine 
(Lorenzo Press) These fiction¬ 
alized stories, based on the 
author’s personal history and 
experiences, explore the emo¬ 
tional lives of doctors and their 
patients and bring the realities 
of the medical profession to life. 
Clinical Nuclear Cardiology: 
State of the Art and Future 
Directions, 3rd ed. 
by Barry L. Zaret, m.d., the 
Robert W. Berliner Professor of 
Medicine, and George Beller, m.d. 
(Mosby) This book describes the 
most recent developments in 
technology, instrumentation and 
radiopharmaceuticals used in 
nuclear cardiology applications. 
Invisible Cities: A Metaphorical 
Complex Adaptive System 
by Chloe E. Atreya, ph.d. '04, 
m.d. candidate (Festina Lente 
Press) This work of creative non¬ 
fiction explores the principles 
of complex adaptive systems to 
demonstrate how art and sci¬ 
ence inform each other. 
Academia to Biotechnology: 
Career Changes at Any Stage 
by Jeffrey M. Gimble, m.d. ’82 
(Elsevier Academic Press) This 
book evaluates the abstract 
and practical aspects of moving 
from a university laboratory to a 
position in the biotech industry. 
It shows the parallels and con¬ 
trasts between a postdoctoral 
fellowship and a job at a bio¬ 
technology company, and it pro¬ 
vides "how-to” guides for the 
preparation of manuscripts, 
patents and grants. 
Viral Encephalitis in Humans 
by John Booss, M.D., fw ’71, pro¬ 
fessor of neurology and labora¬ 
tory medicine, and Margaret M. 
Esiri (asm Press) The authors 
provide guidelines for diagnos¬ 
ing and treating viral encepha¬ 
litis. Their recommendations 
reflect advances in molecular 
virology, imaging technology 
and molecular pharmacology. 
Acid Related Diseases: Biology 
and Treatment, 2nd ed. 
by Irvin M. Modlin, m.d., profes¬ 
sor of surgery (gastroenterology), 
and George Sachs, d.sc. (Lippin- 
cott Williams & Wilkins) This 
textbook explores the history, 
biology and treatment of acid- 
related diseases, including gas¬ 
tric and duodenal ulcer disease, 
gastroesophageal reflux disease, 
and the role of H. pylori. 
Principles and Practice of 
Radiation Oncology, 4th ed. 
by Carlos A. Perez, m.d., Luther 
W. Brady, m.d., Edward C. 
Halperin, m.d. ’79, and Rupert 
K. Schmidt-Ullrich, m.d. 
(Lippincott Williams & Wilkins) 
This text is designed to provide 
a better understanding of the 
natural history of cancer, the 
physical methods of radiation 
application, the effects of irra¬ 
diation on normal tissues and 
the most judicious ways in 
which radiation therapy can be 
used to treat cancer patients. 
From Neuroscience to 
Neurology: Neuroscience, 
Molecular Medicine, and 
the Therapeutic Transfor¬ 
mation of Neurology 
by Stephen G. Waxman, ph.d., 
m.d., professor and chair of 
neurology, pharmacology and 
neurobiology (Elsevier Academic 
Press) Containing chapters by 
more than 29 internationally 
recognized authorities, this book 
reviews the development of new 
therapies in neurology from 
their inception in the laboratory 
to their introduction into the 
clinical world. It also explores 
evolving themes and new tech¬ 
nologies that offer hope for 
even more effective treatments 
and, ultimately, cures for cur¬ 
rently untreatable disorders of 
the brain and spinal cord. 
A Woman’s Guide to Menopause 
& Perimenopause 
by Mary Jane Minkin, m.d. '75, 
hs ’79, clinical professor of 
obstetrics, gynecology and repro¬ 
ductive sciences, and Carol V. 
Wright, ph.d. (Yale University 
Press) Drawing on new informa¬ 
tion from recent research, this 
book offers advice for women 
dealing with physical and emo¬ 
tional health issues surround¬ 
ing menopause.Topics include 
the pros and cons of hormone 
replacement therapy; control¬ 
ling the symptoms of pms; and 
treatments for menopause- 
related hot flashes, insomnia 
and depression. 
Cut Your Cholesterol: Featuring 
the Exclusive Live It Down Plan 
by David L. Katz, m.d., m.p.h. 
’93, associate clinical professor 
of public health and medicine, 
and Debra L. Gordon (Reader’s 
Digest Association) With advice 
about nutrition, physical activ¬ 
ity, supplements and stress- 
management techniques, this 
book provides a plan to reduce 
cholesterol and lower blood 
pressure. 
Cancer: Principles & Practice 
of Oncology, 7th ed. 
by Vincent T. DeVita Jr., m.d., 
hs ’66, the Amy and Joseph 
Perella Professor of Medicine, 
Samuel Heilman, m.d., hs ’62, 
and Steven A. Rosenberg, m.d., 
ph.d. (Lippincott Williams & 
Wilkins) Acclaimed as “the ulti¬ 
mate authority on cancer,” 
this volume reflects the latest 
breakthroughs in molecular 
biology, cancer prevention and 
multimodality treatment of 



















Carrying the Message 
Jeffrey D. Roth, MD 
Library keeps a watchful eye 
on what works on the Web 
Healthcare for Children on the 
Autism Spectrum: A Guide to 
Medical, Nutritional, and 
Behavioral Issues 
by Fred R. Volkmar, M.D., the 
Irving B. Harris Professor of 
Child Psychiatry, Psychology 
and Pediatrics in the Child Study 
Center, and Lisa A. Wiesner, 
m.d., hs '82, fw ’83, assistant 
clinical professor of pediatrics 
(Woodbine House) This book 
offers parents of children with 
autism spectrum disorder infor¬ 
mation on issues such as sleep 
problems, unusual eating habits 
and impulsive or aggressive 
behaviors. 
Locating Medical History: 
The Stories and Their Meanings 
edited by Frank Huisman and 
John Harley Warner, ph.d., pro¬ 
fessor and chair of the Section of 
the History of Medicine (Johns 
Hopkins University Press) At a 
time when the study of medical 
history is facing choices about 
its future, these scholars explore 
the discipline’s distant and 
recent past in order to rethink 
its missions and methods today. 
Group Psychotherapy and 
Recovery From Addiction: 
Carrying the Message 
by Jeffrey D. Roth, m.d. ’78 
(Haworth Press) This book 
examines recovery, demonstrat¬ 
ing the elements of the group 
process, including free associa¬ 
tion, resistance, transference 
and boundary management, 
and lets readers compare and 
contrast participation in a 
psychotherapy group and in a 
Twelve Step group. 
Experiences of Depression: 
Theoretical, Clinical, and 
Research Perspectives 
by Sidney J. Blatt, ph.d., profes¬ 
sor of psychiatry and psychology 
(apa Books) Using clinical 
examples and empirical investi¬ 
gations, Blatt demonstrates the 
value of considering the psycho¬ 
logical dimensions of depres¬ 
sion. He identifies two primary 
sources of depression: feelings 
of loneliness and abandonment 
and feelings of failure and 
worthlessness. Understanding 
these differences helps to 
elucidate the nature, etiology 
and treatment of the disorder. 
Field Guide to Internal Medicine 
by David S. Smith, m.d., associ¬ 
ate clinical professor of medicine, 
Lynn E. Sullivan, m.d. ’96, assist¬ 
ant clinical professor of medi¬ 
cine, and Seonaid F. Hay, m.d., 
assistant professor of medicine 
(Lippincott Williams & Wilkins) 
This volume offers an overview 
of internal medicine, including 
discussions of pathophysiology, 
clinical presentation, diagnosis 
and management of medical 
emergencies and the most com¬ 
mon diseases encountered 
among hospitalized patients. 
The descriptions above are based on 
information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to cheryl.violante@yale.edu 
In days of yore—before the year 2000, that is—libraries generally set 
up websites for their patrons “and assumed everyone could use 
them without a problem,” recalls Richard Zwies, m.l.I.S., Web services 
librarian at the Cushing/Whitney Medical Library. 
Those days are over. A new research genre, based on usability 
studies, reflects libraries’ growing interest in streamlining their web¬ 
sites. Usability studies test how easily users can navigate a site, 
whether their aim is to scan the contents of the latest issue of a jour¬ 
nal, track down an article or find out if a book is on the shelf. If a 
study shows that users are confused, librarians can change labels or 
reconfigure links. 
The new approach has caught on fast. When the Association 
of Research Libraries offered an interactive Web-based class on usabil¬ 
ity studies last fall, 72 of its 123 member libraries, including Yale, 
signed up for the 90-minute session. 
“The virtual front door of the library is becoming more impor¬ 
tant than our actual, physical front door,” says Zwies. In the 2003- 
2004 academic year, researchers, physicians, students and other users 
knocked on that front door—the Cushing/Whitney home page—more 
than 4.4 million times. In comparison, people walked into the library 
329,000 times that year. Zwies says people use the Web for research 
because it’s accessible from almost anywhere, day and night. 
Zwies just completed a small usability study of the medical 
library home page. He timed five volunteer testers as they tracked 
down several types of information. Zwies also counted the number 
of visitors to the “front door” for a week: users clicked on it 30,000 
times. The most popular link? Webmail. Zwies actually finds that 
encouraging, as it suggests that many people at Yale set their browsers 
to the library home page. The second most popular link was to elec¬ 
tronic journals. 
The study showed that the site is generally easy to navigate, 
so Zwies plans only small changes. Even for this minor redesign, which 
eliminated redundant links, he sketched a new “wire frame,” Web 
parlance for the site’s “bone structure.” He then passed that on to 
Web designer Patrick J. Lynch, director of the MedMedia Group at its- 
Med, saying, “... it’s like a rough skeleton and Pat puts flesh on it.” 
(The home page already has some flesh on it, by the way: a woodcut 
of a cadaver, taken from the 16th-century anatomist Andreas Vesalius’ 
De Humani Corporis Fabrica. Visit http://info.med.yale.edu/library/.) 
Usability testing will be a perennial task, says Zwies. “As Web 
technologies arise that might be useful to our patrons’ research, we 
will want to test them on human beings. We will be testing and 
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PAUL BERG 
What role for the states 
in stem cell research? 
When scientists wanted to dis¬ 
cuss the safety of recombinant 
dna technologies in the mid- 
1970s, they convened the Asilomar 
Conference, where they agreed 
on guidelines that would mini¬ 
mize risk while allowing the 
research to blossom, said Stan¬ 
ford biochemist Paul Berg, ph.d. 
The first researcher to combine 
dna from two different species, 
Berg shared the 1980 Nobel Prize 
in chemistry. 
Berg doubts that a confer¬ 
ence could resolve the current 
dispute about human embry¬ 
onic stem cell research, because 
it centers not on science but 
on politics, ideology and moral 
beliefs.The Bush administra¬ 
tion limits federal funding for 
research to a handful of embry¬ 
onic stem cell lines, and Congress 
may even criminalize some 
therapeutic stem cell research. 
The pending legislation, said 
Berg in a September talk spon¬ 
sored by the Bioethics and Public 
Policy Seminar Series, would 
deny 290 million American peo¬ 
ple access to potential therapies. 
Berg supports efforts such 
as the recent ballot initiative 
approved by voters in November 
in California, which opened the 
way for state funding of stem 
cell research.“There is a role for 
the state to act for the welfare 
of its citizens,” he said. 
—C.S. 
MARI ALE HARDIMAN 
A molecular link between 
the brain and learning 
"When axons send signals that 
are received by dendrites, learn¬ 
ing is taking place,” said Mariale 
M. Hardiman, ed.d., the princi¬ 
pal of a high-achieving public 
elementary/middle school in 
Baltimore and a speaker at a 
symposium in October celebrat¬ 
ing the 35th anniversary of the 
Yale Child Study Center’s Comer 
School Development Program 
(See "Leaving No Child Behind,” 
p. 24). 
“We know that [making a] 
connection is important,” 
Hardiman said, citing the way a 
teacher and student may con¬ 
nect in the classroom. “What is 
fascinating is that it is happen¬ 
ing on a molecular level.” 
Hardiman has developed a 
"brain-targeted teaching” 
model that applies neuroscience 
to teaching.Teaching, she said, 
is most effective when it builds 
on what students know and 
prods them to learn more as 
they embark on a task. 
Unfortunately,said Hardiman, 
the No Child Left Behind Act 
favors higher test scores over 
activities that require higher- 
order thinking. "What I see across 
the country is that education is 
moving back to a time when 
teaching was primarily test- and 
textbook-driven. While this 
traditional style of teaching has 
a place in our educational sys¬ 
tem, brain research seems to sup¬ 
port more active, experiential 
teaching and learning,” she said. 
—John Curtis 
ROBERT BALLARD 
Using revolutionary technology 
to find “a rusty old ship” 
After he discovered the wreck of 
Titanic in 1985, Robert D. Ballard, 
ph.d., heard from his mother. 
“That’s all they’re going to 
remember you for,” she said, 
“having found a rusty old ship.” 
Since then Ballard, founder 
and president of the Institute for 
Exploration at Mystic Aquarium, 
where he works with Dean 
Emeritus Gerard N. Burrow, m.d. 
’58, hs ’66, has gone on to 
find PT109 and Roman trading 
ships, among others. But his 
real accomplishment in finding 
the Titanic was the validation 
of a new approach to exploring 
the 72 percent of the Earth 
under the sea. Frustrated by the 
limitations of sending people 
underwater, he developed a 
telepresence—remotely oper¬ 
ated vehicles with sophisticated 
digital cameras.“It had all the 
characteristics of my submarine, 
except me,” he said in October 
during the Wayne O. Southwick 
Lecture for the Department of 
Orthopaedics and Rehabilitation. 
"The first application of this new 
exploratory technology was the 
discovery of the Titanic.” 
When he saw the high 
degree of preservation on the 
ship—including a chandelier still 
hanging in the ballroom—he 
came to another realization. “It 
hadn’t dawned on me that the 
sea was a museum,” he said. 
—J.C. 
RACHEL COHEN 
A moral argument for 
fighting diseases of the poor 
Rachel M. Cohen called for a new 
approach to drug research and 
development based on need, not 
profit, in a September talk spon¬ 
sored by the Justice and the 
Allocation of Health Care work¬ 
ing group of the Yale Interdisci¬ 
plinary Bioethics Project. 
"We have made a societal 
choice that drug development 
should be confined to the pri¬ 
vate sector and that medicines 
are a commodity like any other 
that should be developed in 
order to maximize profit," 
said Cohen, U.S. director of the 
Doctors Without Borders/ 
Medecins Sans Frontieres 
Campaign for Access to Essential 
Medicines. As a result, most new 
drugs benefit inhabitants of the 
world’s richest nations and little 
is invested in drugs for diseases 
of the developing world, such as 
tuberculosis and malaria. 
“Well, we’re sick of it,” she 
said, calling for a global frame¬ 
work that would define a health 
agenda, commit wealthy 
nations to contribute to health 
care internationally and 
strengthen international mecha¬ 
nisms for exchanging research 
results. “Our patients are dying, 
and we need to change the 
rules. We need a needs-driven 
global approach to thinking 
about how to finance research 
and development, with a gen¬ 
eral acknowledgement that 


















this page Societal notions of what constitutes 
a healthy body weight and pleasing form have 
varied greatly over the centuries, and it is only in 
eras of nutritional abundance that anxieties 
about the effects of too much food have figured 
prominently in the public psyche. Scarcity was 
the overriding concern of millions of Americans 
who struggled to find enough to eat during the 
Great Depression, such as these New Yorkers 
waiting for bread. 
By Cathy Shufro 
Living as we do in the “low-carb 
nation”—where, despite the gospel 
according to Atkins, obesity rates 
are escalating—it’s easy to forget that 
as recently as the 1930s many 
Americans worried about eating too 
little, not too much. 
Yale medical historian Susan E. 
Lederer, ph.d., sees the end of World 
War II as a turning point. Until then, 
scarcity dominated people’s anxieties. 
Now, we worry about the effects of 
abundance on our bodies. Given her 
arly perspective, you’d think 
might have anticipated that 
even her daughter might be affected 
by “an ideal [of thinness] that virtually 
no one can achieve.” But when five- 
year-old Emma declined to sample a 
Flintstones vitamin after seeing a 
picture of a chubby baby Pebbles (“It’s 
going to make me fat.”), Lederer 
recalls, “I was really kind of stunned.” 
That incident, in part, inspired 
the associate professor of the history 
of medicine to offer a course at Yale 
College called “Fat and Thin: A History 
of American Bodies.” Lederer expected 
50 to 75 students, and she ended up 
with 358. She had to expand her team 
of teaching fellows from two to nine. 
The course, offered last spring, 
surveyed the evolution since Colonial 
times of notions of nutrition, food 
choices and ideal body weight, and 
how both scarcity and plenty can mark 
the body. The story began with scarcity. 
Although Native Americans had 
developed strategies to avoid famine, 
by following food or by storing it, 
European newcomers arrived unpre¬ 
pared. In a 1607 diary entry, 
Jamestown settler Master George Percy 
describes his group’s reprieve from 
hunger: “It pleased God, after a while, 
to send those people which were our 
mortall enemies to releeve us with vict¬ 
uals, as Bread, Corne, Fish and Flesh 
in great plentie. ... Otherwise we had 
all perished.” During the winter of 
1609-1610, 80 percent of the James¬ 
town settlers did perish, of starvation 
and sickness. 
Three centuries later, Lederer’s stu¬ 
dents learned, scarcity still marked the 
bodies of Americans. In the South, 
prisoners and orphans suffered from 
below The subjects of Flemish painter Peter 
Paul Rubens’ canvases were amply endowed 
with body fat—a sign of beauty, good health 
and prosperity—as seen in this version of The 
Judgment of Paris, circa 1635-1638. In the New 
World, where famine struck the Jamestown set¬ 
tlement three decades earlier, colonists would 
have been grateful to emulate them. 
RIGHT AND BELOW RIGHT In the 194OS, 
promoting proper nutrition was the aim of 
this poster produced by the Works Projects 
Administration. By the end of the 20th century, 
Americans had become obsessed with thin¬ 
ness—and fatter than ever—as they looked to 
medicine, fad diets and technology to solve 
the problem. Here, three thermograms of an 
obese woman show the distribution of both 
ERICH LESSING / ART RESOURCE, NY TOP W P A POSTER COLLECTION / LIBRARY OF CONGRESS 
ABOVE RAY CLARK AND MERVYN GOFF / PHOTO RESEARCHERS 
“the four D’s” of pellagra—dermatitis, 
diarrhea, dementia and death. U.S. 
Public Health Service physician Joseph 
Goldberger, m.d., set out to prove that 
pellagra resulted from their cornmeal- 
based diet. In his 1915 Rankin prison 
farm experiment, he induced pellagra 
in convicts in return for clemency. 
(Except for one protest, the only objec¬ 
tion to this experiment came from 
those who were upset that convicts in 
prison for serious crimes were released 
in return for their participation.) Even 
then, he failed to convince detractors 
that the disease was caused by a diet 
deficient in niacin, not by microbes. 
The contemporary obesity epidemic 
derives in part from the plethora of 
manufactured snacks, says Lederer. In 
the 1920s, she notes, ready-made snacks 
were few: popcorn, Graham crackers, 
biscuits, penny candy. “Now we have 
more food choices than anyone else on 
the planet, and we’re so conflicted over 
them,” she says. When researchers 
asked people what they associate with a 
slice of double-chocolate cake, French 
respondents said “Celebration.” 
Americans said “Guilt.” 
A study of 2,600 elementary school 
children in New York City, reported by 
the city’s health department in 2004, 
found that 40 percent were overweight, 
and one in four was obese. Hispanic chil¬ 
dren were most likely to be overweight 
and Asian students were least likely. 
Among Yale students, Lederer says, 
“There’s a lot of interest in bodies,” espe¬ 
cially among athletes. Twenty-five 
women from the Yale track team 
enrolled in the course, along with foot¬ 
ball player Nate Lawrie, a senior who 
was drafted by the Tampa Bay 
Buccaneers last spring. Tire caption next 
to Lawrie’s photo on the team’s website 
reads: “TE Nate Lawrie has the frame to 
add weight without sacrificing speed.” 
For historical perspective on 
obesity, Lederer uses a cartoon from 
The New Yorker. Two witches watch as 
a plump boy and girl walk by the 
witches’ candy-festooned gingerbread 
cottage. One witch asks the other: 
“Remember when we used to have to 
fatten the kids up first?” 
Cathy Shufro is a contributing editor of 
Yale Medicine. 
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By Jennifer Kaylin 
Photographs by Frank Poole 
Accounts of death row inmates released from prison based 
on dna evidence have become as routine as news stories 
about celebrity births, betrothals and breakups. On televi¬ 
sion, the popularity of shows such as CSI, Crossing Jordan 
and Cold Case Files attests to the public’s familiarity with 
this field of research. 
In 1983 Kary B. Mullis, ph.d., who 10 years later was a 
co-winner of a Nobel Prize in chemistry for his discovery, 
enabled this revolutionary application of genetic science with 
a method called polymerase chain reaction (pcr), which 
allows scientists to analyze dna samples by generating copies 
of a genetic fragment. But the process, which relies on the 
enzyme polymerase, was as time-consuming as it was ground¬ 
breaking. dna strands had to be unwound and separated 
through a three-step process involving about 40 heating and 
cooling cycles. It wasn’t until scientists figured out how to 
streamline the technique, through a method called rapid auto¬ 
mated pcr, that it became the medical and forensic bonanza 
Scientists are increasingly turning 
to aquatic organisms as they 
seek clues to human physiology 
and disease, Zebrafish, coral 
and sea hares are becoming 
model organisms on a par with 
Drosophila, mice and yeast. 
it is today. What made the breakthrough possible was the 
identification of a bacterium, Theimus acquaticus, which 
thrives in hot springs. Its polymerase can survive tempera¬ 
tures that fluctuate between 72 and 90 degrees Celsius. 
This is just one example of how scientists have expanded 
research capabilities by shifting their gaze from earth to water. 
The guinea pig was once synonymous with biological 
research. Rats and mice are still ubiquitous in research labs, 
but researchers are increasingly pulling up anchor to find 
aquatic animal models that might offer better solutions to 
specific research questions. At Yale several scientists are 
embracing their potential, using aquatic specimens to study 
everything from liver and kidney diseases to neurophysiol¬ 
ogy and the effects of toxic substances on living organisms. 
James L. Boyer, m.d., hs ’67, fw ’69, director of Yale’s 
Liver Center, has spent the last 33 summers conducting 
research at the Mount Desert Island Biological Laboratory in 
Salsbury Cove, Maine. Recently Boyer has been studying 
Zhaoxia Sun, who studies the 
genetic causes of polycystic 
kidney disease, keeps thousands 
of zebrafish in her laboratory 
in the School of Medicine. Also 
known by the Latin name 
Brachydanio rerio, zebrafish have 
emerged in recent years as a 
model organism for basic research 
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the skate liver to see how it sheds itself of toxic substances. He 
initially used the livers of dogfish sharks, but found the skate 
liver easier to handle and more mammalian in size and shape. 
Boyer, who is the director of the Comparative 
Toxicogenomics Database at the Mount Desert Island facility, 
says scientists long believed that if you wanted to learn 
about human biology, you had to study other mammals. 
Now researchers are finding that studying less-similar crea¬ 
tures can also be illuminating. "By comparing our genes 
with the genes of lower vertebrates we can often get a better 
estimate of what the most important parts of our genes are, 
because the differences are greater than when we compare 
our genes with genes of a mouse or other mammal, which 
are very similar if not nearly identical," he says. 
According to Boyer, the most famous example of an 
aquatic specimen shedding light on human physiology is the 
squid axon, which is so large that when scientists probe it 
with electrodes they can easily see how nerves conduct signals. 
Another is the sea slug. With its large cells, it has helped 
scientists understand signaling pathways in nerve tissues. 
At the Mount Desert Island lab, scientists have spent 
years studying the rectal gland of the dogfish shark. This 
gland has one job only—to pump salt. Their research has 
provided insights into such diseases as cystic fibrosis, which 
stems from a salt imbalance caused by the body’s inability 
to regulate chloride transport. “There are many examples 
of this type of story,” Boyer says, “but it’s not yet appreciated 
how useful these species can be.” Aquatic animal research 
has lagged, he says, partly because the study of marine 
specimens requires travel to remote locations as well as 
special facilities and equipment. 
The search for clues to human physiology in the sea 
dates to the early 20th century, when scientists, inspired by 
Darwin, founded marine biology labs, including the Mount 
Desert Island facility and the Woods Hole Oceanographic 
Institution in Massachusetts, along the East Coast. But, 
according to Boyer, it wasn’t until the genetic revolution— 
the cloning and sequencing of genes—that the use of 
marine specimens for research really gained currency. 
“Through comparisons of genes from lower organisms 
'h human genes, we demonstrated that our genetic 
Trial was more similar to these lower vertebrates than 
bought,” Boyer says. The gene that codes for the 
C’e -alt export pump in the skate liver, for example, is 
70 percent identical at the amino acid level to the human 
gene. “We find that all of the human mutations occur in the 
same regions that are identical between skate and man,” 
Boyer says. “Thus, we are beginning to learn that the 30 per¬ 
cent of our bile salt export gene that is different from the 
skate is not very important from a functional point of view.” 
Scientists now have a pretty good library of mammalian 
cell lines, but according to Boyer, similar models need to be 
developed in aquatic animals. That is a priority for researchers 
at the Mount Desert Island lab, who have a grant from the 
National Institute of Environmental Health Sciences to create 
the Comparative Toxicogenomics Database. 
A new model from India 
The current poster fish for aquatic animal research is the 
zebrafish, a small freshwater fish originally found in slow 
streams and rice paddies in the Ganges River in India. 
In the early 1970s, George Streisinger, ph.d., at the Univer¬ 
sity of Oregon, determined that zebrafish were an invaluable 
model for studying vertebrate development and genetics. 
Since then, their embryos have been used worldwide to 
study how all vertebrates, including humans, develop. 
What makes the zebrafish ideal is their eggs—they are 
transparent and they develop outside the mother’s body. 
And while a mouse takes 21 days to develop, zebrafish grow 
from a single cell into a tiny fish within 24 hours. Scientists 
can watch under the microscope as the zebrafish cells divide 
and form different parts of the infant fish's body. Scientists 
can easily move or destroy a cell to see what happens. 
And zebrafish, like humans, have a backbone, making them 
more similar to humans than commonly studied inverte¬ 
brates such as Drosophila and C. elegans. 
Zebrafish are also easy and relatively inexpensive to 
maintain, manipulate and monitor in the lab. This makes 
large-scale studies far more feasible and affordable. They 
thrive in many environments, can be kept together in large 
numbers, are easy to breed and require less stringent 
research protocols than mammals. In fact, the zebrafish 
has become so popular in recent years that it has its 
own magazine, Zebrafish, and, like all celebrities, its own 
website, www.zfin.org. 
Zhaoxia Sun, ph.d. ’98, established the first zebrafish 
facility at the School of Medicine in 2003 in a former auto¬ 
clave dishwashing room down the hall from her lab. It now 
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resembles an aquarium, with shelf upon shelf of shoebox¬ 
sized tanks, each swarming with tiny striped fish. Sun, an 
assistant professor of genetics, returned to New Haven in 
2003 from a postdoctoral fellowship at the Massachusetts 
Institute of Technology, where she used zebrafish to explore 
the genetic causes of polycystic kidney disease. 
“Zebrafish provide so many unique features,” Sun 
says. “So many things not previously possible are now 
possible.” In collaboration with researchers at mit, 
she performed a large-scale zebrafish screen and identified 
12 genes that, when defective, can cause polycystic kidney 
disease. “It would have taken a lot longer without the 
zebrafish,” Sun says. 
Her zebrafish studies are starting to attract the attention 
of other Yale researchers, and she has received inquiries 
from faculty in nephrology, physiology, genetics and cardiol- 
For the past 33 years James Soyer, 
below left, has spent his summers 
on Maine’s Mount Desert Island, 
where he has used dogfish sharks 
and other fish to explore human 
physiology. Boyer, who directs the 
Liver Center at Yale, is studying the 
liver of the skate to see how it rids 
itself of toxic substances. 
Leonard Kaczmarek has long used 
marine organisms for his research 
into nerve cell function. One of his 
favorites is the sea hare, which has 
nerve cells large enough to be seen 
with the naked eye. 
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from left Fluorescent proteins 
in corals such as Lobophyllia hawaii 
respond to a blue excitation light. 
Like Lobophyllia, the Acmpora tenuis 
coral also has both green and red 
fluorescent proteins that respond to 
blue light. Blue light brings out the 
fluorescence in this high-power 
image of a polyp from a species of 
Goniastrea coral. The same coral 
seen at low power. 
ogy about possible collaborations. She welcomes these 
opportunities. “I think zebrafish will be helpful in bridging 
different fields,” she says. “It’s still a young field, but it’s a 
field with huge potential.” 
Across campus, Scott A. Holley, ph.d., assistant profes¬ 
sor of molecular, cellular and developmental biology, is the 
only other Yale scientist working exclusively with zebrafish. 
Holley, who studies early vertebrate development and genes 
related to skeletal defects, meets regularly with Sun, and the 
two plan to teach a course together. “The field is in a rapid 
growth phase,” says Holley, noting that at his first zebrafish 
conference in 1997 about 120 scientists attended. At a meet¬ 
ing in 2004, attendance topped 1,000. 
A tool from the coral reefs 
Vincent A. Pieribone, ph.d., associate professor of cellu¬ 
lar and molecular physiology and neurobiology, credits the 
green fluorescent protein (gfp) found in Aequorea victoria 
jellyfish with revolutionizing his studies of how the human 
brain works. He wanted to see how collections of nerve 
cells fire, but the density of cells in the mammalian brain 
and the speed at which they fire make it next to impossi¬ 
ble, and recording one cell at a time “was like listening 
to an individual phone line in New York City and trying to 
figure out from that how the city functions,” he says. Plus 
there was the challenge of recording what was happening 
without resorting to invasive, damaging procedures. 
Enter gfp. “You can put it into any cell in any animal and 
the cell will fluoresce green and be identifiable,” Pieribone 
says. “It's been hugely important to scientific study.” gfp has 
been used to track cells in a wide range of animals and has 
enabled scientists to watch cells develop in real time without 
having to kill the specimen. Kaeda-type gfps have taken the 
promise of this research tool one step further, because they 
work as “reporters.” “They don’t just tag cells,” Pieribone 
says. “They can be made to change color (from green to red), 
allowing scientists to monitor the movement and synthesis 
of the protein.” Pieribone’s laboratory is focused on fusing 
gfps to other proteins that cause the fluorescence emission 
of gfp to be altered by a cellular process. “This tells us 
what’s going on—is the calcium going up, for instance— 
when the cells do what they do.” 
The success of gfp from jellyfish prompted scientists to 
return to the sea in search of proteins in other colors. In 
June 2001, on Lizard Island, part of the Great Barrier Reef 
in Australia, Pieribone and his colleagues identified two 
corals (Lobophyllia hcmprichii and Flavites spp.) that produce 
fluorescent proteins. One glows red; the other switches 
from green to red when exposed to UV light. 
“A lot of biological specimens have backgrounds that fluo¬ 
resce a kind of greenish glow,” Pieribone says, “so with 
these new fluorescent proteins, things stand out better. 
They’re a lot easier to see.” 
In all, he has identified about 40 species of fluorescent 
coral. The two gfps Pieribone and his colleagues cloned 
are not currently in use, but others like it are. Besides corals 
and jellyfish, scientists have also cloned GFP-like sequences 
from anemones, sea pansies, sea pens and copapods, bring¬ 
ing the total number to around 70. 
Along with new fluorescent proteins, Pieribone also 
found that coral reefs the world over are dying, which he 
says would be a huge loss for science, to say nothing of 
the ecological ramifications. “When we lose these reefs, 
we’ve lost an amazing library of genes,” Pieribone says. To 
save what he and other scientists consider a vital resource, 
Pieribone is trying to apply biomedical technology to under¬ 
stand how global warming is killing the corals. While this 
is a diversion from his work as a neurophysiologist, he says 
there’s an important connection. “Nature makes mutations 
that can be cloned and studied for utility in the laboratory,” 
he says. “If we kill the animals, we lose that ancient library 
and we don’t have millions of years to wait around for 
another to be formed.” 
Pieribone’s work with aquatic specimens prompted him 
in September 2003 to found Marinus Pharmaceuticals, based 
in Branford, Conn., which has seven employees. The company 
seeks to use information gathered through marine research 
to create drugs to treat epilepsy, depression, schizophrenia 
and heart disease. “The environment in the ocean is harsh. 
Organisms that have adapted to survive there are very tough,” 
he says. “They have a lot to teach us about survival strategies.” 
Sea hares and nerves of steel 
As a researcher who studies nerve cell function, Leonard K. 
Kaczmarek, ph.d., professor of pharmacology and cellular 
and molecular physiology, is particularly fond of the squid and 
the sea hare. Their main appeal is their large cells. Some of 
the sea hare’s nerve cells, for example, can be seen with the 
naked eye. “They’re also color-coded, from white to bright 
orange,” Kaczmarek says, “so you can give each one a name 
and number. It’s very easy to figure out how nerves control 
behaviors.” Sea hares are also desirable research specimens 
because their cells are so hardy. “The human brain, if deprived 
of oxygen, dies in a few minutes,” Kaczmarek says. “Sea hare 
nerve cells have been known to live up to a week.” Using this 
species, Kaczmarek is studying bag cell neurons, which serve 
as a master switch for the control of reproductive behaviors. 
Despite the differences between humans and marine 
organisms, the way nerve cells respond to the outside world 
and generate electrical activity that controls behavior is 
highly conserved across evolution. For example, many ion 
channels—the proteins that control the electrical behavior of 
neurons—are almost identical in molluscs and humans. 
The main attraction of the squid, Kaczmarek says, is that 
its synapses are so large they can be seen without a micro¬ 
scope. Many human synapses are round and measure 1 to 2 
microns in diameter. The squid giant synapse is 300 
microns wide and as long as a millimeter. “It makes it very 
easy to study how one neuron can stimulate another neuron. 
It also allows us to investigate ion channels in different parts 
of the synapse in ways that are simply not possible with 
mammalian cells.” 
Although he uses rats and mice for most of his research, 
Kaczmarek sees himself continuing to study sea animals for 
the foreseeable future. “So many breakthroughs happen with 
simple model systems,” he says. “Besides, it’s very nice to 
have both perspectives.” 
Like Boyer and Pieribone, Kaczmarek worries that fund¬ 
ing, fashion or affronts to the environment could threaten 
marine animal research. This, he says, would be a shame. 
Noting that research based on squid led to Nobel prizes in 
1963 and 1970, he says, “Just look at the history. It’s very 
obvious that looking at really simple systems gives insights 
into understanding more complicated systems.” ym 
Jennifer Kaylin is a writer in New Haven. 









Leaving no child behind 
In 1968 a newly minted psychiatrist at the Child Study Center 
began working on a plan to help two underachieving elementary 
schools in New Haven. Behind this effort was his belief that, 
regardless of race, geography or background, all children can learn 
at high levels. Now known as the School Development Program, 
referred to more familiarly as “the Comer process” or “the Comer 
model,” the young doctor’s vision is in practice in more than 600 
schools in 20 states. The Comer model celebrated its 35th anniver¬ 
sary in October with a symposium that explored brain research 
and its implications for child development, education and teacher 
preparation. At the program’s 30th anniversary in 1999, First Lady 
Hillary Rodham Clinton, who interned at the Child Study Center 
while a law student at Yale, was the keynote speaker. 
The program’s namesake, James P. Comer, m.d., hs ’66, M.P.H., 
the Maurice Falk Professor of Child Psychiatry in the Child Study 
In a memoir of his formative years, child 
psychiatrist James Comer describes what he 
learned from his family and neighbors— 
and how he sought to make those values 
the linchpin of an educational philosophy. 
Center, applied the lessons he learned as a child growing up in 
a nurturing environment of family, church and neighborhood. 
His program takes into account the developmental needs of 
children, as well as their social environment. At its heart is a 
strengthening of the bonds among families, schools and neigh¬ 
borhoods—relationships that were crucial to Comer during 
his youth in industrial northern Indiana. No school stands alone, 
Comer believes, and in order to succeed, each school needs to 
work with other community institutions. 
In his book Leave No Child Behind: Preparing Today’s Youth 
for Tomorrow’s World, published last summer, Comer tells the 
story of his program, how it started, how it nearly failed and 
how, ultimately, it succeeded. In this excerpt, Comer describes 
the values he and his siblings learned from his church, his 
neighbors and, most of all, his parents. 
I went off to kindergarten with three black friends who were 
as bright as anybody in my family and anyone in our school. 
They went on a downhill course in school and in life despite 
the fact that our parents had the same level of education 
and similar jobs and we were in the same good school. My 
siblings and I went on to earn a collective total of 13 univer¬ 
sity degrees. Eventually I realized that the only difference 
between my siblings and me and our three friends was the 
quality of the child-rearing and developmental experience 
that we received at home and in our primary social network 
of friends, kin and organizations in which our family felt a 
sense of belonging—namely, our church. 
My siblings and I were born into a family in which we 
were very much wanted and valued, and our parents were 
skillful child-rearers. This was the case despite my mother’s 
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left At the Columbus School in 
New Haven’s Fair Haven neighbor¬ 
hood, James Comer visits a class¬ 
room where teachers, teachers’ aides 
and parents employ an approach 
to reading that is part of his School 
Development Program. 
below In a family photo taken at 
his childhood home in Indiana, Comer 
poses with his parents and siblings. 
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own difficult upbringing and the limited school time of both. 
My mother was born into extreme poverty in rural Missis¬ 
sippi. She was the third of five children, and her father had 
two children from a previous marriage. Her father was a 
good man who loved and provided for his family. But when 
she was 6 years of age, in 1910, he was killed by lightning. 
Because the children were too small to help with the work, 
a cruel stepfather came into their lives. There were two more 
children from this marriage, nine in all. They moved from 
place to place, living in one shack after another; and he 
unexpectedly abandoned the family from time to time. Also, 
he was abusive in many ways and would not let the children 
go to school. 
When my mother, Maggie, was 8 years of age, it 
occurred to her that the way to a better life was through edu¬ 
cation. When she was 16, she ran away to a sister in East 
Chicago, Ind., with the hope of going to school. But her 
sister could see no benefit in a “colored girl getting an edu¬ 
cation” and was not supportive. After several months, she 
had to drop out of school. She began to do domestic work. 
When she left school she declared, “If I ever have children, 
I’m going to make certain that every one of them gets a 
good education!” Then she set out to very carefully find a 
like-minded husband. 
He was 12 years older. They met in Sunday school— 
my father as teacher, my mother as student. He had been 
married once before and had a child, a reason for great cau¬ 
tion given my mother’s childhood experience. She only 
agreed to go out with him after his ex-mother-in-law wrote 
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top Both his mother, Maggie, 
and father, Hugh, came from 
poor families in the South, and 
both believed that education 
was the key to a better life. 
above Comer, second from 
right, with his sister and brothers, 
also dressed as soldiers. 
ii 
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My father, Hugh, was from rural Alabama, the son of 
a minister. He had about a sixth-grade rural Alabama educa¬ 
tion. His family was poor but well-functioning and in the 
process of buying their farm from the former slave master’s 
heirs. To save the farm after boll weevils destroyed the crop 
in 1918, he left Alabama and worked in the steel mills in East 
Chicago. He, too, felt that the only way to a better life was 
through education. 
They set out to have a family and to provide us with 
what they had not been able to acquire for themselves. But 
they were not in a hurry. It was 12 years before I was bom. 
During that time my parents reared my older sister, Louise, 
my father’s daughter. They were enmeshed in a church-based 
culture and community. And my mother continued to do 
domestic work for some of the most successful families in 
town. My father worked as a steel mill laborer, and they built 
their home with their own hands. Then we came, four of us— 
I was the oldest of three boys and a girl—almost one year 
apart over a five-year period. 
A rich culture 
As I describe our childhood, keep in mind the fertile ground 
in which we sank our roots—an emotionally rich church 
culture, exposure to and participation in the mainstream cul¬ 
ture, parental ambition and a belief in the American dream 
of better opportunity for all, and just enough income to keep 
hope alive. And our parents had an understanding that chil¬ 
dren had to be prepared for a better future, and they delighted 
in doing so. As a result we received a great deal of nurturance 
from the very beginning. 
In the summer, after work or on weekends, my mother 
and father would take us to Lake Front Park, where they would 
play with us, or sit and talk while we played. I still remember 
sitting on the front porch eating popcorn and drinking malted 
milks on warm summer evenings. Also, we were served ice- 
pops from the freezer. All of the snacks were homemade 
because it was less expensive, more fun and more personal. 
Every Sunday evening my mother would read us the 
“Sunday funnies.” Two of us would sit on her lap and two 
down in front. We would squeeze in as close to her as we could 
get. Each of us had a favorite column that we would ask her 
to read again until she had read the paper two or three times. 
The funnies were not great literature, and my mother 
read at a second-grade level or less. But that was not impor¬ 
tant. The nurturance, emotional warmth and closeness that 
we received provided us with the beginnings of a powerful 
sense of belonging and security; again, the most important of 
human needs. And in the process, reading was given a power¬ 
ful, positive emotional charge. 
A reasonable sense of security and belonging fosters 
confidence and prepares children to take on the challenges 
of their environment and, with help and approval, gain com¬ 
petencies that enable them to successfully manage the chal- 
lenges of their world. As they succeed they begin to feel, “I am 
somebody of worth, value and competence. I am. I can. I will.” 
These conditions, combined with the need for self-expression, 
are the foundation of motivation. Caretaker guidance helps 
make the process constructive. 
A philosophical father and a pragmatic mother 
We received the guidance, skills and values needed for appro¬ 
priate social functioning and self-expression through many 
casual interactions, interactions that reflected our parents’ atti¬ 
tudes, beliefs and ways of approaching life. From my more 
philosophical father we often heard: 
“If you can’t be the best, be among the best”—be com¬ 
petitive, excellent. 
“Nothing beats a failure but a try”—initiative, effort, 
chance taking. 
“A man’s word is his bond”—be responsible, show 
trustworthy behavior. 
“The measure of a man is the way he treats his fellow 
man”—respectful relationships. 
“Never let your race stop you from doing anything you 
want to do”—and much more. 
And from my pragmatic mother: 
“Be reasonable.” 
“A procrastinator’s work is never done.” 
“Never mind the teacher, you get it upstairs. They can’t 
take that away from you.” 
“If you are on time, you are five minutes late.” 
“Recognize trouble, and stay away from it.” 
One of the places such mental and moral morsels were 
frequently served was at the dinner table. But dinner time was 
more than messages. We ate at the same time every evening— 
regularity. We were expected to talk about tire things that 
went on during tire day that might be of interest to everyone— 
reflection and reporting. Through subtle clues, sometimes 
insistent suggestions, we were asked not to talk too long, to 
give others a chance to speak, to listen to what they had to 
say—skills of conversation. Spontaneous discussions were 
encouraged, even strong emotions, but we were expected to 
keep emotions under reasonable control—free expression 
within limits and with self-control. Teasing was fine and fun, 
but you could not hurt anybody’s feelings too much—a 
family value. Pretending you were hurt to get sympathy was 
frowned upon—no victims here. 
My mother prepared everyone’s favorite dish from time 
to time—collard greens, cherry pie, German chocolate cake, 
hot rolls, cube steak. Each child received special recognition 
on the day his or her favorite food was prepared and on birth¬ 
days—you are special and we celebrate each other. Sharing, 
cooperating and enjoying the success of brothers and sisters 
were encouraged. These practices discouraged jealousy. The 
product of all of this was a family environment of warmth, 
trust and mutual respect and appreciation. 
Our parents, and sometimes friends, took us to the 
museums in Chicago, the zoo, the circus, Marshall Field 
department store during the Christmas season, the Chicago 
Cubs park and on other trips. When President Franklin 
Delano Roosevelt’s caravan came through town, we were 
there. There was much discussion about what was going on 
during these “field trips.” And before all such occasions, my 
mother gave us social interaction “suggestions.” “Talk enough 
to be interesting, but don’t tell all of your business.” And 
wisdom to reflect on: “If you talk too much, people will find 
out how big a fool you are.” 
Solving problems by listening and watching 
I learned effective ways of solving problems by listening to 
and watching my parents. Once I listened to my mother 
talking on the telephone with my principal, Ms. McFeely. A 
bully had knocked my brother Norman down and sat on him. 
Norman bit the bully, through his pants, on the butt. 
During the conversation my mother never raised her voice. 
Initially I could hear the sound of tire principal’s voice, but she 
gradually quieted down. My mother’s responses went some¬ 
thing like this: “No, I don’t approve of my children fighting.” 
(Pause while listening.) 
“But you said that the boy was a bully, bigger, and that 
he started the fight.” (Listening.) “While I don’t expect them to 
fight, I do tell them that they are not to let anybody walk over 
them (or sit on them)! Fight back if necessary!” (Listening.) 
“Now, if there’s a medical bill we will pay for it.” 
(Listening.) 
“Thank you for calling, and please let me know when¬ 
ever there’s a problem.” 
When I was about 3 or 4 years of age, our family doctor 
was called to treat me. When he left I said, “I’m going to be a 
doctor when I get to be a big man!” My parents responded by 
buying me a doctor’s kit and playing doctor with me—remind¬ 
ing me that the candy pills were for the patient, not the doctor. 
A neighbor asked, “Why are you encouraging him to be 
a doctor? We’re poor people. You know he will never be a doc¬ 
tor!” My mother told her that if she said that again she would 
have to leave. These neighbors were African-Americans. Their 
comments reflect the high level of group- and self-deprecation 
and the low level of aspiration and hope that existed, and still 
exists, among many. 
Self-doubt-producing experiences were and are even 
more common outside the family network. In the middle of 
my fourth-grade year, a student transferred into our class. She 
told me that she knew my mother. Tire reason turned out to 
be that my mother had worked as a domestic for her mother 
years before. By age 10 or n, social status is an identity issue. 
Although children don’t think “social status,” they make obser¬ 
vations and ask questions that help them place themselves in 
the scheme of things—how they are valued, where they stand 
as reflected by their house, car, race, religion, occupation of 
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their parents, and so on. Their conclusions can influence 
their aspirations and effort. My mother noted that I was a little 
troubled by knowledge of that previous relationship. The 
knowledge was a threat to my quest for a sense of adequacy, 
belonging and security. 
She stopped what she was doing, looked me in the eye 
and said, “Don’t let that bother you none. You’re just as clean 
as she is. You’re just as smart as she is. And you can do just as 
well in school.” She paused and with a no-nonsense facial 
expression said, “And you had better!” Fortified by the positive 
sanction of one of the two most powerful people in my young 
world, 1 did well. 
All of these experiences helped me grow along all the 
developmental pathways. Growth in the social-interactive, 
psychological-emotional and ethical areas or pathways is par¬ 
ticularly important in complex social systems, but these are all 
but ignored by educators and policymakers. The often subtle, 
challenging social situation can have huge negative conse¬ 
quences for any student, and for minority students in particu¬ 
lar because they face them more often. Without good 
preparation, such environments can become hurtful and limit¬ 
ing. With adequate preparation, young people can turn the 
negative to positive support, or at least not be harmed. 
A problem I encountered in the nth grade comes to 
mind. Grades were given at the end of io weeks and a final 
grade at the end of 20. At the end of the first 10 weeks, I was 
one and two points, respectively, behind the two white students 
who received As in our language arts course. I was almost 30 
points ahead of the next-closest student, but 1 received a B. 
After being told that a B was a good grade and other palliative 
things, my teacher eventually said kindly, “I just don’t think 
you’re capable of making an A.” That was the end of the discus¬ 
sion. I knew exactly what that meant. Tire grade she gave me 
was an expression of her racial stereotyping. 
I did not raise my voice. I did not even tell my parents. I 
worked very hard that next semester and earned all As, and the 
top score in her class. But I did not take a chance. Her class 
was my first in the monring. I told her that I had forgotten my 
grade book. I collected all my grades, all As, and went back to 
her at the end of the day. She gave me an A without comment. 
During my senior year, when I was no longer in her 
class, she asked my advice about how she might help an 
African-American student whom she was concerned about. He 
was very smart but not working up to his potential. Perhaps 
our discussion tire year before, and the way tire incident was 
managed, helped her confront her bias. Let me hasten to add 
that almost all of my white teachers were just. Some went out 
f their way to make certain that I was treated fairly. I did not 
. ve a blade teacher until I went to medical school. 
Learning values in church 
Our family was enmeshed in a church culture that generated 
and reinforced the set of attitudes, values and behaviors we 
lived by. Our church culture was in sync with the mainstream 
culture—personal excellence, hard work, a delayed reward, 
good relationships. The church-based culture affirmed our 
value when society did not do so at the necessary level. 
My experiences at home and in our primary social net¬ 
work prepared me for school. They enabled me to elicit a 
positive response from school people, to attach and bond with 
them and with the program of the school. Doing well aca¬ 
demically and doing well socially were our prime family and 
social-network values. And being involved in sports, the arts 
and student government could be expected because our family 
supported participation in any activities that were believed to 
be educational. I n fact, at one point, all four of us were student 
council representatives from our respective classes. 
As a result of the care that had been given to nurturing 
us in our early years, before we started school, and our 
resultant ability to elicit positive responses, our family, school 
staff, classmates and community all supported our growth 
along all the developmental pathways. My three friends men¬ 
tioned above were not so well-prepared for school, did not 
elicit positive responses and began a downward course almost 
from the beginning. 
An incident many years later provided me with support 
for my notion that student-staff attachment and bonding are 
important. When my mother was a patient in the hospital in 
1990, Ms. Walsh, my first-grade teacher, was then a spry 80- 
plus-year-old hospital volunteer. When she saw me, she threw 
her arms around my neck and said, “Oh, my little James!” 
(I was 55 years old at the time, but you are always 6 years old 
to your first-grade teacher.) She then stepped back, looked 
me over and said, “Oh, we just loved the Comer children. You 
were so bright, so eager to learn, got along so well with other 
children,” and on and on. 
She was describing the outcome of dedicated, skilled 
child-rearing interactions; good development; and a genetically 
determined potential that was at least at or above the modest 
threshold level necessary for school and life success. It was “all 
of the above,” not intelligence alone, that made our academic 
success possible. Good development and a supportive family 
and church-based primary social network made it possible to 
manage the environment of the schools we attended and the 
world beyond, ym 
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In a reading classroom at the 
Columbus School students move 
from one station to another as they 
approach stories by analyzing plot. 
studying vocabulary and predicting 
the outcome. Teachers, aides and 
parents work with the children in 
small groups. 
What’s in a name? 
No Child Left Behind. Leave No 
Child Behind. Two slogans almost 
alike but for one word and the 
placement of the others. One is 
the creation of progressive child 
advocates and the other comes 
from a presidential campaign. 
It is no accident that James P. 
Comer, M.D., HS ’66, M.P.H., the 
Maurice Falk Professor of Child 
Psychiatry in the Child Study Center, 
chose Leave No Child Behind as 
the title of his latest book. It is 
the registered trademark of the 
Children’s Defense Fund (cdf), 
which has worked since 1973 to 
ensure that children receive ade¬ 
quate education and health care. 
During his 2000 campaign, 
President George W. Bush appro¬ 
priated the slogan, much to the 
dismay of the cdf, which asked 
Bush to “cease and desist” from 
using it. According to news 
accounts, the cdf even considered 
legal action to prevent those 
words from passing Bush’s lips. 
Comer’s choice of Leave No 
Child Behind should not be seen 
as an endorsement of the act of 
Congress that carries a similar 
name.“The accountability piece of 
it is good,” Comer said of the leg¬ 
islation, “but it goes about it in 
the wrong way, punishing rather 
than helping.”The legislation, 
Comer believes, places enormous 
pressure on schools to “teach to 
the test” in order to meet account 
ability goals. Instead, Comer says, 
teachers should be encouraging 
students to learn along develop¬ 
mental pathways in a “friendly, 
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In the anatomy lab, a new way of thinking 
ale’s fall semester has only 
been in session for about six 
weeks, but first-year medical 
student Jason Frangos is 
about to attempt surgery for 
a thoracic aortic aneurysm. 
He dons an apron and 
gloves, picks up a scalpel 
and prepares to make the 
first incision. “I’m afraid of 
cutting something I don’t want to cut,” he says. It’s a real 
concern, not because this is real surgery, but because it is an 
opportunity to learn: Frangos and his classmates are “operat¬ 
ing” on cadavers for “Human Anatomy and Development,” 
a course that is a rite of passage for medical students across 
the country. But while many of the basic elements of the 
course—preparation, dissection and lecture—have been in 
place for years, Yale’s class of 2008 will learn anatomy in a 
way that is significantly different from that of past years. 
The reasons for the shift are both practical and philo¬ 
sophical. Thanks to advances in medicine, students have more 
to learn in just about every field, and curricula are becoming 
more streamlined. While a classically taught anatomy course 
used to consist of upwards of 200 hours spread over two 
semesters, today’s course is half that. At the same time, the 
pool of anatomy professors nationwide is dwindling, as 
young scientists turn to other disciplines in the life sciences 
where there are more abundant discoveries still to be made. 
According to a survey by the American Association of Anato¬ 
mists (aaa), more than 80 percent of anatomy-related depart¬ 
ment chairs anticipate having “great” or “moderate” difficulty 
finding qualified faculty in the next few years. In response, 
medical schools have recruited professors from other depart¬ 
ments, as well as physicians in the community. And a new con¬ 
cept has emerged to play an increasingly pivotal role in medical 
education at Yale—functionality. “Tire notion of a functional 
approach is a philosophy we’ve developed for dealing with the 
staggering amounts of information students have to learn,” 
says Herbert S. Chase Jr., m.d., deputy dean for education. 
In the past, students memorized anatomical features 
that they either would forget by the time they needed the 
information or never needed to know in the first place. “Given 
the myriad anatomical details, rather than examine every 
sti ucture, we ask ‘What does a physician who interacts with 
human anatomy need to know?”’ says Chase, adding that sur¬ 
geons need to know the anatomy of operations they perform, 
radiologists need to know anatomy to identify abnormalities 
and disease and emergency physicians and anesthesiologists 
need to know anatomy to perform essential procedures. 
Even more important is finding ways for students to 
retain what they’ve learned so they can apply it when treating 
patients. Accordingly, the new focus of the course is not on 
information, but on transformation—a change in the students’ 
thinking process. No one learns a foreign language by memo¬ 
rizing a dictionary and rules of grammar; fluency occurs only 
when one begins to think in the new language, says Lawrence 
J. Rizzolo, ph.d., associate professor and course director. 
Similarly, students learn the language of medicine not by 
memorizing anatomical details, but by learning to think 
anatomically. “What we’re trying to do is prepare students for 
lifelong learning,” explains Rizzolo. “We’re trying to give them 
the tools and skills so when they see new information they 
have a way to assimilate and acquire that information.” 
To achieve that goal, the course addresses four areas: 
clinical reasoning, visual reasoning, structure/function rela¬ 
tionships and knowledge of anatomy. The tools used to 
achieve proficiency in those areas have been constructed to 
reinforce different skills and learning styles. 
A clinical context 
Dissection remains at the heart of the course, but it is now 
anchored in clinical medicine. Previously students studied 
structures in terms of their relationship to other structures. 
Now every dissection is a clinical case, and surgeons special¬ 
izing in that day’s procedure are brought in as guest instruc¬ 
tors. Instead of telling his clinical colleagues what anatomy 
he wanted to teach and asking them to come up with clinical 
cases, Rizzolo was asking them to teach cases that students 
were likely to see, along with the anatomy behind those 
cases. It was a sea change in how anatomy courses have 
been organized. Using real surgical instruments, the stu¬ 
dents are practicing actual surgical procedures under the 
assumption that they will better retain information that they 
learn in a practical context. 
While other medical schools use some surgical cases to 
teach anatomy, Yale is the only medical school in the country 
that uses surgery as the basis for the course for first-year stu¬ 
dents, according to Rizzolo, who sits on the educational affairs 
committee of the aaa. Both students and faculty say the 
method works. “In a lot of anatomy programs you just dissect,” 
says student Judah D. Weathers. “Here we relate to disease and 
surgery.” Even mistakes offer moments of insight. “When you 
make one and understand it, you never forget it,” says Alicia 
Little. Instructors accustomed to the old system are already con¬ 
verts to tire new approach. Shukrulla Ghofrany, m.d., a retired 
surgeon who has taught anatomy for the past four years, 
thought clinical cases would be confusing to students who have 
little knowledge of medicine. But feedback from students and 
his own observations have changed his mind. “I have to admit 
that I was totally wrong,” he says. Using a clinical outcome as 
the basis for teaching anatomy is bound to work, according to 
Chase. “If students can identify every important anatomical 
structure while doing a hysterectomy, then they know tire rele¬ 
vant anatomy of the pelvis,” he says. 
Another new aspect of the course is the expanded use 
of computers and the Internet. In the year-old anatomy labs 
at the Anlyan Center, each dissection table has its own work¬ 
station suspended from the ceiling. These computers are 
meant to be used during labs: the keyboards are made of 
soft rubber that is washable and virtually indestructible, and 
the course’s dissection manual, Anatomy Clinic, is distrib¬ 
uted oxrline. The manual, an interactive tutorial developed by 
Yale faculty, prods students with questions, and if they 
answer at least partially correctly, it supplies the full answer. 
If not, it directs them to resources with the correct informa¬ 
tion. Students can also access the Visible Human Dissector, 
a simulator based on the National Library of Medicine’s 
Visible Human Project and developed by researchers at the 
University of Colorado. This software allows students to view 
thousands of three-dimensional images of the human body 
in which each anatomical feature is color-coded and can be 
isolated, rotated, eliminated or viewed in cross section. 
“We try and supply a variety of different learning 
modalities and teaching styles,” says William B. Stewart, 
ph.d., associate professor and chief of the Section of Anatomy 
and Experimental Surgery. “Some students love computers, 
others always look at the dissection, others always have their 
nose in the manual.” Some schools have abandoned cadavers 
in favor of virtual dissections done via computers. Encouraging 
that trend are the scarcity of cadavers as well as instructors, 
and, in part, scandals at Tulane University and the University 
of California, Los Angeles, where employees sold cadavers or 
body parts to body-brokerage and research companies. But 
these computer programs haven’t been successful, because 
students need to learn in three dimensions. “It’s like having a 
map and direchons,” says Frangos. “You can study it, but once 
you drive it, you never forget it.” 
The tools of diagnostic imaging also help students 
visualize the inner workings of the human body. In the past, 
imaging was used intermittently, but in the new course it’s 
used during each lab. Groups of students gather around 
Michael K. O’Brien, m.d., ph.d., who is both an active sur¬ 
geon and an anatomy professor. Using X-rays and CT and 
MR scans, students learn basic principles of radiology as well 
as the concepts of anatomy. O’Brien asks them to sketch 
structures and leads them to answers to their questions. 
Students say radiology allows them to make two-dimensional 
images three-dimensional, helping them visualize what may 
be difficult or too messy to see in the dissection lab. 
Learning as a group 
Under the Yale System of Medical Education, students are 
expected to be independent learners who seek out information 
and take responsibility for their education. Yale students tend 
to be highly motivated to study on their own, but Rizzolo has 
found that they learn anatomy better in small groups. For the 
past two years, students have formed “learning societies” of 20 
students divided into four groups, with a mentor for each. 
Students prepare for class individually, then meet with their 
societies to explore unresolved questions. Individual students 
become experts in their assigned areas and, at conferences, 
pool information and teach their classmates. Each group 
explores the core principles of clinical anatomy by combining 
different perspectives on a problem. 
Even lectures, one of the traditional pillars of the 
anatomy course, utilize group dynamics. Students often 
break into groups at the beginning of a lecture to take a test, 
first individually and then, following a discussion, as a 
group. Lectures often come after a dissection, a policy that 
some students find perplexing. But according to Rizzolo, 
“The documented reality is the lecture doesn’t make sense 
unless you struggle with the material first.” This year’s stu¬ 
dents will find that less time is spent in the lecture hall. “It’s 
a difficult transition going from receiver of information to 
seeker of information,” Stewart points out, but an important 













34 In the anatomy lab, a new way of thinking 
The anatomy course guides students through the 
process of acquiring information they will need. But it’s also an 
introduction to death and dying, and tire course strives to make 
students comfortable with these topics. For most students, 
Rizzolo says, the dissecting lab will be the first encounter with 
a dead person or tire first observation of the ravages of disease. 
In a 2002 paper published in The Anatomical Record, he main¬ 
tained that it is an ideal place to introduce concepts of human¬ 
istic care. “The lab evokes the students’ memories, speculations, 
and fears about serious illness in themselves, their families, 
and loved ones,” he wrote. He tells the class that to be able to 
help their future patients and their families, they have to con¬ 
front their own emotions first. He encourages students not to 
suppress their emotions, but to express them freely, aird not to 
be embarrassed in front of their peers or professors. 
For the last several years students have channeled 
their feelings through a memorial service, called a service of 
gratitude. Those who participate spend about half a semester 
on the project, in which they express themselves through 
whatever means they choose, including poetry, music and 
art. In the anatomy hallway hang two contributions from 
past years: an intricate and beautiful drawing called Handed, 
by Brent Schultz ’06, and a quilt assembled by the medical 
school Class of 2006 and the physician associate Class of 
2004, with panels dedicated to each donor in the course. 
State of the art 
The anatomy course’s new direction is largely due to 
Rizzolo’s efforts to study and implement methods of teach¬ 
ing anatomy in a way that will allow students to recall infor¬ 
mation when they need it. A 10-day course for medical 
educators at the Harvard Macy Institute in Boston in 2003 
was the genesis of a grant proposal to the Fund for the 
Improvement of Postsecondary Education (fipse), a pro¬ 
gram of the U.S. Department of Education. A $400,000 
grant to the anatomy program was approved and funded in 
2003, and proposes a “modular, multimedia, multidimen¬ 
sional approach” to teaching anatomy from high school 
through college and clinical education. The course has been 
■eloped and used at the medical school since the fall of 
2003, when students benefited from a pilot program that 
included some of the new features, such as interactive Web 
versions of sections of the dissection manual. This year it 
will be further refined before being rolled out to the physi¬ 
cian associate and assistant programs at Yale and Quinnipiac 
University and the medical schools at ucla, the University 
of Utah, the Mayo Clinic, the University of North Carolina 
and the University of Connecticut. “The fipse idea is a 
national solution to a national problem,” says Rizzolo, refer¬ 
ring to shrinking anatomy resources. “I think there are 
many schools that would want to do this,” adds Chase, “but 
they need a blueprint and Larry and Bill are creating it.” 
William C. Rando, ph.d., director of the McDougal 
Graduate Teaching Center at Yale, surveyed last year’s 
anatomy students to get their feedback and find out how they 
spent their time doing course work. “I was amazed at the 
overall positive response, but what was even more amazing 
was how easily students could articulate what it was about 
this course that was working for them,” he told instructors at 
a faculty meeting at the beginning of the fall semester. 
Students said that dissection, conferences and computer- 
based learning played a major role in helping them learn 
anatomy. Students also said that the course offers more ways 
to learn and has helped them become more independent 
thinkers. “The way they learn anatomy is structured in a way 
that’s more like how they work when they get on the floor— 
combining knowledge to solve problems and knowing where 
to go to get additional information,” says Rando. 
Meanwhile, Rizzolo has been studying the connection 
between Web-based activities and learning. Last year, he kept 
track of how much students used computer-based instruc¬ 
tion and asked them to take an exam at the end of the 
course. On questions where Web activities had been avail¬ 
able, he found that students who used them far outper¬ 
formed those who didn’t. If more Web activities were 
available (as they are in this year’s course), those students 
may have scored much higher on the exam. 
Redesigning the course has been a huge undertaking, 
one that is ongoing. Rizzolo asks faculty members to meet 
weekly to discuss what is or isn’t working in the course, and 
find ways to improve and develop it. “What I’m most excited 
about is the reaction of the students when they hear what 
the course will be like,” says Stewart, who wishes that he 
could have taken the course when he was a student. “I’m 
enthusiastic, but at the same time I’m a little jealous.” ym 
Jill Max is a writer in Connecticut. 
Christian Northeast is an illustrator in Ontario, Canada. 
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How to save the life 
of a young driver 
Doctors in states without graduated 
licensure can make a difference 
by insisting on restrictions. 
“So we drove on toward death through 
the cooling twilight.” 
—F. Scott Fitzgerald (The Great Gatsby) 
Sixteen years as a teacher and practi¬ 
tioner of emergency medicine at Yale 
have taught me that there is no greater 
tragedy than the loss of a child, and no 
more difficult duty for a physician than 
to deliver unthinkable news to disbe¬ 
lieving parents. 
Ironically, parents fear dangers 
unlikely to affect their children, such 
as kidnapping or murder, while neglect¬ 
ing a far greater menace: motor vehicle 
trauma. Car crashes are the leading 
cause of death for people ages 16 to 
20, according to the National Highway 
Traffic Safety Administration (nhtsa), 
where I recently completed a two-year 
fellowship. The Centers for Disease 
Control and Prevention reported that 
4,700 American teenagers died in cars 
in 2001. (By comparison, the number 
of child kidnappings ending in death is 
estimated at 100 annually.) 
The teenage years usher in a period 
of dramatically increased risk of vehicu¬ 
lar death and serious injury. A newly 
issued driver’s license may be seen as a 
ticket in a lottery of death and disability. 
The nhtsa reports that the fatality 
rates per million miles driven by 16-, 
17- and 18-year-olds are 17, 13 and 7 
deaths, respectively, far higher than the 
rate of 3 deaths per million miles for 
older drivers. 
In view of these numbers, does it 
make any sense that most parents 
allow their newly licensed children to 
drive with few or no restrictions, 
and that some parents actually give 
children their own car at this age? 
Traffic safety advocates oppose this 
laissez-faire approach and have per¬ 
suaded states to enact legislation to 
protect new drivers. Known as gradu¬ 
ated licensure, or GL, the laws impose 
restrictions on young novice drivers, 
gradually easing limitations over 
periods of three to 12 months. These 
restrictions, which vary by state, 
include a no-passenger rule, zero toler¬ 
ance of alcohol and a ban on nighttime 
driving. For young drivers, these three 
factors are the major variables associ¬ 
ated with high crash and fatality rates. 
The effectiveness of GL is well- 
established. A 1996 study commis¬ 
sioned by the nhtsa found that GL 
reduced injury, fatality and moving- 
violation rates among 16- and 17-year- 
old drivers by about 20 percent. 
So what can a parent do if his or 
her child is about to become a new 
driver in a state with no GL laws? This 
was what I experienced in Connecticut, 
which was not yet a GL state when 
my oldest son was licensed. First, after 
getting his learner’s permit, for over 
a year he had lots of practice with an 
adult at his side. When he got his 
license at 17, I imposed house rules 
including no passengers (except par¬ 
ents), no solo night driving and no 
“just driving around for fun” before 
age 18. Perhaps most important to 
the big picture, I used my position as 
president of the Connecticut College 
of Emergency Physicians to work with 
other groups to win passage of a GL 
law, making all teen drivers in 
Connecticut safer. 
Concerned parents living in states 
that do not have GL laws can and 
should take action. Educating state 
officials using information obtained 
from nhtsa and Insurance Institute 
for Highway Safety websites is a good 
start. Letters to the editor and the sup¬ 
port of civic and school organizations 
are also essential. Finally, support from 
police is critical because of their role 
in enforcement. 
The Emergency Department acts as 
a filter for illness and injury in the sur¬ 
rounding community. This gives emer¬ 
gency physicians the opportunity to 
identify seemingly random incidents 
and recognize patterns of pathology 
that call out for preventive measures. 
It would be short-sighted and, frankly, 
irresponsible to simply “treat and 
street” without going to the source of 
certain injury or illness patterns in an 
effort to reduce or eliminate them. 
There will be more heartbreaking 
moments of delivering unimaginable 
news to anguished parents. We owe it 
to ourselves and our children to do 
everything we can to make those 
moments as infrequent as possible. 
Phillip A. Brewer, M.D., is an assistant professor 
of surgery (emergency medicine) at the School 
of Medicine. 
WE WELCOME SUBMISSIONS 
Do you have an opinion to share on 
a vital topic in medidne, health or science? 
Send yours to Essay, Yale Medicine, 
P.O. Box 7612, New Haven, CT 06519-0612, 
or via e-mail to ymm@yale.edu. 
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Noted chemist is 
named provost 
Andrew Hamilton becomes 
second scientist named to 
Yale’s top academic post. 
AskANDREW D. HAMILTON, 
ph.d., Yale's new provost, if it’s 
an accident that both he and his 
immediate predecessor are scien¬ 
tists, and he chuckles. He points 
out that it took three centuries for 
the university to name its first sci¬ 
entist, Susan Hockfield, ph.d.— 
who left Yale to become president 
of the Massachusetts Institute of 
Technology in December—as 
provost. 
“Two scientists in 300 years is 
not a flood,” Hamilton said. “But, 
yes, I do think it represents a 
recognition by the institution that 
we need to place a very major 
focus on science, engineering and 
medicine in order to maintain 
Yale’s place at the very top ranks 
of universities worldwide.” 
To that end Yale has embarked 
on a $1 billion building and reno¬ 
vation project for facilities in sci¬ 
ence, engineering and medicine, 
both on the central campus and at 
the medical school. But that’s only 
the beginning. "My hope is that 
we will be able to use these new 
buildings to attract some of the 
very best scientists in the world to 
ply their trade at Yale,” Hamilton 
said. “At the same time, we must 
maintain those traditional 
strengths of Yale University, which 
reside in the humanities, the social 
sciences and the professional 
schools.” 
Hamilton joined the Yale fac¬ 
ulty in 1997. He became chair of 
the chemistry department in 1999, 
where he is currently the 
Benjamin Silliman Professor of 
Chemistry. He was appointed 
deputy provost at Yale in 2003. 
Before coming to Yale he taught 
at Princeton and at the University 
of Pittsburgh. A native of the 
United Kingdom, he was elected 
a Fellow of the Royal Society 
last May. 
His studies of small molecules 
that influence biological proc¬ 
esses have provided insights into 
drug design and cancer therapies. 
He has also studied neglected 
diseases such as malaria, Chagas 
disease and African sleeping 
sickness. 
As provost, Hamilton is advanc¬ 
ing President Richard C. Levin’s 
vision of Yale’s role in the world. 
Hamilton recently traveled to 
China with medical school faculty 
members to establish and cement 
relationships with Chinese scien¬ 
tists and universities. 
Hamilton is also keeping his 
eye on relationships within 
the university. “I think there are 
many opportunities for collabo¬ 
ration in research between scien¬ 
tists and social scientists on this 
side of campus and researchers 
at the medical school,” he said. 
“I hope, with my scientific back¬ 
ground, to be able to further 
those connections.” 
New finance officer 
crosses country to 
assume post at Yale 
JACLYNE w. BOYDEN, a senior 
administrator at the University of 
California, San Francisco (ucsf), 
has been named deputy dean for 
finance and administration at the 
School of Medicine, effective 
November 1. 
Boyden, who served as vice 
dean of administration and 
finance at the ucsf School of 
Medicine from 1992 until last year, 
has worked in academic medicine 
for more than 30 years, serving as 
associate dean at the State 
University of New York at Stony 
Brook from 1988 until 1992. At 
Yale, Boyden will oversee a finan¬ 
cial operation that totaled more 
than $750 million in income and 
expenditures for the year ending 
June 30, 2004. She comes to New 
Haven from a slightly larger, public 
institution with an operating 
budget of $893.7 million in 2003. 
“I am absolutely delighted to 
have Jackie join us in this new 
role,” said Robert J. Alpern, M.D., 
dean of the medical school and 
Ensign Professor of Medicine. “She 
possesses strong financial skills and 
has gained considerable experience 
in her similar position at ucsf.” 
Boyden said her focus will be on 
supporting the school’s three mis¬ 
sions of research, education and 
clinical care and on helping to real¬ 
ize goals set by Alpern and 
President Richard C. Levin. “My job 
here will be to make sure there is 
an administrative infrastructure in 
place to support the missions and 
make improvements possible,” she 
says. “On the financial side, there is 
seldom enough money to do every¬ 
thing that we might want to, but it 
will be my priority to ensure that 
the dean has accurate and reliable 
information so we are able to 
match resources with his strategic 
vision.” 
Roberta Hines Margaret 
Hostetter 
Three named to 
endowed 
professorships 
The university named three mem¬ 
bers of the faculty at the medical 
school to endowed professorships 
in 2004. 
ROBERT J. ALPERN, M.D., 
who became the 16th dean of the 
medical school in June, was named 
Ensign Professor of Medicine. Alpern 
came to Yale from the University 
of Texas Southwestern School of 
Medicine, where he was dean. He 
studied medicine at the University 
of Chicago and trained in internal 
medicine at Columbia University 
and in nephrology at the University 
of California, San Francisco. 
ROBERTA L. HINES, M.D., HS 
’77, was named the Nicholas M. 
Greene Professor of Anesthesiology. 
She joined the faculty in 1982 
and became chair of anesthesiol¬ 
ogy in 1995. 
MARGARET K. HOSTETTER, 
m.d., was named the Jean McLean 
Wallace Professor of Pediatrics. She 
also serves as chair of pediatrics 
and is a professor of microbial 
pathogenesis. From 1998, when 
she joined the faculty, until 2002, 
when she was named department 
chair, she directed the Yale Child 
Health Research Center. 
NOTES 37 
Charles Cha Susan Hardy 
Charles H. Cha, M.D., assistant 
professor of surgery (gastroen¬ 
terology), has received a two- 
year, $200,000 Dennis W. 
Jahnigen Career Development 
Scholars Award from the 
American Geriatrics Society. Cha 
will investigate the effects of 
aging on tumor angiogenesis 
and growth. 
Gilbert H. Glaser, M.D., SC.D., pro¬ 
fessor emeritus of neurology, 
received honorary-member sta¬ 
tus in the American Neurological 
Association in October. The 
honor is awarded to those who 
have made unique contributions 
to neurology and neuroscience 
as investigator and teacher. 
Roberto J. Groszmann, M.D., pro¬ 
fessor of medicine and director 
of the Section of Digestive 
Diseases at the VA Connecticut 
Healthcare System in West 
Haven, received the 2004 Ismar 
Boas medal from the German 
Society of Digestive and Meta¬ 
bolic Diseases in September in 
Leipzig, Germany. 
Susan E. Hardy, M.D., FW ’04, 
instructor in geriatric medicine, 
has received a 2004 Pfizer/ 
ags Foundation for Health in 
Aging Junior Faculty Scholars 
Award for Research on Health 
Outcomes in Geriatrics. Hardy 
will receive $130,000 over two 
years to continue her research 
into transitions between dis¬ 
ability and independence 
among community-dwelling 
older persons. 
Janet B. Henrich, M.D., associate 
professor of medicine and of 
obstetrics, gynecology and 
reproductive sciences, received 
a 2004 Scholarship in Medical 
Education Award, in the category 
John Parsing Marina Picciotto Sally Shaywitz Barry Zaret 
of Scholarship of Integration, 
from the Society of General 
Internal Medicine. 
Judith H. Lichtman, PH.D., M.P.H. 
’88, assistant professor of epi¬ 
demiology in the Division of 
Chronic Disease Epidemiology, 
has received a three-year, nearly 
$959,000 Health Protection 
Research Initiative grant from 
the Centers for Disease Control 
and Prevention for a study of 
the burden of cardiovascular 
disease in the elderly. 
Albert C. Lo, M.D., PH.D., HS '01, 
assistant clinical professor of 
neurology, received a Presi¬ 
dential Early Career Award for 
Scientists and Engineers from 
the White House Office of 
Science and Technology Policy 
at a reception at the White 
House in September. Lo was 
honored for his contributions to 
new therapeutic strategies to 
restore function in people with 
multiple sclerosis. 
Susan T. Mayne, PH.D., professor 
of epidemiology in the Division 
of Chronic Disease Epidemiol¬ 
ogy, was appointed to the nutri¬ 
tion subcommittee of the Food 
Advisory Committee of the 
Food and Drug Administration's 
Center for Food Safety and 
Applied Nutrition. 
John A. Persing, M.D., professor 
of surgery (plastic) and 
neurosurgery, will begin his 
term as chair of the American 
Board of Plastic Surgery in 
May. Persing, who is just finish¬ 
ing his term as president 
of the American Association 
of Academic Chairmen in 
Plastic Surgery, has been chief 
of piastic surgery at Yaie 
since 1992. 
Marina R. Picciotto, PH.D., associ¬ 
ate professor of psychiatry, 
pharmacology and neurobiology, 
has received a $100,000 Inde¬ 
pendent Investigator Award 
from the National Alliance for 
Research on Schizophrenia 
and Depression for a project on 
new antidepressant targets 
in the brain. Picciotto will study 
the antidepressant effect of 
blocking the nicotinic acetyl¬ 
choline receptor. 
Teresa A. Ponn, M.D., assistant 
clinical professor of surgery, has 
been named associate director 
for breast surgery at the Yale- 
New Haven Breast Center. In a 
private practice in the New 
Haven area since 1985, Ponn has 
focused on caring for patients 
with breast malignancies. 
A symposium in September 
honored the lifetime work of 
Charles M. Radding, M.D., profes¬ 
sor of genetics and molecular 
biophysics and biochemistry, 
who retired last fall. During his 
37 years at Yale Radding focused 
his research on recombination, 
making major contributions to 
both theory and experimenta¬ 
tion. Radding is a member of the 
National Academy of Sciences 
and an editor of the Proceedings 
of the National Academy of 
Sciences. 
Sally E. Shaywitz, M.D., professor 
of pediatrics and a member of 
the Child Study Center, received 
the Townsend Harris Medal from 
her alma mater, the City College 
of New York, in November. The 
medal honors distinguished 
alumni. 
Robert S. Sherwin, M.D., FW ’74, 
the c.n.h. Long Professor of 
Internal Medicine, has received 
the Long-Standing Achievement 
Award from the Novartis 
Pharmaceutical Corp. for his role 
in developing insulin pump 
therapy, a crucial advance in dia¬ 
betes care. He received the 
award in September in Munich, 
Germany, at the 40th annual 
meeting of the European Asso¬ 
ciation for the Study of Diabetes. 
Stephen G. Waxman, PH.D., M.D., 
professor and chair of neurology, 
pharmacology and neurobiology, 
has been named the first recipi¬ 
ent of the National Multiple 
Sclerosis Society’s Stephen C. 
Reingold Award for 2004. The 
award recognizes the contribu¬ 
tions of Stephen C. Reingold, 
ph.d., who, until his recent retire¬ 
ment, was responsible for the 
society’s national research and 
training programs. 
A symposium,“Advances in 
Cardiovascular Medicine and 
Surgery,” was held in October to 
honor Barry L. Zaret, M.D., the 
Robert W. Berliner Professor of 
Medicine, who stepped down 
last year as chief of the Section 
of Cardiovascular Medicine after 
26 years. 
Heping Zhang, ph.d., professor 
of public health (biostatistics), 
has received two grants totaling 
$1.5 million over five years from 
the National Institute on Drug 
Abuse. He will use the grants 
to develop statistical methods 
for identifying candidate genes 
for nicotine dependence, drug 
use and psychiatric conditions. 
SEND FACULTY NEWS TO 
Claire M. Bessinger, Yale Medicine. 
P.O. Box 7612, New Haven, 
CT 06519-0612, or via e-mail to 
claire.bessinger@yale.edu 
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The eternal triangle of 
a sound health system 
A misfiled application steered Bill 
Kissick away from his dream job and 
into the world of health policy. 
The ongoing drama of Bill Kissick’s 
life involves a triangle, not of romance, 
but of health policy. The three sides of 
Kissick’s triangle are access, quality 
and cost containment. “I can deliver 
any one of these three by compromis¬ 
ing one or both of the other two,” said 
Kissick. 
William L. Kissick, m.d. ’57, m.p.h. 
’59, dr.ph. ’61, has been puzzling over 
his triangle’s three sides since he began 
his professional life in Washington, in 
1961. He was planning to start his 
As they watched the signing of Medicare 
legislation in 1965, a mentor advised 
William Kissick that if he wished to continue 
working in health policy, he must learn to 
eciate delayed gratification. 
dream job at the National Institutes 
of Health (nih), assisting in the lab 
of future Nobel laureate Baruch S. 
Blumberg, m.d. Thanks to a misfiled 
application, the young physician ended 
up not at the nih, but at the office of 
the Surgeon General, where he was 
assigned to work on a health insurance 
plan for elderly Americans. With a fur¬ 
ther nudge from what he calls “The 
Princes of Serendip,” Kissick became 
one of the authors of Medicare. In 
the 18 months that he worked on the 
program, Kissick got a crash course 
in the art of the possible from Wilbur 
J. Cohen, then assistant secretary of 
health, education and welfare. 
By the time Kissick arrived in 
Washington, Cohen had survived 
almost three decades in government 
in administrations of various political 
persuasions, beginning with President 
Franklin Delano Roosevelt. Cohen, 
one of the architects of the New Deal, 
had proposed that it include national 
pensions and health insurance. The 
pensions came to pass when Roosevelt 
signed Social Security into law in 1935. 
“fdr dropped the health care idea, 
but Wilbur didn’t,” Kissick said. Thirty 
years later, after President Lyndon 
Johnson signed Medicare legislation, 
Cohen told the young physician, “If 
you choose to continue working in 
health policy, you must learn to appre¬ 
ciate delayed gratification.” 
His old mentor, were he alive, 
would be angered by the recent 
changes in Medicare, particularly the 
privatization of the program, said 
Kissick. He brands the new legislation 
entirely “political” and attributes it to 
the lobbying strength of the pharma¬ 
ceutical and insurance industries. For 
example, under the new legislation, 
Medicare will no longer use its enor¬ 
mous purchasing power to negotiate 
prescription drug prices. The lost sav¬ 
ings further compromise Medicare’s 
financial stability, Kissick said. 
Not that Kissick—who is the 
George Seckel Pepper Professor 
Emeritus of Public Health and 
Preventive Medicine at the University 
of Pennsylvania School of Medicine, 
professor emeritus at the Wharton 
School and Penn’s School of Nursing 
and visiting professor emeritus of 
health policy and management at the 
Yale School of Public Health—con¬ 
siders the original legislation he 
helped write to be perfect. As Kissick 
sees it, the drafters made three seri¬ 
ous mistakes. They dramatically under¬ 
estimated the growth of the elderly 
population and the sophistication of 
medical technologies that would 
become available in ensuing years. 
Perhaps most importantly, they did not 
count on rising patient expectations. 
Those expectations are discussed at 
length in Kissick’s Medicine’s Dilemmas: 
Infinite Needs Versus Finite Resources 
(Yale University Press, 1994), currently 
in revision. “No society has sufficient 
resources to provide all the health serv¬ 
ices its population could utilize,” 
Kissick explained. “We all expect the 
ultimate in health care.” 
In the 1970s Kissick took a sabbati¬ 
cal in the United Kingdom, where he 
had an eye-opening conversation with 
a man who was wearing a bilateral 
truss. Kissick advised him to have sur¬ 
gery for his hernia. 
“I intend to,” the Englishman 
answered. “I’m waiting.” 




“My neighbor has been waiting for 
six,” the man replied. 
The British system relies on citi¬ 
zens’ willingness to wait. “Ignore the 
queue and the system collapses,” said 
Kissick. He finds it unlikely that 
Americans would patiently wait years 
for surgery. 
“Health care transcends the bio¬ 
medical sciences. It’s a cultural affair,” 
Kissick said. In a vast and populous 
country like the United States, where it 
is difficult to define a single culture, he 
suggests that health care plans organ¬ 
ized by states are more viable than a 
single-payer federal system. 
But state-by-state health care is by 
no means a panacea, Kissick cautions. 
“The more I read, the more confused 
I get,” he said. But he is not giving 
up on the idea of a health policy that 
serves America well, despite his per¬ 
plexing triangle. “By the time I finish 
the revision of my book, hopefully, I’ll 
have some idea,” he said. (He’s also 
counting on more than 150 physicians 
who have graduated from an m.b.a. 
program in health care management 
he and a Wharton colleague estab¬ 
lished there in 1968. “They are now 
challenged to address the issues,” 
Kissick said.) 
Kissick’s model of perseverance is 
his wife, Priscilla, who in 1982 founded 
and directed the first Medicare-approved 
hospice program, which became part of 
the University of Pennsylvania Health 
System in 1998. The Kissicks met at a 
Yale tea when he was a medical student 
and she was at the School of Nursing. 
Kissick committed the social error of 
turning up at the refined white-glove 
affair run by faculty wives with several 
friends, all dressed in khakis and laugh¬ 
ing and joking as if they were on their 
way to The Game. Spotting her future 
husband, Priscilla Dillingham remarked 
to a friend, “Somebody needs to 
straighten that guy out.” 
The Kissicks, who have three sons 
and a daughter, recently celebrated their 
48th wedding anniversary. According to 
Kissick, “She still hasn’t given up trying 
to straighten me out.” 
—Colleen Shaddox 
Hunting the secrets of the 
cell in San Francisco, and game 
fish across the globe 
John D. Baxter, m.d. ’66. hs ’68, has 
an imposing presence. At 64, he is a 
tall, strongly built man with shaggy 
hair, an affable Kentucky drawl and a 
passion for the specialized hunt. As 
often as he can, he packs his gear and 
heads for Alaska, the Seychelles or the 
South Pacific to go fishing. He goes 
after marlin, tarpon, bonefish, trout, 
salmon and sailfish, and if you want to 
see him beam, ask him about the five 
world records he holds. But Baxter 
doesn’t go out with powerhouse rods 
and tackle; that would be too easy. No, 
he goes after the biggest fish in the sea 
with only a fly rod and delicate test 
line, tools requiring an artist’s touch. 
“I love Alaska,” Baxter says, kicking 
back in his office at the University of 
California, San Francisco (ucsf), cam¬ 
pus. “And I’m very passionate about 
my fishing.” 
For the past three decades, Baxter 
has also passionately devoted himself 
to another specialized hunt: he has 
been trying to decipher the delicate 
mechanisms by which hormones, pro¬ 
teins and receptors interact inside 
our cells. Here, too, he has bagged 
some impressive trophies. In 1977, he, 
Peter H. Seeburg, ph.d., Howard M. 
Goodman, ph.d., and John Shine, 
ph.d., were the first to isolate and 
clone the human growth gene. That 
led to the creation of the first synthetic 
drug to stimulate growth in children 
of short stature. It also led to drugs 
that increase milk production in dairy 
cows. Then Baxter and a ucsf research 
colleague, Robert J. Fletterick, ph.d., 
became the first to reveal what a 
nuclear receptor looks like when it is 
binding to a hormone, a breakthrough 
that led to new structures in drug 
design. In 2003, in recognition of his 
pioneering research, Baxter was 
named to the National Academy of 
Sciences. 
Now he believes he may be on to 
his biggest catch yet. Working with 
Thomas S. Scanlan, ph.d., another 
colleague at ucsf, Baxter has de¬ 
veloped GC-i, a new compound that 
is showing great promise in prevent¬ 
ing and treating high cholesterol, 
heart attack and stroke. By working 
on multiple sites in the liver, GC-i 
could prove far more effective in low¬ 
ering cholesterol than the statins that 
most doctors prescribe today. Baxter 
says it also shows promise in reduc¬ 
ing obesity and diabetes, especially 
the highly prevalent type 2 form. 
“This compound is about 1,000 
times more potent than the statins,” 
Baxter says. “It will not replace the 
statins. If it works out, it will probably 
be used in conjunction with the 
statins. It attacks a different part of the 
cholesterol pathway, so they’d work 
phenomenally well together. ” 
If GC-i does fulfill its promise, it 
will crown for Baxter a lifelong quest. 
He was born and raised in Lexington, 
Ky., and did his undergraduate work at 
the University of Kentucky on an ath¬ 
letic scholarship, majoring in chemis¬ 
try and graduating Phi Beta Kappa. 
When he entered Yale in 1962, it was 
quite a shock: “ Even though I had a 
good education at Kentucky, I was not 
prepared for the Ivy League. I had a 
significant adjustment, adapting to the 
Eastern intellectual establishment. I 
40 Alumni faces 
John Baxter has fished all over the world, and in 
his laboratory in San Francisco he explores the 




thought my Kentucky accent was just 
fine, but that was not the prevailing 
view at Yale.” 
Baxter struggled in his first two 
years, but then he found his legs, 
thanks in large measure to Philip K. 
Bondy, m.d., the head of endocrinol¬ 
ogy. “He was a wonderful mentor,” 
Baxter recalls. “By the time I graduated 
in 1966, Dr. Bondy was head of medi¬ 
cine. So I elected to stay on at Yale and 
do an internship and residency in 
internal medicine.” 
Yale left a deep imprint on Baxter. 
“When I look back, the most wonder¬ 
ful thing about Yale was that it was 
patient. I struggled and Yale put up 
with me. And I’ll forever be indebted 
to Yale for that,” Baxter says. “And I 
could not have gotten better training. 
Once I got out and mingled with the 
guys who went to Harvard, Johns 
Hopkins, wherever, we guys who came 
out of Yale were quite competitive.” 
After leaving Yale in 1968, Baxter 
joined the National Institutes of 
Health and began probing the inner 
workings of nuclear receptors. In 
1970 he went west to ucsf, where his 
work on receptors led him into the 
field of human growth hormones. 
After he and his colleagues cloned the 
human growth gene, Baxter teamed 
with Fletterick to show how hor¬ 
mones bind to their thyroid receptor 
proteins. “That has had all kinds of 
implications for helping us design 
things that ultimately become phar¬ 
maceuticals. It has really paid off.” 
In 1979, Baxter was named chief of 
endocrinology at ucsf and director 
o; the ucsf Metabolic Research Unit, 
and continues today to lead a team 
of researchers. 
Baxter was among the first univer¬ 
sity researchers to create biotech startup 
companies. Not everyone approved. “At 
a time when interactions with industry 
were highly controversial in the univer¬ 
sity setting, John started biotech com¬ 
panies, several of which were very 
successful,” says Jan-Ake Gustafsson, 
ph.d., m.d., professor and chair of 
medical nutrition at the Karolinska 
Institute in Stockholm. “Although he 
received scorn from his academic col¬ 
leagues, John kept working in new 
directions and thereby substantially 
contributed to modernizing the think¬ 
ing in academia.” 
Bert W. O’Malley, m.d., professor 
and chair of molecular and cellular 
biology at Baylor College of Medicine 
in Houston, says that even greater 
renown for Baxter may be in the off¬ 
ing. “Although GC-i is not being tested 
on humans yet, it looks very promis¬ 
ing,” O’Malley says. “It could rival or 
exceed the importance of J ohrf s work 
with human growth hormone.” 
In conversation, John Baxter comes 
across as a man fulfilled. For the 
past 40 years he has been married to 
Lee, his Kentucky sweetheart, and 
the couple has two grown daughters. 
Clearly, though, Baxter is a man 
who still dreams of sailing distant seas 
and hooking even bigger fish, and 
right now those dreams are riding on 
the wings of GC-i. “You go to medical 
school to be a doctor and make a 
difference. If this thing could ever 
work and not be bad for some unfore¬ 
seen toxicity, that would be a very 
satisfying thing.” 
—Paul Chutkow 
Turning the tide of aids 
in New Haven, 
in a collaborative style 
When Yale College turned him away 
as an applicant in 1961, it came as a 
shock to Matthew F. Lopes Jr., m.p.h. 
’77. He’d grown up at Yale, living at 
the Elizabethan Club on College Street, 
where his father was the steward. 
Lopes naively assumed that Yale, the 
only school he’d applied to, would 
accept him. 
He applied again to Yale College 
after a stint as an Army cryptographer 
during the Vietnam War. After another 
rejection, he argued his case at the 
admissions office and ultimately was 
accepted. 
Today, Lopes is the coordinator for 
aids services for the New Haven 
Health Department, where he oversees 
a staff of 17 who deliver education, out¬ 
reach and care to New Haven’s hiv- 
positive community. He chose a career in 
public health after his plans to become a 
physician didn’t pan out. Nearing gradu¬ 
ation from the combined m.d./m.p.h. 
program at the medical school in 1977, 
he had written his thesis on Reye syn¬ 
drome, completed his course work 
for his m.p.h. and finished all but two 
semesters of medical school. After sev¬ 
eral attempts and near misses, however, 
he failed to pass his medical boards. He 
graduated from Yale with an m.p.h. 
“The world doesn’t necessarily stop 
because you don’t get everything you 
want,” he said. “I’m living testimony to 
the fact that you can survive not passing 
your boards and still be involved in 
medicine or practice public health.” 
Lopes had chosen the combined pro¬ 
gram because he wanted to practice 
Matt Lopes grew up on the Yale campus and 
received bachelor’s and master’s degrees at the 
university. He still lives in New Haven, where 
he coordinates efforts to control hiv/aids. 
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medicine in an urban environment and 
he felt he would need a public health 
background. As it turned out, public 
health was probably the better choice 
for him, because it gives him the oppor¬ 
tunity to deliver health care to a larger 
segment of the population than he 
could were he in private medicine. “In 
public health we see a lot more people 
and have a better impact in some 
respects,” he said. “A lot of people with 
hiv/aids need primary care and sup¬ 
portive services, and we have the mod¬ 
els to make it work.” 
Lopes came to the city’s health 
department after working as an epi¬ 
demiology consultant at the state health 
department, a hospital administrative 
intern at the state’s Department of 
Mental Health and a minority recruiter 
at the School of Public Health. He 
joined the city’s aids division in 1993, 
about three years after the city initiated 
its groundbreaking needle exchange 
program. Lopes has kept the program 
going, sending a van out five days a 
week to sites around the city where 
people can exchange used syringes for 
new ones and receive support services 
such as drug treatment referrals and 
hiv counseling and testing. With intra¬ 
venous drug users accounting for 48 
percent of New Haven’s aids cases, 
Lopes believes the program is essential 
to fighting the spread of hiv/aids. He 
shuffles resources to fund it, since fed¬ 
eral support is not available. “We try to 
meet people where they are and bring 
them to where we want them to be, 
without being judgmental,” he said. 
When Lopes joined the health 
department at the height of the aids 
epidemic, there were almost 280 new 
cases reported that year in New Haven; 
today there are about 80. But there are 
680 hiv/aids patients and their fami¬ 
lies in New Haven who receive care 
through the New Haven hiv/aids Case 
Management Consortium, and deliver¬ 
ing that care can be complicated. Lopes, 
with the support of community-based 
organizations, has built an infrastruc¬ 
ture with funds from the Ryan White 
care Act, a federal program designed 
to help provide care for hiv/aids 
patients and their families. He coordi¬ 
nates hiv/aids case management for 
the city of New Haven through another 
consortium of five community agencies 
(including the aids Interfaith Network 
and Hill Health Center), and oversees 
the health department’s outreach and 
education efforts, hiv counseling and 
testing, and drug treatment referral. He 
is also the coordinator of the Mayor’s 
Task Force on aids, whose mission is 
to foster community response to the 
hiv epidemic and raise awareness of 
aids at the local, state and federal lev¬ 
els. “We’ve built a huge network of col¬ 
laboration,” he said, referring to the 
myriad agencies and officials involved 
in the fight against aids. 
Although the number of new cases 
of hiv continues to decline, the Cen¬ 
ters for Disease Control and Prevention 
estimates that 25 percent of those 
infected may not know they harbor the 
virus. Lopes sees his mission as finding 
those people and getting them tested 
and into treatment. To do that, he has 
looked at new ways of reaching people 
who are at risk, those who engage in 
intravenous drug use and unprotected 
sex. In an effort to address New Haven’s 
needs, Lopes has introduced flex hours 
so that his staff can start and end their 
day later, when they have a better chance 
of connecting with residents who need 
services; some of the agencies in the 
consortium have extended their hours 
as well. His department’s outreach 
efforts include visiting drug sites, beauty 
parlors and even soccer fields on the 
weekends to help disseminate informa¬ 
tion, as well as running peer education 
groups with teens and going into 
schools to promote harm reduction. In 
addition, Lopes organizes community- 
level interventions, such as World aids 
Day, which took place at Center Church 
on the Green on December 1 last year. 
At 61, Lopes shows no signs of 
slowing down, although retirement 
isn’t far off. He and his wife, Evelyn, an 
artist, plan to retire to either Brazil or 
Costa Rica in about four years. Lopes is 
undaunted at the prospect of picking 
up and starting over in a foreign coun¬ 
try; over the course of his lifetime he 
has learned Spanish, Portuguese, 
French, Japanese and German. “I’m 
nosy and I like languages,” he said, 
“so I could live anywhere.” 
—Jill Max 
Familiar Faces 
Do you have a colleague who is making 
a difference in medicine or public 
health or has followed an unusual path 
since leaving Yale? We’d like to hear 
about alumni of the School of Medicine, 
School of Public Health, Physician 
Associate Program and the medical 
school’s doctoral, fellowship and 
residency programs. Drop us a line at 
ymm@yale.edu or write to Faces, 
Yale Medicine, P.O. Box 7612, New Haven, 
CT 06519-0612. 
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Gordon receives the 
Peter Parker Medal for 
years of service 
MARTIN E. GORDON, M.D. ’46, 
has taken on many roles in his var¬ 
ied career. Of late the semiretired 
gastroenterologist has chaired 
the board of trustees of the Harvey 
Cushing/John Hay Whitney 
Medical Library and has lured such 
prominent speakers as genome 
researcher J. Craig Venter, ph.d., 
and recent Nobelist Peter C. Agre, 
M.D., to the library board’s annual 
lectureships. 
In October, at a ceremony in the 
Medical Historical Library, Cordon 
received the Peter Parker Medal, 
named for the 19th-century Yale 
medical and divinity school alum¬ 
nus who went to China as a medi¬ 
cal missionary. The medal is 
awarded for outstanding contribu¬ 
tions to medicine and the well¬ 
being of the School of Medicine. 
“He has been a supporter of 
many parts of the medical school,” 
said Dean Robert J. Alpern, M.D., 
Ensign Professor of Medicine. 
“Probably his greatest contribution 
has been to this library. I can’t think 
of a more appropriate recipient 
than we have this year. Marty has 
been described as dynamic and 
charismatic and a fixture at the Yale 
School of Medicine, and one that 
we have been thrilled to have. He 
really exemplifies what we look for 
in training doctors to become lead¬ 
ers of medicine.” 
Gordon offered thanks to 
legendary physicians at the school 
of medicine, including Milton C. 
Winternitz, M.D., and Gerald 
Klatskin, m.d. “Their wisdom 
became applied lessons, amplified 
while sharing the angst and joy 
of the life of so many patients,” 
Gordon said, before adding thanks 
to his wife, Evelyn, and his children 
and their spouses. 
“I cannot fully express how the 
Yale School of Medicine has shaped 
my own life,” he said, noting that 
the school and Parker shared the 
same mission—“promoting the 
health and advancing the welfare 
of others.” 
He has produced award¬ 
winning films such as Microscopy: 
Tools of Biomedical Science, as well 
as teaching tools, including the 
Global Disease Guide. He continues 
as a dean of the Academy of Judges 
for the International Health & 
Medical Media Awards Ceremony. 
Dean Robert Alpern congratulated 
Martin Gordon on his receipt of 
the Peter Parker Medal as Gordon’s 
wife, Evelyn, looked on. 
Three med school 
alumni elected to 
Institute of Medicine 
Three alumni of the medical 
school were elected to the 
Institute of Medicine in October. 
They are: 
FRANCINE M. BENES, PH.D. 
’72, M.D. ’78, director of the 
Harvard Brain Tissue Resource 
Center at McLean Hospital in 
Belmont, Mass. The center is the 
largest resource for the collection 
and distribution of postmortem 
brains from people with move¬ 
ment disorders, dementias and 
major psychoses. 
HOWARD K. KOH, M.D. ’77, 
m.p.h., professor of health policy 
and management, Harvard School 
of Public Health, and former 
commissioner of public health for 
Massachusetts. Koh’s areas of 
interest include early detection 
and prevention of skin cancer, 
policy aspects of tobacco control 
and cancer disparities in racial 
and ethnic minorities. 
JAMES S. MARKS, M.P.H. ’80, 
director of the National Center for 
Chronic Disease Prevention and 
Health Promotion, Centers for 
Disease Control and Prevention. 
Marks develops ways to reduce 
or prevent the consequences of 
tobacco use, obesity and diseases 
such as cancer, heart disease and 
diabetes. 
NOTES 43 
William Hindle Frederick Greene 
195QS 
William H. Hindle, M.D. ’56, 
was honored in July by the 
Department of Obstetrics and 
Gynecology at the University of 
Southern California Keck School 
of Medicine with the naming of 
The William H. Hindle, M.D., 
Breast Diagnostic Center in 
Women’s and Children’s 
Hospital at the use Medical 
Center-Los Angeles. Hindle 
founded the clinic and served as 
director for 12 years before 
becoming an emeritus professor 
in 2000. 
196OS 
Steven Jonas, M.D., M.P.H. ’67, 
ms, has been named a fellow 
of the New York Academy of 
Sciences. Jonas, a professor of 
preventive medicine at the 
School of Medicine at Stony 
Brook University, has focused on 
preventive medicine, public 
health and health care delivery 
systems analysis and has 
authored, co-authored, edited 
and co-edited more than 20 
books and published more than 
135 papers in scientific journals. 
1970S 
Frederick L. Greene, M.D., HS ’76, a 
surgical oncologist and chair of 
surgery at Carolinas Medical 
Center in Charlotte, N.C., was 
named chair of the Commission 
on Cancer of the American 
College of Surgeons (acs) for 
2004 to 2006 at the annual 
Clinical Congress of the acs 
meeting in October in New 
Orleans. Greene has served for 
the last four years as the chair 
of the American Joint Commit¬ 
tee on Cancer. 
Najaf Ahmad and Fraz Ahmed Ismat Peter Krause Alan Silken 
Peter J. Krause, M.D., HS ’73, 
director of infectious disease at 
Connecticut Children’s Medical 
Center, is one of three authors 
of a chapter on institutional 
responses to Lyme disease and 
companion infections in North 
America in Emerging Illnesses 
and Society: Negotiating the 
Public Health Agenda, published 
last year. 
Judith Rodin, PH.D., M.A.H. '79, 
former president of the Univer¬ 
sity of Pennsylvania and the first 
woman to lead an Ivy League 
institution, has been named 
president of the Rockefeller 
Foundation. She is the first fe¬ 
male president of the founda¬ 
tion, which does community 
development work on a global 
scale. Rodin was on the faculty 
at Yale for 22 years and served 
as dean of the graduate school 
and as provost. 
Alan B. Silken, M.D. ’74, HS ’78, 
assistant clinical professor of 
pediatrics at Tufts University 
School of Medicine and director 
of pediatric neurology at Newton- 
Wellesley Hospital in Newton, 
Mass., is the author of “Long- 
Term Management of Seizure 
Disorders,” a chapter in Pediatrics, 
a textbook published last fail by 
Elsevier Mosby. One of the text¬ 
book editors is also a Yale alum¬ 
nus, Thomas G. DeWitt, M.D., HS 
’80, the Carl Weihl Professor and 
director of the Division of General 
and Community Pediatrics and 
associate chair of education in 
the Department of Pediatrics, 
University of Cincinnati College 
of Medicine. 
1980s 
Guy L. Fish, M.D. ’85, M.P.P.M. '94, 
of Cambridge, Mass., a senior 
consultant and director of 
Fletcher Spaght, has been 
elected to the Board of Over¬ 
seers of Beth Israel Deaconess 
Medical Center. Fish specializes 
in health care policy, biotechnol¬ 
ogy and finance issues. Before 
joining Fletcher Spaght, he 
served as the vice president of 
business and international 
development at Collagenesis. 
199OS 
Jason R. Klenoff, M.D. ’98, HS '03, 
an otolaryngologist at the 
Ear, Nose, and Throat Center in 
Stamford, Conn., and Serena 
Mayeri, j.d. ’01, a Samuel I. 
Golieb fellow in legal history at 
the New York University School 
of Law, were married on July 
27 in New York City. Klenoff 
is also a clinical instructor at 
the Yale School of Medicine 
and an attending physician 
at Stamford Hospital. 
2000S 
Najaf Ahmad, M.P.H. ’02, a 
researcher and analyst for the 
Robert Wood Johnson Founda¬ 
tion, and Fraz Ahmed Ismat, 
m.d., were married on June 20 in 
Princeton, N.J. Ismat is a post¬ 
doctoral fellow in cardiology 
and attending cardiologist at 
Children’s Hospital of Philadel¬ 
phia, and an instructor in 
pediatrics at the University of 
Pennsylvania School of Medicine. 
Megan C. Leaderer, M.P.H. '02, 
a manager of outcomes research 
at Pfizer with a focus on Alz¬ 
heimer’s disease and schizophre¬ 
nia, and Cisco Del Valle, m.a., a 
Joyce Oen-Hsiao 
founding member of Springbok 
Capital Management, were mar¬ 
ried on August 21 in Battell Chapel. 
The couple lives in New York City. 
Joyce Oen-Hsiao, M.D. ’02, and 
her husband, Allen Hsiao, a 
pediatric emergency medicine 
physician, welcomed the birth 
of their first child, Timothy, on 
May 24. They live in Hamden, 
Conn., and she is a resident at 
the Hospital of Saint Raphael in 
New Haven. She writes that they 
would love to hear from friends 
(joyce.oen-hsiao@aya.yale.edu). 
Ingrid E. Paulson, M.P.H. ’04, and 
Alexander J. Pugh, a student at 
Columbia Law School in New 
York, were married in Pentwater, 
Mich., on July 24. They met while 
working in San Francisco and 
plan to live there after Pugh’s 
graduation. 
A 15-minute educational video 
produced by llene Wong, m.d. 
’04, is being used in multiple 
sites in South Africa to promote 
adherence to antiretroviral 
therapy. The video, which Wong 
produced while she was a medi¬ 
cal student, emphasizes basic 
drug-taking concepts and advice 
on improving adherence. It has 
been translated into Zulu, and 
may also be used in Botswana 
and Namibia. It is available 
online through the Yale Medi¬ 
cine Thesis Digital Library 
(http://ymtdl.med.yale.edu/). 
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Good doctors and 
great doctors 
Dean Robert Alpern urges the Class 
of 2008 to practice medicine with 
humility, empathy and compassion. 
Stitched through the threads of the 
physician’s white coat are emblems of 
both power and responsibility, Robert 
J. Alpern, m.d., dean of the medical 
school, told the Class of 2008 in late 
August, as the new students gathered 
for the ceremony that marks the begin¬ 
ning of their medical education. 
Each of the 100 first-year students— 
who come from 14 countries, 44 
undergraduate institutions and previ¬ 
ous endeavors in public health, scien¬ 
tific research, the performing arts and 
investment banking—can be proud 
to have won admission to a highly 
competitive medical school, Alpern 
said. But he urged them to temper 
that pride with a sense of duty. “Each 
slot in a medical school is a precious 
resource to this country,” he said, 
advising students to use that resource 
wisely and to assume primary respon¬ 
sibility for their education under the 
Yale System. “We’re so confident that 
[you will] that we’re not going to give 
you grades for a few years.” 
He encouraged his listeners to pur¬ 
sue paths to leadership positions in 
public policy, service, medical educa¬ 
tion and research and to use their time 
at Yale to “find out what separates a 
good doctor from a great doctor.” 
While urging the first-years on to 
high achievement, his primary mes¬ 
sage was one of humility, empathy and 
compassion for patients. “You control 
something that is the most impor¬ 
tant possession of people, and that is 
their health,” the dean said. The most 
important question physicians will ask 
themselves is: “How would I feel if I 
were in the position of my patients?” 
The answer, Alpern said, should deter¬ 
mine how a doctor runs a practice, 
including how long patients are kept 
waiting, when their phone calls are 
returned and what sort of respect they 
receive from their doctor. 
"All people deserve your respect. ... 
Perhaps no one needs it more than a 
patient who is struggling to cope with 
an illness,” Alpern said. He cautioned 
against the desensitizing aspects of 
a physician’s daily routine and urged 
students to remember that sickness 
“is not a daily event for your patients.” 
Following the dean’s remarks, 
students walked on stage one by one 
to be clothed in their white coats 
by senior faculty. The day was, as the 
dean said, a celebration of their 
“talent and hard work.” 
But along with high praise, he 
sent the new class out with a gentle 
reminder: “As others look up to you, 
never look down on them.” 
—Colleen Shaddox 
far left Geordie Glass and Julie Guentner 
listened to the Commencement address 
by former Surgeon General Antonia Novello. 
left Before the ceremony began Bernadette 
Shaw got a hug from a well-wisher as Rebecca 
Schuman looked on. 
Former surgeon genera! 
urges PA graduates to “look 
for a calling” 
Antonia C. Novello, m.d., m.p.h., 
dr.ph., the first woman and first His¬ 
panic to become surgeon general, 
offered congratulations and counsel¬ 
ing and posed challenges to the 34 
graduates of the Physician Associate 
Program at their Commencement 
in September. 
“It has been said by the sociologist 
Robert Bellah that your work as a 
professional defines you as a human 
being,” said Novello, now the health 
commissioner for New York state. 
“First there is a job, where the goal is 
simply earning a living and supporting 
your family. Then there is a career, 
where you trace your progress through 
appointments and achievements. 
Then there is a calling, the ideal blend¬ 
ing of activity and character that 
makes work inseparable from life. 
I hope you are not just looking for 
a job. I hope you are not just building 
a career. I hope you are looking for 
a calling.” 
The first of the challenges facing 
the new graduates, said Novello, is an 
increasingly diverse society, one that is 
aging, comes from all over the world 
and speaks a multitude of languages. 
Health care providers, she said, must 
understand all aspects of their patients’ 
lives. “Patients don’t care how much 
you know until they know how much 
you care.” 
Access to health care was the sec¬ 
ond challenge she cited, pointing out 
that 45 million people in this country 
lack health insurance. “Don’t treat poor 
people as second-class citizens just 
because they may not have the same 
economic or educational advantages 
that you enjoy.” Again citing the diver¬ 
sity of the patient population and the 
14 million Americans who lack profi¬ 
ciency in English, she said, “Medical 
AUCTION RAISES MORE THAN $26,000 
Among the first fund-raising events of the 12th annual Hunger and 
Homelessness Auction in November was a flag football game pit¬ 
ting first-years against second-years. The game, played on a soggy 
Harkness Lawn under a light rain with temperatures in the 40s, 
featured faculty “ringers” on the second-year team—Dean Robert 
Alpern, Associate Professor Jack Hughes and Registrar Terri Toison. 
At half-time, with the second-years leading 12-6, Alpern couldn’t help 
teasing the opposing side. “I’m a little disappointed in the admis¬ 
sions committee,” he joked. An anonymous first-year offered a 
rejoinder: “You better not come back on the field!” The second-year 
team won the game 28-12.The activities, including silent and live 
auctions, raised more than $26,000 for several New Haven charities. 
—.J.C 
training has to address the biases that 
we bring to medical school.” 
Domestic violence is another chal¬ 
lenge. “Health care professionals will 
fail 95 percent of the time to identify 
victims of domestic violence,” she said. 
The final, and most important, 
challenge, she said, is professionalism. 
“Can we health care professionals 
maintain the traditional humanistic 
qualities of medicine in an increas¬ 
ingly corporate structure?” she asked. 
“I think we can. To do that, take care 
of people. Become a voice for the dis¬ 
enfranchised. Use your voice. Have the 





















46 students notes 
Kyeen Mesesan 
Kyeen Mesesan, an M.D./ph.D. 
student in the Division of Epi¬ 
demiology of Microbial Diseases 
at the School of Public Health, 
received the Lee B. Lusted 
Student Prize for best student 
presentation at the 26th annual 
meeting of the Society for 
Medical Decision Making in 
Atlanta in October. Her abstract, 
"Predicting the Impact of a 
Partially Effective hiv Vaccine 
and Subsequent Risk Behavior 
Change on the hiv Epidemic 
in Developing Countries: A South 
African Example,” was one of 
six delivered at the opening ple¬ 
nary session. 
Angela Snyder Ranjit Bindra Lisa Cary Nicole Ouon 
Three ph.d. candidates in the 
Division of Health Policy 
Administration at the School of 
Public Health have received 
grants to support their research. 
Lisa Cary has received a grant 
from the Nonprofit Sector 
Research Fund of the Aspen 
Institute to support her research 
on racial disparities in health 
care and the role of the non¬ 
profit sector in promoting more 
equitable health care. Nicole C. 
Ouon has received awards from 
the National Science Foundation 
and the Horowitz Foundation 
for Social Policy to support her 
research into decision making at 
the National Institutes of Health 
and the Food and Drug Adminis¬ 
tration. Angela B. Snyder has 
received a dissertation grant 
from the Department of Health 
and Human Services Substance 
Abuse and Mental Health Services 
Administration to pursue her 
research. Her thesis is titled 
The Effect of Substance Abuse 
Treatment on Wages. 
Ranjit Bindra, a student in his 
fifth year of the m.d./ph.d. 
Program, has received the Marie 
Curie Award from the Radiation 
Research Society.The award rec¬ 
ognizes the scholar-in-training 
who shows the highest potential 
for a successful career in radia¬ 
tion and hyperthermia research. 
The award-winner receives $1,500 
to attend the annual meeting 
and present research findings. 
DOWNS FELLOWS SHARE A WORLD OF KNOWLEDGE 
Last summer, 17 students in medicine, nursing and public health 
traveled to Africa, Asia, the Middle East, the Caribbean and Latin 
America on research projects supported by the Downs Interna¬ 
tional Health Student Travel Fellowship. In October they reported 
on their findings on topics including diabetes risk in Haiti and 
post-traumatic stress disorder among victims of chemical attacks 
in Iran. Three students made oral presentations. Medical student 
Jessica Beard described the mental health of children in a refugee 
camp in northwestern Kenya. Anna M. Beitin, a student in public 
health, reported on the genetic susceptibility of children in 
Zambia to malaria. And nursing student Catherine E. Virostko, on 
right in photo, discussed the beliefs and practices of traditional 
birth attendants in Kenya regarding hiv/aids. 
—John Curtis 
in Memoriam 47 
Henry Bicker Bruyn, M.D. ’43, 
died on August 7 at his home in 
Kentfield, Calif., at the age 
of 86. During World War II, Bruyn 
served as a lieutenant com¬ 
mander in the U.S. Naval Reserve 
medical corps. Bruyn, a pediatri¬ 
cian, was the director of student 
health services at the University 
of California, Berkeley, from 1959 
to 1972, and was also a clinical 
professor of medicine and 
pediatrics at the University of 
California, San Francisco, 
School of Medicine. 
Daniel W. Elliott, M.D. ’49, of 
Dayton, Ohio, died at home on 
August 1 at the age of 81. Elliott 
was a medical corpsman during 
World War II and a captain in 
the U.S. Air Force Reserve during 
the Korean War. After his surgi¬ 
cal residency at Ohio State 
University in 1957, Elliott joined 
the faculty there as an assistant 
professor and became a full pro¬ 
fessor in 1963. He later became 
a professor of surgery at the 
University of Pittsburgh. In 1976 
he helped found the medical 
school at Wright State University 
in Dayton, where he was chair 
of surgery. 
Lawrence Z. Freedman, M.D., HS 
’48, died from a stroke on Octo¬ 
ber 6 at his home in Chicago. He 
was 85. Freedman, a pioneer in 
forensic psychiatry who explored 
the causes of assassinations, 
terrorism and mass murder, held 
joint appointments in the 
Department of Psychiatry and 
the Law School between 1949 
and 1960 at Yale, where he co¬ 
founded and chaired Yale’s study 
unit In psychiatry and law. In the 
1960s he served on the National 
Commission on the Causes and 
Prevention of Violence. 
Robert C. Lange, PH.D., associate 
clinical professor of diagnostic 
radiology, died on October 6 
in New Haven at the age of 69. 
Lange, an advocate for the pro¬ 
tection of human subjects in 
research studies, was a pioneer 
in mri technology. After receiv¬ 
ing his doctorate from mit in 
1962 and working at the Mon¬ 
santo Research Corp., he came to 
Yale in 1969. Until his retirement 
in 2000 he held a variety of 
posts, including technical direc¬ 
tor for the Section of Nuclear 
Medicine in the Department of 
Diagnostic Radiology and mri 
physicist and clinical technical 
director for the Magnetic 
Resonance Imaging Research 
Center. He also chaired the 
Radiation Safety Committee and 
the Radioactive Drug Research 
Committee for Yale-New Haven 
Hospital. After his retirement he 
worked part time, as chair of 
one of the medical school’s two 
Human Investigation Committees. 
William Lee, M.D. ’41, of Bath, 
Maine, died on July 19 at the 
age of 89. During World War II, 
Lee was a Navy doctor in the 
South Pacific, where he earned a 
battle star and unit citation. Lee, 
who spent 20 years in occupa¬ 
tional medicine, was instrumen¬ 
tal in founding the Constructive 
Workshops, a sheltered work¬ 
place for people with disabilities. 
For 14years he directed the 
employees’ health clinic at 
Hartford Hospital. 
Darius G. Ornston Jr., M.D., HS ’63, 
of Greenville, S.C., died on 
November 19, 2003, at the age 
of 69. Ornston came to Yale as 
a psychiatry resident in i960 
and by 1982 had become an 
associate clinical professor of 
psychiatry. In 1986 he moved 
to South Carolina, where he 
researched and translated the 
works of Sigmund Freud. He also 
authored a book, Translating 
Freud. Ornston was a longtime 
member of the Associates of 
the Harvey Cushing/John Hay 
Whitney Medical Library at Yale. 
Alex Poljak, m.d., fw ’96, m.p.h. 
’03, of Branford, Conn., died on 
July 3, at the age of 41, while 
biking with his wife and son on 
Block Island, R.l. Poljak was 
director of occupational medi¬ 
cine at Greenwich Hospital and 
a clinical instructor of internal 
medicine (occupational) at the 
School of Medicine. He also 
founded and served as chair and 
chief medical officer at MedLinx 
Interactive, a medical software 
company in New York City, and 
established two companies, 
Integrated Medical Systems and 
Occupational Health Solutions. 
Jeffrey S. Schechner, M.D. ’91, 
of Guilford, Conn., died on 
September 7 at the age of 39. 
Schechner, an associate profes¬ 
sor of dermatology at the School 
of Medicine and director of the 
Dermatology Service at the VA 
Connecticut Healthcare System 
in West Haven, focused on vas¬ 
cular biology tissue engineering, 
and conducted research on 
blood vessels in the skin and 
human skin grafting. 
Charles D. Spangler, PH.D. '42, died 
on July 5 at Holy Cross Hospital 
in Silver Spring, Md., of pneumo¬ 
nia after a stroke. As a commis¬ 
sioned officer for the U.S. Public 
Health Service, Spangler traveled 
the world designing water sup¬ 
ply and sanitation systems until 
his retirement in 1968. He then 
worked as a project manager for 
the World Bank in the Far East 
and retired a second time in 
1980. Spangler invented a sim¬ 
ple, easy-to-repair hand water 
pump, and to keep it affordable, 
he refused to patent it. Spangler 
also taught environmental 
health through the Centers for 
Disease Control and Prevention. 
Parker J. Staples II, M.D. ’66, died 
at the age of 64 on September 
23 at his home in Barrington, R.l. 
Staples had a private practice 
in allergy and immunology and 
was the medical director for 
Medicare Services in Rhode 
Island. He also did research for 
the National Institutes of 
Health and taught at the medi¬ 
cal schools at the University of 
Rochester and Brown University. 
SEND OBITUARY NOTICES TO 
Claire M. Bessinger. Yale Medicine, 
P.O. Box 7612, New Haven, 
CT 06519-0612, or via e-mail 
to daire.bessinger@yale.edu 
Follow-Up Archives 50 and 25 
Compleat Pediatricians disbanded 
After 48 years, The Compleat Pediatricians have taken in their 
shingle. The discussion group, formed in 1957 [“A Running 
Conversation About Children,” Spring 1999] to give young doc¬ 
tors insight into the psychological and social factors affecting 
their patients, has called it a day. 
The group was dealt a blow when founding member 
Albert J. Solnit, m.d., hs ’52, of the Child Study Center, died in a 
car accident in 2002. Solnit had remained a guiding force while 
John E. Schowalter, m.d., hs ’61, served as the group’s consult¬ 
ing psychiatrist. Schowalter’s retirement from the faculty 
last year precipitated the group’s official end, but he said that 
the timing felt "natural” for other reasons. Most members 
had retired from practice, and for those who continue to see 
patients, years of case reviews and frank discussion had done 
their job. "I finally feel competent to help families with behav¬ 
ioral issues," Richard L. Shelling, m.d., hs ’59, said with a smile. 
When the group started meeting in the 1950s, Shelling 
and his contemporaries knew how to fight childhood infec¬ 
tious diseases that were all but eradicated by immunizations 
but had not learned to give “anticipatory guidance,” advice 
about child development and matters as profound as death of 
a sibling and as commonplace as sleep disturbances. Weekly 
discussions led to a psychoanalytic understanding of the prob¬ 
lems, and input from psychiatrists helped them help families 
resolve their issues. 
While the original group has disbanded, physicians 
locally and nationally have embraced its ideas and its model. 
Around the country the Maternal and Child Health 
Bureau of the Department of Health and Human Services 
funds "collaborative office rounds” on The Compleat Pediatri¬ 
cians model—discussions involving pediatricians, psychiatrists, 
psychologists and social workers—at 12 academic medical 
centers. And another group of pediatricians continues to meet 
at Yale. 
For Shelling, teaching students in the office takes the 
place of the group’s meetings. "I want them to learn some¬ 
thing about well child care and anticipatory guidance, which 
can help parents understand normal behavior and hopefully 
help prevent misunderstandings between parents and their 
children,” he said. 
—Colleen Shaddox 





The Codex Paneth 
“One of the world’s most famous 
medical manuscripts, the six hun¬ 
dred year old Codex Paneth, has 
been acquired by the Yale Medical 
Library. This rare, early medieval 
manuscript on velum measuring 
23.5 by 33.7 cm., contains 1,378 
pages. The numerous beautifully 
colored miniature initials illustrat¬ 
ing medical scenes, the many 
representations of surgical instru¬ 
ments, and the rubrication in 
blue and red are by two different 
and unnamed artists, one a 
North Italian, the other probably 
a Bohemian artist of the early 
XIV century school. These illumi¬ 
nations give an insight to the 
medical and surgical procedures 
of the period. Many of the 
scalpels, saws, forceps and other 
instruments shown are amazingly 
modern in appearance and in 
some cases closely resemble surgi¬ 





Minority High School 
Students Learn First Hand About 
Biomedical Research 
“Nine students from New Haven 
area high schools participated this 
summer in a Minority High School 
Biomedical Research Program at 
the School of Medicine. They were 
among 200 minority students 
enrolled in a nationwide program 
sponsored by the Department 
of Health and Human Services, 
National Institutes of Health, 
which provides an opportunity to 
learn about biomedical research ... 
as apprentices in universities, 
health professional schools, hospi¬ 
tals and other research centers. 
“The nine New Haven area 
students, who were selected from 
50 applicants, worked as research 
apprentices to faculty in the 
Departments of Pharmacology, 
Diagnostic Radiology, Internal 
Medicine, Neurology, Human 
Genetics, Epidemiology and Public 
Health, and in the Child Study 
Center. Yvedt Matory, a fourth-year 
medical student, was coordinator 
of the program at Yale. At the end 
of the summer, Ms. Matory and the 
students submitted written reports 
summarizing their experiences in 
the program to the nih. ... 
“This was the first year for the 
nih Program, which funded 200 
students at a cost of $400,000. 
Forty-five institutions in 21 states 
participated.” 
Stay connected 
Yale Medicine can help you stay connected with fellow alumni 
of the School of Medicine, School of Public Health, Physician 
Associate Program and the medical school’s doctoral, fellowship 
and residency training programs. Share your personal and pro¬ 
fessional news for publication in the Alumni Notes department 
of Yale Medicine and on the Web, using this card or the online 
form at info.med.yale.edu/ayam. 
□ _ 
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YALE TEAM PROVIDES TSUNAMI RELIEF 
Within five days of the December 26 tsunami that devastated 
coastal areas in South Asia, six doctors and a public health worker 
from the New Haven area were on their way to Sri Lanka. Led by 
Ramin Ahmadi, m.d., m.p.h. ’97, an assistant clinical professor of 
medicine and founder of the Griffin Center for Health and Human 
Rights at Griffin Hospital in Derby, Conn., the team included 
Joanne Cossitt, director of the Griffin Center for Health and Human 
Rights; Padmini D. Ranasinghe, m.d., a resident at Griffin Hospital, 
and Anu Walaliyadda, m.d., a physician at the Hospital of Saint 
Raphael in New Haven, both from Sri Lanka; Monique A.Tello, m.d., 
a pediatrics fellow at Yale; Sherwin B. Nuland, m.d. ’55, hs ’61, 
clinical professor of surgery; and Majid Sadigh, m.d., associate clinical 
professor of medicine. 
Nuland compared the disaster response to that of 9/11, 
when emergency rooms geared up for patients who never came. 
Most people, he said, were killed outright by the tsunami, and 
those with major injuries were already hospitalized by the time 
the team arrived. “The surgical patients I saw had been digging in 
the debris, looking for bodies,” he said. Nuland debrided wounds 
and applied antiobiotic ointments and dressings. His colleagues 
treated hundreds of patients with respiratory infections, diarrhea, 
dysentery, malaria and other diseases. 
A major concern for survivors is post-traumatic stress disor¬ 
der (ptsd). On their return on January 15, Ahmadi and Nuland began 
efforts to send mental health professionals to Sri Lanka to train 
local health care workers in the treatment of ptsd. Rather than 
medical care, Nuland said, “it is psychiatric care that is needed.” 
Monique Telio, a pediatrics fellow at Yale- 
New Haven Hospital, examines a young 
Sri Lankan girl at a church in Valachennai, 
Sri Lanka, on January 4. 
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Books & Ideas 
Capsule 
The silent scourge of development” 
More than two decades ago Yale public health experts warned 
that dams along the Senegal River would bring disease. 
A Yale medical student’s research finds their predictions have 
come true. A letter from Senegal. 
By Kohar Jones, M.D. ’05 
ON THE COVER 
The Rev. Audrey Tinsley is the 
pastor of the Pentecostal Assembn 
Church of Deliverance in New ! 
Haven, a community health adl|bjl 
and a diabetic. All these aspec^H 
of her life come together in d|ie of 
the projects of the Yale-Griffin 
Prevention Research Center, which 
is worj^pg to reduce diabetes 
among African-Americans. 
Promoting health, from the ground up 
Part of a national effort to create commuhity health partnerships, 
a Yale center is working with New Haven churches to prevent 
diabetes and with suburban school nurses to stop teen smoking 
The goal? Healthier communities invested in their own outcomes. 
By Jennifer Kaylin 
BACKGROUND 
Low-fat cooking is key to preventing 
and managing diabetes, one of 
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Lessons from the depths 
From color-tagged proteins 
to transparent eggs and oversized 
neurons, our water-dwelling 
providing new tools 
HOW TO REACH US 
Yale Medicine welcomes news and 
commentary. Please send letters 
to the editor (250 words or less) 
and news items to Yale Medicine, 
P.O. Box 7612. New Haven, 
CT 06519-0612, or via electronic 
mail to ymm@yale.edu, and 
include a daytime telephone num¬ 
ber. Submissions may be edited 
for length, style and content. 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
Have an opinion? 




make fewer mistakes 
“Recreating the Residency" by 
Peter Farley [Fall/Winter 2004] 
contains a large amount of 
palaver garnered from second¬ 
ary sources. The grand jury 
found insufficient evidence to 
return an indictment of mur¬ 
der against the attending physi¬ 
cian. Instead they indicted 
the system of graduate medi¬ 
cal education. 
Ms. Zion did not die from 
an overdose of cocaine. She died 
from hyperpyrexia—her last 
recorded temperature was 108 
degrees. 
The Accreditation Council for 
Graduate Medical Education 
rules governing residents’work 
hours are based on New York 
state regulations enacted in 
1989. Yale will find, as have many 
programs in New York state, that 
eliminating sleep deprivation 
and chronic fatigue will improve 
the physical and mental health 
of young doctors and reduce 
medical errors in patient care. 
Bertrand M. Bell, m.d., 
Distinguished University Professor, 
Professor of Medicine, Albert 
Einstein College of Medicine of 
Yeshiva University 
The writer was chair of the com¬ 
mission now known as the 
Bell Commission, formed by New 
York state health commissioner 
David Axelrod, m.d., after Libby 
Zion’s death to investigate issues 
surrounding patient care and 
the training of physicians in New 
York hospitals. 
The cause of Libby Zion’s death 
remains a subject of debate, and 
indeed, no consensus emerged 
among investigating agencies as 
to what went wrong. A jury in a 
civil trial split the blame for her 
death between Cornell Medical 
Center's New York HospitaI and 
Zion herself. An autopsy found 
traces of cocaine in her nasal 
passages, but subsequent tests 
turned out negative. A grand jury 
blamed the death on inadequate 
care and numerous mistakes, 
including a mishandled diagno¬ 
sis, made by unsupervised 
interns and residents.—Eds. 
Zaccagnino to retire 
as CEO of YNHH 
As this issue of Yale Medicine 
was being prepared, Joseph A. 
Zaccagnino, m.p.h. ’70, president 
and CEO of Yale-New Haven 
Hospital (ynhh) and the Yale 
New Haven Health System 
since 1991, announced his retire¬ 
ment after 35 years at the 
hospital. He will retire effective 
September 30. 
“My decision to retire was 
not an easy one, but it was 
made with the recognition that 
as time passes, the opportuni¬ 
ties for new experiences and 
challenges as well as the flexi¬ 
bility to spend more time 
with family cannot be deferred 
indefinitely,” Zaccagnino said 
in a statement at the end of 
May. “I plan to continue to 
actively serve in the health 
care sector as an advisor to 
senior management and gov¬ 
erning boards, by lecturing at 
the graduate level more fre¬ 
quently than has been possible 
recently and by serving on 
additional corporate boards.” 
Zaccagnino began working 
at the hospital in 1970 under the 
mentorship of John D. Thompson, 
r.n., m.s., professor and direc¬ 
tor of the Program in Hospital 
Administration at the School of 
Public Health. By 1978, when he 
was 32, Zaccagnino had become 
executive vice president and 
chief operating officer of ynhh. 
Over the next 27 years, 
under Zaccagnino’s leadership, 
the medical school’s primary 
teaching hospital grew into a 
health care system that oper¬ 
ates three hospitals in Connecti¬ 
cut, has annual revenues of $1.5 
billion, has 1,500 acute care beds 
and serves one out of every five 
hospitalized patients in the state. 
At ynhh Zaccagnino also over¬ 
saw construction of the Children’s 
Hospital and the renovation of 
adult patient care areas. 
A search committee repre¬ 
senting both the hospital and 
the health system is already 
at work seeking a successor, and 
a new ceo is expected to be 
named this summer. 
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From the Editor 3 
Small answers to big questions 
They say an ounce of prevention is worth a pound of cure, 
but changing unhealthy behaviors is not always a simple 
matter—as anyone who has tried to stop smoking or lose 
weight can tell you. It’s that much more complicated when 
the goal is encouraging healthy choices for an entire com¬ 
munity. The public health work of the Yale-Griffin Preven¬ 
tion Research Center, described by Jennifer Kaylin in this 
issue’s cover story (“Promoting Health, From the Ground 
Up,” page 24), is even more ambitious in that its goal is to 
help not just one community but a half-dozen New Haven- 
area towns. When you consider that Yale-Griffin is one of 
28 such centers across the United States, you get a true idea 
of the scale and scope of the undertaking. 
Nonetheless, the guiding principles of the projects are 
that the solutions to some national public health challenges 
are local, rather than global or grandiose, and that people will 
solve their own problems when aided by solid information 
derived from careful research. The community-academic part¬ 
nership has already produced results: close to half the subur¬ 
ban high school students enrolled in the center’s smoking 
cessation program quit cigarettes, and in New Haven a dozen 
churches have educated their parishioners about diabetes 
prevention through a partnership with Yale-Griffin. 
The other feature article this summer (“The Silent 
Scourge of Development,” page 18) looks at a public health 
crisis in Africa that evolved predictably but without restraint 
over several decades and has affected hundreds of thousands 
of people. Here, too, the prevention of disease—in this case 
schistosomiasis spread by freshwater snails in the Senegal 
River—was a key goal championed by Yale researchers hired 
in the 1970s to evaluate the public health impact of dam 
construction. Unfortunately, their recommendations were 
ignored. Kohar Jones, m.d. ’05, who wrote her medical 
school thesis on this topic after several trips to Senegal, does 
a skillful job of describing the economic and cultural back¬ 
drop to the crisis and telling a story that connects several 
generations of Yale scholars. 
On a sad note, we received the news that the former 
managing editor of Yale Medicine, Marjorie B. Noyes, died on 
May 7. A 1953 graduate of tire School of Art and Architecture, 
Noyes kept the magazine on the mark and on schedule from 
1971 to 1986, according to former Editor and Deputy Dean 
Arthur Ebbert Jr., m.d., now a professor emeritus of medicine. 
“She was a very careful, very meticulous editor,” says Ebbert. 
“We would discuss what we wanted to put in each issue, and 
then she made sure it all got done.” Noyes’ history of New 
Haven industry, co-edited with Preston Maynard, was pub¬ 
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4 chronicle news from cedar 
Yale trauma training 
preps Navy corpsmen 
In two-day workshops at Yale the 
Navy’s independent duty corpsmen 
learn the basics of trauma care. 
When the Navy submarine uss San 
Francisco struck an uncharted, under¬ 
sea mountain in early January, respon¬ 
sibility for the dozens of injured 
sailors fell to James H. Akin, the ves¬ 
sel’s medical corpsman. For 22 hours, 
Akin triaged the wounded—whose 
injuries ranged from bruises and 
pulled muscles to a fatal blow to the 
head—and put sailors and officers 
to work cleaning and irrigating lacera¬ 
tions until he could suture them. 
As he stitched up the wounded, 
Akin’s main concern was machinist’s 
mate Joseph A. Ashley, who had 
struck his head during the impact. 
Akin immobilized Ashley, checked 
his airway, breathing and circulation, 
and inserted an IV. He showed other 
During their yearlong medical training, 
the Navy’s independent duty corpsmen 
spend two days at Yale, where they learn 
the basics of trauma care. Among the 
Yale faculty teaching the corpsmen was 
trauma surgeon Lewis Kaplan. 
STREET 
sailors how to monitor Ashley’s airway 
while he tended to other patients. As 
rescue vessels approached the stricken 
submarine, Navy doctors on ships and 
bases around the Pacific advised the 
medical corpsman by radio. But when 
the rescuers arrived, heavy seas made 
evacuations impossible. Ashley ulti¬ 
mately died of his injuries. 
In March, Akin received a Meritori¬ 
ous Service Medal for his performance 
during the crisis. And he credited 
his ability to handle the medical emer¬ 
gency to the trauma training he 
received at Yale, under the direction 
of Reuven Rabinovici, m.d., professor 
of surgery and chief of the Section 
of Trauma, Surgical Critical Care and 
Surgical Emergencies. 
For the past several years, Rabinovici 
has directed a course in the basics of 
trauma treatment for the Navy’s inde¬ 
pendent duty corpsmen, or idcs, given 
by trauma surgeons at Yale. It’s part of 
the 56 weeks of training the corpsmen 
receive before they’re assigned to sub¬ 
marine duty and the care of crews of 
between 130 and 170 men. 
“Their scope of practice is very 
narrow—primary care medicine for 
adult males, 20 to 45 years old,” 
said Lt. Donald Harris, pa-c, clinical 
program manager at the Naval Opera¬ 
tional Medicine Institute Detach¬ 
ment. The detachment is stationed 50 
miles east of New Haven at the Naval 
Undersea Medical Institute (numi) 
at the Naval submarine base in Groton, 
Conn. (In May the base appeared on 
a Pentagon list of military facilities to 
be considered for closing.) 
In addition to medical duties, the 
1 dc monitors shipmates for exposure 
to radiation, practices preventive 
medicine and is responsible for envi¬ 
ronmental and occupational health. 
Corpsmen are also responsible for 
the mental health of the crew, not an 
unlikely concern in a cramped, self- 
contained environment that recycles 
its own air, converts sea water into 
drinking water and can stay under¬ 
water for as long as food supplies 
last—up to 65 days. 
“They’re the doctor, nurse, chaplain 
and psychologist,” said Capt. Paul C. 
Kelleher, m.d., director of education at 
numi. Their emergency medical sup¬ 
plies and equipment, Kelleher said, 
roughly correspond to what is available 













training at Yale covers different kinds 
of trauma, including blunt injuries 
as well as gunshot and stab wounds. 
One classroom scenario involves a 
wounded Navy seal coming on board 
for emergency treatment. 
The sessions at Yale began three 
years ago when numi sought to 
enhance trauma training. Yale’s in- 
house program that teaches resi¬ 
dents advanced trauma life support 
was adapted for idcs. “This program 
is less than what the doctor needs, 
but it’s what the idcs need,” said 
Harris. As the first line of care, idcs 
learn how to stabilize patients until 
they can be evacuated to definitive 
medical facilities. 
The training starts with classroom 
sessions that cover the initial evalu¬ 
ation and resuscitation of a trauma 
patient. Then corpsmen move on to an 
animal lab to practice basic surgical 
techniques such as intravenous access, 
chest tube placement, opening a 
surgical airway and emergency ampu¬ 
tations. “They are all basic lifesaving 
procedures that the idc may need to 
perform on board,” said Rabinovici. 
The next day the i dcs attend inter¬ 
active sessions with Yale trauma 
surgeons who pose real-life scenarios— 
such as a stab wound in the neck— 
and expect the idcs to describe the 
appropriate treatment. The idcs 
also rotate through clinical electives 
in surgery and anesthesia at Yale- 
New Haven Hospital. 
The training made a difference for 
Akin when the uss San Francisco 
collided with the uncharted mountain 
350 miles southeast of its base in 
Guam. According to Harris, the pro¬ 
gram manager in Groton, “he felt 
confident in his knowledge and man¬ 
agement of the injuries to his crew 
because of the trauma training he 
received” from Yale surgeons. 
Rabinovici said he was glad to learn 
that the training had paid off. “It is not 
that we said we could help—indeed, we 
did help. I feel very good about that.” 
—John Curtis 
Drugmaker invests in 
New Haven facility and 
joint projects at Yale 
Like many enterprises with interna¬ 
tional reach, Pfizer makes its corporate 
home in New York. But the company 
has deep roots in southeastern Connect¬ 
icut, having built what was then the 
world’s largest manufacturing plant for 
antibiotics in Groton in 1946. Today, 
more than 6,000 Pfizer scientists and 
personnel work in drug discovery in 
Groton and at the company’s Global 
Research and Development headquar¬ 
ters in nearby New London. 
With the April opening of the $35 
million New Haven Clinical Research 
Unit (cru), a 50-bed dedicated facility 
for Phase I drug trials, Pfizer further 
strengthened its ties to Connecticut 
and added new luster to a three-year- 
old research alliance with Yale. 
At the cru, volunteers will partici¬ 
pate in trials of potential medicines 
that have cleared several years of safety 
studies in the laboratory. Pfizer will 
collaborate with bioimaging experts at 
the School of Medicine, who will use 
positron emission tomography (pet) 
and other technologies to track the 
action of drugs in the human body, 
especially in the brain. 
Diane K. Jorkasky, m.d., Pfizer’s 
vice president of clinical pharma¬ 
cology, said that the ability to draw on 
the expertise of Yale scientists figured 
heavily in the company’s decision 
to locate the cru in New Haven. But 
those collaborations are just one exam¬ 
ple of Pfizer’s partnerships with Yale. 
In 2003, the company established 
a fellowship in memory of the late 
Patricia S. Goldman-Rakic, ph.d., a 
renowned Yale neurobiologist, to sup¬ 
port a graduate student in neurosci¬ 
ence in Yale’s Combined Program in 
Biological and Biomedical Sciences. 
Through Pfizer Faculty Development 
grants, five assistant and associate 
professors in the School of Medicine 
have been granted up to $50,000 
worth of research time at the medical 
school’s Magnetic Resonance Research 
Center. And in a new joint effort of 
Pfizer’s Women Leaders Network and 
the medical school’s Office for Women 
in Medicine, a female medical school 
faculty member will spend 12 weeks 
working alongside Pfizer researchers 
in Groton and New London each year. 
“The relationship is one of win- 
win for Yale and Pfizer,” said Jorkasky, 
“and the biggest winners will be the 
patients who will benefit from the sci¬ 
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For stem cell researcher, 
Connecticut's initiative offers 
a new avenue for progress 
In her Yale laboratory in 2001, Diane S. 
Krause, m.d., ph.d., surprised the sci¬ 
entific community with her discovery 
that adult stem cells taken from the 
bone marrow of mice can produce liver, 
lung, intestine and skin cells. To her 
dismay, her studies and similar findings 
have provided ammunition to oppo¬ 
nents of embryonic stem cell research, 
who have used her results to argue that 
research with stem cells derived from 
human embryos is unnecessary. 
Speaking in January at a hearing of the 
Connecticut General Assembly, the 
associate professor of laboratory medi¬ 
cine and pathology said, “To close off 
this avenue of research based on the 
early promise of adult stem cells is to 
play the odds with people’s lives.” She 
called upon the legislature to support 
both adult and embryonic stem cell 
research in the state. 
In May the state legislature did just 
that as it approved a bill to commit 
$100 million to embryonic stem cell 
research over 10 years. At a ceremony 
in Farmington a few weeks later, with 
Krause and medical school Dean Robert 
f. Alpern, m.d., looking on, Gov. M. 
Jodi Rell signed the bill into law. The 
bill’s passage is expected to boost 
this research at Yale and the Univer¬ 
sity of Connecticut. The legislation 
establishes a two-step process in which 
experts in both science and ethics 
review requests for funding. 
Unlike adult stem cells, which have 
shown a limited ability to develop into 
other cells, embryonic stem cells can 
generate virtually any type of cell in the 
body. Biologists believe they have the 
potential to help treat diseases such as 
diabetes and Alzheimer’s and to repair 
the spine, heart and other organs. 
Along with Alpern, Krause advised the 
General Assembly as it drafted legisla¬ 
tion to make Connecticut a “safe haven” 
for embryonic stem cell research. 
This field of study has been limited 
in the United States by guidelines 
established by President Bush that 
restrict federal funding exclusively to 
specific embryonic stem cell lines 
established prior to August 9, 2001. 
Supporters of the research contend 
that many of those pre-existing lines 
have been tainted by cells from other 
animals, such as mice, and that the 
limited number of lines hampers 
opportunities for study. 
The controversial research received 
a major boost last year after California 
voters approved $3 billion in funding 
for stem cell research over 10 years. 
New Jersey’s acting governor, Richard 
j. Codey, announced in January that 
his state would invest an additional 
$150 million in its stem cell institute, 
created in 2004 with $11.5 million in 
startup funding. 
In her Yale office, Krause pointed to 
an increasingly competitive research 
environment. “I’ve been contacted by 
states that have announced funding to 
see if I’d be willing to move,” she said. 
“Connecticut doesn’t want to lose the 
opportunity and researchers.” 
Krause is spearheading the effort to 
establish a stem cell program at Yale, 
and is one of more than 20 scientists 
across the university doing stem cell- 
related work. Recruitment of a senior 
leader for the Yale program began this 
past winter with an international 
search and will likely be followed by 
the recruitment of five to seven addi¬ 
tional faculty members whose work is 
focused solely on stem cell biology. 
Once established, the new program 
will likely have investigators perform¬ 
ing both adult and embryonic stem cell 
research, with separate laboratories 
for any research using embryonic cell 
lines not approved for federal funding. 
“No one can predict,” Krause said, 
“which lines of investigation will lead 
to development of effective and safe 
treatments. We can say with 100 per¬ 
cent certainty, though, that what we 
learn from embryonic stem cells will 
be useful for developing new thera¬ 
pies.” Although she does not currently 
work with embryonic stem cells, she 
said, “I want the freedom to use 
embryonic stem cells as a tool when 
I need to use that tool.” 
—Marc Wortman 
Cells culled from mouse bone marrow 
differentiate into blood cells. 
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From the operating room 
to hospitals in need, remedy 
provides surgical supplies 
In 1991, after several volunteer mis¬ 
sions to Latin America, William H. 
Rosenblatt, m.d., hs ’90, fw ’91, pro¬ 
fessor of anesthesiology and surgery 
(otolaryngology) at the School of 
Medicine, made an observation that 
was to have far-reaching effects: 
many of the hospitals he visited were 
in dire need of medical supplies, 
while at Yale-New Haven Hospital 
(ynhh) many of those same supplies 
were discarded without being used. 
Thus was born remedy (Recovered 
Medical Equipment for the Develop¬ 
ing World), a nonprofit committed to 
recovering surplus medical supplies 
and teaching others how to do it. 
What started as a local program 
at ynhh to collect opened but 
unused surgical supplies—which have 
never touched a patient but can’t be 
reprocessed due to liability concerns— 
has grown into a grass-roots organiza¬ 
tion involving hundreds of hospitals 
around the United States. From Yale 
alone, the remedy program has donated 
more than 30 tons of medical supplies 
to hospitals overseas. “Each of these 
pieces of material, whether it be a suture, 
a glove or a sponge, is going to wind up 
in another part of the world and be use¬ 
ful,” said Rosenblatt. The program has 
also saved the hospital over $30,000 
in disposal costs since its inception, at 
a cost of about $200 per year for 
disinfecting and bagging the supplies. 
Today, remedy trains hospitals to 
organize their own programs and 
has helped 358 hospitals begin recov¬ 
ery activities. The organization pro¬ 
vides teaching packets free of charge, 
and with Yale’s Office of Interna¬ 
tional Health, has developed a noti¬ 
fication program called AiRE-mail, 
in which medical supplies donated by 
hospitals and vendors are advertised 
via e-mail to 125 participating non¬ 
profit humanitarian organizations. 
It has also developed a catalog called 
remedy Atlas, consisting of the 
240 supplies most often recovered, 
which will help ensure that recipi¬ 
ents are getting supplies they need. 
Meanwhile, the collecting, sorting, 
packing and shipping of surplus 
medical supplies has largely been 
taken over by students. In 2001, rysa 
(remedy at Yale Students Association) 
was started by Jonathan $. Cohen, 
pa ’04, who is now a pa surgical resi¬ 
dent at The Johns Hopkins Hospital. 
“It’s been incredible to see all this 
stuff come from what would have been 
the garbage in New Haven and end 
up being packaged and shipped all over 
the world,” said Cohen. Between last 
August and January, rysa volunteers 
shipped 3,500 pounds of supplies from 
the New Haven area to eight countries. 
For rysa volunteers, long hours 
organizing medical supplies has its 
rewards. “The volunteers are having 
a direct effect with everything that 
they do,” said Rosenblatt. 
—Jill Max 
Alumni interested in starting a local 
REMEDY program may contact 
Silvia Botero at info@remedyinc.org. 
ORA OPENS OFFICE IN INDIA 
President Richard C. Levin inaugurated a new 
office for the Center for Interdisciplinary 
Research on aids (cira) in India in January. 
Joining him in the city of Chennai were 
ora's director, Michael H, Merson, m.d., and 
University Secretary Linda K. Lorimer, j.d. ’77. 
The new office will initially administer 
three projects. Project Parivartan, which is 
supported by a three-year grant from the Bill 
& Melinda Gates Foundation, will study 
community interventions designed to reduce 
hiv risk among sex workers, truckers and 
injection drug users. 
A second project, supported by the 
Children’s Investment Fund Foundation, will 
evaluate a model program that provides 
medical, psychosocial and nutrition services 
to families with a child infected with or 
affected by hiv/aids. The third project is a 
research and training program that will 
study the influence of religious and cultural 
factors on the mental health and transmis¬ 
sion risk behavior of Hiv-infected persons. 
—John Curtis 
CIS CONTRACT RENEWED 
The National Cancer Institute (nci) has 
renewed a five-year, $5 million contract with 
the Yale Cancer Center to operate the 
nci’s Cancer Information Service (cis) in New 
England. The cancer center has operated 
the New England service since it was created 
in 1976 to provide up-to-date cancer infor¬ 
mation to the American public. The as part¬ 
ners with state and regional organizations 
to develop education efforts for people lack¬ 
ing access to cancer information and serv¬ 
ices, provide current scientific information in 
understandable language and study ways 
to promote healthy behaviors. 
“The cis is a critical resource for the 
American public, and we feel privileged to 
be able to continue to provide this service,” 
said Linda Mowad, r.n., program director 
for the cis at Yale. 
The contract also includes a research 
component covering New England and seven 
other states to help the cis educate the 
public about cancer and contribute to the 









Rounds MEDICINE AND HEALTH AT YALE 
Psychiatry, the law and 
the death penalty 
For more than 30 years a Yale 
program has examined the interface 
of law and psychiatry. 
Although death penalty decisions are 
always controversial, the case of con¬ 
victed serial murderer Michael B. Ross 
has proven to be one of the most com¬ 
plex legal battles seen in Connecticut 
in recent years. Ross, who was found 
guilty of murdering six young women 
in the early 1980s, was sentenced to 
death 18 years ago. Since then, a series 
of appeals, hearings and overturned 
decisions has involved not only the 
courts but also two of Yale’s forensic 
psychiatrists. Howard V. Zonana, m.d., 
professor of psychiatry, interviewed 
Ross before his 1987 trial, and Michael 
A. Norko, m.d., associate clinical pro¬ 
fessor of psychiatry, evaluated Ross 
in 1995, in 2004 and again in March 
when Ross attempted to waive his 
right to appeal. Norko found no evi¬ 
dence that Ross suffered from “death 
row syndrome” or that he was incom¬ 
petent to waive his right to appeal. 
Ross was executed on Friday, May 13. 
The Ross case is one of about 
1,000 consultations for court cases 
both local and national that the 
Law and Psychiatry Division at the 
School of Medicine tackles each 
year. What began in 1973 as an elec¬ 
tive for residents examining the 
interface between law and psychiatry 
has grown into a division of five 
units and 23 staff members that 
offers a one-year fellowship in foren¬ 
sic psychiatry, as well as courses 
for psychiatric residents. 
“Forensic psychiatry is defined as 
the use of psychiatric expertise to 
aid in the resolution of legal problems, 
and it also deals with patients in 
settings like prisons, where there are 
special needs that have to be accounted 
for,” explained Zonana, who directs 
the division. 
That definition brings forensic psy¬ 
chiatrists into the courtroom as well as 
the clinic. They consult on everything 
from insanity defenses to the termina¬ 
tion of parental rights. As part of their 
training, law and psychiatry fellows 
rotate through various settings: they 
work with law students in the Jerome 
N. Frank Legal Services Organiza¬ 
tion, they see the victim’s perspective 
through postings with the state’s 
attorney and they may work in the fed¬ 
eral public defender’s office or at the 
Connecticut Juvenile Training School 
run by the Department of Children 
and Families. 
The division also contracts with the 
state of Connecticut to evaluate the 
competency of defendants in the New 
Haven region to stand trial—almost 
200 cases a year. Under close faculty 
supervision, residents conduct evalu¬ 
ations, write reports and testify in court. 
“We try to get them to approach 
each case from an objective, critical 
viewpoint, which may be different 
from the objective in clinical work, 
where you’re trying to establish a rap¬ 
port with the patient,” said Norko. 
“In forensic psychiatry that’s not neces¬ 
sarily the goal, because the outcome 
of your evaluation may or may not be 
helpful to the person.” 
On a broader scale, the division 
frequently examines legal issues such 
as a statute on the competency of 
juveniles to stand trial or the legal regu¬ 
lation of psychiatry. “Psychiatry is the 
most legally regulated subspecialty in 
medicine because of the fact that we 
can detain people against their will,” 
explained Zonana. The division also 
created a jail diversion project in 1995 
that places a clinician in the court to 
assess defendants charged with drug- 
related misdemeanors and develop 
treatment plans as alternatives to incar¬ 
ceration. Thanks to the success of the 
project, the Connecticut legislature has 
since expanded it to all lower criminal 
state courts. 
“It’s a very diverse program, which 
1 think is probably one of our biggest 
strengths,” said Norko, who is the divi¬ 
sion’s deputy training director. “The 
other is that we make a conscious 
effort to present more than one view¬ 
point about how forensic psychiatry 
should be done.” 
—Jill Max 
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Complex congenital heart 
patients live longer, need new 
treatment paradigm 
“Sometime in the next decade,” said 
James C. Perry, m.d., professor of 
pediatrics (cardiology) and chief of the 
Section of Pediatric Cardiology, “there 
will be, for the first time, more people 
over 18 living with congenital heart 
disease than people under 18.” 
Congenital heart disease (chd), 
the most common of birth defects, 
affects 0.8 percent of all live births in 
any given year in the United States. 
Thanks to advances in surgical and 
medical management techniques for 
treating children born with structural 
abnormalities of the heart, many 
children for whom chd would once 
have been an early death sentence can 
now expect to live well into adulthood. 
That fact underlies the work of 
the Yale-New Haven Adult Congenital 
Heart Program, the first of its kind in 
Connecticut and one of only two dozen 
in the country. The outpatient clinic is 
staffed by Perry and coordinator Nicole 
K. Boramanand, a.p.rn. ’99, and the 
program provides a collaborative and 
multidisciplinary approach to moni¬ 
toring and treating adult survivors of 
pediatric chd. The most common 
problems experienced by these patients 
are arrhythmias and heart failure. 
“Pediatric heart patients in the past 
were often discharged from pediatric 
care based on age, but adult cardiolo¬ 
gists are not usually trained to manage 
congenital heart disease. Those patients 
had nowhere to go,” Perry said. “Our 
program offers access to pediatric 
and adult cardiologists, heart failure 
specialists, pulmonologists, transplant 
specialists, specialists in high-risk 
obstetrics and other medical staff with 
essential expertise.” 
Patient education is also critical. 
“Our focus is on preventive mainte¬ 
nance,” Boramanand said. “What 
treatments and lifestyle adjustments 
can increase the length and quality 
of life? For instance, we emphasize to 
our patients that the old notion that 
all people with adult chd should avoid 
exercise is no longer accepted.” 
Boramanand notes that another 
aspect of education and prevention is 
obtaining extensive diagnostic informa¬ 
tion up front. “If we get readings early 
and track them regularly, we can see 
situations that may require treatment.” 
Perry points out that individuals 
who survive into adulthood with chd 
also experience the full range of health 
concerns, from catching the flu to 
developing arthritis to managing preg¬ 
nancy and childbirth, and notes that 
the center helps clinicians learn more 
about this population. 
As of this spring the Yale-New 
Haven Adult Congenital Heart 
Program, which began in July of 
2004, had seen nearly 100 patients 
ranging in age from 17 to their late 
50s. “Life expectancies vary,” said 
Perry, “and this is a group of patients 
we are just beginning to learn about. 
But to see people with complex 
congenital heart defects going strong 
into middle age is remarkable.” 
—Rhea Hirshman 
MOLECULE LINKED TO IMMUNE ATTACK 
A Yale scientist has found that blocking a key 
molecule protects implants, pacemakers, 
artificial joints and other foreign biomateri¬ 
als from attack by the immune system. 
“Implantation of biomaterials, devices, 
and tissue-engineered constructs into 
tissues causes the development of a foreign- 
body reaction that can lead to implant 
failure,” said Themis R. Kyriakides, ph.d., 
assistant professor of pathology and 
biomedical engineering, a member of the 
interdepartmental program in Vascular 
Biology and Transplantation and lead author 
of a study published in December in The 
American Journal of Pathology. 
Kyriakides and his team focused on 
areas where tissue and implants meet and 
foreign body giant cells form. In studies 
with mice, the team genetically eliminated 
the molecule, CC chemokine ligand 2 (CCL2), 
or blocked its action with decoy proteins. 
The success of the experiments with 
mice opens up the possibility of finding tar¬ 
gets for drugs to sustain implants. 
—John Curtis 
YALE TO LEAD STROKE STUDY 
The School of Medicine will lead a $33 
million trial to examine a novel approach 
for preventing stroke—the Insulin Resist¬ 
ance Intervention after Stroke (iris) trial. 
Sponsored by the National Institute of 
Neurological Disorders and Stroke, the iris 
trial will test the effectiveness of reducing 
insulin resistance with pioglitazone, com¬ 
pared with placebo, for preventing recurrent 
stroke and myocardial infarction among 
nondiabetic stroke patients with a recent 
ischemic stroke and insulin resistance. 
“This is the first trial that will look at 
the effect of this drug specifically to prevent 
clinically significant vascular events in non¬ 
diabetic patients,” said principal investigator 
Walter N. Kernan, m.d., associate professor 
of medicine. 
Researchers at Yale designed the study 
and will coordinate its conduct at more than 
60 research sites in the United States and 
Canada, recruiting more than 3,000 nondia¬ 
betic men and women over 45 who have 
insulin resistance and have had a recent 
ischemic stroke. 
—J.C. 
Findings from the bench 
Prions found outside 
nervous system 
Finding suggests more stringent 
monitoring of farm animals may be 
needed to protect the public. 
Nancy H. Ruddle, ph.d. ’68, the 
John Rodman Paul Professor of 
Epidemiology and Public Health and 
professor of immunobiology, is the 
first to admit that she’s no expert on 
mad cows. Her laboratory studies 
the human lymphoid system and how 
it mediates chronic infection and 
autoimmune diseases such as diabetes 
and multiple sclerosis. But Ruddle’s 
recent collaboration with pathologist 
Adriano Aguzzi, m.d., ph.d., in Swit¬ 
zerland has overturned one of the 
major tenets of public health efforts 
to curb mad cow disease. 
More formally known as bovine 
spongiform encephalopathy (bse), mad 
cow disease is caused by prions—mis- 
folded protein fragments that clump 
together and destroy the brain. Other 
animals, such as sheep, goats and 
mink, are also susceptible to prion dis¬ 
eases. In fact, researchers believe that 
the mad cow epidemic started because 
animal feed was contaminated with 
the brains of sheep infected with the 
prion disease scrapie. In humans, 
contraction of the variant Creutzfeldt- 
Jakob Disease has been attributed to 
eating BSE-infected beef—specifically, 
the animals’ brain, spinal cord and 
immune system tissues such as the 
spleen and lymph nodes. Experts 
have assumed that other parts of the 
animal were safe to eat. 
Aguzzi, a professor of neuropathol¬ 
ogy and molecular biology at the Uni¬ 
versity of Zurich, has long been on 
the trail of prion diseases. In 1997 his 
team showed that the immune system’s 
B cells, or B lymphocytes, which are 
activated when the body mounts an 
immune response against common 
infections, may cause prions to replicate 
and spread. But no one knew how far. 
Ruddle’s team was working with 
mouse models of inflammation in the 
kidneys, pancreas and liver. Her work 
had shown that in chronic immune 
diseases, T and B cells can form out¬ 
posts outside of the immune system 
that are very similar to lymph nodes. 
Since prion levels are known to be 
high in lymph nodes, the international 
team hypothesized that the organized 
outposts may allow spread of prions 
to other organs of the body beyond the 
nervous and immune systems. Sure 
enough, the researchers reported 
in January in the journal Science that 
when Ruddle’s mice were infected 
with prions, their inflamed kidneys, 
pancreases and livers carried enor¬ 
mous prion levels—as high as those 
found in diseased spleens. 
“It was thought that even if a 
cow was infected (with bse), what was 
most important was that the brain 
didn’t get into the feed. But if you have 
a chronic infection in that animal, you 
need to think about that, too,” Ruddle 
said. The work may have far-reaching 
implications, such as the need for 
increased monitoring of farm animals, 
says Ruddle. Although cattle are rou¬ 
tinely checked for fever, some inflam¬ 
matory conditions such as early forms 
of diabetes, she notes, would not 
necessarily have visible symptoms. 
—Alla Katsnelson 
Yale scientists find a genetic 
connection to age-related 
macular degeneration 
Biomedical research into the genetic 
basis of disease has progressed at a 
rapid clip since the sequence of the 
human genome was announced in 
2000, but this past March io saw the 
scientific equivalent of a triple play. 
Three research teams, including 
one led by Josephine J. Hoh, ph.d., 
an assistant professor in Yale’s Depart¬ 
ment of Epidemiology and Public 
Health, simultaneously announced 
that they had identified a gene variant 
associated with a greatly increased 
risk of age-related macular degenera- 
On this genome map of a subject with age- 
related macular degeneration, red and 
white squares represent strong matches with 
probes that find gene variants. 
tion (amd), a progressive disease lead¬ 
ing to blindness that affects more than 
io million elderly Americans. 
The human genome can be 
thought of as a vast string of 3 billion 
letters in which each letter represents 
one of the four nucleotides that pro¬ 
vide instructions to the body’s protein¬ 
building machinery. The genome is 
99.8 percent identical among humans, 
but after every 100- to 300-letter stretch 
on average are single nucleotide poly¬ 
morphisms, or snps (pronounced 
“snips”), sites where one letter is substi¬ 
tuted for another. Scientists believe that 
snps may help explain why some peo¬ 
ple are predisposed to certain diseases 
or respond differently to drug therapies. 
Remarkably, all three of the teams 
who published their findings in March 
independently zeroed in on precisely 
the same snp, a spot on chromosome 
1 that is home to a gene that codes for 
an immune system protein known as 
complement factor H (cfh). In its 
usual form, cfh acts as a brake on the 
complement system, a component 
of the body’s innate immune response. 
According to Hoh, whose group 
scanned the full genomes of 96 individ¬ 
uals with amd and those of 50 controls, 
those who carry two copies of the newly 
identified variant in the cfh gene are 
nearly 7.5 times more likely than the 
rest of the population to develop amd. 
“This is only an association,” Hoh 
emphasized. “It doesn’t really tell you 
that this is the cause of the disease.” 
Nonetheless, a faulty version of cfh 
may indeed be a culprit in amd. For 
example, yellowish deposits at the back 
of the eye known as drusen, the clini¬ 
cal hallmark of amd, contain comple¬ 
ment proteins. 
Hoh credits the Raymond and 
Beverly Sackler Fund for the Arts and 
Sciences for making the study pos¬ 
sible. “This particular kind of study is 
expensive, not the normal thing a 
junior faculty member can perform,” 
she said. “I am extremely grateful for 
the support from the Sackler Family.” 
Michael B. Bracken, m.p.h. ’70, 
ph.d. ’74, the Susan Dwight Bliss 
Professor of Epidemiology and Hoh’s 
collaborator, adds that the work repre¬ 
sents an entirely new way of doing 
epidemiology. “For the past 100 years, 
we’ve used a hypothesis-testing 
approach, where hypotheses were gen¬ 
erated from animal studies or small 
human studies and then we did large 
epidemiology studies.” 
By contrast, whole-genome searches 
for snps are “hypothesis-free”: “The 
association between a gene and disease 
is established first, and the biology is 
done after,” Bracken said. “This takes 
all that we’ve thought about doing 
science and turns it on its head, and 
it’s likely to have major payoffs in 
the future.” 
—Peter Farley 
MICRORNA LINKED TO ONCOGENE 
A Yale scientist has identified a microRNA, 
let-7, that controls an oncogene implicated 
in about 20 percent of cancers, including 
lung cancer. The finding, reported in March 
in the journals Cell and Developmental Cell, 
presents new possibilities for diagnosis and 
treatment, according to Frank J. Slack, ph.d., 
assistant professor of molecular, cellular 
and developmental biology. 
Oncogenes are segments of dna that 
can induce uncontrolled cell growth and, 
ultimately, the formation of cancerous 
tumors. MicroRNAs regulate gene expres¬ 
sion. Let-7, said Slack, stops the oncogene 
known as Ras from producing the Ras pro¬ 
tein. In the absence of let-7 RNA, cells in the 
nematode C. elegans continued to divide 
instead of differentiating normally. Let-7 in 
humans, Slack said, is almost identical 
to the worm sequence. 
Lung cancer has a poor prognosis, said 
Slack, “but gene therapy with let-7 maY 
be a way to alleviate it or slow it down." 
—John Curtis 
SMOKING TURNS RECEPTOR ON AND OFF 
Cigarette smoking turns on and then inacti¬ 
vates brain receptors that are critical to 
the effectiveness of antidepressants, accord¬ 
ing to a study published by Yale scientists 
in Biological Psychiatry last fall. 
Finding a way to manipulate those recep¬ 
tors could make antidepressants work 
more quickly—most now take up to three 
weeks to bring emotional relief. “This 
finding has implications for those patients 
who are depressed to the point of being 
suicidal and for the 30 percent of people 
who are not responsive to antidepressants 
that are now available,” said Marina R. 
Picciotto, ph.d., associate professor of psy¬ 
chiatry, pharmacology and neurobiology, 
and senior author of the study. 
The next step, Picciotto said, will be to 
study the role of these nicotine receptors, 
nAChRs, in regulating behavioral and cellular 
responses to antidepressants. The recep¬ 
tors may have a direct effect in mediating 
responses or they may act indirectly, by 
modulating neurotransmission in other 
cell types. 
—J.C. 
Books & ideas bookshelf 
Pediatrician Robert Needlman 
spent two years revising and 
updating the classic Dr. Spock's 
Baby and Child Care. The eighth 
edition of the guide, the first revi 
sion since Benjamin Spock died 
in 1998, was published last year. 
SPOCK'S 
BABY AND CHILD CARE 
•TM IDITION 
THE ONE ESSENTIAL PARENTING BOOK 
A HANDBOOK FOR PARENTS OF 
DEVELOPING CHILDREN FROM 
BIRTH THROUGH ADOLESCENCE 
BENJAMIN SPOCK. M.O. 
Rohtrt Netdlman. M.O. 
A radical notion of child rearing 
Following in the footsteps of Dr. Spock, 
a Yale alumnus updates the classic guide for parents. 
According to Robert D. Needlman, m.d. ’85, Dr. Spock’s 
Baby and Child Care—which has found a place on the book¬ 
shelves of 50 million parents across three generations— 
is “subversive.” 
Benjamin M. Spock, m.d., med ’29, initiated a revolu¬ 
tion, said Needlman, with the first words of his 25-cent book, 
published in 1946. “Trust yourself,” Spock told parents. 
“You know more than you think you do.” 
“Those famous lines were subversive to the doctor as 
expert,” says Needlman, who revised and expanded the book 
for its eighth edition, the first revision since Spock died 
in 1998 at age 94. In Spock’s day, pediatricians dictated rigid 
schedules for sleeping and feeding and warned parents to 
resist the temptation to pick up fussy children for fear of spoil¬ 
ing them. Spock, in contrast, encouraged parents to discover 
what their children needed as individuals and to foster rela¬ 
tionships of mutual affection and respect. This model of par¬ 
enting is now so unexceptional that contemporary Americans 
may not appreciate how much of it originated with Spock. 
"We understand that it’s no longer optimal, or even appropri¬ 
ate, to dictate to people what to do,” said Needlman. 
An associate professor at Case Western Reserve Univer¬ 
sity in Cleveland, Needlman incorporated his own insights 
in the new 992-page edition. He discusses gay and lesbian 
parents, how to stimulate a love of reading, how children 
respond to disaster and how young adults react when they 
leave home for college. 
Needlman felt no qualms when he disagreed with Spock’s 
recommendations. “I changed them—it was easy,” he said 
with a laugh. For instance, he eliminated the suggestion that 
a woman with postpartum blues cheer herself up by buying 
a new outfit. Instead, he suggests exercise, renewed contact 
with friends, talking to one’s partner—and seeking medical 
help if the change of mood is severe. 
The book combines the practical with the abstract, he 
said. “Some of it is very nuts-and-bolts: How do you change 
a diaper.' A lot is philosophical: How do you raise children 
to be responsible citizens?” Needlman preserves Spock’s 
exact words in short passages labeled “Classic Spock,” such 
as Spock’s views on TV: “There seems to be very little simi¬ 
larity between the world the electronic babysitter is selling 
to our children and the world we would like to see.” 
Raised in Chicago in a household with the 1958 edition 
of Spock’s book on the shelf, Needlman coincidentally 
followed Spock’s career path. Both majored in English at 
Yale College. Both attended medical school at Yale, although 
Spock transferred to Columbia. After training in pediatrics 
at Boston University, Needlman took a job at Case Western 
in the same clinic where Spock had worked. 
Needlman has found his own experience of the parent- 
child relationship endlessly interesting. He has a 16-year-old 
daughter, Grace, with his wife, Carol F. Farver, m.d. ’85, a 
surgical pathologist he met on their first day at Yale medical 
school. As a father and a doctor, he has observed that chil¬ 
dren can be both predictable and surprising. “A wonderful 
mystery of parenting is that there are some qualities that 
show a lot of continuity. You can look at a child at two and 
then at 15 and say, ‘I recognize that.’ But there are a lot of 
things that you can’t recognize: the same kid who was 
unhinged at five can be amazing, interested, interesting and 
capable of handling things beautifully at 15.” Six months 
after its publication by Pocket Books in June 2004, the Spock- 
Needlman edition of Dr. Spock’s Baby and Child Care had 
sold nearly 100,000 copies. Not bad for a subversive little 
book that’s been around since 1946. 
—Cathy Shufro 
Bookshelf is a column focusing on matters related to books and 
authors at the School of Medicine. Send ideas to Cathy Shufro at 
cathy.shufro@yale.edu. 
BOOK NOTES 
Sighting Anton Pavlovich 
by Elizabeth Loewald, m.d., fw 
’77 (Hermitage Publishers) The 
author considers Chekhov’s life 
as a doctor and writer, describ¬ 
ing how his chronic tuberculosis, 
interests and talents affected 
his character, life choices and lit¬ 
erary work. 
Preventive Cardiology: 
A Practical Approach, 2nd ed. 
edited by Nathan D. Wong, 
m.p.h. ’85, ph.d. '87, Henry R. 
Black, m.d., fw ’74, hs ’75, and 
Julius M. Gardin, m.d. (McGraw- 
Hill Professional) This updated 
source provides clinically rel¬ 
evant information about the 
prevention of coronary heart 
disease, including risk factors 
and screening guidelines. 
Radiology Illustrated: 
Gynecologic Imaging 
by Seung Hyup Kim, m.d., Bruce 
L. McClennan, m.d.. professor 
and chair of diagnostic radiology, 
and Eric K. Outwater, m.d. (W.B. 
Saunders) Over 3,000 images 
and brief descriptions of clinical 
disorders and diseases followed 
by case studies demonstrate 
the spectrum of benign and 
malignant gynecologic disorders 
and the optimal modality for 
imaging each condition. 
Guide to Publishing a 
Scientific Paper 
by Ann M. Korner, ph.d. ’74 
(Bioscript Press) This book 
explains how to produce, submit 
and revise a scientific paper 
for publication and offers advice 
about applying for funding. 
Pathology & Genetics: 
Tumours of the Breast and 
Female Genital Organs 
edited by Fattaneh A. Tavassoli, 
m.d., professor of pathology, 
and Peter Devilee, ph.d. (Oxford 
University Press) This guide 
describes the pathology and 
genetics of each lesion, along 
with its epidemiology, etiology, 
clinical features, prognosis 
and predictive factors. 
50 Signs of Mental Illness: 
A User-Friendly Alphabetical 
Guide to Psychiatric Symptoms 
and What You Should Know 
About Them 
by James W. Hicks, m.d. '91, hs 
’95 (Yale University Press) From 
anger to sexual preoccupations, 
from cravings to obsessions, 
this volume describes the clues 
that may signal mental illness. 
Starting each topic with a 
vignette to illustrate a symp¬ 
tom, the author considers 
whether it arises from illness or 
constitutes a normal response 
to stress. The book outlines 
available treatments and coping 
strategies for each symptom. 
Parent Management Training: 
Treatment for Oppositional, 
Aggressive, and Antisocial 
Behavior in Children and 
Adolescents 
by Alan E. Kazdin, ph.d., direc¬ 
tor of the Child Study Center 
and the John M. Musser Professor 
of Psychology (Oxford University 
Press) This manual covers the 
background, principles and 
theory of parent management 
training and discusses tech¬ 
niques for treating children 
and adolescents who display 
oppositional, aggressive and 
antisocial behavior. 
Sharing the Land of Canaan: 
Human Rights and the Israeli- 
Palestinian Struggle 
by Mazin B. Qumsiyeh, ph.d., 
associate professor of genetics 
(Pluto Press) Qumsiyeh docu¬ 
ments the core issues in the 
conflict between Israelis and 
Palestinians and articulates 
a road map for peace based on 
human rights and a shared 
future rather than apartheid. 
American Dreaming and 
Other Stories 
by Doris M. Iarovici, m.d. ’92 
(Novello Festival Press) The 
author explores the American 
ideal of success based on self- 
reliance and draws upon her 
own immigrant childhood to 
create stories of people in tran¬ 
sition. She tells of their trials, 
resilience, empathy and hope. 
The Breast Cancer Book: 
What You Need to Know to 
Make Informed Decisions 
by Ruth H. Grobstein, m.d., 
ph.d. ’57, fw ’63 (Yale Univer¬ 
sity Press) This guide provides 
the tools women and men 
facing breast cancer need to 
make informed decisions. 
I’m Your Father, Boy: 
A Family Memoir of Barbados 
by Ezra E.H. Griffith, M.D., 
professor of psychiatry and 
African American Studies (Hats 
Off Books) The author talks 
of father-son relationships, the 
cultural changes involved in 
moving to New York City in 1956 
and the impact of moderniza¬ 
tion and globalization on his 
memories of his father. 
A Field Guide to North Atlantic 
Wildlife: Mammals, Seabirds, 
Fish, and Other Sea Life 
by Noble S. Proctor and Patrick J. 
Lynch, director of the MedMedia 
Group at the School of Medicine 
(Yale University Press) With 
range maps and text on pages 
directly opposite full-color illus¬ 
trations, this guidebook provides 
concise information that facili¬ 
tates quick identification of 
more than 200 species of wild¬ 
life on or near the Atlantic coast. 
The Synaptic Organization 
of the Brain, 5th ed. 
edited by Gordon M. Shepherd. 
m.d., ph.d., professor of 
neurobiology and neuroscience 
(Oxford University Press) This 
book covers new advances in 
the study of the neural basis of 
brain function resulting from 
the mouse and human genome 
projects, biochemical analyses 
and laser microscopy of den¬ 
drites. Each chapter highlights 
the principles common to all 
regions and the adaptations 
unique to each. 
Carotenoids in Health 
and Disease 
edited by Norman I. Krinsky, 
ph.d., Susan T. Mayne, ph.d., 
professor of epidemiology, 
and Helmut Sies, ph.d. (Marcel 
Dekker) Carotenoids such as 
beta carotene and lycopene 
are a focus of research on the 
relationship between plant 
nutrients and human health. 
This reference reviews studies 
on the latest biochemical 
research and reports findings 
regarding the use of carot¬ 
enoids in preventing cancers 
and sunburn, as well as eye, 


























A Health Professional'! Guide 
As the library enters cyberspace, 
patrons still arrive to read, write, 
research—and listen to music 
Medical Physiology: A Cellular 
and Molecular Approach 
by Walter F. Boron, m.d., ph.d., 
professor of cellular and molecu¬ 
lar physiology, and Emile L. 
Boulpaep, m.d., professor of cel¬ 
lular and molecular physiology 
(W.B. Saunders) This textbook 
links molecular and cellular 
biology to the study of human 
physiology and disease and 
includes new material on hemo¬ 
stasis and fibrinolysis. 
Health and the Income 
Inequality Hypothesis: 
A Doctrine in Search of Data 
by Nick Eberstadt and Sally L. 
Satel, m.d., hs ’88, lecturer 
in psychiatry (AEI Press) While 
a number of recent studies 
suggest that inequality in 
income—not poverty perse— 
is bad for people's health, the 
rich included, this volume offers 
another view of this hypoth¬ 
esis. By controlling relevant 
variables, the authors suggest 
that income distribution is 
less a determinant of popula¬ 
tion health than the inequality 
hypothesis would suggest. 
Dietary Supplements and 
Multiple Sclerosis: 
A Health Professional’s Guide 
by Allen C. Bowling, m.d. ’88, 
ph.d. ’88, and Thomas M. 
Stewart, j.d., pa-c, m.s. (Demos 
Medical Publishing) Health 
professionals knowledgeable 
about complementary and alter¬ 
native medicine can guide MS 
patients away from possibly 
harmful therapies and toward 
low-risk, possibly effective thera¬ 
pies.The supplements selected 
for inclusion are those with spe¬ 
cific relevance to MS that are 
popular among the general pub¬ 
lic or known to have serious 
adverse effects. 
Listening to Fear: Helping 
Kids Cope, from Nightmares 
to the Nightly News 
by Steven Marans, m.s.w., ph.d., 
the Harris Associate Professor of 
Child Psychoanalysis in the Child 
Study Center (Owl Books) This 
text seeks to equip readers with 
hands-on tools: specific words 
and actions to elicit information 
and ease distress. The book is 
organized by age group, from 
infancy to adolescence. 
Diagnostic Atlas of Renal 
Pathology 
by Agnes B. Fogo, m.d., and 
Michael Kashgarian, m.d. ’58, hs 
’63, professor of pathology and 
molecular, cellular and develop¬ 
mental biology (W.B. Saunders) 
This new atlas covers all major 
inflammatory, infectious, pre¬ 
neoplastic and neoplastic dis¬ 
eases of the kidney. More than 
600 illustrations help readers 
to recognize the pathologic fea¬ 
tures and clinical manifestations 
of both common and rare renal 
disorders and to formulate con¬ 
fident and accurate diagnoses. 
The descriptions above are based on 
information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to cheryl.violante@yale.edu 
Arthur E. Broadus, m.d., ph.d., Ensign Professor of Medicine, hesitates 
to advertise his not-so-private sanctuary: Yale’s Medical Historical 
Library. He is hoping the crowds won’t catch on. 
“I escape over here for about an hour a day when I can, because 
it’s peaceful and lovely and I can think and read, and sometimes 
write—and mostly get away from the din,” said Broadus, section 
chief in endocrinology. 
Down the hall and past the rotunda, in the Information Room 
of the Harvey Cushing/John Hay Whitney Medical Library, medical 
student Tejaswini More is studying from Robbins Pathologic Basis of 
Disease while listening to Haydn through earphones. The library 
computers have a really good music program, says More, and she gets 
more done here than in her room. 
Just a few years ago, ophthalmology resident Amir Ahmadi, m.d., 
would have been a more typical library visitor: he has come to look up 
an article. But now Ahmadi is the exception, because patterns of library 
use have changed radically. Where annual electronic visits number in 
the millions, those who walk in the door just top 500,000, a ratio of 
18 remote users for every person who walks in. And yet, said Director R. 
Kenny Marone, m.l.s., “Come in here in the afternoon, and you can’t 
find a seat.” 
Medical students come to use the conference rooms for study 
groups, to seek guidance from a reference librarian or to borrow a 
laptop. Residents and students bring their personal digital assistants 
to a workstation in the Information Room, where they install appli¬ 
cations such as InfoPOEMs, eMedicine and Griffith’s 5-Minute Clinical 
Consult, which provide information about drugs and diagnoses. 
Students isolate themselves in carrels. Researchers read journals in 
the sun-drenched Morse Periodical Room. Downstairs, students 
click away in the Computer Resource Laboratory (crl), night and day. 
“We used to have people leave at quarter of twelve, and they 
were unhappy,” says Marone. “So we decided to make the crl a 
24-hour facility.” 
The library is also open to the general public. “They have access: 
It’s Yale’s way of giving back to the greater New Haven community,” 
said Marone. Sometimes patients or parents drop in to look up infor¬ 
mation after a visit to the doctor or hospital. 
When library service assistant George Moore began working at 
the library in 1978, “the furniture was dark, very heavy, very male, 
and there were heavy drapes on the windows. It was really a very 
forbidding place. Now we have carpeting, comfortable furniture, 
plants and better lighting. It’s warm, it’s alive. It’s a very pleasant 
place to be—a livable space.” 
—Cathy Shufro 
ON CAMPUS 15 
The poor need help 
from the rich 
You don’t get much health care 
for $4 per person. That’s what 
India spends on public health 
each year, far too little to con¬ 
front its growing aids crisis, said 
economist Jeffrey D. Sachs, 
ph.d., author of The End of 
Poverty: Economic Possibilities for 
Our Time and director of the 
Earth Institute at Columbia 
University. 
India must increase health 
spending 10-fold, and to do so, 
Sachs argued at a February con¬ 
ference, "Health Crisis in South 
Asia,” it needs help from the 
developed world. As its economy 
grows, India will be able to 
finance its own health system 
within a decade, but until then 
it requires assistance. That pro¬ 
posal is among the recommen¬ 
dations of the U.N.’s Millennium 
Project, directed by Sachs, a plan 
to meet the Millennium 
Development Goals, including 
halving the world’s extreme 
poverty by 2015. 
Sachs points out that in 
2002,22 donor countries includ¬ 
ing the United States promised 
to give 0.7 percent of their gross 
national product annually as 
development assistance to poor 
countries. The United States’ 
rate is now only 0.15 percent. 
"In many cases governments 
are ready to take action but 
need the donor countries to give 
the help they promised,” said 
Sachs. 
—Cathy Shufro 
Humans change their world, 
with no end in sight 
Over the last 20 years writer 
Bill McKibben has looked at the 
ways humans have altered the 
world around them, and he has 
come away worried. "Without 
quite realizing it,” he said at 
a talk in February sponsored by 
the Yale Divinity School and 
Yale’s Interdisciplinary Bioethics 
Project,“we had grown so large 
that there was nothing except 
tectonic and volcanic forces 
that remained outside our deep 
influence.... Humans have 
always interfered with the world 
around them, but their altera¬ 
tions have always had an edge. 
We live in a world where, all of 
a sudden, that is not true. There 
is no longer any edge to our 
effects on the world around us.” 
With the advent of genetic 
engineering, the influence of 
humans has turned inward and, 
McKibben said, it is important 
to draw a moral line.“I would say 
we draw it at germ line manipu¬ 
lation of human embryos, what 
a layman would call the crea¬ 
tion of designer babies,” said 
McKibben, author of The End of 
Nature and Long Distance and 
scholar-in-residence at Middle- 
bury College."It is a line that 
is very real and very palpable, 
yet allows room for human 
therapy.” 
—John Curtis 
Iceland’s national health 
service provides for all 
In Iceland, universal access to 
health care is enshrined in law. 
As a result the country has no 
private health insurance and the 
island’s 290,000 residents rely 
on a national health service— 
state-run hospitals and primary 
health care centers—at minimal 
charge. If they see specialists 
in private practice, about 75 per¬ 
cent of the fees are reimbursed 
by the government. 
Margret Oddsdottir, m.d., hs 
’92, professor and chief of sur¬ 
gery at Landspitali University 
Hospital in Reykjavik, described 
the Icelandic health system in 
March at the 50th annual 
Samuel Clark Harvey Lecture 
sponsored by the Department 
of Surgery. Most surgical pro¬ 
cedures, she said, can be done 
in Iceland, but patients travel 
abroad for heart operations in 
infants, solid organ transplanta¬ 
tion (other than living-related 
renal transplantation) and 
allogenic bone marrow trans¬ 
plantation. The national health 
system has a waiting list for 
surgery, but if waiting time 
exceeds six months, patients 
may travel abroad for treat¬ 
ment at government expense. 
Today, the only waiting list 
longer than six months is for 
cataract eye surgery. 
Such a health system— 
which accounts for 10 percent of 
the country’s gross domestic 
product—is possible in a small, 
homogeneous population, 
Oddsdottir said, adding,"I don’t 
know if it’s possible in a large, 
heterogeneous population like 
the United States.” 
—J.C. 
Silence among doctors in 
the face of torture 
Even as fbi agents and intelli¬ 
gence officers were warning 
their superiors that interroga¬ 
tions of detainees in Iraq and 
Afghanistan and at Guantanamo 
Bay in Cuba had gone terribly 
wrong, military doctors and 
nurses remained silent."I have 
reviewed 14,000 pages of docu¬ 
ments and can find only two 
instances of health care pro¬ 
fessionals trying to stop this 
abuse,” said Steven H. Miles, 
m.d., director of the Center for 
Bioethics at the University of 
Minnesota, in a talk at medical 
grand rounds in March. 
Those whose duty it was to 
see to the well-being of pris¬ 
oners, he said, often failed: They 
provided inadequate health 
care.They supplied confidential 
medical data to interrogators 
and oversaw coercive interroga¬ 
tions. They filed false reports to 
cover up torture. And they failed 
to report abuses. 
“I think we can look at the 
failure in two ways,” Miles said. 
"There was a policy environ¬ 
ment going down the chain of 
command authorizing the 
abuse. And there was a failure 
of accountability going up.” 
—J.C. 
NITROGEN MUSTARD THERAPY capsule 
Use of Methyl-Bis(Beto-Chloroethyl)amine Hydrochloride and 
Tris(Beta-Chloroethyl)amine Hydrochloride for Hodgkin's 
Disease, Lymphosarcoma, Leukemia and Certain Allied 
and Miscellaneous Disorders 
LOUIS S. GOODMAN, M.D., Salt Lake City 
MAXWELL M. W INTRO BE, M.D., Solt Lake City 
WILLIAM DAMESHEK, M.D., Boston 
MORTON J. GOODMAN, M.D., Portland, Ore. 
MAJOR ALFRED GILMAN 
Medical Corps, Army of the United States 
and 
MARGARET T. McLENNAN, M.D., Salt Lake City 
By John Curtis 
In a recent report the historical aspects of the use 
of /J-chloroethyi amines (halogenated alkyl amines, 
nitrogen mustards) in the treatment of certain diseases 
of the blood-forming organs were presented and the 
chemical, pharmacologic, toxicologic and animal experi¬ 
mental aspects of these compounds reviewed.1 The 
interested reader is referred to that report for orien- , 
tation. 1 
The present preliminary communication concerns the ; 
clinical use of halogenated alkyl amines in the treatment • 
of lymphosarcoma, Hodgkin’s disease, leukemia and a ; 
limited number of allied and miscellaneous disorders. 
In all. 67 patients have been studied. These include : 
7 patients2 treated by L. S. Goodman and Alfred ; 
Gilman at the New Haven Hospital; 34 patients treated . 
by M. M..Wintrobe and Margaret T. McLennan at the 
Salt Lake County General Hospital; 16 patients treated ' 
by William Dameshelc, Boston, and 10 patients treated - 
by M. J. Goodman, Portland, Ore. The types of diseases 
treated are shown in the accompanying table. The 1 
youngest patient was 3 years of age and the oldest 76. 
The sexes were approximately equally represented in 
the series. Twenty-six of the 67 patients are still alive 
and tinder observation or therapy. 
No attempt will be made at this time to analyze 
statistically the results obtained or to compare them 
with those observed after roentgen irradiation. The 
reasons for this are (1) the small number of patients 
in the series, (2) the prior use of radiation treatment 
for most patients, (3) the terminal nature and radia¬ 
tion refractory character of the disease in the majority 
of cases and (4) the small number of patients in the 
early stage of their disease. Rather, our purposes in 
this report are mainly to summarize briefly the clinical 
experiences obtained and to present the considered 
opinions of the various investigators concerned as to 
the status and the potential value of the /3-chloroethyl- 
amines in the syndromes enumerated. In subsequent 
more complete communications, comparison with the 
results of radiation therapy will be made and detailed 
hematologic and pathologic data will be presented. 
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Alfred Gilman and Louis Goodman (far left and 
left) had just published a pharmacology text¬ 
book when they were asked to study nitrogen 
mustard, a version of the sulfa mustard used 
in World War I gas attacks. In survivors the 
gas was found to destroy lymphatic tissue and 
bone marrow. The scientists believed it could 
also attack lymphoma. Their findings remained 
a military secret until 1946, when they were 
published in The Journal of the American Medi¬ 
cal Association. 
Early in 1942 two young assistant 
professors in Yale’s new Department 
of Pharmacology, Louis S. Goodman, 
m.d., and Alfred Gilman, ph.d., took 
on the study of nitrogen mustard. 
This agent was derived from a lethal 
gas used in the trenches of World 
War I, and the United States, which 
had just entered World War II, 
feared it might again be used in battle. 
By year’s end, the two young scien¬ 
tists had found in an agent of death a 
medicine with lifesaving possibilities. 
Their use of nitrogen mustard with a 
human patient ushered in a new era of 
cancer treatment. “This was the first 
patient in the world treated by chemo¬ 
therapy,” said David S. Fischer, m.d., 
clinical professor of medicine, who 
gave a talk on the history of chemo¬ 
therapy for the Beaumont Medical 
Club in March. 
Scientists had been seeking a 
“magic bullet” for cancer since ancient 
times—the Romans practiced mas¬ 
tectomy, and Egyptians used topical 
preparations derived from medicinal 
herbs. By the nth century the Arab 
physician Ibn Sina, known in the West 
as Avicenna, was using arsenical 
therapy systemically. The use of arseni- 
cals in an effort to treat cancer con¬ 
tinued for centuries, but without effect, 
said Fischer. “Until about 1900, the 
only real therapy for cancer was to cut 
it out,” he said. “Cancer, by definition, 
was a surgical disease.” Following 
Wilhelm Conrad Roentgen’s discovery 
of the X-ray in 1895, medicine added 
radiation, which could shrink tumors, 
to its arsenal of cancer therapies. 
After World War I, however, medi¬ 
cal researchers noticed an interesting 
effect of mustard gas—it destroyed 
lymphatic tissue and bone marrow. 
Perhaps, they reasoned, it could also 
kill cancer cells in the lymph nodes. 
But, Fischer said, this idea went 
nowhere. “They saw the relationship, 
but they didn’t do anything about it.” 
Some experiments in this area 
continued and revealed that topical 
applications of nitrogen mustard, 
derived from the sulfa mustard used 
in battle, caused tumors in mice to 
regress. But that line of research also 
languished for a decade, until 1942, 
when the government’s Office of 
Scientific Research and Development 
contracted with institutions around 
the country, including Yale, to study 
chemical warfare agents. Goodman 
and Gilman, who had recently pub¬ 
lished the first edition of what would 
become a classic text, The Pharmaco¬ 
logical Basis of Therapeutics, began to 
study the effects of nitrogen mustard 
on lymphoma. 
“They did their studies mainly in 
mice,” Fischer said. “They found 
absolutely dramatic regression of the 
lymphoma.” Further studies in rabbits 
were equally encouraging. Goodman, 
Gilman and their team decided it was 
time for a clinical trial. Gustaf E. 
Lindskog, m.d., an assistant professor 
of surgery, recommended a patient, 
J.D., a 48-year-old silversmith in the 
terminal stages of lymphosarcoma. 
Radiation no longer had any effect on 
his tumors. 
“As his condition seemed hopeless, 
he was offered experimental therapy 
with nitrogen mustard,” Fischer said. 
“In December of 1942, this 48-year-old 
patient was given 10 consecutive doses 
of nitrogen mustard, a 10th of a milli¬ 
gram to a milligram per kilogram of 
body weight, roughly 2.5 times what 
became the standard dose. Nobody had 
any idea of what dose to give him.” 
(The scientists had decided that there 
was a safe distance between a lethal 
dose and a therapeutic dose of nitro¬ 
gen mustard.) 
Within two days they noted a soften¬ 
ing of the tumor masses. By the end 
of treatment the tumors disappeared. 
A month later, however, the patient 
relapsed, and subsequent courses of 
treatment were less effective. Never¬ 
theless the scientists were encouraged. 
“This was proof,” said Fischer, “that 
cancer could be treated by chemicals.” 
Further trials followed. Around the 
country, 67 patients, including seven 
at Yale, were treated with nitrogen 
mustard. The clinical trials remained 
a military secret, even from caregivers, 
until 1946—the first Yale patients’ 
charts said only, “0.1 mg. per kg. 
compound X given intravenously.” 
By 1943 the team responsible 
for the first successful clinical trial 
of chemotherapy had disbanded. 
Goodman continued his research in 
Salt Lake City. Gilman entered the 
Army. Lindskog went on to become 
chair of surgery at Yale. But they 
had made a major contribution to 
cancer therapy by proving the worth 
of nitrogen mustard. Scientists 
began to look at other alkylating 
agents—which can attack cells at any 
point in their life cycle. And nitro¬ 
gen mustard, which was incorporated 
into multidrug chemotherapy for 
Hodgkin's disease, remains a potent 
agent against cancer today. 
John Curtis is the managing editor of 
Yale Medicine. 
The silent scourge 
of development” 
mtm 
The Diama dam in Senegal was 
built to bring progress to the West 
African country. Instead, it brought 
schistosomiasis, an insidious but 
preventable parasitic disease. 
In the Senegalese village of Mbagam, health worker Fatou 
Kine Manga fines those who enter the waters of the Senegal 
River. Despite her warnings to others, Manga admits to 
breaking her own rule. “Even me, I go to the river!” 
Snails that carry parasites lurk there, threatening 
infection with schistosomiasis. This debilitating chronic 
disease attacks the poorest of the poor—those who, like 
Manga, lack access to clean water and sanitation and rely on 
infected water for drinking, cooking, cleaning and bathing. 
Poverty and schistosomiasis are rampant in Mbagam, both 
J i'-ite. and because of the dams along the Senegal River. 
i arrived in the West African nation of Senegal in 
Sept nber 1998, on my 21st birthday, to examine the health 
eh< of tin: darns for my senior essay at Yale. This research 
'••• > b ;•*. become the topic of my medical school thesis, 
c c ti. f or two months 3 lived in the capital city of Dakar, 
the westernmost point of Africa. Described by a friend as a 
miniature version of Paris—after a bombing—downtown 
Dakar had multistory apartments with ornate wrought-iron 
railings and crumbling facades. Outside the skyscraper 
that housed the West African Bank, I dropped change on the 
blankets of beggars with polio. At the West African Research 
Center, as part of my study abroad program, I studied the 
country’s economics, politics and culture. 
For my monthlong field project, my instructor in 
the indigenous language of Wolof encouraged me to follow 
in a Yale tradition and study schistosomiasis along the 
Senegal River. Twenty-one years earlier, he proudly told me, 
he had been the interpreter for a Yale team studying the 
potential effects of the dams on human disease. Wilbur G. 
Downs, m.d., m.p.h., led the team, which included Herbert 
S. Sacks, m.d., hs ’53; George A. Silver, m.d., m.p.h.; 
More than two decades ago Yale public health experts warned 
that dams along the Senegal River would bring disease. 
A Yale medical student’s research finds that their predictions 
have come true. 
A letter from Senegal. 
Article and photographs by 
Kohar Jones, M.D. ’05 
Eric W. Mood, m.p.h. ’43; Robert B. Tesh, m.d.; and Curtis L. 
Patton, ph.d. My Wolof teacher’s enthusiasm sparked my 
own. When the director of the nongovernmental organiza¬ 
tion Environment and Development Action in the Third 
World asked me to conduct an informal field survey on 
whether schistosomiasis would limit the socioeconomic 
development of the Senegal River region, I gladly agreed. 
Sugar fields, rice paddies and near-desert 
That November, I left the city for the Sahel, the region south 
of the Sahara, to begin my survey. Two months after the 
rainy season, the Sahel was already tan and dry. Herders 
wearing the traditional wraparound headdresses of the 
Pulaar people drove thin cattle over the land. Barbed wire 
prevented the herds from encroaching on the irrigated 
plots that nurtured dreams of agricultural development. 
From the sugar cane boomtown of Richard Toll I con- 
tinued a few kilometers downstream to Mbagam, a rice¬ 
farming village. My hosts were a prosperous farming family, 
wealthy enough to own a latrine and a mosquito net for 
guests. There was no electricity, but at night we gathered 
with villagers in a neighboring compound to watch televi¬ 
sion—powered by wires connected to a car battery—under 
the stars on a dirt floor next to cows. A relative of these 
neighbors lived in France, where he washed dishes and sent 
his wages home to support the family, pay the taxes and 
buy the car that provided power for the flickering images 
that allowed the villagers to dream of a different life. 
The dams along the Senegal River also fed hopes of 
a new life. Omar Niang, president of the village farming 
cooperative, praised the dams for doubling the rice harvest. 
But standing next to a pump that transported water from 
“The silent scourge of development" 
In 1998 author Kohar Jones, then 
a senior at Yale College, traveled 
to Senegal to investigate the links 
between dams and the spread 
of schistosomiasis. 
the river to the rice paddies, he noted the negative aspects. 
Workers wore uncomfortable plastic boots for protection from 
infected water, and they all took the anti-schistosome drug 
praziquantel. “Everything has a good side and a bad,” he said. 
Schistosomiasis, named “the silent scourge of devel¬ 
opment” by the World Health Organization in 1998, is the 
bad side of dams. It follows water development projects that 
create the perfect habitat for the snails that carry the disease 
(See sidebar, p. 21). 
In 1994, less than 10 years after the dams were com¬ 
pleted, Mbagam had a disease prevalence of 91 percent. 
About 2,500 villagers joined the estimated 200 million peo¬ 
ple worldwide who are infected with schistosomiasis. The 
other 9 percent joined 400 million people around the world 
at risk of infection. 
The dams and the disease they brought emerged 
from Senegal’s colonial legacy. Senegal, the former jewel in 
the crown of colonial French West Africa, became independ¬ 
ent in i960 but maintained close trading ties with France. 
In 1968, however, France stopped subsidizing the dominant 
peanut economy just as a drought hit sub-Saharan Senegal. 
Both peanut farmers and nomadic herders saw their 
economies and lives devastated. Villagers flooded the capital 
cities in search of work, and starving masses threatened to 
undermine political stability. In 1972, amid widespread 
famine, Senegal adopted French colonial plans to dam and 
irrigate land along the Senegal River. 
With its neighbors Mali and Mauritania, Senegal 
formed the Senegal River Development Organization 
(Organisation pour la Mise en Valeur du fleuve Senegal— 
omvs). Dams provided hope for a desperate population. 
The massive hydroelectric Manantali Dam in Mali promised 
both electricity and a link between landlocked Mali and 
Atlantic trade routes. The small Diama Dam at the mouth 
of the river, between Senegal and Mauritania, would pre¬ 
vent salt water from creeping up the river bed during the 
dry season, allowing for two harvests of rice each year. 
Unfortunately, reality never matched the hopes. 
By 1988 the dams were completed, but the promised 
new civilization never came to be. Following the dictates 
of Structural Adjustment Programs (saps) of the World Bank 
and International Monetary Fund, which demanded a bal¬ 
anced budget, Senegal dismantled and privatized its national 
health system and agricultural agencies just as they were 
needed most. Senegalese economists wryly renamed the 
saps “the Suffering of the African People.” 
Disease comes to Richard Toll 
During my month surveying schistosomiasis, my base 
was in Richard Toll, home to the Senegal Sugar Company 
(Compagnie Sucriere Senegalaise—css). My new home 
became the gated Cite Cadre, where electricity generated by 
the burning of sugar cane stalks powered the air condi¬ 
tioners of the expatriate and Senegalese managers of the 
css, who directed development in the region. It was a city on 
a hill, separated from the center of town by a scattering of 
neighborhoods and the tall green waving stalks of irrigated 
sugar cane. 
Trucks carrying molasses and sugar cubes to 
Dakar rumbled along the paved, two-lane National Route, 
dodging horse-drawn carriages, pedestrians and the 
occasional cow. The paychecks of the sugar cane workers 
supported a bustling market, a regional economic mag¬ 
net. Electric lines strung overhead connected cement 
block homes. Two water towers were under construction. 
A latrinisation program promised to sanitize the town. 
Richard Toll was the model of agroindustrial development 
for the nation. 
Without dean water and sanita¬ 
tion, the river becomes kitchen, 
laundry and bathroom, promoting 
an ongoing cycle of infection and 
reinfection. 
A disease of poverty 
and progress 
No disease is as clearly linked with 
development as schistosomiasis. 
Nicknamed the “germ of progress” 
in the 1970s for its close association 
with water development projects 
that allowed freshwater snails to 
thrive, schistosomiasis remains the 
"silent scourge of development.” 
Though preventable and treatable, 
it flourishes throughout the devel¬ 
oping world. It has infected 200 
million people worldwide, and 
threatens an additional 400 mil¬ 
lion, primarily in Africa, Asia and 
Latin America. Of those infected, 
120 million people are sympto¬ 
matic, 20 million have severe com¬ 
plications and 200,000 die each 
year, more than the number of 
deaths from aids, diabetes, kidney 
disease, pneumonia and influenza 
combined in the United States. 
Humans are at risk when they 
enter freshwater sources infested 
with snails that release fork-tailed 
parasites called cercariae. Cercar- 
iae burrow through skin and grow 
into worms that inhabit the capil¬ 
laries of the intestines or bladder. 
The worms mate and lay barb¬ 
tailed eggs that cut through vessel 
walls, eventually leaving the body 
in the feces or urine. When people 
relieve themselves near snail- 
infested water, the eggs enter the 
water and hatch, then grow into 
parasites called miracidia that 
lodge in the shells of specific snail 
hosts. Each miracidium gives rise 
to thousands of cercariae, and the 
cycle explodes. 
An initial acute infection with 
schistosomiasis is followed by 
chronic debilitating disease. After 
an initial itchy rash at the site of 
cercaria entrance, accompanied by 
fever, weeks go by with minimal 
symptoms. The cercariae grow into 
worms that use molecular mimicry 
to evade detection by the immune 
system. Schistosome eggs, not the 
worms, bring disease. Anemia— 
often severe, sometimes deadly— 
accompanies blood loss in 
diarrhea or urine. In many regions 
with endemic urinary schistoso¬ 
miasis, a boy is considered to be 
a man after blood appears in his 
urine, thought to be a form of 
male menstruation. 
Severe complications ensue 
when excess eggs wash deeper 
into the body, eliciting an inflam¬ 
matory immune response. Liver 
scarring clogs the return of blood 
to the heart. Initial heavy infection 
with intestinal schistosomiasis 
can kill with bloody diarrhea, or 
cause irreversible paralysis if eggs 
are washed into the spinal cord. 
Communitywide access to clean 
water, sanitation and snai! eradi¬ 
cation programs can prevent schis¬ 
tosomiasis outbreaks. Praziquantel, 
a miracle drug discovered in the 
1970s, kills both the worms and 
their eggs in a single dose with 
minimal side effects. It does not 
prevent reinfection, but it does 
prevent serious complications of 
heavy infection. Unfortunately, all 
these measures to prevent and 
treat schistosomiasis are costly, 
often beyond the means of devel¬ 
oping communities. (Happily, 
the cost of praziquantel recently 
dropped considerably, increasing 
access worldwide.) 
Schistosomiasis is a disease of 
poor sanitation, contaminated 
water, ineffective health systems 
and unaffordable medications. 
It threatens impoverished com¬ 























22 "The silent scourge of development” 
In Mbagam, a rice-farming village 
on the Senegal River, workers 
wear awkward rubber boots and 
take yearly doses of praziquantel 
to ward off infection with 
schistosomiasis. 
But development had already brought disease. In 
1986, the completion of the Diama Dam blocked the 
saltwater tongue of the Atlantic. Freshwater snails migrated 
from a nearby lake through a sugar company canal and into 
the fresh water of the Senegal River, where their population 
exploded. The human population of the sugar boomtown 
was also exploding. From 10,000 when the css was founded 
in 1972, Richard Toll’s population had more than quintupled 
by 1988, to an official 50,000 (but closer to 75,000) resi¬ 
dents, largely due to immigration. Urban amenities had not 
kept up. An infected migrant worker is believed to have 
brought the parasite to Richard Toll. The css canals became 
ground zero in a massive schistosomiasis outbreak. 
Although there had been 50 isolated cases of intes¬ 
tinal schistosomiasis among migrant workers between 1970 
and 1980, before the dam was built, in January 1988 Diokel 
Dieng, a government health worker in Richard Toll, diag¬ 
nosed a new case of intestinal schistosomiasis along the 
Senegal River. By the end of the year, he had found 29 cases. 
By the end of 1989, there were nearly 2,000. By August 
1990, a full 60 percent of the population of Richard Toll was 
infected with intestinal schistosomiasis. And it spread. By 
1998, schistosomiasis had infected hundreds of thousands 
of people in the Senegal River region. In many towns and 
villages, as in Richard Toll, the prevalence rates were just shy 
of 100 percent—only the youngest children, who had not 
yet had extensive contact with infected water, remained free 
of disease. It was the largest public health problem facing 
the region, greater than the looming threat of aids and the 
constant presence of malaria—and all because of the ecologi¬ 
cal changes wrought by dams and irrigation. 
Still, when I asked Aboubakry Gassama, m.d., the head 
of the css health services, whether schistosomiasis would limit 
socioeconomic development, he said no. Although most work¬ 
ers were sick with schistosomiasis, there were enough healthy 
migrant workers desperate for a paycheck to replace them. 
The limiting factor, he said, was the lack of financial resources 
to irrigate the land around the river. (Of the 600,000 acres 
that planners had hoped to irrigate by 2000, only 75,000 were 
in use—the same number that had been irrigated 10 years 
earlier). This was not to say that schistosomiasis wasn’t a prob¬ 
lem. Of every 100 workers waiting on benches that lined the 
clinic’s long concrete hallway, nursing machete wounds from 
the fields or parasitic lesions from the Senegal River, Gassama 
estimated that all but two had schistosomiasis. “If people don’t 
do anything, then in 10 years they are indisposed, and in 30 
years they are dead,” he said. 
Return to the States 
From Mbagam, I took a donkey cart to the main road to catch 
a car rapide to the regional capital of Saint-Louis to take a 
sept place (a seven-seated old Peugeot) back to Dakar to catch 
my plane home—a century’s worth of development com¬ 
pressed into 24 hours. Descending through the cloud cover 
over New York City, I appreciated the rains that watered 
the gardens that provided food for farmers and industrial 
workers alike. I returned to New Haven, where libraries 
serve as cathedrals of knowledge and the sum of human 
experience could be consulted to shape future planning. 
medline provided information about schistosomiasis and 
disease outbreak in Senegal. Patton, a professor of epidemi¬ 
ology (microbiology) and one of the original Yale researchers, 
provided the team’s reports. 
The schistosomiasis epidemic, I learned, could have 
been prevented. In 1972, when the omvs decided to develop 
the Senegal River, the link between dams and disease was 
well-established. Nevertheless, dam planning progressed 
with minimal attention to public health concerns. 
In 1978, the Yale researchers warned development 
planners that schistosomiasis was a “serious public health 
problem” that, without adequate control measures, “might be 
aggravated by irrigated agriculture. ... inhibiting both agri¬ 
cultural and economic development.” They recommended a 
disease surveillance team to track outbreaks and implement 
immediate control measures. They “strongly urged” that 
Senegalese groups with “considerable experience” as well as 
“the necessary trained personnel and mobile units to carry 
out such work” conduct the health surveys. The only reason 
the Senegalese weren’t already doing this work was that they 
were “rather short of funds and supplies.” 
Unfortunately, as budgets contracted under the saps, 
the recommendations were ignored. Nothing was done to 
avert the preventable outbreak of schistosomiasis. And a 
generation later, I arrived in Senegal to ask if schistosomia¬ 
sis would limit the socioeconomic development of the river 
region. After my first visit in 1998, I made three more 
trips to Senegal, with support from the Fund for Investi¬ 
gative Journalism and the medical school’s Office of Student 
23 
A drought in the 1960s and 1970s 
drove cattle herders off the dry 
plains of the Sahel and into the 
cities. In response, the Senegalese 
government and its neighbors 
resolved to spur agriculture and 
economic development by 
building dams along the Senegal 
River. Development, however, 
remains elusive. 
Research, to explore this question. There was no easy answer, 
I found. It depended on how you defined development. 
For individuals struggling to become masters of their 
own destiny, schistosomiasis severely limited their progress 
to greater personal and economic freedom. Sick, they could 
not work. Without work, they could not pay for health care, 
school expenses for their children or even food. 
For industries struggling to make a profit, schistoso¬ 
miasis had little impact. There were always healthy workers 
to replace the sick. The limiting factor for economic develop¬ 
ment was simply the lack of local money to invest in irriga¬ 
tion, factories and industry. Foreign investors shied away 
from supporting further irrigation at the edge of a desert. 
Instead of boosting macroeconomic indicators, the 
dams ushered in an era of epidemic infectious disease. 
Poverty trapped villagers in an endless cycle of infection and 
reinfection. In retrospect, Patton described it as an “extraor¬ 
dinary example of poor planning.” 
The Yale team’s recommendations—disease surveil¬ 
lance, strengthened health systems, implementation of 
available measures to control disease—remain apt today. 
Health planning must be part of all development planning. 
In Mbagam, where four spigots provided water 
for up to 3,000 people, Manga continued to violate 
the very rules she had set to protect the health of the 
villagers. “Only four flasks a day,” said Manga, 
bemoaning the daily ration—about eight gallons for 
each household of up to 30 people. “That’s not enough 
water for sure. You have no choice but to enter the 
river. It’s the financial means that we’re missing. Above 
all, the means.” ym 
Kohar Jones, M.D. ’05, is a resident in family practice at Middlesex Hospital 
in Middletown, Conn. She plans to publish her medical school thesis 
under the title Cerms of Progress: Schistosomiasis in Senegal and the Ethics, 
Politics and Economics of International Health Research and Development 
in the 20th Century. 
SOURCE: CIA WORLD FACTBOOK 
Senegal at a glance 
Population 10,852,147 
Population living 
below poverty line 
54 percent (12 in the u.s.) 
Unemployment 48 percent (urban youth, 40 percent) 
Literacy 40.2 percent 
Area 117, 714 square miles (slightly smaller than South Dakota) 
Arable land 12.78 percent 
HIV/AIDS prevalence 0.8 percent (7.4 in sub-Saharan Africa) 
Infant mortality 56.53 deaths per 1,000 live births (6.5 in the u.s.) 
Religion Muslim, 94 percent 
Christian, 5 percent 
indigenous beliefs, 1 percent 
Industries fish processing, agriculture, phosphate mining, 
























health, from the 
ground u 
Part of a national effort to create community 
health partnerships, a Yale center is working 
with New Haven churches to prevent diabetes 
and with a suburban school to stop teen 
smoking. The goal? Healthier communities 
invested in their own outcomes. 
By Jennifer Kaylin 
Photographs by Gale Zucker 
In 1997, when Veronica Puleo, r.n„ became the nurse at 
Amity High School in the New Haven suburb of Woodbridge, 
she was prepared to handle the fevers, sore throats, head¬ 
aches, sprained ankles and other ailments that routinely 
afflict students, but there was one health problem that 
confounded her. 
Cigarette smoking was so rampant that school offi¬ 
cials imposed a $65 fine on any student caught smoking in 
the school. The hard-core smokers chose to try their luck in 
“Marlboro Country,” a secluded area behind the school where 
students gathered to light up. If caught there, they faced an 
after-school detention, with Puleo sometimes presiding. 
“For three hours we’d sit and talk,” she says. “They’d 
tell me how they were coughing up blood, or that they felt 
awful in the morning until they’d had their first cigarette, or 
that they couldn’t fall asleep at night until they had a cigarette. 
They were almost pleading with me. They were so addicted, 





















26 Promoting health, from the ground up 
At weekly Bible Study meetings, 
the Rev. Audrey Tinsley, pastor of 
the Pentecostal Assembly Church 
of Deliverance in New Haven, 
spends a few minutes discussing 
diabetes. “It affects people of 
color disproportionately,” says 
Tinsley, herself a diabetic. 
Puleo knew she had to do something, but with limited 
resources and no program geared for adolescents, she was at a 
loss. “I was spinning my wheels,” she says. Then she learned 
about the Yale-Griffin Prevention Research Center (prc). 
The prc is a partnership between the Department of 
Epidemiology and Public Health at Yale and Griffin Hospital 
in Derby, where it is headquartered. It was established in 
1998 with a $350,ooo-a-year grant from the Centers for 
Disease Control and Prevention (cdc). That allotment grew 
to $800,000 annually in the second funding cycle, which 
began last October. Funding from other sources brings the 
prc budget to between $2 million and $2.5 million each year. 
One of 28 such centers nationwide, the Yale-Griffin 
prc collaborates with the community to develop innovative 
approaches to health promotion and disease prevention. 
Collectively, the national prc network conducts about 500 
research projects a year on such topics as aging, arthritis, 
asthma, job safety, nutrition, cardiovascular health, tobacco 
control, obesity, diabetes prevention and control, school 
health and violence prevention. 
“The prc model, which was developed about 20 years 
ago, grew out of a productive period in the history of public 
health,” says Eduardo J. Simoes, m.d., m.sc., m.p.h., program 
director of the cdc’s prevention research centers. “We had 
conquered a lot of diseases through immunizations. We were 
making progress in the areas of occupational and environmen¬ 
tal health, so the logical next step was to invest in prevention 
research at the community level.” Besides funding the prcs, 
the cdc provides oversight and makes periodic site visits. 
Michael H. Merson, m.d., the former dean of public 
health and the Anna M.R. Lauder Professor of Public 
Health, is the principal investigator of the cdc grant. He 
calls the prc program “one of the most important initiatives 
the cdc has in this country.” Too often, he says, there’s a 
divide between academic research and real-world applica¬ 
tion. “These centers are really critical in bringing the two 
together, in taking the best in public health knowledge and 
applying it in a field setting.” 
Pizza, soda and cigarettes 
When Puleo contacted the Yale-Griffin prc, she was put in 
touch with the director, David L. Katz, m.d., m.p.h. ’93, asso¬ 
ciate clinical professor of epidemiology and public health, 
who, along with Merson, founded the prc. “He immediately 
took charge of the situation and helped me out,” Puleo 
recalls. Katz introduced her to scientists doing research 
on adolescent smoking. He joined her at meetings with 
students and helped her write a news bulletin for parents. 
Eventually, their work became a research project on the 
effectiveness of tailored behavioral interventions and the 
drug Zyban in fighting adolescent nicotine addiction. 
Although Zyban has helped adults quit smoking, Puleo says 
it proved ineffective with her study group. Study findings 
were published in the journal Behavior Modification last year. 
What did work was the eight-week program she and 
Katz developed. Each week focused on a different topic— 
from what cigarette smoking does to the body and identifying 
why students smoke to preparing them for withdrawal. 
Students received gum, pencils and water bottles to fulfill the 
oral fixation that cigarettes satisfy. Puleo and Katz set out to 
identify what incentives work best with adolescents. “We gave 
them a choice: money or pizza and soda at our weekly meet¬ 
ings,” Puleo says. The answer provided some insight into 
why adult treatment models don’t necessarily work with ado¬ 
lescents. “The money meant nothing; they just use it to buy 
more cigarettes,” Puleo says. “The pizza and soda was front 
and center. It allowed them to socialize, which is so impor¬ 
tant for young people, and gave them something to look 
forward to from week to week.” Katz, a nutrition expert, was 
somewhat reluctant to go the pizza and soda route. “But 
I am a practical guy,” he notes. “I try very hard not to make 
‘perfect’ the enemy of‘good.’ I figured we could get to 
dietary detox once we helped these kids quit smoking.” 
There are now about 60 students enrolled in the 
program. Katz estimates that between a third and a half 
either quit smoking or cut back significantly. The prc stayed 
involved with the Amity smoking cessation program for 
about four years, until it could run on its own. “This is the 
kind of thing we’re hoping to achieve on a larger scale,” 
Katz says. “A big part of what our center does is to take the 
knowledge we acquire and translate it into a real-world 
setting until it can become self-sustaining.” 
The Yale-Griffin prc has generated studies and publi¬ 
cations in the area of smoking cessation for adults, and 
invented a novel behavior modification technique Katz terms 
“impediment profiling,” which identifies barriers to behavior 
change. “Then we tailor the intervention components to cor¬ 
respond,” Katz says. “We’ve had success with this approach 
in smoking cessation and physical activity promotion, and 
just received notice of our first grant award to develop 
the technique for dietary change and weight control as well.” 
Another prc study found positive results with 
congestive heart failure patients who received a treadmill 
and access to a cardiac rehab nurse to help them use it. 
“The participants really liked it, which is proof of principle," 
Katz says. “Now we’re looking for collaborators to help 
us study whether this could reduce the number of hospitali¬ 
zations and mortality.” 
A randomized trial just completed by the prc found 
that massage therapy was highly effective for patients 
with osteoarthritis of the knee. Katz says the next step is to 
crunch the financial numbers. “Given all the press about 
the dangers of anti-inflammatory medicine, what if massage 
is as good, or better? This could lead to a significant policy 
change. But to get there requires showing not only that it 
works, but that it’s cost-effective.” 
Partnering with the community 
Beth P. Comerford, m.s., the prc’s deputy director, says 
prcs focus on different health issues, depending on the 
needs of the community, but their basic approach is always 
the same: partnering with the community. “Everybody at the 
table holds an equal place and is involved in the decisions 
being made.” This is a time-consuming and, at times, frus¬ 
trating process, Comerford concedes, but because the goal 
is real-world application, it can also be rewarding. 
“With the traditional clinical trial model, you’re basi¬ 
cally saying, ‘You’re the subject, we do things to you.’ Then 
we leave,” Comerford says. While researchers may develop the 
perfect scientific protocol, if it requires test subjects to do some¬ 
thing that makes them uncomfortable, such as take a medica¬ 
tion or have blood drawn, they may refuse to participate. And 
any scientific results may not be lasting in real-world settings. 
“What we do,” Comerford says, “is go to the community at the 
start and ask them, 'What are your priorities? What would work 
to address them? What would people be willing to do?’ This is 
key for participation and sustainability.” 
In 2002, the Yale-Griffin prc embarked on a long¬ 
term project called predict (Partners Reducing Effects of 
Diabetes: Initiatives through Collaboration & Teamwork). 
While researchers want to determine why information about 
diabetes isn’t reaching the at-risk population, they know 
that for this project to succeed, there are side issues they 





















issue, you may need to work with people on issues related to 
jobs, child care, housing,” Comerford says. 
While it may seem digressive for public health 
researchers to address such social ills as unemployment, Katz 
says it’s essential. “If you tell a group of people you want 
to talk to them about diabetes and they say they’re more con¬ 
cerned about finding jobs and you say, ‘Yeah, well that’s 
not our thing,’ they’re going to show you the door,” he says. 
He offers an example from his clinical work: A patient 
couldn’t quit smoking. The resident physician kept focusing 
on smoking cessation, but Katz found out she was homeless, 
and the focus shifted to the patient’s more pressing needs. 
Three months after she’d moved into a new home, she was 
ready to quit smoking. 
The predict project will evaluate the Community 
Health Advisor model for getting people at risk to adopt 
healthier lifestyles. This method identifies natural leaders 
in a community and trains them to serve as surrogates for 
health care professionals. “Rather than the traditional 
we’re-here-to-help-you model,” Katz says, “members of the 
community spread the gospel.” New Haven will be the test 
community and Bridgeport will be the delayed control— 
meaning it won’t get any intervention until after the study 
is over. A related pilot study seeks to improve the patient- 
doctor relationship by coaching patients who have been 
newly diagnosed with diabetes on how to talk to their doctors. 
For predict, researchers initially planned to work 
through the public schools to disseminate information about 
diabetes , but an advisory committee of community mem¬ 
bers felt it should be a church-based initiative. “We helped 
them tweak their structure,” says committee member 
Sharon Bradford. “We decided they should work through the 
religious community. We felt there was a captive audience 
in the churches.” The committee also put researchers in 
touch with local ministers and helped select and hire a local 
outreach coordinator to serve as a liaison between the com¬ 
munity and the prc. 
That outreach worker is Maurice Williams, who also 
saw that working through the schools wouldn’t be effective. 
“When parents go to a school they’re thinking about how 
their child is doing in school, not about health issues,” he 
says. “Plus, if you work through the churches the message 
1 flowing from the parent down. The child isn’t carrying 
all the weight of bringing the information home.” 
Twelve African-American churches in New Haven 
were chosen for the study. Two volunteers from each were 
recruited as community health advisors. During 10 weeks of 
training they learned about the causes, symptoms and treat¬ 
ment options for diabetes. They also learned about nutrition, 
how to read food labels, low-fat cooking techniques and 
different methods they might use to educate their congrega¬ 
tions. Church members were then given a baseline survey 
to see how much they know about diabetes. The next step, 
which is under way, is for the community health advisors 
to go back to their churches and educate their congregations 
about diabetes. Church members will then be surveyed 
again to see whether their understanding about diabetes 
has increased. 
“Why don’t they serve fruits and vegetables?” 
The Rev. Audrey Tinsley, the pastor of the Pentecostal 
Assembly Church of Deliverance, signed up as a community 
health advisor because she has diabetes. “I wanted to learn 
ways I could keep my diabetes from escalating into some¬ 
thing worse, and I wanted to help keep other people from 
getting the disease,” she says. She spends 15 minutes of 
every Bible Study period sharing information about diabetes 
and passes out diabetes literature at her church. 
Tinsley now talks about diabetes with a convert’s 
zeal. “It affects people of color disproportionately,” she says. 
“It affects us more because of the food we eat. Fast food, 
junk food, something quick. Diet is the number one thing 
that causes diabetes.” 
When the conversation turns to school lunches, 
Tinsley’s voice takes on an angry edge. “Pizza, chicken 
nuggets,” she says. “There’s nothing nutritional here! 
Why don’t they serve fruits and vegetables? Why don’t the 
kids have decent food?” 
Tinsley isn’t alone. At a meeting of community health 
advisors in the basement of Bethel ame Church, everyone 
had stories to tell. Several people talked about their own 
experiences with diabetes. Food was a recurring subject of 
conversation—low-fat ways to prepare favorite dishes, the 
benefits of Mrs. Dash salt substitutes, the merits of cooking 
collard greens with smoked turkey instead of pork. At one 
point, someone suggested putting together a cookbook 
of healthy recipes. One health advisor wrote a skit about dia¬ 
betes she hoped the group could present at a community 
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opposite At the March work¬ 
shop Sharon Bradford, a member 
of a community advisory commit¬ 
tee, led the group in line dancing. 
"People think that dancing is 
just fun, but it’s also movement 
and exercise,” Bradford says. 
below Eggs, says researcher 
Zubaida Faridi, are a good source 
of nutrition. At Griffin Hospital in 
Derby, she uses an ultrasound to 
measure the effects of egg con¬ 
sumption on the ability of blood 
vessels to dilate, an indicator of 
cardiac and vascular health. 
event. It contained three scenes; by the end of the meeting it 
had grown to seven. 
When the Yale-Griffin prc began, it served the six 
towns of the Lower Naugatuck Valley—Derby, Ansonia, 
Seymour, Shelton, Oxford and Beacon Falls. One of its early, 
major initiatives was the Valley Health Profile—a collection 
of data about diseases and causes of death over a three-year 
period. “The local data helped us see local patterns we used 
to develop our priorities,” Katz says, noting, for example, 
that physical activity and fitness levels of Valley schoolchil¬ 
dren were of concern. This information was disseminated 
among health care agencies to be used for setting priorities. 
The prc now produces a “Community Health Profile” every 
two years, covering not only the Lower Naugatuck Valley, 
but also New Haven, Bridgeport and Hartford. In addition, 
a health newsletter goes out to approximately 40,000 house¬ 
holds twice a year. 
As the Yale-Griffin prc has grown, emphasis has 
shifted away from the Valley, but residents who live near 
Griffin Hospital still participate in clinical trials. The prc 
has about 15 to 20 active projects involving between 200 
and 500 participants, mostly from the Valley communities. 
One project is looking into the effects of egg con¬ 
sumption on the ability of blood vessels to dilate, a reliable 
indicator of cardiac and vascular health. The first egg study 
looked at 50 healthy people from the Valley who ate two 
eggs a day. “We found that the blood vessel response was 























30 Promoting health, from the ground up 
Like other once-thriving industrial 
towns in the Naugatuck Valley, 
Derby has fallen on hard times. 
Health issues in the Valley were 
the initial focus of the Derby- 
based Yale-Griffin Prevention 
Research Center, led by David Katz, 
which promotes self-sustaining 
projects for better health. 
says clinical research associate Zubaida Faridi, m.d., m.p.h. 
This means egg consumption did not have a negative effect 
on the endothelium—the inner lining of the blood vessel— 
nor did it raise serum cholesterol levels. Faridi is now repli¬ 
cating the study on test subjects with elevated cholesterol 
levels. “We see this study as having practical applications for 
a large element of the population,” Faridi says. “Eggs are 
a very commonly used food, with an excellent nutrition pro¬ 
file, and their exclusion from the diet comes at a cost.” 
Katz believes the move toward community-based 
research models represents a sea change in public health 
research. “It's health with and for communities, rather than 
the paternalistic, ‘Trust us, we’re from an academic environ¬ 
ment,’” he says. “Gertrude Stein had it right: ‘A difference, 
to be a difference, must make a difference.’ For research to 
make a difference, it must be put to use in the real world.” 
While Katz says research universities are slow to deviate 
from their time-tested ways, he sees the prc’s methodology 
as the wave of the future, from the standpoint of both 
public acceptance and financial support. 
“I’m hoping we’re tossing a pebble in the pond and 
that the ripples go to the far shore.” ym 
Jennifer Kaylin is a writer in New Haven. 
Gale Zucker is a photographer in Branford, Conn. 
From medicine to media, 
a doctor extends his reach 
After becoming an expert in nutri¬ 
tion, obesity and chronic-disease 
prevention, David L. Katz, M.D., 
m.p.h. ’93, wasn’t satisfied treat¬ 
ing patients in his office; he 
wanted to get the message out to 
the widest possible audience. 
That led to his now-flourishing 
second career as a media star. 
It began in 1997 with a health 
column in the New Haven Register, 
followed by appearances on local 
TV, and then a monthly health 
column in O, The Oprah Magazine. 
He contributed articles to maga¬ 
zines and newspapers and was 
soon appearing on Good Morning 
America, the Today show, 48 Hours 
and 20/20. Most recently, he was 
named medical correspondent for 
the ABC network, and he will soon 
begin a nutrition/health column 
for The New York Times. 
“I was drawn to the media for 
the same reason I was drawn to 
public health: to have the greatest 
impact on the health of the popu¬ 
lation,” he says. 
A self-described multitasker— 
Katz, 42, typically works at least 
10 hours a day, seven days a week, 
and once juggled three book 
deadlines simultaneously—he 
recognizes that his expanding 
media obligations will require him 
to cut back on his clinical and 
academic duties. He plans to teach 
a bit less and relinquish his post 
as director of medical studies in 
public health at the School of 
Medicine, which he has held for 
eight years. He will continue to 
see patients and to direct Yale’s 
Prevention Research Center. 
“What’s mattered to me from 
the start,” he says,"is making a 
difference. I’m interested in real- 
world impact, as soon as possible.” 
That’s why he sees his work in the 
media as worthwhile. “We could 
all but eradicate heart disease, 
and greatly reduce the toll of can¬ 
cer, just by implementing what we 
already know,” he says. “So the 
question is: how do we get people 
to make changes in their lives? 
One thing that’s clear, you need to 
reach them. Through my work in 
the media, I can reach many more 
people in one day than I could 
hope to reach treating patients in 
my office over the span of my 
entire career.” 
Besides teaching, treating 
patients, writing and making 
public appearances, Katz is also a 
successful inventor and poet. 
Among his inventions—he holds 
five patents—are an anatomically 
appropriate bicycle seat, a multi¬ 
use winter sport boot for children 
and a child-safe nail clipper. As 
an antidote to all his medical writ¬ 
ing he turns to poetry, which has 
been published in anthologies and 
journals ranging from the strictly 
literary to JAMA: The Journal of the 
American Medical Association. 
Katz, who has five children, 
says that when he’s not working 
he enjoys cooking, horseback 
riding, hiking, skiing and carpen¬ 
try. His wife, Catherine, a neuro¬ 
scientist, is collaborating with him 
on a book about nutrition. 
He attributes his productivity 
to passion for the things he does. 
“Loving what you do makes all the 
difference,” he notes. 
—Jennifer Kaylin 
| Essay NORA E. GROCE, PH.D. 
An assumption with 
deadly consequences 
Throughout the world, health 
workers find it hard to believe that the 
disabled are at risk for hiv/aids. 
Because of the strange sores that had 
begun to appear on the inside of James’ 
mouth and on his arms, the 28-year- 
old finally decided to get tested for 
hiv. Heterosexual, with more than one 
girlfriend, and living in a region of 
southern Africa where almost 40 per¬ 
cent of the population is Hiv-positive, 
James had good reason to worry. He 
begged a neighbor for a ride into town 
to avoid walking seven hours to the 
hiv clinic, and once there he waited 
three hours for his name to be called. 
As soon as he stepped to the front 
desk, however, he was dismissed; the 
nurse had been watching James 
while he waited, and right away she 
told him, “You don’t need a test; you 
couldn’t possibly have hiv.” 
When I spoke with James six months 
later, the wasting caused by the aids 
virus had already begun to take its toll. 
Like millions of other Africans, this 
young man would soon die of aids. 
James was different from them in only 
one way: James was deaf. 
The vulnerability to hiv/aids of the 
world’s 600 million disabled people 
has been virtually ignored. Conven¬ 
tional wisdom dictates that people with 
disabilities are unlikely to be at risk— 
unlikely to have sex, use drugs or be 
vulnerable to rape. Yet disabled indi¬ 
viduals are at equal or increased risk 
for all known aids risk factors. High 
rates of poverty and illiteracy and the 
stigma associated with disability only 
increase these risks for the millions 
of people who live with a physical dis¬ 
ability or psychiatric illness or who 
are blind, deaf or mentally retarded. 
As a researcher on disability issues, 
I suspected that the impact of aids 
on those with pre-existing disabilities 
was being overlooked. I was unpre¬ 
pared, however, for how little attention 
this issue had received. A search of 
the global literature yielded only 38 
short articles on the topic. 
I wanted to fill this gap. In 2003, 
with funding from the World Bank I 
undertook a global survey on hiv/aids 
and disability. We sent it to 5,500 aids 
researchers, rehabilitation programs and 
disability advocacy groups worldwide. 
Responses came from 57 countries. 
Worldwide, the data showed, aids 
education and outreach programs are 
extremely unlikely to reach disabled 
individuals, aids radio campaigns do 
not educate the deaf. Billboard and 
newspaper campaigns do not reach the 
blind. With global literacy rates for 
disabled adults averaging as low as 
3 percent (and around 1 percent for 
disabled women), many disabled indi¬ 
viduals can’t understand complicated 
aids education messages. For those 
who do seek testing or medical care, 
accessibility remains a problem: stairs 
impede entrance to clinics for those 
with physical mobility problems. 
Concerns do not end there. The 
assumption that people with disabilities 
are virgins endangers lives in two 
ways. In dozens of countries, individ¬ 
uals with disabilities are turned away 
from testing centers by health workers 
who assume that they are neither sexu¬ 
ally active nor Hiv-positive. In many 
countries they are targeted for rape by 
Hiv-positive people who believe in “vir¬ 
gin cleansing.” Even those diagnosed 
with hiv are at the bottom of lists for 
medical care and social support; their 
lives are considered less valuable than 
those of people without disabilities. 
These results carry a message for 
clinicians worldwide: they must be 
aware of the risks that their disabled 
patients face. Yet people with disabil¬ 
ities find that doctors rarely ask them 
whether they are sexually active or dis¬ 
cuss safer sex, even though their risk of 
physical abuse and rape is significantly 
higher than for nondisabled people, par¬ 
ticularly in group homes or institutions. 
The survey results have fostered 
increased awareness of hiv/aids and 
disability, and over the past year, a 
consortium of UN agencies has joined 
the World Bank and disability advo¬ 
cacy organizations to press for inclu¬ 
sion of a disability component in aids 
outreach and education. My colleagues 
and I have begun a new series of stud¬ 
ies to better identify and evaluate pro¬ 
grams for disabled individuals at risk. 
I hope it will make a difference: the 
need is immediate, and millions of 
lives are at stake. 
For more information, visit 
www.cira.med.yale.edu/globalsurvey. 
The American Sign Language symbols above 
spell AIDS. 
Nora E. Croce, ph.d., is an associate professor 
of public health and anthropology in the Global 
Health Division of the School of Public Health. 
WE WELCOME SUBMISSIONS 
Do you have an opinion to share on a vital 
topic in medicine, health or science? 
Send your thoughts to Essay, Yale Medicine, 
P.O. Box 7612, New Haven, CT 06519-0612, 




















32 Faculty NOTES 
David Leffell Kim Bottomly Thomas Gill Steven Hebert Stefan Somlo Hal Blumenfeld 
As deputy dean, 
Leffell moves practice 
into 21st century 
With his appointment as deputy 
dean for clinical affairs in February, 
DAVID J. LEFFELL, M.D., HS ’86, 
continues a task he began almost 
10 years ago, when he added a 
new portfolio to his work in the 
clinic and laboratory. As associate 
dean for clinical affairs and direc¬ 
tor of what was then called the 
Yale Faculty Practice, Leffell sought 
to improve the business side of 
medicine. The faculty practice is 
now the Yale Medical Group (ymg), 
where recent surveys show 
improved patient satisfaction, as 
well as areas where improvement 
is needed. Most importantly, 
the ymg has begun to introduce 
changes in the practice of medi¬ 
cine, helping it move outside 
traditional departmental bounda¬ 
ries into interdisciplinary, 
disease-based teams that include 
researchers as well as physicians. 
“Because our knowledge of 
disease is so much more refined, 
we understand that solutions to 
illness are not limited to a particu¬ 
lar organ in which the disease is 
expressed,” said Leffell, who will 
oversee the growth and develop¬ 
ment of the clinical practice. Among 
his goals are strengthening ties 
between clinical care and medical 
research and spreading the word 
about Yale’s faculty expertise. He 
also hopes to improve the clinical 
infrastructure by making it easier 
for patients to make appointments 
and by ensuring close communica¬ 
tions between referring physicians 
and specialists. 
"To teach medical students to 
be doctors of the 21st century, 
to take care of patients with new 
technology and medications of 
the 21st century, you have to have 
a clinical practice of the 21st 
century,” Leffell said. 
Bottomly named 
deputy provost for 
science, technology 
H. KIM BOTTOMLY, PH.D., has 
been named deputy provost for 
science, technology and faculty 
development, effective July 1. 
Bottomly, who has been at Yale 
since 1980, is professor of immuno¬ 
biology, dermatology and molecu¬ 
lar, cellular and developmental 
biology. She also served as acting 
chair of the Section of Immuno¬ 
biology. Provost Andrew D. 
Hamilton, ph.d., announced the 
appointment in April. 
As deputy provost, Bottomly 
will help shape and implement 
policies in the natural sciences, 
anthropology, psychology, statis¬ 
tics and linguistics. She will over¬ 
see Yale Engineering, the School of 
Forestry & Environmental Studies, 
the Peabody Museum of Natural 
History, the Yale Institute for 
Biospheric Studies and the Yale- 
affiliated Haskins Laboratories. 
Bottomly will also work on initia¬ 
tives to increase faculty diversity, 
improve recruitment and reten¬ 
tion of women and underrepre¬ 
sented minorities in science, and 
enhance career development 
for faculty. 
Three Yale scientists have received 
close to $1 million each from 
the Ellison Medical Foundation to 
pursue research into infectious 
disease. The three are among the 
to Senior Scholars in Global 
Infectious Disease announced 
in December. 
Jorge E. Galan, PH.D., D.V.M., 
the Lucille P. Markey Professor 
of Microbiology and chair of 
the Section of Microbial Patho¬ 
genesis, will study the bac¬ 
terium Campylobacter jejuni, 
one of the most common causes 
of gastrointestinal infection 
worldwide. 
John R. Carlson, PH.D., the 
Eugene Higgins Professor of 
Molecular, Cellular and Develop¬ 
mental Biology, will explore 
new approaches to the design 
of repellents and traps for 
disease-carrying insects. 
Ruslan Medzhitov, ph.d., pro¬ 
fessor of immunobiology and a 
Howard Hughes Medical Insti¬ 
tute investigator, will examine 
how immune system responses 
to one infectious agent affect 
the body’s defenses against con¬ 
current infections. 
Thomas M. Gill, M.D., FW ’94, 
associate professor of medicine 
(geriatrics), and Michael Cappello, 
m.d., fw ’95, associate professor 
of pediatrics and epidemiology, 
have been elected to the Ameri¬ 
can Society for Clinical Investi¬ 
gation (ASCi),one of the nation's 
oldest and most respected 
medical honor societies. The 
asci membership includes 
physician-scientists elected for 
their achievements in biomedi¬ 
cal research. 
Two Yale physician-scientists 
were honored with major 
awards in the field of kidney 
research at the World Congress 
of Nephrology meeting in 
Singapore in June. 
Steven C. Hebert, M.D., the 
chair and c.n.h. Long Professor 
of Cellular and Molecular Physi¬ 
ology and professor of medicine, 
and Stefan Somlo, M.D., fw ’91, 
the c.n.h. Long Professor of 
Medicine and chief of the Section 
of Nephrology, are being recog¬ 
nized for important discoveries. 
Hebert will receive the A.N. 
Richards Award, which carries a 
$10,000 cash prize, from the 
International Society of Nephrol¬ 
ogy (isn) for three discoveries in 
the field of ion transport and ion 
sensing. Somlo will share the 
Lillian Jean Kaplan International 
Prize for Advancement in the 
Understanding of Polycystic 
Kidney Disease for his work in dis¬ 
covering genes that cause poly¬ 
cystic kidney and liver diseases. 
Somlo and co-recipient Gregory G. 
Germino, m.d., hs ’87, of the Johns 
Hopkins School of Medicine will 
receive $50,000 each from The 
pkd Foundation and the isn. 
A third Yale nephrologist, 
Walter F. Boron, M.D., ph.d., pro¬ 
fessor of cellular and molecular 
physiology, has been selected 
to receive the Homer W. Smith 
Award, the American Society of 
Nephrology’s top honor for basic 
research. The award, which 
carries a $10,000 cash prize, will 
be presented at the society’s 
annual meeting in November 
in Philadelphia. 
Two Yale psychiatrists received 
the American Psychiatric Asso¬ 
ciation’s APiRE/Kempf Fund 
Award for Research Development 
in Psychobiological Psychiatry at 
the association’s annual meeting 
in Atlanta in May. 
John H. Krystal, M.D. '84, the 
Robert L. McNeil Jr. Professor 
of Clinical Pharmacology and 
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Ronald Breaker Linda Degutis 
deputy chair for research in the 
Department of Psychiatry, and 
Daniel H.Mathalon, M.D., PH.D., 
assistant professor of psychiatry, 
were recognized for providing 
new insights into the neurobiol¬ 
ogy and treatment of cognitive 
impairments associated with 
schizophrenia. 
In March Sidney J. Blatt, ph.d., 
professor of psychiatry and psy¬ 
chology and chief of psychology 
in the Department of Psychiatry, 
in collaboration with colleagues 
in Belgium, published a book, 
The Theory and Treatment of 
Depression: Towards a Dynamic 
Interactionism Model, that grew 
out of a collaboration begun 
in 2003. Blatt spent a month 
that year at the Catholic Univer¬ 
sity of Leuven as a visiting pro¬ 
fessor. A colleague at Yale, Paul L. 
Errera, M.D., HS ’57, professor 
emeritus of psychiatry and a 
native of Belgium, sent greet¬ 
ings via videotape. 
Hal Blumenfeld, M.D., PH.D., 
fw ’98, assistant professor of 
neurology, neurobiology and 
neurosurgery, has received the 
Dreifuss-Penry Epilepsy Award 
from the American Academy of 
Neurology. The award recognizes 
physicians in the early stages 
of their careers who have con¬ 
tributed to epilepsy research. 
Ronald R. Breaker, ph.d., associ¬ 
ate professor of molecular, cellu¬ 
lar and developmental biology, 
has been named a Howard 
Hughes Medical Institute inves¬ 
tigator and the Henry Ford II 
Professor of Molecular, Cellular 
and Developmental Biology. 
Breaker’s lab explores the “rna 
world,” the idea that the Earth’s 
first life forms were composed 
of rna rather than dna. His 
Vincent DeVita Jr. John MacMicking Bruce McClennan Anna Marie Pyle 
studies have led him to discover 
dozens of regulatory struc¬ 
tures, known as riboswitches, 
which might be used to control 
the activity of genes inserted 
into cells during the course of 
gene therapy. 
David C. Cone, M.D., associate pro¬ 
fessor of surgery (emergency 
medicine) and public health, was 
installed as president-elect of 
the National Association of ems 
Physicians at the group’s annual 
meeting in January. 
Linda C. Degutis, m.s.n. '82, 
dr.ph. ’94, associate professor 
of surgery (emergency medicine) 
and epidemiology and public 
health, was elected chair of the 
executive board of the American 
Public Health Association, the 
primary association for public 
health professionals. 
Vincent T. DeVita Jr., M.D., HS '66, 
the Amy and Joseph Perella 
Professor of Medicine, has been 
named editor in chief of a new 
journal for oncologists, Nature 
Clinical Practice Oncology. DeVita 
previously served as head of the 
Yale Cancer Center and director 
of the National Cancer Institute. 
Marie L. Landry, M.D., HS ’77, FW 
'81, professor of laboratory medi¬ 
cine and director of the Clinical 
Virology Laboratory at Yale-New 
Haven Hospital, received the 
2005 Diagnostic Virology Award 
from the Pan American Society 
for Clinical Virology in May 
for outstanding contributions to 
the field. 
Robert J. Levine, M.D., HS ’63, pro¬ 
fessor of medicine and co-chair 
of the Yale Bioethics Project, has 
received the Health Improvement 
Institute’s Lifetime Achievement 
Award for Excellence in Human 
Research Protection. Levine has 
contributed to the literature of 
the field of protection of human 
research subjects by publishing 
over 200 articles and one major 
monograph and by founding and 
editing IRB: A Review of Human 
Subjects Research. 
John D. MacMicking, ph.d., assist¬ 
ant professor in the Section 
of Microbial Pathogenesis, has 
been selected as a 2005 Searle 
Scholar as part of a program 
that supports the independent 
research of young faculty in 
the biomedical sciences and 
chemistry. In 2004 MacMicking 
also received the Mallinckrodt 
Foundation Program Scholar 
Award, given annually to young 
scientists starting their careers. 
He studies host innate immu¬ 
nity, with an emphasis on the 
role played by interferon path¬ 
ways against intracellular infec¬ 
tions like tuberculosis. 
Bruce L. McClennan, M.D., profes¬ 
sor and chair of diagnostic 
radiology, was elected president 
of the American Roentgen Ray 
Society, effective May 15. The 
oldest radiology society in the 
United States, it has advanced 
radiology through annual scien¬ 
tific and educational meetings 
and the American Journal of 
Roentgenology. 
Stephanie S. O’Malley, ph.d., pro¬ 
fessor of psychiatry and director 
of the department’s Division of 
Substance Abuse Research, has 
received the 2004 Dan Anderson 
Research Award.The award, 
sponsored by the Butler Center 
for Research at the Hazelden 
Foundation, honors researchers 
who have advanced the study of 
addiction recovery. 
Robert Udelsman Stephen Waxman 
Anna Marie Pyle, PH.D., has been 
appointed the William Edward 
Gilbert Professor of Molecular 
Biophysics and Biochemistry. 
Her research explores how rna 
folds and organizes itself to 
catalyze reactions. Since 2002, 
Pyle has also been a Howard 
Hughes Medical Institute 
investigator. 
The Bayer Pharmaceuticals Corp. 
has given the 2004 Bayer Award 
to Raymond R. Russell, M.D., ph.d., 
fw ’00, assistant professor of 
medicine (cardiology). Russell 
studies cardiac function and 
metabolism and the changes 
associated with disease states. 
Robert Udelsman, M.D., m.b.a., 
the Lampman Professor of 
Surgery and Oncology and chair 
of surgery, was elected presi¬ 
dent of the American Associa¬ 
tion of Endocrine Surgeons. 
Membership includes surgeons 
who devote significant portions 
of their practice or research to 
endocrine surgery and who are 
certified by the American Board 
of Surgery. 
Stephen G. Waxman, ph.d., M.d., 
professor and chair of neurol¬ 
ogy and professor of pharma¬ 
cology and neurobiology, has 
been named the Bridget Marie 
Flaherty Professor of Molecular 
Neurology. Waxman, a renowned 
neurologist and molecular 
neuroscientist, studies the roles 
of sodium channels in multiple 
sclerosis, spinal cord injury and 
neuropathic pain. 
SEND FACULTY NEWS TO 
Claire M. Bessinger, Yale Medicine, 
P.O. Box 7612, New ITaven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu 
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above Medical students sported toy 
stethoscopes as a symbol of their calling. 
opposite left Graduates Mariah Ruth 
and Michael Shapiro joked with Associate 
Dean Nancy Angoff before the procession 
to the main campus. 
opposite right Helena Hansen, who 
graduated from the m.d./ph.d. program, 
took her daughter, Kirin, onstage as she 

















An unfinished agenda: 
keeping people healthy 
At Commencement, a former 
surgeon general urges access to 
health care and sex education. 
Growing up in a small town in Arkansas, 
M. foycelyn Elders, m.d., never saw a 
physician until she went to college. But 
in 1993 she became the nation’s top 
doctor, and as surgeon general her out¬ 
spoken support of sex education pro¬ 
voked controversy. Access to knowledge 
about sexual health issues was a theme 
she echoed in her Commencement 
address at the School of Medicine in 
May, and the crowd loved it. 
Elders told the 96 graduating stu¬ 
dents—who offered standing ovations at 
the beginning and end of her address— 
that an increase in hiv infections, ris¬ 
ing rates of sexually transmitted diseases 
and the highest teenage pregnancy rates 
in the industrialized world prove that 
there’s an important place for sexual- 
health education in schools. “You can’t 
keep people healthy if you don’t educate 
them,” said Elders, professor emeritus 
of pediatric endocrinology at the Univer¬ 
sity of Arkansas for Medical Sciences. 
“And you can’t educate them if they’re 
not healthy.” 
Although she has long advocated 
abstinence, she also feels that young 
people need to know about safe sex. 
“The vows of abstinence,” she told the 
cheering crowd, “break far more easily 
than a latex condom.” 
She also cautioned the graduates 
that, despite having the best medical 
education, the best training, the best 
hospitals and the best colleagues in the 
world, they have a huge unfinished 
agenda. “We need to make sure we have 
improved access to care for all of our 
people,” she said, noting that more than 
40 million people in the United States 
lack health insurance. Elders ended on a 
note of optimism, asking the graduates 
to use their power, prestige and position 
in their communities to effect change. 
At the Commencement on 
Harkness Lawn, the Class of 2005 
The Class of 2005 chose Joycelyn Elders, 
who served as surgeon general under 
President Clinton, as its keynote speaker. 
students 
top Stephanie Colegio-Eisenbarth celebrated 
with her husband, Oscar Colegio, who gradu¬ 
ated from the medical school last year. 
above Inna Landres and Michele Flagge 
before the university ceremony on Old Campus. 
honored Robert D. Auerbach, m.d., 
hs ’87, lecturer in obstetrics, gynecol¬ 
ogy and reproductive sciences, with 
the Francis Gilman Blake Award for 
outstanding teaching. Jennifer M. 
Gaudiani, m.d., a resident in internal 
medicine, received the Betsy Winters 
House Staff Award, given to the resi¬ 
dent who has made the most signifi¬ 
cant contribution to the education 
of medical students. This year’s class 
gift was the largest ever: $2,000 was 
given to the Society for Distinguished 
Teachers, and $2,000 was pledged 
to the medical school’s endowment for 
scholarships, an amount that will be 
matched by the university. 
The Bohmfalk Prize for teaching 
basic sciences was awarded to a 
husband-and-wife team for the first 
time: Marie L. Landry, m.d., hs ’77, 
fw ’81, professor of laboratory medi¬ 
cine, and Peter S. Aronson, m.d., 
fw ’75, the c.n.h. Long Professor of 
Medicine and professor of cellular 
and molecular physiology. Tire Bohmfalk 
Prize for teaching clinical science 
went to Michael K. O’Brien, m.d., 
ph.d., assistant clinical professor of 
surgery (gastroenterology). Sharon K. 
Inouye, m.d., m.p.h. ’89, professor of 
medicine, received the Leonard Tow 
Humanism in Medicine Award, while 
Catherine Chiles, m.d., associate clini¬ 
cal professor of psychiatry, won the 
Leah M. Lowenstein Prize, which rec¬ 
ognizes faculty who promote humane 
and egalitarian medical education. 
The first annual Alvin R. Feinstein 
Award for outstanding clinical skills 
was awarded to Ronald R. Salem, 
m.d., associate professor and chief 
of surgery (oncology). 
—Jill Max 
An “old-fashioned” idea: 
nothing is more important 
than the public health 
Fast Food Nation author Eric Schlosser 
peered at the 107 public health students 
gathered for Commencement in Battell 
Chapel on May 23 and called them 
“strange.” In a culture that insists that 
“everything is better when it’s for 
profit,” he said, these new graduates of 
the School of Public Health believe 
in “incredibly old-fashioned” ideas: the 
public good, the public interest and 
public service. 
“There is nothing more important 
than the public health,” said Schlosser, 
a journalist whose bestselling book 
describes how the fast food industry has 
transformed America’s diet and its 
economy. “We have lost sight of this 
basic truth, and the greed and the self¬ 
ishness of the past two decades have 
obscured it.” Even the wealthiest will 
not be safe from what Schlosser calls 
“the great levelers of mankind: the 
viruses and microbes that don’t really 
care where you went to school.” 
Good public health saves money in 
the long run, said Schlosser. Just as 
disease mapping helped pioneering epi¬ 
demiologist John Snow, m.d., discover 
the water pump responsible for much 
of a London cholera outbreak in 
1854, modern maps would locate the 
American public health crisis in the 
poorest neighborhoods. “It is an illu¬ 
sion—a dangerous illusion—to think 
that the poor health of the poor can 
be ignored. We will all pay for it one 
way or another,” said Schlosser, noting 
that microbes from a sick busboy 
can find their way into the finest of 
gourmet meals. 
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In closing, Schlosser told the gradu¬ 
ates, “We need more strange people like 
you. I have enormous respect for the 
path you have chosen.” 
Also speaking was graduate Reshma 
Trasi, who told her classmates to 
persist despite barriers and to listen. 
“The next time you want to say some¬ 
thing, try stopping yourself and let¬ 
ting the other person talk. ... It will 
open your mind.” 
The students chose Elizabeth H. 
Bradley, m.b.a., ph.d. ’96, associate 
professor of public health, for the 
Award for Excellence in Teaching, her 
third in her nine-year career at Yale. 
Other awardees included Lisa M. 
DiFedele, Famoosh Hashemian, Asa 
Margolis and Bonnie E. Gould Rothberg, 
m.d. ’94, hs ’96, each of whom 
received a Dean’s Prize for outstanding 
master’s thesis. 
The Wilbur G. Downs International 
Efealth Prize went to Anna Beitin; the 
Henry J. (Sam) Chauncey Jr. Inspiration 
Award to Elinor Schwimmer; and the 
Cortlandt Van Rensselaer Creed Award 
to Edward Magee and Anika Hines. 
—Cathy Shufro 
CLOCKWISE FROM TOP LEFT 
Before the ceremony on Old Campus, public 
health student Koren Odierna helped Aruna 
Dhara adjust her stole as Nabila Alibhai 
watched. 
Fast Food Nation author Eric Schlosser, left, with 
public health Dean Brian Leaderer, said in his 
Commencement address that the health of the 
poor cannot be ignored. Viruses and microbes, 
he said, are “the great levelers of mankind.” 
Elizabeth Bradley received the award for excel¬ 
lence in teaching. 
Kevin Neill waited with classmates for the 
procession into Battell Chapel. 
Reshma Trasi, who gave the student address, 



































Match Day sees more bound 
for New Haven residencies and 
training as generalists 
While many people celebrated March 17 
as St. Patrick’s Day, medical students 
from the Class of 2005 had another 
reason to celebrate. There were shouts, 
cheers and tears of joy at Harkness 
Ballroom on Match Day, the half-century- 
old ritual that will likely determine 
the course of their careers. Nationwide, 
almost 94 percent of medical school 
seniors matched to residencies this year. 
Students applied to programs 
around the country, but a larger number 
than ever before—27 out of 94—are 
staying in Connecticut, mostly at Yale- 
New Haven Hospital. “People worry 
about New Haven—is it keeping good 
students? Well, it’s keeping really good 
students,” said Nancy R. Angoff, m.p.h. 
’81, m.d. ’90, hs ’93, associate dean for 
student affairs. Another trend at Yale is 
that more students this year are going 
into internal medicine, primary care 
and pediatrics than in past years, which 
saw higher numbers of graduating 
seniors entering surgical subspecialties. 
For the most part, students were 
calm and poised as they approached the 
Douglas Jacobson, Michele Flagge, Christopher 
Kwong, David Oman, Brendon Craeber, Suzanne 
Baron and Christoph Lee toasted their matches. 
tables stacked with the envelopes that 
held news of their futures for the next 
four years. But Michael Shapiro was 
unable to contain himself as he sprinted 
ahead of the crowd, ripped open his 
envelope, let out a yell and then burst 
into tears. He was accepted to the 
University of Pittsburgh Medical 
Center’s plastic surgery program, his 
goal after volunteering for Operation 
Smile two years ago, when he went 
to Morocco to assist with reconstructive 
surgery. “It sounds schmaltzy,” he 
said, “but it’s been my dream.” 
Many students whipped out cell 
phones to share the good news with 
family and friends, but Brad Raphael 
was able to share it in person with his 
father, Irving G. Raphael, m.d. ’71, who 
was on hand. “It’s excitement, nervous¬ 
ness and relief all combined into one,” 
the younger Raphael said before open¬ 
ing his envelope. Upon learning the 
good news—that he was going to the 
Hospital for Special Surgery at Cornell 
University Weill Medical College to pur¬ 
sue orthopaedic surgery—he hugged 
his father, also an orthopaedist, and 
said, “It’s exactly where I want to be. 
I’m feeling euphoria right now.” 
—Jill Max 
Brad Raphael was joined by his father, Irving 
Raphael, an orthopaedist who graduated from 
the medical school in 1971. 
2005 residency placements 
for Yale medical students 
The Office of Student Affairs has pro¬ 
vided the following list, which outlines 
the results of the National Resident 
Matching Program for Yale’s medical 
graduates. Some names appear twice 
because the graduate is entering a one- 
year program before beginning a specialty 
residency. The transitional designation 
is a one-year program with three-month 
rotations in different specialties. 
California 
Harbor-UCLA Medical Center,Torrance 
Leo Kim, medicine-preliminary 
Stanford University Programs 
Jeffrey Chi, internal medicine 
Douglas Jacobson, medicine¬ 
preliminary 
Inna Landres, obstetrics and 
gynecology 
Christoph Lee, diagnostic radiology 
Nir Modiano, internal medicine 
UCLA Medical Center, Los Angeles 
Edidiong Ikpe, emergency 
medicine/internal medicine 
University of California, 
San Francisco 
Neelendu Dey, internal medicine 
Jessica Yager, internal medicine 
University of Southern California, 
Los Angeles 
Leo Kim, ophthalmology 
Colorado 
HealthONE Presbyterian/St. Luke’s 
Medical Center, Denver 
Mariah Ruth, transitional 
University of Colorado School of 
Medicine, Denver 
Heidi Cook, obstetrics and 
gynecology 
Mariah Ruth, dermatology 
Connecticut 
Hospital of Saint Raphael’s, New 
Haven 
Annika Dronge, transitional 
David Oman, transitional 
Middlesex Hospital Program, 
Middletown 
Kohar Jones,family practice 
3 
LEFT TO RIGHT Edidiong Ikpe 
and Niya Jones were ecstatic with 
their matches. Ikpe is pursuing 
emergency medicine and internal 
medicine at ucla and Jones is 
doing an internal medicine resi¬ 
dency at the Hospital of the 
Yale-New Haven Hospital 
David Aversa, psychiatry 




Gina Constantine, internal 
medicine/primary 
Vicente Diaz, ophthalmology 
Annika Dronge, ophthalmology 
Thomas Fernandez, psychiatry- 
adult/child 
John Forrest, internal medicine 
Adam Gafni-Kane, obstetrics and 
gynecology 
Barton Kenney, pathology-anatomic 
and clinical 
Brett King, dermatology 
Eleanor Knopp, dermatology 
Christopher Kwong, internal 
medicine/primary 
Catherine Loerke, surgery-preliminary 
Javier Lopez, obstetrics and gynecology 
Coeurlida Louis, internal 
medicine/primary 
Ernest Mandel, internal medicine 
Deanne Nakamoto, medicine¬ 
primary-preliminary, ophthalmology 
Sarah Nikiforow, internal medicine 
Damani Piggott, medicine/pediatrics 
David Ross, psychiatry 
Isaac Sasson, obstetrics and gynecology 
Grace Smith, medicine-preliminary 
Curtis Weiss, internal medicine 
Carlos Wesley, emergency medicine 
Florida 
Jackson Memorial Hospital, Miami 
Matthew Whitley, otolaryngology 
Georgia 
Emory University School of Medicine, 
Atlanta 
Michele Flagge, emergency medicine 
Andre Matthews, emergency 
medicine 
Hawaii 
University of Hawaii Program, 
Honolulu 
Christoph Lee, transitional 
Indiana 
Indiana University School of 
Medicine, Indianapolis 
Nicholas Countryman, dermatology 
Iowa 
University of Iowa (Des Moines) 
Program 
Andrew Chen, medicine-preliminary 
Maryland 
Johns Hopkins Hospital, Baltimore 
Yuri Agrawal, surgery-preliminary, 
otolaryngology 
Amy Duffield, pathology 
Naudia Lauder, internal medicine 
Martine Solages, pediatrics 
Massachusetts 
Beth Israel Deaconess Medical 
Center, Boston 
Jillian Catalanotti, internal medicine 
Dagan Coppock, internal medicine 
Eric Golding, internal medicine 
Joshua Klein, medicine-preliminary 
Boston University Medical Center 
Katherine Gergen Barnett, 
family practice 
Brigham and Women’s Hospital, 
Boston 
Cristina Baseggio, internal 
medicine/primary 
Michael Herce, internal medicine 
Eleanor Knopp, medicine-preliminary 
Janelle Luk, obstetrics and 
gynecology 
Harvard Combined Program, Boston 
Susan Rushing, pediatric neurology 
Massachusetts General Hospital, 
Boston 
Suzanne Baron, internal medicine 
Brett King, medicine-preliminary 
Mandy Krauthamer, internal 
medicine/primary 
Erin Mahony, pediatrics 
Brian Nahed, surgery-preliminary, 
neurosurgery 
Massachusetts General Hospital/ 
Brigham and Women's Hospital, 
Boston 
Joshua Klein, neurology 
Massachusetts General Hospital 
(Harvard Combined) 
Ariel Frey, medicine/pediatrics 
Michigan 
University of Michigan Hospitals, 
Ann Arbor 
Raymond Lynch, general surgery 
Mississippi 
Keesler Medical Center Program, 
Keesler afb 




Daniel Gibson, surgery-preliminary, 
neurosurgery 
New York 
Albert Einstein College/Montefiore 
Medical Center, Bronx 
Margo Simon, family practice 
Flushing Hospital Medical Center 
Daniel Khaimov,transitional 
Hospital for Special Surgery/Cornell 
Medical Center 
Bradley Raphael, orthopaedic surgery 
Mount Sinai Hospital 
Jocelyn Softer, psychiatry 
New York-Presbyterian Hospital- 
Columbia 
Rohit Chandwani, general surgery 
Daniel Khaimov, anesthesiology 
Aimee Lee, internal medicine 
New York-Presbyterian Hospital- 
Cornell 
Jennifer Davids, general surgery 
Matthew Davids, internal medicine 
Elena Gimenez-Hubbard, surgery¬ 
preliminary, urology 
Edison Machado, internal 
medicine/primary 
New York University School of 
Medicine 
Helena Hansen, psychiatry 
David Oman, diagnostic radiology 
nyu Downtown Hospital 
Vicente Diaz, medicine-preliminary 
Sound Shore Medical Center of 
Westchester, New Rochelle 
Neil Lester, medicine-preliminary 
Staten Island University Hospital 
Neil Lester, diagnostic radiology 
University of Rochester/Strong 
Memorial Hospital 
Lorky Libaridian, medicine/pediatrics 
University of Pennsylvania. 
Erin Mahony shared her news— 
a residency in pediatrics at 
Mass General. News of his resi¬ 
dency brought Michael Shapiro 
to tears of joy. 
North Carolina 
Duke University Medical Center, 
Durham 
Hardean Achneck, general surgery 
Richard Chung, medicine/pediatrics 
Sean Lee, general surgery 
University of North Carolina 
Hospitals Program, Chapel Hill 
Jesse James, internal medicine 
Trevor Phillips, emergency medicine 
Pennsylvania 
Children's Hospital of Philadelphia 
Frances Balamuth, pediatrics 
Christina Lynch, pediatrics¬ 
preliminary, pediatric neurology 
Hospital of the University of 
Pennsylvania, Philadelphia 
Niya Jones, internal medicine 
June Spector, internal medicine/ 
primary 
University of Pittsburgh Medical 
Center 
Michael Shapiro, plastic surgery 
Washington 
University of Washington Affiliated 
Hospitals, Seattle 
Chloe Atreya, internal medicine 
Andrew Chen, ophthalmology 
Jing Feng, dermatology 
Sharon Gill, internal medicine/ 
primary 
Lianne Hirano, internal medicine 
Douglas Jacobson, ophthalmology 
Wisconsin 
Medical College of Wisconsin 
Program, Milwaukee 
Matthew Streckert, emergency 
medicine 
St. Joseph Regional Medical Center, 
Milwaukee 
Jing Feng, transitional 
Three students are pursuing career 
opportunities other than residency. 
Julie Cantor will be an associate at 
Munger,Tolies & Olson, a lawfirm in 
Los Angeles. Eric Poolman has a pub¬ 
lic health postdoctoral fellowship at 
the School of Medicine. Louis Moreno 
has a position as research manager 
at Gerson Lehrman Group, a firm in 
Manhattan that specializes in cus¬ 






















below Caryn St. Clair, Cicely Williams and 
Danielle Guez sang and danced the show finale, 
"Bust Your Ass,” based on the 1990s Young 
M.C. hit: “This here’s a jam for all the students, 
tryin’ to get by, but it’s such a nuisance, get 
shut down cuz of your impudence. Studying a 
bit would show some more prudence.” 
middle Ryan Kelly sang “Hey, Yale,” a song 
about the Yale System, to the tune of Outkast’s 
“Hey Ya.” 
bottom Michael Martinez of Uberstein, a 
band with four medical students and one public 
health student, brought down the house with 
one original song and covers of oldies adapted 
to medical themes. 
Boffo reviews for Golden 
Probe!! Raves for Alpern!! 
Uberstein rocks Harkness!! 
The excitement was palpable at the 
First Annual Golden Probe Awards, the 
Class of 2007’s entry in the ever- 
popular parade of shows put on annu¬ 
ally by second-year medical students 
at Yale. Fans gathered behind a rope 
line at the entrance to Harkness Audi¬ 
torium to greet the nominees and 
wonder who among them would win 
the statues of gilded hands with erect 
index fingers honoring the best in the 
business. Fans cheered and snapped 
photos at the sight of celebrity docs on 
the other side of the rope. 
Inside, it was all about entertain¬ 
ment, not to mention the minutiae of 
being a medical student. The nod for 
Best Situation Comedy went to Seinfelder 
XXY, a spoof melding the television 
show Seinfeld with Klinefelter XXY syn¬ 
drome, a common chromosomal abnor¬ 
mality. Erotic Admissions took the award 
for Best Pornographic Film (heavens!), 
with a cast starring admissions dean 
Thomas L. Lentz, m.d. ’64, and adult- 
film actress Jenna Jameson, portrayed by 
Danielle Guez, as an applicant willing 
to get into med school “at any cost.” 
(Line from script: “The mcat is so long 
and hard!”) There was even an award 
for Best Physiology Textbook, pitting 
Costanzo’s Physiology, a top-rated text for 
med students, against Medical Physiology 
by local heroes Boron and Boulpaep. It 
ended in a tie. 
Dean Robert J. Alpern, m.d., made 
his Yale singing debut with the theme 
song from Dean Alpem’s Neighborhood, 
the winner of Best Children’s Show, 
which evoked the late Fred Rogers, 
complete with nerdy sweater and blue 
tennis shoes. The rock band Uberstein 
raised the roof with their original com¬ 
position, “New Haven Blues,” and the 
musicians—Michael Martinez and Eric 
Huebner on guitars, Brian Yablon on 
keyboards, Dario Englot on bass and 
public health student Jared Novak on 
drums—played the four nominations 
for Best Oldies Song. The titles? “This 
Gians is Made for You and Me,” by 
Woody Urethrie; “Doc Around the 
Clock,” by Bill Frist and the Congress: 
“Here Comes the Shunt,” by the 
Needles: and “Don’t Know Much” by 
Cram Booke. 
When it came to the cluelessness 
that defines at least a part of second 
year, the last entry said it all: 
Don’t know much biochemistry 
Don’t know much physiology 
Don’t know much about a histo book 
Don’t know much about those pills you took ... 
Of course that will all change in two 
years, when the singers and dancers 
of ’07 will have traded their status as 
resident comedians for the real drama 

















below The five students chosen to make oral 
presentations—Eric Poolman, Raymond Lynch, 
Margo Simon, Suzanne Baron and Joshua 
Klein—joined John Forrest, director of student 
research, keynote speaker Arthur Horwich 
and Dean Robert Alpern before their talks. 
middle David Ross studied the phenomenon 
of perfect pitch. 
bottom Jenna Giltnane described her research 
in protein expression to Linda Bi. 
Balancing the bedside 
and the bench, and having fun 
along the way 
As he delivered the 18th annual Farr 
Lecture at Student Research Day in 
May, Arthur L. Horwich, m.d., hs ’78, 
fw ’83, described his own path to a 
career in research. He trained as a 
pediatrician, but the lure of the labora¬ 
tory ultimately proved too strong 
to resist. Still, he found a balance, he 
said. “Research and the bedside,” he 
said, “are inextricably linked.” Horwich, 
a geneticist whose work has shown 
how proteins fold, still consults on 
clinical cases. 
“You cannot predict exactly what 
you will be doing in some balance of 
research and clinical medicine,” said 
Horwich, the Eugene Higgins Profes¬ 
sor of Genetics and professor of pedi¬ 
atrics, as he offered some advice. 
“Make sure it is a balance that really 
causes you to have fun.” 
Among the 75 students who pre¬ 
sented this year was second-year 
medical student Mary Dombrowski, 
who examined whether transplants of 
olfactory ensheathing cells can regen¬ 
erate myelin. She chose the topic 
because her father has multiple scle¬ 
rosis. In her experiments with rats 
she found that the cells did encourage 
myelin growth. “It has stimulated my 
interest in neurology as a career 
choice,” she said. 
Fourth-year student Hardean E. 
Achneck found the bright side to a dev¬ 
astating disease. Ascending aortic 
aneurysms are associated with a 
decrease in systemic atherosclerosis, 
and there may be a genetic mechanism 
involved, he said. “If we find out what 
the genes are, we may find the mecha¬ 
nism of this and, eventually, treat ath¬ 
erosclerosis,” he said. 
Research topics ranged from a mix 
of basic science and clinical findings to 
at least one offbeat subject. David A. 
Ross, a student in the m.d./ph.d. pro¬ 
gram, studied the phenomenon of 
absolute pitch. “The vast majority of 
great composers,” he said, “have had 
perfect pitch.” Alison H. Norris, also 
an m.d./ph.d. student, studied the hiv 
risk for workers on a sugar plantation 
in Tanzania. Helena Hansen, who 
completed the m.d./ph.d. program in 
May, studied faith-based substance 
abuse treatment in a Pentecostal com¬ 
munity in Puerto Rico. 
Five students were chosen to make 
oral presentations: Margo D. Simon, 
Eric Poolman, Suzanne J. Baron, 





































42 Alumni faces 
When he’s not caring for children, 
pediatrician Richard Dormont is 
often out birding near his home in 
Minot, North Dakota. 
65 years out of Yale 
and still practicing 
History taking and the physical exam 
remain at the heart of pediatrician 
Richard Dormont’s practice. 
In Minot, N.D. (population 36,567), the 
local tourism board had to make up a 
slogan to help outsiders remember the 
place’s name. (Why not Minot? rhymes 
when pronounced correctly.) Yet the 
small north-central North Dakota 
town draws families from large cities in 
surrounding states and Canada who 
come seeking medical help for children 
with hard-to-diagnose diseases. They 
come to consult pediatrician Richard E. 
Dormont, m.d. ’40. Still in practice at 
the age of 89, Dormont enjoys a repu¬ 
tation as a brilliant diagnostician as 
well as a dedicated doctor available to 
patients at all hours. For several years, 
he has had a reduced patient load and 
shorter office hours, which allows more 
time for bird-watching and for visiting 
his four daughters. But retirement is 
not on his radar. 
“I like keeping busy and using 
my skills,” Dormont said, 65 years 
after earning his medical degree. 
A voracious reader of journals and 
a regular at medical conferences, 
Dormont is scrupulous about keeping 
up with new science. But he believes 
passionately that the tools he relied 
on in the early days of his practice— 
history taking and physical examina¬ 
tion—remain the bedrock of medi¬ 
cine. Recently a couple raised in Minot 
brought their 19-month-old child 
home to consult Dormont after several 
physicians were puzzled by the child’s 
breathing problems. He made the 
potentially lifesaving diagnosis of con¬ 
genital heart disease with equipment 
no more high-tech than a stethoscope 
and his own ears. The other doctors, 
Dormont said, had focused on breath¬ 
ing problems and examined the lungs 
rather than the heart. In addition, he 
said, physicians nowadays too often fail 
to perform a thorough physical exam. 
Minot parents keep bringing him 
their newborns for routine care. “Every 
time someone has a new addition, they 
say, ‘Now you can’t retire until so-and- 
so’s 18!’,” said Leann Hayton, l.p.n. 
Hayton met Dormont in 1968 
when she came to work in pediatrics 
at Trinity Hospital in Minot. At first, 
Dormont’s “encyclopedic” knowledge 
was intimidating, but he quickly put 
her at ease. “Dr. Dormont is a wonder¬ 
ful and patient teacher,” she said. “I 
learned more listening to and working 
with him than I could have in any 
amount of schooling.” 
Ruth Ann Rexine, R.N., also came 
to know Dormont through hospital 
pediatrics. She remembers his routine 
of making rounds before 7 a.m. (after 
breakfasting over medical journals), 
spending the day in his office, then 
doing rounds again at 5 p.m. If a 
child’s condition worsened, day or 
night, Dormont would be at the hospi¬ 
tal in minutes. “Always in a suit and 
bow tie,” Rexine remembered. 
She chose Dormont for her own 
children because of his legendary thor¬ 
oughness, his custom of answering 
parents’ questions by phone every 
morning from 8:30 to 9 a.m. and for 
the way he could put children at ease. 
Dormont had initially planned to 
pursue a career in internal medicine. 
But when he lost the residency he 
wanted, his pediatrics professor came 
to the rescue with a job in the pediatric 
outpatient department at Johns 
Hopkins Hospital. He saw diseases 
that have disappeared or are a rarity— 
polio, measles, mumps—and each of 
the 55 patients he saw every day got a 
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Last November David Graham told a 
Senate committee that the Food and Drug 
Administration had mishandled the 
drug Vioxx, which he considered dangerous. 
physical examination. “It can be done,” 
Dormont said. 
After Johns Hopkins, Dormont 
taught at Louisiana State University for 
two years, but decided academic medi¬ 
cine was not for him. “You have to be 
a politician,” he said. “I’m the world’s 
worst politician.” 
Dormont served in the South 
Pacific during World War II and also 
practiced briefly in Texas. In 1953 he 
came to Minot, drawn by the chance 
to work in a group clinic. “That was 
almost considered communist on the 
East Coast,” he remembered. 
But the practice suited him because 
it provided him with his own lab, 
was connected to a hospital and, most 
importantly, allowed him his own 
medical library. 
Dormont has spent the later years of 
his career in solo practice. “That can be 
dangerous,” said James Moller, m.d., a 
University of Minnesota pediatric cardi¬ 
ologist who regularly comes to Minot for 
consultations. But, said Moller, Dormont 
is so intellectually rigorous that he chal¬ 
lenges himself the way a good partner 
would. “He is always questioning, look¬ 
ing up things, studying,” Moller said. 
Known universally as “Dr. Dormont,” 
he has cared for most of his commu¬ 
nity at one time or another. 
“Whenever I’m birding, someone 
will stop and say hello. Usually it’s one 
of my patients,” Dormont said. 
He estimates that he’s seen several 
hundred thousand patients during 
his career. As long as they keep seek¬ 
ing him out, he said, his practice 
will stay open. 
—Colleen Shaddox 
fda’s top safety critic 
keeps a watchful eye on 
the public good 
Whenever David J. Graham, m.d., m.p.h., 
hs ’81, wonders whether he made 
the right career move from Yale-New 
Haven Hospital resident to resident 
critic of the Food and Drug Adminis¬ 
tration (fda), he recalls with remorse 
a patient who died under his care. 
At the time, 1979-1981, he was 
doing a residency in internal medicine 
at Yale after graduating from the Johns 
Hopkins School of Medicine and plan¬ 
ning to become an expert on viral infec¬ 
tions of the central nervous system. 
But the patient died of an unexpected 
adverse drug reaction, and even though 
Graham was not at fault, “I was the 
person who had prescribed the drug,” 
Graham says. The incident “contributed 
to my interest in studying drug safety.” 
He also discovered during his time 
at Yale that he “didn’t enjoy the day-to- 
day grind of patient care,” so he settled 
on epidemiology. Since then, he has 
had a 20-year career as an epidemiolo¬ 
gist at the fda, forgoing more lucrative 
offers in the private sector. He is now 
associate director for science and medi¬ 
cine in the agency’s Office of Drug 
Safety. Despite (and because of) that 
title, he has also become the fda’s 
most vocal and listened-to critic. 
For years, Graham, 51, has been the 
fda’s equivalent of an ingrown toenail, 
causing his employer pain as he went 
public with allegations that the agency 
was allowing prescription drugs it 
approved to stay on the market despite 
evidence from its own researchers that 
the medications were harming and 
killing people by the thousands. 
In Graham’s view, the drug safety 
problems began in 1992 with the pas¬ 
sage of a law aimed at getting lifesav¬ 
ing drugs onto the market faster. To 
speed up approvals, the law forced 
pharmaceutical companies to foot 
most of the bill for the review process. 
That left the fda “captured by indus¬ 
try,” says Graham. “He who pays the 
piper calls the tune.” In the meantime, 
the same officials who approved the 
drugs were being asked to monitor 
their safety after they’d hit the market. 
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they’ve got to do an about-face,” he 
says. “At its heart, that is an inherent 
structural conflict of interest.” 
Graham said a former boss told him 
that the drug industry was the fda’s 
client, but Graham, an assistant scout¬ 
master and devout Catholic with six 
children, didn’t buy it. If he sees that a 
drug may be harmful, he’ll investigate. 
If the evidence warrants it, he’ll chal¬ 
lenge tire fda’s regulatory position inter¬ 
nally, even if it earns him the enmity 
of his superiors, which it often has. The 
fda labeled one of his studies “junk 
science,” and forbade him to publish 
it in a major medical journal. (Six 
weeks later the fda changed its mind 
and the article was published, last 
February, in The Lancet.) 
Graham has called for the with¬ 
drawal of a dozen prescription drugs, 
and almost all of them have since been 
removed from the market—often after 
a fight with his superiors—in some 
cases by the drugmakers themselves. 
One case made Graham a star witness 
before the United States Senate’s 
finance committee in 2004, when 
Merck & Co. suddenly removed 
Vioxx, its popular painkiller, after the 
company’s studies showed a higher 
risk of heart attacks and strokes among 
users of the drug. Graham had been 
warning about Vioxx for years, but the 
fda refused to pull the drug on his 
recommendations. He testified that the 
agency also urged him to change the 
conclusions of another damning study 
about Vioxx just before Merck’s sur¬ 
prising announcement. The voluntary 
withdrawal placed the agency in an 
unwelcome spotlight over its alleged 
failures to protect Americans against 
unsafe drugs. Meanwhile, Graham 
sought whistleblower status, and tele¬ 
phone calls disparaging him to the 
Government Accountability Project, a 
nonprofit that protects maverick 
insiders, were traced back to the fda. 
(fda officials say they allow employees 
to speak their minds, and couldn’t 
explain the incident.) 
“The fda has let the American people 
down and, sadly, betrayed a public trust," 
Graham told the Senate committee. 
“I think I’ve had a substantial impact, 
as much as fda officialdom wants to 
bad-mouth me,” he says. “I point to the 
evidence and I say, ‘Look, I’m almost 
always right.’ I don’t recklessly recom¬ 
mend the withdrawal of drugs.” 
He says he hopes to finish his 
career at the agency, even if more diffi¬ 
culty lies ahead. He has two sugges¬ 
tions for improving drug safety. First, 
the government should create a drug 
safety center parallel to the fda’s 
drug approval center. The new center 
would oversee postmarketing regula¬ 
tion and would be able to call on 
the fda commissioner to pull a drug 
it deems unsafe. Second, this center 
should be provided with enough 
money to do its job. (A bipartisan 
Senate bill co-sponsored by Democrat 
Christopher J. Dodd of Connecticut 
and Republican Charles E. Grassley of 
Iowa would do just that.) 
“I feel fairly certain that I’ve prob¬ 
ably saved more lives taking the career 
path I have taken than I would have 
with another career path,” Graham says. 
“That’s something that colleagues both 
within government and in academia 
remind me of periodically when I tell 
them of my tales of woe at the fda— 
they remind me that I’m doing good.” 
—John Dillon 
With an interest in the past, 
admissions dean doubles 
as a chronicler of local lore 
Two years after receiving his medical 
degree, Thomas L. Lentz, m.d. ’64, 
made the decision, along with his wife, 
Judith, to leave New Haven and move 
to the country. They found a pre- 
Revolutionary War house in Killing- 
worth, Conn., about 40 minutes from 
Lentz’s job as an instructor in anatomy 
at the School of Medicine. (When the 
medical school offered him a position 
he decided not to pursue a residency.) 
Soon everything started growing: 
the Lentz family, the size of their 
new home, the Ohio native’s involve¬ 
ment in his adopted community and 
his role at the School of Medicine, 
where he is now associate dean for 
admissions and financial aid and pro¬ 
fessor of cell biology. 
On moving day the Killingworth 
house was “livable,” but needy. “There 
was a lot of work to do,” said Lentz. “It 
never ends.” He painstakingly restored 
an antique barn that was reduced to its 
stone foundation. He and his wife 
bought surrounding parcels as they 
became available. Today their place in 
the country is an 80-acre spread that 
requires a great deal of landscaping 
work, though the five sheep they raise 
for wool keep the grass trimmed. 
Restoring a 1759 house piqued 
Lentz’s interest in Killingworth history. 
He was a founding member of the his¬ 
torical society and serves as historian 
of the Congregational Church in 
Killingworth. (He also is a member of 
the town’s land trust and an elected 
member of the planning and zoning 
commission.) In 1976 when the his- 
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torical society was raising funds to 
restore a 19th-century schoolhouse, 
Lentz assembled a pamphlet of old 
photographs from the town that sold 
for $5. This year a copy sold on eBay 
for $180. Clearly, there is a market for 
vintage Killingworth images. So in 
another attempt to enrich the historical 
society, Lentz wrote A Photographic 
History of Killingworth, a much more 
ambitious project. The softcover book 
features more than 200 photographs 
along with his narrative. 
Lentz said that he wrote the book 
“in his spare time,” a curious choice of 
words for a man with teaching respon¬ 
sibilities, his own research interests and 
a passionate commitment to selecting 
applicants who will be not only excep¬ 
tional physicians, but also leaders in 
their profession. “It never gets old and 
stale, because there’s always something 
new,” Lentz said of his interactions with 
students and applicants. “These kids are 
doing such amazing things that it’s 
really exciting to talk with them. I wish 
I could take them all.” 
The typical applicant has changed 
since Lentz began serving on the 
admissions committee in 1968. Today 
many arrive at the medical school 
with postcollege experience working in 
health care as well as authorship of 
one or more scientific articles. Lentz 
wondered whether the medical school 
would accept him today. 
“We went to college, we majored 
in biology, maybe we belonged to the 
premed club. We worked summers 
as an orderly in a hospital. We might 
have worked a semester in the lab,” 
Lentz said. 
Lentz is particularly suited to admis¬ 
sions as “one of the staunchest sup¬ 
porters of the Yale System,” said James 
D. Jamieson, m.d., ph.d., professor 
and past chair of cell biology. “It’s been 
a joy to work with him, because I’ve 
learned so much from him.” 
Jamieson is impressed with Lentz’s 
low-key style in the lab and classroom. 
With some students coming from 
humanities backgrounds, Lentz’s thor¬ 
ough, methodical teaching of histology 
leaves each student excellently pre¬ 
pared, said Jamieson. Lentz fine-tunes 
lectures he has given literally hundreds 
of times, added Jamieson, to incorpo¬ 
rate new information and increase 
his effectiveness. 
While Lentz’s students still spend 
time bent over traditional microscopes, 
his lab also uses a “virtual micro¬ 
scope”—high-resolution scans of slides 
that students can view and manipulate 
on computer screens. The new tech¬ 
nology makes it easier for students to 
work together and with faculty, as 
everyone is viewing the same image 
simultaneously. 
The soft-spoken professor is slow to 
speak about his own accomplishments 
but quick to talk about his department, 
which began as a section in 1973 under 
the leadership of Rockefeller Univer 
sity scientist George E. Palade, m.d., 
who would win a Nobel Prize two 
years later. In addition to pursuing his 
own research on primitive nervous 
systems, structure-function relation¬ 
ships of the nicotinic acetylcholine 
receptor and, more recently, the entry 
and transport of rabies virus in neu¬ 
rons, Lentz serves as the department’s 
historian—he stores departmental 
photographs and papers and wrote a 
history of cell biology at Yale for the 
department website. 
In the almost 40 years that Thomas Lentz has 
lived in Killingworth, he has restored an 18th- 
century house, helped found the town historical 
society and served on the land trust and 
planning and zoning commission. He recently 
published a softcover book with more than 
200 historical photographs of the town. 
The history of his department and 
of the School of Medicine itself is 
palpable in Lentz’s office. He rescued 
from the garbage the chair he offers 
to visitors. It belonged to Thomas R. 
Forbes, ph.d., who came to Yale in 
1945. Forbes eventually became the 
Ebenezer K. Hunt Professor of 
Anatomy and chaired the admissions 
committee throughout the 1950s and 
1960s. Lentz had sat in that chair for 
his own admissions interview. It gives 
him a good deal of pleasure to offer 
the chair to accomplished hopefuls 
today. “They inspire me,” he said. 
—Colleen Shaddox 
Familiar Faces 
Do you have a colleague who is making 
a difference in medicine or public 
health or has followed an unusual path 
since leaving Yale? We’d like to hear 
about alumni of the School of Medicine, 
School of Public Health, Physician 
Associate Program and the medical 
school’s doctoral, fellowship and 
residency programs. Drop us a line at 
ymm@yale.edu or write to Faces, 
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John Ferguson Howard Koh 
193QS 
John P. Ferguson, m.d. ’39, dropped 
us a note recently, recalling that 
he "won the Yale Golf Champion¬ 
ship in the year 1934-35. Now 
I’ve found out they don’t make 
the balls as good as they used 
to. They don’t go as far!” 
1960s 
John J. Schrogie, M.D. '60, vice 
president for periapproval and 
geriatric research studies at 
Omnicare Clinical Research in 
King of Prussia, Pa., has received 
the 2005 Henry W. Elliott Distin¬ 
guished Service Award from the 
American Society for Clinical 
Pharmacology and Therapeutics. 
Donald C. Skinner, M.D. ’64, 
received the 2005 Presidential 
Medallion in March from the 
University of Southern California 
(use), where he is professor and 
chair of the Catherine and Joseph 
Aresty Department of Urology 
and holds the Hanson-White 
Chair in Medical Research at the 
Keck School of Medicine of use. 
1970S 
C. Gene Cayten, M.D., M.P.H. '72, 
professor of surgery, community 
and preventive medicine at 
New York Medical College, has 
been appointed senior associ¬ 
ate dean of Our Lady of Mercy 
Medical Center in the Bronx. 
At the college he has served as 
director and senior advisor of 
the Institute forTrauma and 
Emergency Care and was pro¬ 
gram director of the college’s 
surgical residency programs 
at Our Lady of Mercy and 
Lincoln Hospital. 
Andrew Newman Patrick Charmel Jonathon Lewin Edward Tyau Michelle Dequina 
Howard K. Koh, m.d. ’77, has been 
named the first recipient of the 
Harvey V. Fineberg Professorship 
of Public Health at the Harvard 
School of Public Health. The 
chair honors a former dean of 
the school. Koh previously 
served as Massachusetts’com¬ 
missioner of public health. 
Pamela H. Nagami, M.D. ’76, of 
the Kaiser Permanente Wood¬ 
land Hills Medical Center, was 
one of 12 physicians to receive 
the Southern California Perma¬ 
nente Medical Group 2004 
Physicians’ Exceptional Contri¬ 
bution Award. The award recog¬ 
nizes physicians who have made 
noteworthy contributions to 
their communities. 
Andrew B. Newman, M.D. ’75, is 
the chair and managing director 
of the newly founded Ocean 
Medicine Foundation in Califor¬ 
nia. He will maintain his pul¬ 
monary practice and adjunct 
clinical faculty position at 
Stanford while working with 
the foundation to improve the 
health of people on islands by 
increasing the quality of island- 
based health care and ocean 
science and by preventing the 
global spread of epidemics. 
198OS 
Patrick A. Charmel, M.P.H. ’83, has 
been appointed to the National 
Advisory Council for Healthcare 
Research and Quality, which 
advises the U.S. Department of 
Health and Human Services 
and its Agency for Healthcare 
Research and Quality. Charmel 
is president and ceo of Griffin 
Hospital and its parent com¬ 
pany, Griffin Health Services 
Corp., in Derby, Conn. 
Jonathon S. Lewin, M.D. ’85, HS 
'86, a neuroradiologist with a 
research interest in MRi-guided 
interventional procedures, was 
named the Martin W. Donner 
Professor and director of the 
Department of Radiology at 
Johns Hopkins. He and his wife, 
Linda O. Lewin, m.d. ’87, and their 
children live in Baltimore, Md. 
James S. Marks, M.D., M.P.H. ’80, 
has been named senior vice 
president and director of the 
health group of the Robert 
Wood Johnson Foundation. He is 
the former acting director of the 
Coordinating Center for Health 
Information and Service at the 
Centers for Disease Control and 
Prevention. 
Edward S. Tyau, M.D. ’85, of the 
Kaiser Permanente Riverside 
Medical Center, was one of 
12 physicians to receive the South¬ 
ern California Permanente 
Medical Group 2004 Physicians’ 
Exceptional Contribution Award. 
The award recognizes physicians 
who have made noteworthy con¬ 
tributions to their communities. 
199OS 
Senda Benaissa, M.P.H. ’95, was 
married to Mario Hernandez in 
October. Benaissa is a research 
scientist at Gallaudet Research 
Institute and consultant at the 
World Bank in Washington, D.C., 
focusing on health care and 
international disability. 
Mark Coyle, pa ’96, and Stacey L. 
Frasca, pa, were married on Sep¬ 
tember 12. Both the bride and 
groom work as physician assis¬ 
tants at St. Vincent Hospital at 
Worcester (Mass.) Medical Center. 
Michelle P. Dequina, M.P.H. ’98, 
currently studying for her m.b.a. 
at Yale, and Neal K. Nakra, m.d., a 
fellow in pediatric pulmonology 
at Yale-New Haven Hospital, 
were married on January 14. 
Manendiu A. Ndoping, M.P.H. ’98, 
a manager at the Health Strat¬ 
egies Consultancy in Washington, 
D.C., and Reginald P. Bazile, a con¬ 
sultant in Washington, were 
married on December 30. 
Cynthia Carver Smith, M.P.H. '90, 
writes to say that she and her 
husband, Lt. Col. David B. Smith, 
usmc (Ret.), celebrated their 
fourth wedding anniversary last 
September. David is an IT 
executive for the Securities and 
Exchange Commission, and 
Cynthia owns a telecommunica¬ 
tions company in the Washing¬ 
ton, D.C., area. In 1999 Cynthia 
and David founded Cynthia’s Kids, 
a nonprofit devoted to the 
well-being of children, and they 
recently made a gift to Yale 
School of Medicine’s Department 
of Obstetrics, Gynecology and 
Reproductive Services in memory 
of their twins, Jack and Julia 
Smith. 
2000S 
Aviv Halpert, pa ’01, a pediatric 
physician assistant at Montefiore 
Medical Center in New York, was 
married to Jessica Pitt, a pediatric 
occupational therapist, on 
November 26,2003. 
SEND ALUMNI NEWS TO 
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in Memoriam 4/ 
Elisha Atkins, M.D., professor 
emeritus of medicine, died on 
April 22 at the age of 84 in 
Belmont, Mass. With Yale col¬ 
league Phyllis Bodel, m.d., Atkins 
demonstrated the close relation¬ 
ship between the induction 
of fever and the ability to resist 
infection, and was author of 
numerous research articles on 
fever and infection. At the School 
of Medicine, Atkins served on 
the admissions committee and 
for a year was acting associate 
dean. He also served as master 
of Saybrook College, one of 
Yale’s undergraduate residen¬ 
tial colleges. 
John E. Bowers, M.D. ’47, died on 
February 10 at the age of 80. 
Bowers was a lieutenant in the 
U.S. Navy during the Korean War 
and was the chief of staff at 
Plantation General Hospital in 
Plantation, Fla. 
Sonja M. Buckley, M.D., a Yale 
virologist who in 1969 helped to 
identify the deadly Lassa virus, 
which originated in Africa, died 
on February 2 in Baltimore at 
the age of 86. Buckley received 
her medical degree from the 
University of Zurich in 1944. After 
coming to the United States, 
she worked first as a research 
assistant at John Hopkins, then 
at the Sloan-Kettering Institute, 
where she became head of the 
solid tumor program in 1949. 
She began working on viruses 
at the Rockefeller Foundation in 
1957 and came to Yale in 1964. 
She retired in 1994. 
Marshall Edelson, m.d., ph.D., 
died at the age of 76 on January 
16 in Woodbridge, Conn. Edelson 
was a professor emeritus of psy¬ 
chiatry at the School of Medicine, 
where he taught for over 30 
years. He wrote nine books on 
topics ranging from group 
therapy to psychoanalytic theory 
and received many awards for 
his teaching and scholarship. 
Nicholas M. Greene, M.D., founder 
of the Department of Anes¬ 
thesiology at Yale, died in New 
Haven on December 28 at 
the age of 82. Greene, one of 
the founding fathers of modern 
anesthesiology, served as direc¬ 
tor and chair of the department 
for 18 years. He is credited with 
transforming the service at Yale 
from a technical subspecialty 
of surgery into a medical and 
academic discipline in its own 
right. He published several 
books and more than 200 arti¬ 
cles about education and the 
physiological changes associ¬ 
ated with anesthesia. In 2001 
the School of Medicine honored 
Greene with the establishment 
of the Nicholas M. Greene 
Professorship in Anesthesiology, 
an endowed chair. 
William E. Laupus, m.d. ’45, died 
on February 14. Laupus taught 
at New York Hospital before 
going into private practice in 
Detroit. He returned to teaching 
at the Medical College of 
Georgia, Augusta, as assistant 
professor of pediatrics, and then 
became chair of the department 
of pediatrics at the Medical 
College of Virginia in Richmond. 
As founding dean, he trans¬ 
formed the School of Medicine 
at East Carolina University, 
Greenville, N.C., into an accredited 
four-year program. 
James M. Malloy, M.P.H. ’67, died 
on January 27. After his gradu¬ 
ation Malloy worked for Yale 
University and then Waterbury 
Hospital. He also served as the 
ceo of three medical centers 
before moving to Jackson, Miss., 
where he founded one of the 
state’s first hmos. He subse¬ 
quently started a health care 
consulting practice. Malloy 
raised money for health care ini¬ 
tiatives serving underinsured 
communities in Mississippi, 
earning him the Distinguished 
Alumni Service Award from the 
School of Public Health in 2004. 
Yvedt L. Matory, M.D. ’81, died on 
April 15 in Needham, Mass., of 
complications from melanoma. 
She was 48. Matory was an asso¬ 
ciate surgeon in the Division of 
Surgical Oncology and co-chair 
of the Women’s Cancer Program 
at Brigham and Women’s 
Hospital in Boston. In 2000 she 
started HospitalCareOnline, a 
company that uses computers 
and remote monitoring to care 
for patients after their discharge 
from the hospital. 
Eric W. Mood, M.P.H. ’43, died on 
December 31. Mood was a vet¬ 
eran of World War II, who served 
in Italy and the South Pacific. He 
retired from the Army Reserve as 
a colonel. He worked as director 
of the Bureau of Environmental 
Sanitation for the New Haven 
Health Department before join¬ 
ing the Yale public health faculty 
as a lecturer. In the mid-1960s he 
developed the Division of Envi¬ 
ronmental Health and served as 
its director. His research focused 
on food sanitation, waste water 
treatment, swimming pool stan¬ 
dards, drinking water quality, air 
pollution and the health aspects 
of housing. 
Alvin Novick, m.d., professor of 
ecology and evolutionary 
biology, died in New Haven of 
prostate cancer on April 10 at 
the age of 79. After serving in 
World War II, during which he 
was a prisoner of war in 
Germany, Novick studied medi¬ 
cine at Harvard. He taught 
biology at Yale for 48 years and 
was a world-renowned expert 
on bat echolocation. Starting in 
1982, however, he turned his 
attention to the aids crisis. He 
was chair of the Mayor’s Task 
Force on aids in New Haven and 
a founder of aids Project New 
Haven and Leeway, Connecticut’s 
only nursing home for the treat¬ 
ment of people living with aids. 
George A. Silver, M.D., died on 
January 7 at the age of 91 in 
Chevy Chase, Md. A professor 
emeritus of public health at 
Yale, Silver served as deputy 
assistant secretary for health 
and scientific affairs at the U.S. 
Department of Health, Educa¬ 
tion and Welfare from 1965 until 
1968. He served in the Army 
Medical Corps in Europe during 
World War II, helping to liberate 
Dachau and other concentration 
camps. After the war, he was 
chief of the social medicine divi¬ 
sion at Montefiore Hospital in 
New York. He served on the 
World Health Organization’s 
expert committee on medical 
care and was secretary of the 
Federation of American 
Scientists’ national council. 
SEND OBITUARY NOTICES TO 
Claire M. Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
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Antibiotic-resistant ribosomes unmasked 
Five years ago, Yale scientists made a splash with the long- 
sought atomic structure of the large subunit of the ribosome, 
the protein-synthesizing factory of the cell and a target for 
many antibiotics (See "Yale Researchers Solve Structure of the 
Ribosome,” Fall 2000/ Winter 2001). It was the largest asym¬ 
metric structure to be solved up to that time, and the work, 
coming from the laboratories of Thomas A. Steitz, ph.d., 
Sterling Professor of Molecular Biophysics and Biochemistry 
and a Howard Hughes Medical Institute investigator, and Peter 
B. Moore, ph.d., Sterling Professor of Chemistry and professor 
of molecular biophysics and biochemistry, settled many long¬ 
standing questions about protein synthesis. 
This spring the Yale group offered a new collection 
of structures that explain how some bacteria escape the killing 
effects of some antibiotics. With antibiotic resistance threat¬ 
ening to undo years of progress against infectious disease, the 
work provides a road map to new antimicrobial drugs. 
Many commonly used antibiotics bind to the same 
large pocket in the bacterial ribosome and block its ability to 
synthesize proteins. In a study published in the April 22 issue 
of the journal Cell, Steitz and Moore investigated how azithro¬ 
mycin and four other antibiotics bind to the ribosome in 
drug-resistant and nonresistant bacteria. All are affected by 
the same crucial change in just one of the 3,000-plus rna 
nucleotides that make up the large subunit. 
“We found that mutations creating resistance result in 
the insertion of one extra polar bump into the drug binding 
site that pushes a bound drug a little further away from its 
preferred position than it would like to be,” said Moore. "The 
shape and charge complementarity go from nice to not quite 
so nice, and you go from sensitive to resistant because the 
amount of drug it now takes to inhibit these bacteria is more 
than patients can tolerate.” 
Knowing the problem suggests its solution—redesign 
antibiotics so they can fit around the bump. Now researchers 
can exploit structure-based drug design, a technique that has 
yielded successful treatments for aids and cancer. That effort 
will continue close to home, at Rib-X Pharmaceuticals, the 
New Haven startup that Steitz, Moore and several Yale col¬ 
leagues co-founded back in 2001, in the wake of solving their 




New Graduate Program in 
Medical Sociology 
“Yale University will start a new 
graduate program in medical soci¬ 
ology—the first of its kind in the 
nation to train students to apply 
the knowledge and techniques of 
sociology to the fields of medicine 
and public health.The new pro¬ 
gram will attempt to bridge the 
gap between medicine and sociol- 
ogy—between the doctor and 
the society which he serves. It will 
prepare students for teaching, 
research and administrative posi¬ 
tions involving the social aspects 
of health and medicine.... 
“The first year will be spent in 
courses designed to meet special 
interests and training needs. 
The student will study the appli¬ 
cation of medical knowledge to 
public health problems, as well as 
the relationship of public health 
to various sociological phenom¬ 
ena. Courses will be taken in both 
the Department of Sociology 
and the School of Medicine. The 
second year of the program will 
be devoted to a thesis in the field 




Match Day 1980 
"Match Day is the culmination of 
several months of planning, coun¬ 
seling, and decision making on 
the part of senior medical stu¬ 
dents, deans and faculty, as well 
as hospitals participating in the 
National Resident Matching Pro¬ 
gram (NRMP).The program was 
developed during the 1950s when 
there were more internship posi¬ 
tions available than there were 
medical school graduates to fill 
them. As a result, many hospitals 
were exerting pressure on stu¬ 
dents to sign contracts for their 
internships early in their senior 
year; some even pressed for deci¬ 
sions early in the sophomore or 
junior years. In 1953, after several 
attempts to establish an equitable 
system for internship appoint¬ 
ments, the basic rules of the exist¬ 
ing nrmp were set.... 
"This year, March 12 was Match 
Day. At Yale, of the 96 members 
of the Class of 1980, 42 students 
received appointments to the hos¬ 
pital of their first choice; 19 were 
appointed to the hospital they 
listed as second choice; and 10 to 
their third choice.” 
Stay connected 
Yale Medicine can help you stay connected with fellow alumni 
of the School of Medicine, School of Public Health, Physician 
Associate Program and the medical school’s doctoral, fellowship 
and residency training programs. Share your personal and pro¬ 
fessional news for publication in the Alumni Notes department 
of Yale Medicine and on the Web, using this card or the online 
form at info.med.yale.edu/ayam. 
□ _ 
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City, State, Zip 
Home telephone with area code 
Office telephone with area code 
Fax 
E-mail 








House Staff (hs) 
□ 
Other Yale degree(s) and year(s) 
Share your news on the reverse of this card and mail to: 
Claire M. Bessinger 
Yale Medicine Publications 
Yale University School of Medicine 
P.O. Box 7612 
New Haven, CT 06519-0612 
Please include a photograph. 

























































































































































































































































































AFTER 18 YEARS, A FAREWELL TO YALE 
Visitors to the Office of Alumni Affairs will still be able to help 
themselves to a donut or some candy from the ever-present 
dish by the door. But the cheery smile and boundless enthusiasm 
Sharon R. McManus brought to her job as director of alumni 
affairs, a post she assumed in 2000, will be absent. (Not to mention 
the Irish soda bread she brought each year on St. Patrick’s Day.) 
Alumni around the country got to know McManus during 
her frequent trips organizing receptions and meetings, as well 
as at the annual reunion where she was, as office administrator 
Patricia DiNatale said, the ’’ambassador of smiles.” In addition to 
planning and overseeing the annual reunion, McManus launched 
a Web-based program to enlist alumni as mentors for current 
students, especially during the residency application process. 
After 18 years at Yale, including 16 at the School of Medi¬ 
cine, McManus left in May to join the staff of the Nightingale- 
Bamford School, a K-12 school for girls in New York City. 
At a farewell party in early May, an ode to McManus writ¬ 
ten by a colleague recalled her “smiling face, that sweet Irish 
laughter... For all who visit alumni affairs, you’re engulfed with 
the feeling someone truly cares!” 
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